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Abstract           
Prostate cancer (PCa) is a unique and controversial disease.  This is at least due to the 
high prevalence of latent disease, increasing amounts of which is being diagnosed, 
most of which is indolent and not lead to death, and for which treatment carries 
significant risks. An increasing concern in medical sociology is how various social 
structures and actors contribute to the diagnosis and experience of conditions.  For 
PCa, these include print media as an information source for men with prostate cancer 
(MWPCa), and PCa organisations (PCaOrgs) which have recently emerged in the UK. 
Yet, there is a distinct lack of UK studies of print media representation of PCa, of 
PCaOrgs, interaction between the two, and how any of this may impact on the 
experience of MWPCa.  This thesis aims to address this deficit by drawing on narrative 
and framing theory to study 201 illness narratives of PCa across time:  140 illness 
narratives of MWPCa in UK newspapers 1990-2010; 20 with MWPCa interviewed in 
each of 2000 and 2010; and 21 with advocates around PCaOrgs in 2010.  I ask: how 
have PCaOrgs and the UK print media been a force for change in the UK regarding how 
PCa is addressed and experienced by MWPCa? And more broadly what does this say 
about narrative structure and form. My findings indicate that though PCaOrgs and 
print media told stories of injustice around PCa, the substantive focus of this injustice 
changed over time—from PCa as “neglected” and “taboo” in the 1990s to other 
“pockets of injustice” since 2000.  While one might expect that this to lessen any 
interactional difficulty that MWPCa experience in disclosing their illness, my study 
suggests this may not be so. My findings show how ideas of resonance and dissonance 
contribute to understanding the recursive and repetitive language around PCa. 
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 Introduction     Chapter 1
The prostate, a small gland near a man’s bladder with a role in producing semen, has 
been described both as ‘the breast that got lost’  (Kedrowski and Sarow, 2007: 135)  
and ‘the problematic third testicle’ (Oliffe, 2009: 33).  Like the breast and the testicle, 
the prostate does not just biologically ‘hang out’ somewhere but is rather embodied in 
a cultural, social and medical setting.  The cancer associated with the prostate, 
prostate cancer (PCa), is ‘a unique and controversial disease’ (Mazhar and Waxman, 
2002: 594) with it seeming that ‘everyone from the Lockerbie bomber to Adrian Mole 
(aged 39¼) has prostate cancer’ (Profumo and Dinneen, 2010: 730).  This controversy 
has its foundation in the ‘major discrepancy between the true prevalence of prostate 
cancer (PC), the incidence of diagnosed PC and PC specific mortality’ (Wolters et al., 
2012: 108).  What this means is that there is a high prevalence of latent PCa, an 
increasing amount of which is being diagnosed but of which a minority will cause 
mortality (Wolters et al., 2012: 109).  On top of this, PCa is also controversial because it 
is the only human cancer, that while curable, may not need to be cured and for which 
the ‘curing’ may cause significant risks of urinary incontinence and impotence (Parker, 
2004).  Further, despite PCa often having ‘a very indolent history’ (Parker, 2004: 102), 
there were 10,837 PCa deaths in 2012 (Cancer Research UK, 2013a).  Though deaths in 
men with non-lethal prostate tumours in the USA have been attributed in error to PCa, 
such error is thought to be less likely the case for the UK (Cancer Research UK, 2013a). 
I begin this chapter, and thesis, with an overview of PCa in terms of recent trends 
in its prevalence, testing and screening, symptoms, diagnosis, known risk factors, and 
management and forms of treatment as this provides more substance to this 
ostensibly controversial condition.  I continue by giving a brief indication of social 
actors and structures around PCa in the UK in order to define my research questions 
and aims.  Finally I give an overview of my study design, data collection and data 
analysis.  
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1.1 Overview of prostate cancer 
1.1.1 Morbidity and mortality trends 
Excluding non-melanoma skin cancer, PCa is the fourth most commonly diagnosed 
cancer in the UK (after lung, colorectal and breast cancers) (Cancer Research UK, 
2013b).  It is the most frequently diagnosed cancer among men in the UK with an 
estimated 41,000 new cases diagnosed in 2010 and 900,000 worldwide in 2008 
(Cancer Research UK, 2013c).  The latest 5 year average survival rates1 approach 82% 
(ranging from 92% in those aged 60-69 to 60% in those aged 80-99) (Cancer Research 
UK, 2013d).  An estimated prevalence of over 250,000 men living with PCa in the UK in 
2008 (Maddams et al., 2009) is predicted to more than treble to 830,000 
(approximately 2.3% of the male population) by 2040 (Maddams et al., 2012).   
These morbidity statistics indicate a huge increase in PCa incidence rates not 
reflected in mortality rates.  Oliffe and Thorne (2007: 149) propose the likelihood that 
PCa will become a chronic, long-term illness for many men in Australia and Canada, the 
geographical context of their study on PCa and masculinities.  This is because the 
proportion of elderly men in these countries is increasing and while PCa is the most 
commonly diagnosed male cancer, its mortality rate is significantly lower than its 
incidence rate.   Given the above statistics on the morbidity and mortality rates of PCa, 
this may also be true of PCa in the United Kingdom.  After lung cancer PCa is the 
second most common cause of cancer death in men in the UK accounting for 10,837 
deaths in 2012 (Cancer Research UK, 2013a).  Figure 1.12 shows the incidence rates in 
Great Britain (GB) alongside the mortality rates in the United Kingdom (UK) from 1975: 
 
 
 
                                                     
1 Gigerenzer and Wegwarth (2013) argue that survival rates can mislead and that mortality rates are 
better used to communicate the benefits of screening for 2 reasons: 1) lead time bias - earlier detection 
means the time of diagnosis is earlier which alone increases 5 year survival rates; 2) screening increases 
overdiagnosis which in turn increases survival rates 
2 I was advised, through personal email communication from the CRUK Statistical Information Team (23-
24 May 2012), to construct Figure 1.1 as a chart showing the incidence and mortality rates for PCa for 
GB alone 1975-2008 was no longer available on the CRUK website.  More details of this correspondence 
and the original chart is shown in Appendix 1. 
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Figure 1.1.  European age-standardised rates for incidence (GB) and 
mortality (UK) per 100,000 males, PCa, 1975-2010 
 
(Cancer Research UK, 2013a; 2013c) 
 
Figure 1.1 is very similar to a graph describing incidence and mortality rates in the USA 
(Welch et al., 2012: 57) which suggests that the area under the incidence curve 
represents a ‘tremendous amount of overdiagnosis’ (p. 57) in PCa.  Overdiagnosis is 
defined in the context of PCa as ‘the diagnosis in men who would not have clinical 
symptoms during their lifetime’  (Schroder et al., 2009: 1327) or the diagnosis of a 
cancer that would never have been diagnosed in the absence of screening (Godtman 
et al., 2013: 102).  More generally, Moynihan et al. (2012) note that: 
Narrowly defined, overdiagnosis occurs when people without symptoms are 
diagnosed with a disease that ultimately will not cause them to experience 
symptoms or early death. More broadly defined, overdiagnosis refers to the 
related problems of overmedicalisation and subsequent overtreatment, 
diagnosis creep, shifting thresholds, and disease mongering, all processes 
helping to reclassify healthy people with mild problems or at low risk as sick. 
(Moynihan et al., 2012: 19) 
Moynihan et al. (2012) go on to summarise four non-mutually exclusive contributory 
factors to overdiagnosis.  These include overdiagnosis from ever widening disease 
definitions; screening detected overdiagnosis in people without symptoms; and the 
use of increasingly sensitive tests in those with symptoms.   
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1.1.2 Testing and screening 
Much of the increase in incidence is attributed to the PSA test.  Men with prostatic 
diseases, including PCa and benign prostatic hyperplasia (BPH), may have higher PSA 
levels both because of increased production of PSA and also distortions in the gland 
which allow PSA greater access to the circulation (Barry, 2001).  In this way PSA is 
understood as a useful, though limited and controversial, biomarker for PCa (see 
Andriole et al., 2009; Barry, 2009; Collin et al., 2009; Schroder et al., 2009).  
The effect of PSA testing on PCa related mortality remains unclear. The results 
from the European Randomized Study of Screening for Prostate Cancer (ERSPC) show a 
reduction in the rate of death from PCa in the screening group compared to the 
control group of 20% and absolute risk difference of 0.71 per 1000 men (Schroder et 
al., 2009).  This conflicts with results, published in the same issue of The New England 
Journal of Medicine, from the United States Prostate, Lung, Colorectal and Ovarian 
(PLCO) Cancer Screening Trial which shows no mortality gain (Andriole et al., 2009).  An 
updated Cochrane review (Ilic et al., 2011) concludes from a meta-analysis of five 
randomised controlled trials (including ERSPC and PLCO) that PSA screening does not 
significantly reduce PCa mortality between men randomised to screening and control.  
Further, PCa specific mortality is not affected when men of different ages are screened 
and the number of men diagnosed with PCa is significantly higher in those randomised 
to screening rather than to control.  The review also identifies harms of high rates of 
false-positive PSA results, overdiagnosis and adverse events associated with biopsies. 
The mortality benefit found by Schroder et al. (2009) indicates a high risk of 
overdiagnosis with 1410 men needing to be screened and 48 treated to save one death 
from PCa.  This leads to overtreatment which these authors identify as ‘one of the 
major potential drawbacks of PSA screening’ (2009: 106).  Another drawback, 
‘compounded by messages (in the media and elsewhere)’ (Welch and Black, 2010: 611) 
is the ‘popularity paradox of screening: the more overdiagnosis that screening causes, 
the more people will feel they owe their lives to screening, and the more popular it will 
become’ (Welch et al., 2012: 187).  Writing in the New York Times (NYT), the man who 
discovered PSA in 1970 now says it is a ‘hugely expensive public health disaster’ (Ablin, 
2010) and, referring to the ERSPC results (Schroder et al., 2009), ‘that’s 47 men who, in 
all likelihood, can no longer function sexually or stay out of the bathroom for long’ 
17 
 
(Ablin, 2010).  That Ablin has been told both to ‘“shut up and sit down”’ (Hawkes, 
2010: 340) and that his was ‘the number one requested article’ (p. 340) in the NYT 
indicates why this is ‘amongst the most debated topics in contemporary health care’ 
(Lane et al., 2010: 3095).   
 Adding to this debate, the diagnostic testing for PCa of men presenting with 
lower urinary tract symptoms (LUTS) or sexual dysfunction, or asymptomatic men 
‘getting to be that age’ and opportunistically tested by their GP, is also described as de 
facto screening (Little et al., 2003; Collin et al., 2009; Drummond et al., 2009) or 
screening creeping in by the back door (Donovan et al., 2001).  Currently, there is no 
known benefit of screening for PCa by PSA testing, digital rectal examination or any 
other method (Andriole et al., 2009). This has had direct implications in the decision, 
so far, by the UK National Screening Committee (NSC) not to recommend a systematic  
screening  programme for PCa as ‘harms from prostate cancer screening using PSA are 
currently likely to outweigh the benefits’ (Mackie, 2010: 13).  The Prostate Cancer Risk 
Management Programme (PCRMP), an NHS ‘informed choice programme’, currently 
stands in place of a national screening programme (Burford et al., 2010).  There is 
though widespread agreement that national screening programmes are introduced 
due more to social movement advocacy than to clinical or epidemiological evidence 
(Brown et al., 2004; Jutel, 2009; Armstrong and Eborall, 2012; Faulkner, 2012; Welch et 
al., 2012).   
1.1.3 Symptoms 
A ‘symptom’ is not only ‘a bodily or mental phenomenon, circumstance, or change of 
condition arising from and accompanying a disease or infection and constituting an 
indication or evidence of it’ (Hsiao et al., 2007: E21) but is also considered as side-
effects of treatment (p. E21.).  The literature around symptoms of PCa is both scarce 
and ambiguous; scarce regarding the illness experience of men prior to diagnosis of 
PCa (see below for some exceptions) and ambiguous in the informing of those 
concerned with diagnosing PCa (Collin et al., 2008; Ito et al., 2013; Silberstein and 
Eastham, 2013; Weight, 2013; Weight et al., 2013).   
The scarcity of the former is relieved somewhat by the incidental discussion of 
symptoms in research concerned with other aspects of the PCa illness experience, for 
example, treatment, testing or screening, or masculinity.  A study of men with LUTS 
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without PCa reports that most of the men qualitatively interviewed, independent of 
race, social class or symptom severity, express a fear of PCa on presentation of LUTS 
(Brown et al., 2003).  Zeliadt et al. (2008) report men not taking into account pre-
diagnosis urinary symptoms when making decisions for surgical or non-surgical 
treatment for PCa.  Chapple et al. (2002),1 interviewing 52 men with prostate cancer 
(MWPCA), incidentally note that three quarters of these men consult their GP because 
of urinary symptoms. 
The ambiguity of informing those concerned with diagnosing PCa is at least 
partly due to the long-standing debate and uncertainty regarding the association 
between BPH, LUTS and PCa (Weight, 2013) and also inconsistent evidence around 
sexual dysfunction and PCa.  While PCa causes cells in the prostate to form tumours 
which may change the shape of the prostate gland, as men age their prostates may 
also enlarge causing BPH.  If either a benign or cancerous prostate growth is large 
enough to press on the urethra it may cause symptoms of increased frequency, 
urgency or difficulty in passing urine; passing urine more often than usual especially at 
night; pain on passing urine; and blood in the urine or semen (Cancer Research UK, 
2013e).  The latter two symptoms are ‘very rare’ (Cancer Research UK, 2013e) in PCa 
and ‘very early prostate cancer generally does not cause any symptoms at all’ (Cancer 
Research UK, 2013e) (see forthcoming discussion of ‘early’ versus ‘local’ PCa §1.1.4).  
Symptoms of PCa which has spread may include pain in the hips, back, pelvis or other 
bony areas (Cancer Research UK, 2013e).    
The sheer number of men who experience problematic voiding as they age 
means that LUTS are present in more than 50% of men aged over 60 and nearly 100% 
of men aged 90 (Weight, 2013).  Men presenting with LUTS often, at their own or 
doctor’s behest, have a PSA test or other PCa diagnostic tests and may be diagnosed 
with a low risk PCa (Collin et al., 2008; Ito et al., 2013; Silberstein and Eastham, 2013; 
Weight, 2013).  Weight et al. (2013)  find that men treated for their LUTS are not only 
more likely to be tested for PCa but also diagnosed with its localised form than men 
not treated for LUTS.  However, they are no more likely to die from PCa or to be 
diagnosed with intermediate or high-risk cancer.  The key, and controversial, issue 
Weight et al. (2013) highlight is whether men presenting with LUTS should be screened 
                                                     
1 20 of these men were matched along significant variables with 20 MWPCA for the purpose of this 
thesis 
19 
 
for PCa.  They lament that their own and other extant data do not address this and it 
remains unclear whether the benefits of diagnosing these additional men with early 
PCa outweigh the associated harms. 
Collin et al. report from two studies nested in the UK based ‘Prostate testing for 
cancer and Treatment’ (ProtecT) trial on the association between LUTS (2008) and 
sexual dysfunction (2009) with PCa.  In the trial, men were invited to attend a prostate 
check and a PSA test with information collected before diagnosis on LUTS (specifically 
daytime and night-time frequency in urinating and urgency and hesitation) and sexual 
dysfunction (specifically erectile and ejaculatory dysfunction and sexual activity).  
Those with a PSA level ≥ 3.0 were invited to repeat the test, have a digital rectal 
examination (DRE) and a ten-core biopsy.   
First, Collin et al. (2008) correct widespread misconceptions that the presence of 
LUTS means increased risk of PCa and that the lack of such symptoms indicates no 
cancer.  The authors report: 1) a positive association between LUTS and a raised PSA 
among otherwise asymptomatic men; 2) that the lack of LUTS among men who have a 
raised PSA level indicates increased risk for PCa (see also the Ito et al., 2013 study on 
Japanese men); and 3) associations of LUTS with PCa did not differ between local or 
advanced disease.  Their take-home message is that LUTS are more likely to be caused 
by benign rather than malignant prostate disease.   
Second, Collin et al. (2009) investigate the inconsistent evidence around the 
association between sexual dysfunction and PCa.  They suggest that evidence 
indicating the association of impotence with clinically detected PCa is likely to be 
biased given that men with impotence are more likely to present to their GP and 
undergo a PSA test and have PCa clinically detected.   The authors suggest that such 
testing, controversially, equates to screening men with such symptoms.  Also, they 
note that studies indicating that men diagnosed with PCa have more symptoms of 
sexual dysfunction may too be biased in that such a diagnosis is likely to have a 
psychological effect on their sexual function.  From their own study they find only 
weak evidence for associations between sexual dysfunction and PSA detected PCa 
among British men aged 50-69.  Furthermore, this weak association is found only in 
advanced PCa and not that localised to the prostate.  They also report a positive 
correlation between LUTS and sexual dysfunction.  Their take-home message here is 
that unlike LUTS, where the lack of such symptoms does indicate greater risk of PCa 
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and is thus of clinical utility in predicting individual risk of prostate cancer, the 
presence or lack of symptoms of sexual dysfunction does not provide such utility.   
1.1.4 Diagnosis 
The National Institute for Health and Clinical Excellence (NICE, 2008: 5) identifies three 
stages of cancer spread and growth: 1) localised PCa: cancer that is only in the prostate 
and has not spread; 2) locally advanced PCa: cancer that is in the prostate and has 
spread to surrounding tissues; and 3) metastatic (or advanced) PCa: cancer that is in 
the prostate and has spread to the lymph nodes, bones or other parts of the body.  
While NICE uses the more appropriate terminology of ‘local’ PCa, ‘early’ is still 
ubiquitous in the literature and on cancer websites.  The Prostate Cancer Risk 
Management Programme (PCRMP) is ambiguous in its use of both ‘early’ and ‘local’, 
with its first use of early being in scare quotes (Burford et al., 2010: 8)1.  Writing about 
PCa but making a general observation, Faulkner notes that ‘early’ ‘conveys an 
impression that there will be ‘later’ development of cancer associated with its initial 
detection’ (2012: 11-12)2. This ‘impression’ is in line with common sense notions that 
finding things early is valuable as it gives the opportunity to fix small problems before 
they become big (Welch et al., 2012).  However, being recruited into a disease state 
‘earlier’ is a form of ‘diagnosis creep’ (Aronowitz, 2009: 426) ‘or leap’ (Payer, 1992: 11) 
and potentially ‘medicalising the previously healthy’ (Aronowitz, 2009: 426). 
Scholars concerned with the diagnosis and naming of a disease (Brown, 1990; 
Rosenberg, 1992; Chiong, 2004; Jutel, 2009) suggest that naming a disease ‘does’ 
work, for example in providing  relief and conferring social legitimacy or collective 
identity to those ill (Chiong, 2004; Jutel, 2009). Rosenberg suggests that naming 
diseases involves a ‘generation-specific repertoire of verbal constructs reflecting 
medicine’s intellectual and institutional history’ (1992: xiii) and so medicine’s 
diagnoses may be understood as temporally situated according to the technologies 
and values available at a point in time (Jutel, 2009; see also Faulkner, 2012).   
 
 
                                                     
1 My attention was drawn to this through personal correspondence with Alex Faulkner (24 April 2013) 
2 Also making this point is Jenny Donovan (personal correspondence 13 May 2013) who says she “should  
have” pursued ‘the ‘early’ issue in published form” 
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1.1.5 Risk 
There are three established risk factors for PCa: age; family history; and ethnicity 
(Cancer Research UK, 2013f).  Other potential risk factors include the link between 
insulin-like growth factor-1 and related proteins with early life exposures that 
influence adult height (Lane et al., 2010; Cancer Research UK, 2013f); men with a 
previous cancer morbidity; and exposure to radiation (Cancer Research UK, 2013f).  
Factors known to decrease risk of PCa include diabetes (Lane et al., 2010; Cancer 
Research UK, 2013f); vitamins A, D, and E (found in foods containing lycopene, soy and 
selenium) (Cancer Research UK, 2013f); and the drugs warfarin and acetaminophen 
(Cancer Research UK, 2013f).  While there is little literature around socio-economic 
deprivation and risk for PCa, McVey et al. (2010) observe a statistically significant 
difference between the most socio-economically deprived and the most affluent with 
those on low income more likely to choose watchful waiting as treatment for localised 
PCa.  They suggest that such men may opt for this treatment because of the economic 
costs associated with treatment such as time off work and transport costs.   
1.1.5.1 Age risk 
There are two evident aspects of the risk of PCa around age.  First, as men get older 
they are more likely to be diagnosed with PCa (Cancer Research UK, 2013c).  Rates 
have continued to rise for men aged 45-54, 55-64 and 65-74 and decline for those aged 
75-84  from the early 2000s and those aged 85+ from the mid-1990s.  This may be due 
to diagnosis of early prostate cancers in younger men through PSA testing, leaving 
increasingly fewer cases which have not yet been diagnosed by the time men reach 
their 70s and 80s (Cancer Research UK, 2013c).   
The second source of evidence for considering age risk and PCa is post-mortem 
data.  Table 1.1 shows that approximately half of all men in their fifties have 
histological evidence of cancer in the prostate, which rises to 80% by age 80, but that 
only 3.8% of men will die from PCa (Sakr et al., 1996; as cited in Burford et al., 2010) 
(see also National Institute for Health and Clinical Excellence, 2008).  
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Table 1.1. Presence of PCa determined at autopsy  
Age 20-29 30-39 40-49 50-59 60-69 70-79 
Percentage of men in whom PCa was 
detected at autopsy 
8 28 39 53 66 80 
reproduced from Table 1 PRCMP (Burford et al. 2010: 10) originally sourced from Sakr et al. (1996) 
 
Table 1.1 also shows unexpected information which is confirmed by more recent 
autopsy studies seeking to identify the presence of unsuspected PCa in men who died 
from other unrelated causes (Powell et al., 2010; Soos et al., 2005).  Soos et al. show ‘a 
surprisingly high prevalence of premalignant (HGPIN) and maligant [sic] disease in 
young men, starting in the third and fourth decades of life, and increasing steadily 
thereafter’ (2005: 739) and Powell et al. that sub-clinical PCa starts ‘as early as ages 20 
to 29 years’ (Powell et al., 2010: 1793) in both black and white men.  Similarly, Wolters 
et al. (2012: 109) draw attention to the high rates of incidentally detected PCa through 
radical cystoprostatectomy of patients treated for bladder cancer and who had no 
prior evidence of PCa.  While such information may be important for the early 
detection of PCa, it also has implications for screening asymptomatic men as this 
would substantially increase the chance of detecting non-clinically relevant PCas and 
inducing overtreatment (Wolters et al., 2012).   
1.1.5.2 Family history 
There is a large body of evidence indicating that men with a family history of PCa, or 
other cancers, are at increased risk themselves (Hemminki and Chen, 2005; Kicinski et 
al., 2011; Madersbacher et al., 2010).  This risk is impacted further by the relatedness 
of the family member, the age of the MWPCA at diagnosis and the total number of 
family members affected (Madersbacher et al., 2010).  Of note is that ‘family history’ 
does not necessarily imply a genetic or hereditary link but rather recognises the 
complex mix of environmental and genetic factors in an aggregation of cases within a 
family (Madersbacher et al., 2010).   The PCa incidence rate for men whose fathers or 
brothers have PCa is 3.14 times and 2.35 times higher respectively than in other men 
with risk increasing if both father and brother have PCa and also if men are under 65  
(Kicinski et al., 2011). There is also tentative evidence that risk increases somewhat for 
men with an affected second-degree relative.  Further, a Swedish study finds that sons 
23 
 
with mothers diagnosed with breast or ovarian cancer have an increased risk of PCa 
(Hemminki and Chen, 2005). 
1.1.5.3 Ethnicity 
Incidence rates of PCa are lower for Caribbean and African men than for African-
Americans and the latter have a 55% greater incidence than white Americans (Ben-
Shlomo et al., 2008).  The primary research of Ben-Shlomo et al.’s study shows that 
while the absolute risk for first generation all black, black African and black Caribbean 
men in the United Kingdom is less than for African-Americans, they still have an 
approximately three-fold greater risk of developing PCa than white men in the UK.  
This is more apparent for younger men.  Kheirandish and Chinegwundoh (2011), in 
their study of incidence rates and presenting features among African-Caribbean, 
South-Asian and European men aged over fifty in North-east London, show that 
African-Caribbean men have three times greater risk of PCa than European men and 
that South-Asian men have the lowest incidence rates.  A number of tentative 
explanations for this are suggested combining both environmental and genetic factors. 
1.1.6 Management and forms of treatment  
PCa is ‘the only human cancer that is curable but which commonly does not need to be 
cured’ (Parker, 2004: 101) and for which the ‘curing’ causes ‘significant risks of urinary 
incontinence and impotence’ (p. 101).  Localised PCa is classified into risk groups 
defined by PSA level, biopsy Gleason score, and clinical T stage.  Patients with low-risk 
localised disease face particularly difficult treatment choices which rest as much on 
opinion as on evidence (McVey et al., 2010). This is because the natural history of low 
risk localised PCa is not known, without any completed randomised controlled trials.  A 
number of factors are considered when deciding on treatment for PCa.  These include 
age and general health and how far the cancer has grown and spread (CRUK 2013d).   
The NICE (2008) guidelines indicate that potential treatments include: 
• Watchful waiting: treatment is offered only when symptoms develop.  
• Active surveillance: regular testing, with treatment only if and when necessary. 
• Radical prostatectomy: surgery to remove the prostate. 
• Radical external beam radiotherapy: radiation treatment directed at the prostate 
from outside the body to destroy cancer cells. 
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• Brachytherapy: radiotherapy treatment directed at the cancer from within the 
prostate. A substance that gives off radiation is placed in the prostate and the 
radiation destroys cancer cells. 
• Hormonal therapy: medicines that reduce the production or block the effects of 
hormones which cause the cancer cells to grow. 
• Orchidectomy: removal of the part of the testicles that produces the hormone 
testosterone which helps the cancer cells to grow. 
• Chemotherapy: treatment with drugs to destroy cancer cells.  
• Palliative care: aims to relieve the symptoms of cancer. This includes treatments 
for pain relief and practical support 
(National Institute for Health and Clinical Excellence, 2008: 6) 
 
In sum then, there are particular features of PCa which constitute it as a controversial 
condition.  Autopsy studies show the prevalence of PCa in very young men (Soos et al. 
2005; Powell et al. 2010) and other sources of high rates of incidentally detected PCa 
suggest that as PCa is now being looked for harder than ever before (Welch et al. 
2012), it is likely to become an increasingly found and diagnosed disease. Given the 
high proportion of PCa that is indolent, the challenge facing practitioners is to 
distinguish men with ‘clinically relevant cancers from those whose “disease” is 
destined merely to be an incidental histological event’ (Parker, 2004: 101). While there 
is a common sense notion that finding things early is valuable (Welch et al., 2012), 
being recruited into a disease state ‘earlier’ is a form of ‘diagnosis creep’ (Aronowitz, 
2009: 426).  Such diagnosis creep potentially increases the chance of detecting non-
clinically relevant PCas and inducing overtreatment (Wolters et al., 2012).  
Overtreatment would be of less importance, and controversy, if treatment had no 
morbidity, but this is not the case—radical treatment for PCa with its side effects of 
urinary incontinence and impotence can seriously impact a man’s lifestyle (Parker, 
2004: 102-3).  Also, much of the increase in incidence of diagnosed PCa is attributed to 
a test which measures the blood level of prostate specific antigen (PSA), a glycoprotein 
produced almost exclusively by the prostate gland (Barry, 2001; Maddams et al., 2009; 
Maddams et al., 2012; Cancer Research UK, 2013c).  The effect of PSA testing on PCa 
related mortality is unclear (Andriole et al. 2009; Schroeder et al. 2009), yet it is used 
as a de facto screening mechanism (Little et al., 2003; Collin et al., 2009; Drummond et 
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al., 2009).  Additionally, there are misconceptions over whether symptoms of 
incontinence and impotence, common as men age, indicate an increased risk of PCa 
and whether their lack indicates no cancer (see for example Colin et al. 2008, 2009; 
Weight, 2013).  Related to this is the question as to whether men presenting with 
lower urinary tract symptoms (LUTS) should be defacto screened for PCa (Weight et al. 
2013).   
1.2 Social actors and structures around PCa  
Controversial illnesses have proved fruitful ground for conceptualising a ‘social 
diagnosis’ (Brown et al., 2011)—that which considers the variety of social structures 
and actors which might contribute to a diagnosis.  In the UK, in the past twenty years 
the public visibility of PCa has increased as PCa organisations (PCaOrgs) have emerged 
to promote awareness of the condition and lobby for funding of services and research. 
The Prostate Cancer Research Foundation (PCRF) and The Prostate Cancer Charity 
(TPCC), for example, were established in 1993 and 1996 respectively1.    In recent years 
sociologists have become attentive to the impact of social movements around health 
on the experience of illness.  Health social movements (HSMs) (Brown et al., 2004), or 
‘disease-related social movements’ (Kedrowski and Sarow, 2007), are generally 
considered a major force for change in society at large regarding the way health issues 
are addressed and date back at least to concerns around occupational health during 
the Industrial Revolution (Brown et al., 2004; Kedrowski and Sarow, 2004).  
Contemporary scholarship pays attention to conditions such as Alzheimer’s Disease 
(Beard, 2004), HIV/AIDS (Spangler, 2000) breast cancer (Halebsky-Dimock, 2004; 
Klawiter, 2004; Kolker, 2004; Kedrowski and Sarow, 2007; Sulik, 2011), and mental 
health (Crossley and Crossley, 2001).  Little attention though has been paid to PCa with 
research to date tending to focus not only on the USA but also comparing PCa with 
other illnesses—with breast cancer (Halebsky-Dimock, 2004; Kedrowski and Sarow, 
2007) or with both HIV/AIDS and breast cancer (Spangler, 2000).  Moreover, these 
                                                     
1 In March 2011 the PCRF merged with Prostate UK to form Prostate Action.  In June 2012 TPCC 
rebranded as Prostate Cancer UK and on 22 August 2012 it merged with the aforementioned Prostate 
Action because “by working together we can only be stronger, forming one unified force in the fight 
against prostate cancer and prostate disease.  Speaking with a direct, singular voice we will be able to 
better achieve our aim of giving men's health the prominence it needs and address the legacy of neglect 
which surrounds prostate cancer” (http://prostatecanceruk.org/news/merger accessed 19/03/2013)  
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studies tend to highlight the lack of achievement of the potential PCa HSM when 
compared with other HSMs, concluding in part, for example, that the breast cancer 
movement benefitted from the experience and mobilisation of pre-existing networks 
of grassroots activists that had arisen in the context of the women’s movement of the 
1970s (Halebsky-Dimock, 2004; Kedrowski and Sarow, 2007).   
PCaOrgs may then constitute part of the ‘social diagnosis’ (Brown et al., 2011) of 
PCa.  Another social actant which may contribute to the diagnosis of PCa is print 
media. Print media is among the most relied on of sources of information regarding 
disease, illness, death and medicine for people in general (Clarke, 2004), and men with 
prostate cancer (MWPCa) in particular (Halpin et al., 2009). Yet, there are relatively 
few studies of print media representation of PCa (Halpin et al. 2009).  Clarke’s (1999; 
2004) studies of PCa in contemporary ‘mass print media’ (1999: 58; 2004: 541), rather 
than considering print newspaper media, are instead limited to English language 
magazines in the United States and Canada from 1974-1995 (Clarke, 1999) and in 
Canada from 1996-2001 (Clarke, 2004).  MacKenzie et al. (2007) analyse 
representations of PCa in Australian newspaper media and Halpin et al. (2009) do so in 
Canada.  There are no studies of representation of PCa in the UK print media and 
consequentially none which compare how representation may have changed since the 
emergence of PCaOrgs into the UK in the mid-1990s.   
1.3 Research questions and aims 
PCa is the research ‘flagship of men’s cancer’ (Wenger and Oliffe, 2013) and as such 
there are many studies describing various aspects of the experience of MWPCa (for 
example see Gray et al. 2000; Chapple and Ziebland, 2002; Oliffe, 2009; Broom, 2010; 
Mróz e al. 2013; Grunfeld et al., 2013).  If, however, HSMs are a major force for change 
in a society regarding how health issues are addressed, the emergence of a potential 
PCa HSM in the mid-1990s may be relevant in the social diagnosis of this condition and 
may impact on the experience of MWPCa.  Likewise, changes in the representation of 
PCa in the UK print media since the emergence of PCaOrgs may also impact on the 
experience of MWPCa. As yet though, there is a distinct lack of UK studies of print 
media representation of PCa, of HSM activity around PCa, the interaction between the 
two, and how any of this may impact on the experience of MWPCa. 
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 Therefore, in this thesis I ask: how have PCaOrgs and the UK print media been a 
force for change in the UK regarding how PCa has been addressed and experienced by 
MWPCa?  In answering this question I aim to investigate: 1) how key individuals within 
PCaOrgs describe how they have sought to address the condition of PCa; 2) the 
changes in how MWPCa describe their illness experience in research interviews over 
this time; and 3) the changes in how the UK national print media have represented the 
illness experience of MWPCa since the emergence of PCaOrgs in the UK in the mid-
1990s. 
1.4 Study design 
Benford and Snow suggest that ‘the very existence of a social movement indicates 
differences within a society regarding the meaning of some aspect of reality’ (2000: 
626).  Whatever else HSMs do, they are likely to engage in work to affect 
interpretations of reality (Benford, 1997). The concept of framing is set forth as a way 
of understanding the complexities in how individuals and collectives interpret their 
world (Goffman, 1974; Entman, 1993).  It is one of the foremost conceptual tools for 
understanding how social movement actors actively maintain, extend, transform or 
generate meaning to their attentive and bystander audiences (Snow and Benford, 
1992); likewise it is used for understanding how the media produce meaning for their 
audience (Kitzinger, 2000; Brown et al., 2001; Philo, 2008).  ‘Frames matter’,  Polletta 
and Ho (2006: 203) insist, and so ‘framing’ theory offers a useful starting point for 
investigating how the media and actors around a potential PCa HSM may seek to 
produce or transform messages around aspects of PCa.   
However, Polletta and Ho continue, ‘the devil for social movement scholars is in 
showing how and when and how much [frames] matter’ (2006: 203).  In his study of 
how narratives justify military action, Smith (2005) suggests that understanding 
meaning through ‘framing’ has only ‘nuisance value’ and that the ‘fragmentary nature 
of frame analysis permits only guerrilla warfare against the dominant paradigm. For 
cultural explanation to have an impact, what is required is some heavy artillery, not yet 
more scattered sniping’ (p. 9).  By this he means that it is structures within narrative 
which ‘are pivotal as the bearers of meaning’ (p. 14) and which make action ‘legitimate 
and thinkable’ (p. 3). The tendency of people to tell stories about themselves or others 
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is universal (Bury, 2001).  Although not denying the possibility that these stories may 
indeed be ‘very much their own, (…) [people] do not make up these stories by 
themselves’ (Frank, 2010: 14).  The close analysis of stories allows examination of the 
connections between biography and culture (Riessman, 2008) and what Giddens’s 
(1984) theory of structuration indicates as the recursive and repetitive nature of social 
practices common to both individual actors and social structures across space and 
time.   
 The method I used to answer the above research questions and address the 
research aims was to collect and analyse a variety of narratives—illness narratives 
which vary across time and type.  First, I used qualitative open-ended interviews to 
understand how advocates around PCaOrgs narrated stories about PCa and sought to 
interpret this condition to attentive and bystander audiences since the emergence of 
these organisations in the mid-1990s.  Second, I used qualitative open-ended 
interviews to understand how MWPCa narrated their illness experiences in primary 
research carried out in 2010-2011.  I also, through my collaboration with the Health 
Experiences Research Group (HERG)1 at Oxford University responsible for 
www.healthtalk.org, analysed illness narratives of MWPCa interviewed in 2000.  This 
allowed me to compare how MWPCa narrated their illness experience in a 
contemporary setting with how they did so in a historical setting close to the advent of 
PCaOrgs into the UK. Third, I sampled the UK national print media for illness narratives 
of MWPCa 1990-2000 and 2000-2010.  This corresponded to the two 10 year periods 
prior to each set of illness narrative interviews with MWPCa in 2000 and 2010.   
1.5 Data collection 
Access negotiations with the key advocates around PCaOrgs began in mid-October 
2010 with the first interview in mid-November 2010 and the last in mid-April 2011.  My 
access to my first participant was prompted by an opinion piece this participant had 
written about PCa in several prominent newspapers.  Another initial contact was with 
a lobbyist who worked on behalf of a PCaOrg.  I then ‘snowballed’ (Biernacki and 
                                                     
1 HERG is formerly the DIPEx (Database of Individual Patient Experience) and www.healthtalk.org 
(formerly www.healthtalkonline.org) is its award winning website.  Along with its sister website 
youthhealthtalk it allows public access to over 2000 people’s experiences of more than 60 health related 
illnesses and conditions 
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Waldorf, 1981) these participants by asking them to tell me of others whom they 
thought suitable to participate in my research and they each indicated several, 
sometimes mutual, potential people to contact. There were 21 participants recruited 
for this part of the research.  These included 12 participants from five PCaOrgs; seven 
medical professionals who were influential in PCa awareness and often were also 
involved in PCaOrgs; and two public commentators/consultants around PCa. 
The recruitment strategy for the interviews with MWPCa  carried out in 2010 was 
adapted from that of the original HERG interviews in 2000 (Chapple and Ziebland, 
2002).  Access to these participants began in early May 2010 by first identifying 
specialist nurse gatekeepers at both Barts and The London and Belfast City hospitals 
and also a gatekeeper at a London PCaOrg. These gatekeepers acted as participant 
identification centres and distributed participant information packs to MWPCa 
attending the hospital or involved in the PCaOrg.  Men were invited to return a reply 
slip for me to subsequently contact them. Though I interviewed 21 MWPCa for this 
part of my research one man later asked to be withdrawn.  I then matched the 
remaining 20 MWPCa illness narratives along significant variables—age at 
diagnosis/age at interview and socio-economic status—with 20 illness narratives with 
MWPCa carried out around 2000 with HERG. 
I used Nexis UK, a commercially available on-line database of newspaper articles 
to sample the media illness narratives.  I retrieved all articles appearing in the English 
language UK national press from 01/06/1990 to 31/05/2010 (which were to at least 
some extent uploaded to Nexis 01/06/1990-31/05/1995 and fully uploaded thereafter) 
containing three or more mentions of the words ‘prostate cancer’ or ‘cancer of the 
prostate’ or ‘prostatic cancer’—or various misspellings.  This process led to a total of 
306 articles which were then examined, using Hyden’s (1997) typology, to determine 
which could be categorised as an ‘illness narrative’.  For the article to be included in 
the sample, I required it to predominantly (50% or more of its word content) depict 
‘events that have been experienced personally and pose problems for the individual in 
one way or another’ (Hyden, 1997: 54); and/or to be ‘a story the patient tells, and 
significant others retell, to give coherence to the distinctive events and long term 
course of suffering’ (Kleinman, 1988: 49).  This resulted in a final sample of 140 media 
narratives drawn across 2 time periods: 01/06/1990-31/05/2000 and 01/06/2000-
31/05/2010.   
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1.6 Data analysis 
The study design (§1.4) shows that I aim to investigate my research questions by 
collecting and analysing a variety of narratives.  I use a narrative and framing 
theoretical framework as a sensitising tool (Blumer, 1954; Bowen, 2006; Charmaz, 
2006) with which to approach this narrative data. Inasmuch as sensitising concepts 
draw attention to important aspects of the literature and the data, they may also be 
considered to be akin to the notion of ‘keyness’.  I use Wordsmith Tools software 
(Scott, 2013) to perform a comparative keyword in context (CKWIC) analysis of the two 
large data sets which comprise the media illness narratives of PCa.  A CKWIC analysis is 
a way of inductively examining the words or phrases in one corpus, or body of data, 
which appear ‘key’, or statistically frequent (O’Halloran, 2010) when compared with 
another corpus.  The CKWIC analysis gave an ‘aerial view’ (Seale and Charteris-Black, 
2008: 456) of how the UK national print media represented the illness narratives of 
MWPCa since the emergence of PCaOrgs into the UK in the mid-1990s. 
1.7 Structure of thesis 
I now proceed by laying out in detail the theoretical background of this thesis in 
Chapter 2.  In the main, I have drawn on conceptual frameworks around narrative and 
cultural framing theory.  I did though use my initial interest around HSMs and the 
media as social actors around PCa as a compass rather than an anchor (Dixon-Woods 
et al., 2006) and continued to modify my enquiry in response to the emerging 
relevance of unexpected literatures during the data collection, analysis and writing up 
stages of the research process (Kelly, 2009).   In Chapter 3 I more fully describe the 
study design, data collection and data analysis.  I also provide a rationale for changes 
to the originally proposed thesis design. In Chapters 4, 5 and 6 I present my findings 
from the analysis of media illness narratives, advocates from around PCaOrgs, and 
MWPCa respectively.  In Chapter 7 I discuss these findings and in Chapter 8 I offer 
some conclusions, discuss the limitations of the thesis and posit some potential 
avenues for future research. 
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 Literature review Chapter 2
2.1 Introduction 
My aim in this chapter is to describe a range of concepts which shed light on how 
PCaOrgs and the UK print media have been a force for change in the UK regarding how 
PCa has been addressed and experienced by MWPCa.  I first review aspects of the 
interaction between illness and disease, and focus particularly on the concept of social 
diagnosis and the role of health social movements and media as contributors to it. I 
follow this by reviewing framing and narrative theories.   
2.2 The interaction between ‘disease’ and 
‘illness’ 
Armstrong (2014) suggests that the influential thesis of Omran (1971), in explaining 
the emergence of chronic illness as due to the decline of infectious disease and an 
ageing population, has been accepted too uncritically in sociology of health and illness 
scholarship.  Reliance on this explanation, he argues:  
implicitly endorses its central assumption; that the diagnostic labels of any 
period reflect an underlying biological reality and that data in the historical 
record result from a medical perception largely uncontaminated by 
contemporary world views or theoretical frameworks. (Armstrong, 2014: 16) 
Along similar lines, the long-standing distinction between illness and disease 
(Kleinman, 1988; Banks and Prior, 2001; Bury, 2001; Conrad and Barker, 2010) where 
‘disease [is] (the biological condition) and illness (the social meaning of the condition)’ 
(Conrad and Barker, 2010: S67) is argued to be no longer appropriate (Rosenberg, 
1992; Klawiter, 2004; Timmermans and Haas, 2008; Brown et al., 2011).  Rather than 
being distinct, illness and disease are instead, ‘an interactive system, one in which the 
formal understanding of disease entities interacts with their manifestations in the lives 
of particular men and women’ (Rosenberg, 1992. xxiii).  Timmermans and Haas (2008) 
lament the neglect of sociological inquiry into the ‘dialectic interaction between social 
life and specific diseases (...) and how social life matters for morbidity and mortality 
and vice versa’ (2008: 661).  The repeated call for a sociology of diagnosis (Brown, 
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1990; Jutel, 2009; Brown et al., 2011; Jutel and Nettleton, 2011) does though suggest 
that this is not an utter neglect and that the ‘powerful social tool’ (Jutel, 2009: 278) of 
diagnosis is at least one ‘salient juncture’ (p. 278) between disease and illness.  By this 
Jutel means that the: 
Sociology of diagnosis has a salient role to play in understanding health, illness 
and disease – unpacking and identifying the play of interests which enter into 
discussions of what priorities should be set, and what goals attained. (Jutel, 
2009: 294) 
Brown et al.’s (2011) ‘social diagnosis’ concept ‘considers both larger social structures, 
as well as the various social actors which contribute to the diagnosis’ (Brown et al., 
2011: 942).  These include media and social movement actors (Brown, 1995; Brown et 
al., 2001; Brown and Zavestoski, 2004; Brown et al., 2004; Brown et al., 2012; Brown, 
2013).  A ‘social diagnosis’ is particularly conceptualised regarding illnesses with 
uncertainties and contestations around symptoms and aetiology, for example diseases 
such as fibromyalgia, Gulf War syndrome, chronic fatigue syndrome and 
environmental causes of breast cancer (Brown et al., 2011). 
Jutel proposes that ‘[u]nderstanding the social frames within which diagnoses 
are generated, and grasping the impact of the label, is clinically powerful’ (2009: 294).  
Not only clinically powerful though; Aronowitz (2009) cautions that naming certain 
diseases as ‘cancer’ rather than an underlying risk state (he highlights lobular 
carcinoma in situ) is ‘semantic slippage’ (p. 435) which results in those so ‘diagnosed’ 
adopting decision-making styles typically used in more advanced cancer states.  He 
proposes that this at least includes the increasing numbers of women along the 
risk/disease continuum of breast cancer opting for prophylactic mastectomies (see 
also Henderson’s (2013) account of Angelina Jolie’s decision to have such surgery).  
One consequence of this is a ‘larger and highly mobilised disease/risk population, 
resulting in an expanded market for interventions and greater clout for disease 
advocates’ (Aronowitz, 2009: 417-8).  Another consequence is that those with a poor 
prognosis are relatively more uncommon than in the past which ‘makes the public face 
of some transformed diseases seem healthier and in general helps put a veneer of 
optimism onto the expanded group’s identity’ (p. 436).  Aronowitz (2009) (see also 
Gillespie, 2012) argues that as increasing numbers of people are moved onto the 
risk/disease spectrum of any particular illness, the experience of being at risk of a 
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disease converges with the experience of the disease itself.  This, he argues, is 
especially the case for chronic diseases, which PCa is argued to be (Doyle-Lindrud, 
2007; Oliffe and Thorne, 2007; Oliffe, 2009).   
Aronowitz (2009) suggests a variety of reasons for this including ‘the recruitment 
of larger numbers into chronic disease diagnoses via new screening and diagnostic 
technology and disease definitions’ (p. 417).  Though Armstrong and Eborall (2012) 
argue that the sociology of screening is distinct from the sociology of diagnosis, it is 
likely, at least for a study of PCa, that screening is another salient juncture between 
disease and illness. This is because diagnostic testing for PCa of men spontaneously 
presenting to their general practitioner with sexual dysfunction or lower urinary tract 
symptoms (LUTS), or asymptomatic men ‘getting to be that age’, is described as de 
facto screening (Little et al., 2003; Collin et al., 2009; Drummond et al., 2009); 
screening which creeps in by the back door (Donovan et al., 2001). 
In his revisionist account of chronic illness, Armstrong (2014) argues that the 
‘natural processes of ageing’ (p. 15) related to physical and mental changes have been 
‘reconfigured and incorporated into a model of pathological disease (....) engender[ing] 
a new diagnosis of chronic illness’ (p. 16).  There are at least two important factors 
when considering the natural processes of ageing in engendering a diagnosis of PCa.  
First, the proportion of elderly men (aged 60-74 and 75+) in the UK is increasing (Office 
for National Statistics, 2013: Table A1-1).  The long-standing debate regarding the 
association between benign prostate hyperplasia and LUTS and PCa (Collin et al., 2008; 
Weight, 2013; Weight et al., 2013)  and also the inconsistent evidence around sexual 
dysfunction and PCa (Collin et al., 2009) are likely to mean both increased uncertainty 
in informing those concerned with the diagnosis of PCa and misconceptions for this 
ageing male population (§1.1.3).  The question of whether men presenting with 
symptoms of such natural processes of ageing should be screened for PCa is likely to 
continue to be controversial as long as uncertainty regarding the benefits of 
diagnosing these additional men with early PCa outweighs the associated harms.  
Second, the differential between incidence and mortality is increasing with the 
consequence that more men are living longer with PCa. This is likely to result in a 
greater audience and clout for disease advocates and make the public face of PCa 
appear healthier (Aronowitz, 2009). 
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2.2.1 Interaction between ‘disease’ and ‘illness’: 
health social movements 
Broadly speaking, social movements are considered to be a major force for change in 
society with their very existence suggesting differences around the meaning of some 
aspect of reality and a struggle between actors to invest this with a preferred meaning 
(Benford and Snow, 2000).  Generally, social movements are concerned with collective 
action, at least some of which is extra-institutional, and goals or claims which are 
orientated to either promoting or resisting change (Snow et al., 2004).  The locus of 
change is not only in political, corporate, religious institutions or the like, but also in 
‘patterns of cultural authority, such as systems of beliefs or practices reflective of 
those beliefs’ (p. 9).  Historical phenomena such as the rise of Christianity, the 
Reformation, the French, American and Russian revolutions are, at least to some 
extent, examples of social movements (p. 9).  More recent exemplars are the labour 
movement (Fantasia and Stepan-Norris, 2007) and the women’s movement (Taylor 
and Whittier, 1995). 
 Like their non-health counterparts, ‘health social movements’ (HSMs), (Brown et 
al., 2004), or ‘disease-related social movements’ (Kedrowski and Sarow, 2007) are 
thought to be an important impetus for change in society regarding how health issues 
are addressed.  HSMs date at least back to occupational health concerns during the 
Industrial Revolution.  Kedrowski and Sarow (2007) review how the Black Lung and 
Brown Lung associations in the USA, comprising mainly workers and retirees with 
severe breathing problems from inhaling coal and cotton dust respectively, created 
compensation programs and better occupational health standards. Likewise, Brown et 
al. (2004) review how the women’s health movement altered medical conceptions of 
women and increased reproductive rights and also how the disability rights and mental 
health movements improved accessibility rights and decreased job discrimination.   
HSMs are defined as ‘collective challenges to medical policy and politics, belief 
systems, research and practice that include an array of formal and informal 
organisations, supporters, networks of cooperation and media’ (Brown et al., 2004: 52) 
and take at least three, non-mutually exclusive, forms (Brown and Zavestoski, 2004; 
Brown et al., 2004).  First, health access movements are mainly concerned with 
equitable access to healthcare and improved quality.  Second, constituency based 
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movements address health inequity based on ethnicity, gender, class and sexuality  
(c.f. 'population-based groups' [Allsop et al., 2004]).  Third, embodied health 
movements (EHMs) address disease, disability or illness experience by challenging 
science on causation, diagnosis, treatment and prevention.  EHMs may also include 
constituents who are not ill but perceive themselves as vulnerable to the disease, for 
example, women who do not have breast cancer may be involved in activism around 
breast cancer.  Brown et al. (2004) propose a strategic-advocacy1 continuum according 
to whether the movement uses tactics such as education and advocacy or instead uses 
disruptive action to challenge existing medical paradigms.   
While access and constituency based movements may typically challenge 
medical or scientific knowledge and practice and collaborate with scientists and health 
professionals in pursuing treatment, prevention, research and funding, EHMs are 
unique as they also introduce the embodied experience of people with the disease.  
Just as breast cancer does not happen to a disembodied breast ‘hanging out 
somewhere’ (p. 68), so also is the case for the ‘lost breast’ (Kedrowski and Sarow, 
2007) of the prostate.  A PCa EHM may then introduce ‘[d]isease narratives2 [of 
MWPCa which] interweave organic disease processes with a bodily experience that is a 
function of social structures and cultural ways of knowing’ (Brown et al., 2004: 67).  
EHMs may be considered ‘boundary movements’ (Brown et al., 2004: 63-5) as the 
narratives introduced may blur boundaries between lay and expert forms of 
knowledge: lay people becoming experts not only through their embodied illness 
experience but also by accessing knowledge through, for example, the internet 
enabling them to challenge their medical providers.   
That the above ‘types’ of movement are non-mutually exclusive is clear when 
considering a potential PCa EHM is constituency based (the prostate gland is found 
only in men); it may seek greater access to services and quality of care; and seek to 
achieve this through men’s embodied experience.  Likewise, ‘population-based’ and 
‘condition-based’ group ‘types’ (Allsop et al., 2004), concerned with specific 
populations or conditions respectively, may also be non-mutually exclusive.  Though 
Spangler (2000) does not offer ‘types’ of social movements around disease/health, she 
proposes four main reasons for their emergence in the 1980s and 1990s: 1) the nature 
                                                     
1 They describe it as ‘strategic-agenda’ continuum but the context instead indicates ‘strategic-advocacy’ 
2 Note the use of ‘disease’ rather than ‘illness’ narrative 
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of the diseases; 2) the degree of societal stigmatisation surrounding the diseases; 3) 
the governmental and medical organisational response; and 4) the particular 
communities affected.  She suggests that these variables may account for: the 
different ways that organisations relate to government and medical institutions; the 
different methods and tactics used to achieve their organisational goals; and the speed 
of their emergence.  
Another ‘type’ of social movement around health is a ‘disease-related social 
movement’ (Kedrowski and Sarow, 2007: 38).  These are ‘“grassroots survivors’ 
organisations” [GSOs] [....] or collection of organisations that focuses on a problem its 
activists believe is the responsibility of government to remedy’ (p. 38).  ‘Survivor’ is 
used rather than ‘victim’ as the latter implies one has succumbed to the disease when 
the key to activism is instead survivorship.  Kedrowski and Sarow (2007) distinguish 
between groups populated by people with the disease and those populated by 
surrogates; ‘medical professionals, family members, caregivers or philanthropists’ 
(2007: 43).  They argue both that survivors speak more powerfully about their 
experience and that the agenda of survivor organisations may be different to that of 
surrogates.  They propose seven characteristics of successful GSOs, they: 1) form 
around long term health hazards; 2) adopt and use the organisational structures and 
practices of existing activist organisations; 3) offer their own experiences as evidence; 
4) depend on an empowered and educated activist support base; 5) depend on the 
media and courts for keeping their issues alive and in the public’s agenda; 6) depend 
on women as activist leaders; and 7) need financial and promotional support from 
business and industry to ensure long term viability (Kedrowski and Sarow, 2007: 52-
60).   
Kedrowski and Sarow (2007) describe the differing extent to which movements 
around breast cancer and PCa, the substantive context of their research in the USA, 
satisfy these characteristics.  They argue that the breast cancer movement not only 
had the women’s health and feminist movements as a foundation for their activism, 
they could also model the success of the AIDS movement, especially in adopting some 
of its more confrontational techniques.  They were also able to use their selves as 
evidence, not only in their willingness to narrate their experience as persons with the 
disease, but also in how they could draw attention to the breast in ways not culturally 
acceptable for men to do so for the prostate.  In contrast, the US PCa HSM fully shared 
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only the first characteristic and only partially shared the remaining six features1.  
Unlike breast cancer, the US PCa HSM did not have a similar men’s health movement 
as a model and many of the confrontational tactics of the AIDS movement were not 
considered options by the time the National Prostate Cancer Coalition (NPCC)2 was 
formed in 1996.  What the NPCC did have though was the opportunity to model itself 
on, or ‘piggyback’ (Kedrowski and Sarow, 2007: 153), the successes of breast cancer 
lobbyists in the National Breast Cancer Coalition (NBCC), founded in 1991.  Despite this 
‘piggybacking’, its ‘grasstops’ rather than grassroots origins made it hard to generate 
equivalent support (Halebsky-Dimock, 2004).  Such modelling or ‘piggybacking’ is an 
example of social movement spillover where:  
one movement can influence subsequent movements both from outside and 
from within: by altering the political and cultural conditions it confronts in the 
external environment, and by changing the individuals, groups, and norms 
within the movement itself.  (Meyer and Whittier, 1994: 279)   
Social movement spillover is useful in several ways.  First, the goals and interests of 
one social movement may influence people in another to experience their illness as 
some form of inequality.  Second, the success of some social movements may create, 
or remove, sympathetic allies for other social movements as per the examples above.  
Third, the way that activists articulate particular values or beliefs may have a beneficial 
effect on other social movements in that these articulations become ‘culturally potent’ 
(Kolker 2004: 827).  Here proponents of new movements strategically bring their 
frames ‘into alignment with potential recruits' pre-existing frames (...) [and] link their 
perspectives to widely-resonant beliefs or concerns’ (Meyer and Whittier, 1994: 287 
my emphasis - see §2.3.3) and thus make their messages recognisable by audiences as 
meaningful.   
In the UK, in the past twenty years the public visibility of PCa has increased as 
PCa organisations (PCaOrgs) have emerged to promote awareness of the condition and 
lobby for funding of services and research. The Prostate Cancer Research Foundation 
(PCRF) and The Prostate Cancer Charity (TPCC), for example, were established in 1993 
and 1996 respectively.  In recent years there has been an increase in social movement 
studies which have focused on aspects of health and disease, for example, Alzheimer’s 
                                                     
1 Kedrowski and Sarow (2000: 60) present a table the details of which are ambiguously different from 
the accompanying text.  Here I summarise my interpretation of their text which differs from the table 
2 Now renamed ‘ZERO’ 
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Disease (Beard, 2004), HIV/AIDS (Spangler, 2000) breast cancer (Halebsky-Dimock, 
2004; Klawiter, 2004; Kolker, 2004; Kedrowski and Sarow, 2007; Sulik, 2011), and 
mental health (Crossley and Crossley, 2001).  However, little attention has been paid to 
PCa, with research to date tending to focus not only on the USA but also comparing 
PCa with other illnesses, for example, breast cancer (Halebsky-Dimock, 2004; 
Kedrowski and Sarow, 2007) or with both HIV/AIDS and breast cancer (Spangler, 2000).   
2.2.2 Interaction between ‘disease’ and ‘illness’: the 
media  
Print media, as among the most relied on sources of information regarding disease, 
illness, death and medicine for people in general (Clarke, 2004), and men with prostate 
cancer (MWPCa) in particular (Halpin et al., 2009), is another potential contributor to 
the social diagnosis of PCa. 
 Studies of media production include both enquiries around the power of media 
producers and the power of others in influencing them (Seale, 2003).  Philo (2008) 
contends against the trend to seriously neglect media power in favour of the power of 
a reflective resisting audience.  He argues that a large proportion of media audiences 
relies on very traditional news sources and that ‘patterns of belief and understanding 
can be traced to [elite media producers]’ (2008: 542).  Such repetitive patterns are 
seen in the idea of a media ‘boilerplate’ (Cotter, 2010), as though ‘seemingly 
throwaway material (....) repetitious, unattributed (...) and is potentially expendable as 
text (....) its role in framing a news story may also end up influencing public debate’ 
(Cotter, 2010: 171).  Repetitive patterns are also seen in media templates (Kitzinger, 
2000) which are used to (re)construct meaning over time for both journalists and 
audiences, retrospectively making salient particular aspects of past problems in 
explaining current events.  Kitzinger (2000) shows through content analysis of media 
articles, interviews with journalists, and focus groups with audiences how the 
Cleveland child sex abuse scandal of the late 1980s was used as a template to help 
audiences and journalists make sense of the new events in Orkney in 1991.  She 
suggests though that there is nothing innately problematic about journalists repeating 
historical analogies in templates as current happenings are not ahistorical.  Indeed, the 
reconstruction of meaning from repeated texts is suggested as routine by Tannen 
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(2007) and Bakhtin (1981); where problems might arise though is when journalists, and 
audiences, unquestioningly accept templates from prior events as ‘truth’ for new 
events.   
Studies of media reception include investigation of the media audience’s 
reception of news coverage of which two salient studies are Gamson (1992) and 
Kitzinger (2000).  Gamson (1992) finds that people are neither ‘“passive”’ nor ‘“dumb”’ 
but ‘negotiate with media messages in complicated ways that vary from issue to issue’ 
(1992: 4).  Kitzinger (2000) finds that, with some minority resistance and variation, 
particular phrases  provoke ‘a set of powerful pre-packaged associations’ (2000: 70) 
creating images which ‘‘fitted’’ (p. 70) (see also Kitzinger and Miller, 1992) with 
audiences prior conceptions.  Seale (2003) provides an overview of audience theory 
which includes such negotiation and resistance of audiences.  He also notes how 
audiences seek emotional stimulation through entertaining dramatised contrasts 
which exploit oppositions between, say, good and evil, men and women or, as in  
Kitzinger’s study, ‘innocence and incompetence’ (Seale, 2003: 519).  Audiences, having 
had repeated exposure to a variety of played-out forms, such as boilerplates (Cotter, 
2010) or media templates (Kitzinger, 2000), have expectations of how they will be 
‘entertained’ by media producers.  This ‘entertainment’ though is not solely achieved 
by meeting their expectations but rather by an ‘entertaining disruption of 
expectations’ (Seale, 2002: 36).  Indeed, there is an imperative for media producers to 
disrupt, or ‘twitch’ the plot from time to time in order to retain audiences’ interest’ (p. 
36).  ‘Twitching’ may also constitute a ‘reversal’ where previously established polarities 
‘may suddenly be reversed, so that evil and good swap places’ (p. 36).  Such ‘reversals’ 
become normal and imply a continual need for ‘twitching’.  Later in this chapter 
(§2.3.3.1) I explore more fully the concept of repetition and also introduce the concept 
of interest and propose that these are instrumental in ‘twitching’ the plot for the 
‘entertainment’ of media audiences.   
2.2.2.1 The media representation of prostate cancer 
The existing literature in the media and health field is weighted towards studies of 
representation (Seale, 2003), often involving analysis of which ideas or themes are 
discursively dominant in media content.  Although PCa is the research ‘flagship of 
men’s cancer’ (Wenger and Oliffe, 2013) and print media are popular as an 
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information source for disease and illness, for people in general (Clarke, 2004) and 
MWPCa in particular (Halpin et al., 2009), there are relatively few studies of the 
representation of PCa within this medium (Halpin et al., 2009.).  Clarke’s (1999; 2004) 
studies of PCa in contemporary ‘mass print media’ (1999: 58; 2004: 541), rather than 
considering print newspaper media, are instead limited to English language magazines 
in the United States and Canada from 1974-1995 (Clarke, 1999) and in Canada from 
1996-2001 (Clarke, 2004).  Despite this limitation, and also that her sample sizes are 
small, there are interesting findings from these studies which I outline below.  Two 
other studies (MacKenzie et al., 2007; Halpin et al., 2009) analyse representations of 
PCa in Australian and Canadian newspaper media respectively.  There are no studies of 
the representation of PCa in the UK print media. 
 Clarke’s (1999) study involves analysis of a ‘paucity’ (p. 70) of all 36 articles 
containing representations of PCa from three magazine database sources from 1974-
1995 (only one of which extends to the whole sample period).  She conducts a 
‘manifest’ and ‘latent’ thematic analysis. ‘Manifest’ analysis focuses on meanings 
‘evident on the surface’ (p. 63) or ‘obvious intent of the overall article’ (p. 65). ‘Latent’ 
analysis allows meaning to be subject to the legitimate and critical interpretation of 
the researcher and their particular biases, ideologies and knowledge of the wider 
discursive context.  This, Clark suggests, correspond to both quantitative (counting the 
number of times that manifest themes appear) and qualitative (considering the 
underlying, or latent, meaning of the articles) analysis.  Her manifest findings indicate 
that the predominant focus of these articles was on the importance of early detection 
followed by the increasing incidence of PCa.  The ‘latent’ analysis includes findings that 
PCa is relatively neglected when compared with breast cancer; not because of its 
relative incidence in the population, but because of advocacy around breast cancer 
and the consequential lack of funding for PCa and attention to it by medical science 
and the media.   
The primary concern of Clarke (2004) is to update her earlier research (Clarke, 
1999) and compare representation of PCa with that of breast and testicular cancers.  
Here she analyses 19 articles on PCa in 10 Canadian mass print magazines.  Of first 
note, again, is the scarcity of articles around prostate (19 articles) and testicular (11 
articles) cancers relative to breast cancer (approximately 174 articles).  She again 
conducts a manifest and latent thematic analysis with her findings inherently including 
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comparisons of PCa with breast cancer.  Ideas of ‘family’ around PCa primarily focus on 
the MWPCa and his wife and how they cope with incontinence and impotence.  In 
contrast, ‘family’ connections for women with breast cancer are much broader.  Her 
other findings include comparisons with breast cancer activism and ‘felt injustices’ (p. 
548) around the funding for research for PCa when compared to that for breast cancer 
or AIDS.  Journalists explain that this is because men are not understood as ‘victims’ in 
the same way that women or gay men are and thus not offered similar public support.  
Further, journalists position women as helping their spouses to ‘lose their shame’ in 
bringing that disease ‘out of the shadows’ (p. 548).   
Halpin et al. (2009) also conduct a manifest and latent thematic analysis on their 
sample from two English language Canadian national newspapers.  Their initial sample 
of 817 articles containing the phrase ‘prostate cancer’ is reduced by approximately 
50% after an initial manifest analysis excluded ‘peripheral’ articles making only 
superficial reference to PCa; such articles were not included in the subsequent latent 
analysis.  The remaining articles were coded into three non-mutually exclusive 
categories of 96 ‘illness perspective’ articles (focussing, for example, on information 
about men diagnosed and treated or who had died from PCa); 199 ‘medical 
perspective’ articles (focusing, for example, on research, and new developments in 
screening); and 122 supplementary articles (focusing for example on men’s diet, health 
behaviour and fundraising and awareness of PCa).  They find four themes across their 
data (p. 159): ‘“manufacturing the treatment imperative”’ from the medical 
perspective category; ‘“the good fight’” in the illness perspective category; and a 
‘“money for the cure”’ and ‘“boys’ and girls’ cancer”’ in the supplementary category.  
Their conclusions include the observation that readers are offered only: 
a truncated illness trajectory that privileged recovery and biomedically-derived 
‘cures’. As a result, only the beginning story (‘men can get PC’) and the ending 
(‘men can die of PC’) is detailed. There is no middle story about, ‘living with PC’. 
(Halpin et al, 2009: 164) 
This ‘truncated’ illness perspective meant there were no accounts of treatment side 
effects in their data.  They also conclude that socially advantaged and health 
complacent men are positioned in a ‘struggle for fundraising equity against women’ (p. 
164).  Alongside this macro-level gender struggle, paradoxically on a micro-level, 
women were positioned as those who do, and should, look after the health of their 
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men. They suggest that this ‘myopic presentation of health (...) [of elite men] 
encourages a myopic performance of health’ (p. 164) extended across all masculinities. 
 Finally, MacKenzie et al. (2007) examine media coverage of PCa screening in 
Australia.  Their sample included 388 print media articles from Australian capital city 
newspapers between February 2003 and December 2006 and 42 television items from 
Sydney television news over a similar period.  Unlike Clarke (1999; 2004) and Halpin et 
al. (2009) they conduct a ‘framing analysis’; focusing on categorising attributed or 
paraphrased quotes from named individuals as either a positive or negative framing of 
PCa screening.  They find that the Australian print and television discourse on PCa 
during the sampled four year period was very supportive of PCa screening with 86% of 
all quotes categorised as positive.  They conclude that the average consumer of news 
in Australia would find it difficult to believe that PCa screening was not a sensible thing 
to do.  This is despite the real lack of scientific evidence and the almost universal 
tendency of those responsible for national screening programmes to not recommend 
PCa screening.  
2.2.3 Masculinities and prostate cancer 
The case made for the interaction between the social category of ‘illness’ and the 
pathological category of ‘disease’ and how it matters for morbidity and mortality 
(Timmermans and Haas, 2008) is also made for the interaction between the biological 
category of sex and the social category of gender (Annandale, 2013).  While the social 
experiences of men and women provide a ‘template’ (Courtenay, 2009: 13) for how 
they choose to adopt various social behaviours and beliefs, ‘[u]nlike the presumably 
innocent effects of wearing lipstick or wearing a tie, the use of health-related beliefs 
and behaviours to define oneself as a woman or a man has a profound impact on one’s 
health and longevity’ (p. 13).   Courtenay (2009) argues that men are not ‘passive 
victims of a socially prescribed role (...) [but are instead] active agents in constructing 
and reconstructing dominant forms of masculinity’ (p. 12).  Dominant constructions of 
masculinity are conceptualised as hegemonic masculinity: 
the socially dominant gender construction that subordinates femininities as 
well as other forms of masculinity, and reflects and shapes men’s social 
relationships with women and other men, (….) [it] include[s] the denial of 
weakness or vulnerability, emotional and physical control, the appearance of 
being strong and robust, dismissal of any need for help, a ceaseless interest in 
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sex, the display of aggressive behaviour, and physical dominance (Courtenay 
2009: 14).   
Men demonstrate hegemonic masculinity around their health when, for example, they 
brag about how long it is since they have seen a doctor; refuse to take sick leave from 
work; or believe that talking to others about their illness presents them as weak 
[Courtenay, 2009: 14.].  Though hegemonic masculinity is understood as normative 
behaviour and not conceived as that which patterns all men’s behaviour, it, or at least 
this definition, has been heavily criticised.  These criticisms include the lack of 
attention to differences within and between the gender categories and how patterns 
of masculinity vary at least by place, class and generation (for a fuller review of these 
criticisms see Connell and Messerschmidt, 2005). 
Sociological attention to the doing of gender and PCa begins to address, or at 
least recognises, some of these criticisms.  Oliffe (2009) proposes three important 
factors when thinking about PCa and masculinity: 1) age is a risk factor for PCa; 2) the 
increasing differential between incidence and mortality means more men are living 
longer with PCa and, as yet, with no preventable cause or cure, PCa will unfold as a 
chronic illness; and 3) as PCa incidence varies geographically and ethnically men’s 
experiences of PCa will be diverse.  Oliffe’s first two factors indicate that attention 
needs to be paid at least to how elderly men may construct plural masculinities.  I 
suggest though that limiting attention to elderly men is likely to become increasingly 
incongruous.  This is because autopsy studies show incidence of PCa in very young men 
(Soos et al., 2005; Powell et al., 2010) and given that PCa is being looked for harder 
than ever before (Welch et al., 2012) it is likely to be more frequently found in younger 
men. 
MWPCa draw on a range of masculine ideals: denying illness, stoicism, and 
respecting the expertise of their physician (Chapple and Ziebland, 20021; Mróz et al., 
2013).  MWPCa discuss their reluctance to consult doctors; the embarrassment and 
inconvenience of incontinence; the impact of tiredness on their ability to work and 
play sport; and the impact of impotence (Chapple and Ziebland, 2002).  The impact of 
impotence on masculinity differs though according to the treatment men receive: 
those receiving surgery describe impotence as a ‘small price to pay’ (p. 831); men 
                                                     
1 20 of these interviews are included in this present research 
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receiving hormone treatment describe how they feel physically and psychologically 
changed.   
The construction of masculinities also differs according to the context in which 
the talk occurs. Chapple and Ziebland (2002) draw conclusions which reinforce the idea 
that masculinity is socially constructed with men saying that their ‘macho’ image is 
impacted by their illness. Mróz, Oliffe and Davison (2013) show how masculinities are 
co-constructed in the dyadic patient-physician communication encounter in the 
specific context of men, diagnosed with low risk PCa, choosing active surveillance as a 
treatment. They note that active surveillance occupies a unique position within cancer 
communication with the physician able to combine the bad news of ‘(you have 
prostate cancer) with some, albeit provisional, good news (i.e. you don’t have to be 
treated just yet)’ (p. 85).  Broom (2010) examines the complexities between PCa and 
masculinities in Australian men before, during and after treatment.  His stated context 
is that “younger men are now developing prostate cancer, and many die of the disease 
and not with it” (Broom, 2010: 180, citing Frydenberg et al., 19981; Broom, 20042).  He 
concludes that for the majority of men the exposure of their bodies to biomedical 
investigations and treatments threatens their enactment of masculinity around 
potency and continence control.  In addition, he observes the ‘code of silence’ (p. 195) 
surrounding men’s illness. 
In sum, in this section I have shown how illness and disease can no longer be 
considered to be distinct given that ‘social life matters for morbidity and mortality and 
vice versa’ (Timmermans and Hass, 2008: 661) and the biological category of sex 
matters for the social category of gender and vice versa (Annandale, 2013).  I show the 
usefulness of the concept of ‘social diagnosis’ (Brown et al., 2011) in its consideration 
of how media and social movement actors might contribute to a diagnosis.  I note that 
although in recent years there has been an increase in social movement studies which 
have focused on aspects of health and disease, little attention has been paid to PCa.  
Likewise, studies of media representation of PCa are limited, both numerically and 
geographically, with as yet no study of such representation in the UK.   
                                                     
1 Broom cites Frydenberg as sole author but it is a three-authored paper 
2 Broom 2004 also cites Frydenberg 1998.  I was unable to access Frydenberg et al.’s  paper to 
understand the claim that younger men in Australia are dying of rather than with prostate cancer 
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2.3 Framing theory 
The concept of framing is set forth as a way of understanding the complexities in how 
individuals and collectives interpret their world (Goffman, 1974; Entman, 1993).  It is 
common in both every day and academic discourse (Snow and Benford, 1992) and is 
often tacitly understood rather than explicitly defined (Entman, 1993).  Its 
‘omnipresence across the social sciences and humanities’ (p. 51) is shown by its 
various terminology such as ‘‘paradigms’, ‘stereotypes’ [and] ‘schemata’’ (Fowler, 
1991: 17).  A schema (or frame) ‘is a chunk of unconscious knowledge, shared within a 
group of people and drawn upon in the process of making sense of the world’ (Fowler, 
1991: 43 c.f. Goffman 1974).  The utility of the framing concept for this present study 
has its foundation in its use as an explanatory factor in the study of social movements.  
The Goffmanian concept of framing was revived in an influential approach to the study 
of social movements (c.f. Snow et al., 1986; Gamson et al., 1992; Snow and Benford, 
1992, 2000).  Benford and Snow suggest that ‘the very existence of a social movement 
indicates differences within a society regarding the meaning of some aspect of reality’ 
(2000: 626).  Actors around social movements are argued to be: 
actively engaged in the production and maintenance of meaning for 
constituents, antagonists, and bystanders or observers (...) involv[ing] the 
amplification and extension of extant meanings, the transformation of old 
meanings, and the generation of new meanings (Snow and Benford, 1992: 136) 
Such work by social movement actors suggests that though frames may be ‘chunk[s] of 
unconscious knowledge’ (Fowler, 1991: 43), they may also be consciously drawn upon.  
Known cultural frames may be strategically sought in order to focus attention on 
particular aspects of reality to elevate them in salience (Entman, 1993) ‘by placement 
or repetition, or by associating them with culturally familiar symbols’ (p. 53).  This 
bears similarities to the beneficial consequence of social movement spillover where 
new actors strategically bring their messages into line with their potential audience’s 
pre-existing frames (Meyer and Whittier, 1994). 
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2.3.1 Strategic frame alignment processes 
Much of the work of social movement theorists in understanding frames and framing 
activity has centred on strategic frame alignment processes1 (bridging, extension, 
amplification, and transformation) ( Benford and Snow, 2000; Snow et al., 1986) 
Gamson 1988).   
Frame bridging is ‘the linkage of two or more ideologically congruent but 
structurally unconnected frames regarding a particular issue or problem’ (Snow et al., 
1986: 467).  This can occur either across social movement organisations or towards a 
‘probable adherent pool’ (p. 468). It is the most prevalent of the strategic frame 
alignment processes and is effected mainly by ‘organisational outreach and 
information diffusion through interpersonal or intergroup networks, the mass media, 
the telephone, and direct mail’ (p. 468.).  Peace movement organisations, for example, 
may develop mailing lists from records of individuals attending events sponsored by 
like-minded organisations and then assume that those individuals are likely to share 
the aims and values of the peace movement. 
 Frame extension refers to the situation when the current programmes of a social 
movement organisation do not fit with the interests of potential adherents who may 
need to be ‘hooked’ to position their interests alongside that of the SM.  This involves 
the extension of the boundaries of interest of the social movement organisation to 
incorporate the issues presumed to be of importance to potential participants.  For 
example, rock and punk bands have been used to draw attention of otherwise 
indifferent individuals to disarmament rallies (Snow et al., 1986).   
 Frame amplification involves ‘the idealization, embellishment, clarification, or 
invigoration of existing values or beliefs’ (Benford and Snow, 2000: 624).  Values are 
understood as ‘modes of conduct or states of existence that are thought worthy of 
protection and promotion’ (Snow et al., 1986: 469) and beliefs as ‘ideational elements 
that cognitively support or impede action in pursuit of desired values’ (p. 469-470).  
Beliefs include: stereotypical ideas about antagonists or targets of influence; the 
seriousness of the problem; who or what is to blame; and the necessity and efficacy of 
any corrective action (p. 469-470.).  Stereotypic beliefs about homeless men as 
                                                     
1 Snow et al. (1986) use ‘frame alignment’ to describe what Benford and Snow (2000) later refer to as 
‘strategic processes’ and so I have amalgamated the two phrases 
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alcoholic and mentally and morally deranged were amplified to mobilise a 
neighbourhood against proposed local homeless shelters (p. 469-470.).   Breast cancer 
activists drew upon commonly held values and beliefs around ‘family’ and ‘fairness’ in 
the early 1990s to create three interconnecting and culturally relevant frames which 
moved breast cancer from a problem of individual women to a public problem in need 
of social and institutional address: 1) breast cancer as an ‘epidemic’ with unacceptable 
rates of incidence in the young and old; 2) a ‘gender equity’ frame; and 3) a ‘threat to 
the family’ frame (Kolker 2004).  The first two of these justified demands to increase 
funding and portrayed women as the sole victim.  The third highlighted the importance 
of family in American discourse and meant that ‘the pool of victims impacted by the 
disease expanded significantly to include the entire family’ (p. 831) with breast cancer 
‘victims’ and ‘survivors’ appellated with new identities of ‘wives’, ‘mothers’, ‘sisters’ 
and so on. 
 Frame transformation is a redefining of ‘activities, events, and biographies that 
are already meaningful from the standpoint of some primary framework, in terms of 
another framework’ (Snow et al., 1986: 474).  Frame transformation is contingent on 
an interpretive change which includes the adoption of injustice frames and a 
corresponding shift in attribution of blame from the individual self to an external 
other.  Social movement actors are argued to construct a compelling sense of injustice 
around an existing authoritative view of reality, provide a solution, and demand 
correction or eradication of the exposed injustice.  In this way frames: 
1. Highlight, or diagnose, some aspect of social life as problematic and/or unjust in 
need of change  
2. Propose a solution, or make a prognosis, for the diagnosed problem specifying 
what needs to be done 
3. Make diagnostic attributions of blame by identifying a culpable adversarial 
‘they’  (or an internalised ‘we’) of individual, collective or structural agents 
responsible for the problem 
4. Make prognostic attributions by identifying an internalised ‘we’ or externalised 
‘they’ who will bring change by engaging in corrective action to resolve the 
problem 
(Gamson et al., 1992; Snow and Benford, 1992) 
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In adopting an injustice frame, a condition previously understood as tragic is 
subsequently defined as unjust, for example, the tragic loss of a loved son by a careless 
driver may be redefined as an injustice demanding increased judicial penalties.   
2.3.2 Framing hazards 
The inevitable struggle between actors to invest aspects of reality with a preferred 
meaning suggests the likelihood that frames will be contested (Benford and Snow, 
2000) or subject to what Snow and Lessor (2010) have recently described as ‘framing 
hazards’.  Various such contested processes or hazards confronting those engaged in 
framing activities have been identified including: counter-framing; framing disputes; 
framing errors or misframings; framing shifts; ambiguous events; and dialectic tension 
between frames and events (Benford and Snow, 2000; Snow and Lessor, 2010). 
 Counterframing by movement opponents can result in rebuttals or undermining 
of a frame and generate further re-framing in an attempt to ‘ward off, contain, limit or 
reverse potential damage to the movement’s previous claims or attributes’ (Hunt and 
Benford, 1994 as cited by Benford and Snow, 2000: 626).  Benford and Snow (2000) 
lament the lack of progress made on what shapes the outcome.  Though they suggest 
that the winners engaged frames which were more resonant they do not provide an 
answer as to why and how this may be so.   
 Frame disputes have been examined mainly in terms of intramovement 
disagreements over the meaning of some present or projected future aspect of reality.  
This is exemplified in the three competing framings of obesity in the United States: the 
anti-obesity or obesity as risky behaviour frame and within the individual’s control; the 
obesity as a disease frame and beyond the individual’s control; and obesity as fat 
acceptance or body diversity frame where less social discrimination on size is needed 
(Snow and Lessor, 2010: 289-90).  Each poses different problematisations of obesity, 
attribution of causes and actions for solution. 
 Framing errors occur when collective action is based on erroneous beliefs as, for 
example, in the changing ways that the disease pellagra was dealt with in the early 
1900s.  Despite the fact that malnutrition was found to be the cause of pellagra in 
1914, the disease was framed as hereditary in a report by the Pellagra Commission in 
1917, this not changing until after the Great Depression when many previously self-
sufficient people succumbed to the disease.  Ambiguity, common in medical diagnostic 
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uncertainty, may occur when there are questions as to what could possibly be going on 
in a particular event or when deciding between two or more potentially plausible 
explanations for what is going on (Snow and Lessor, 2010).  A dialectic tension 
between frames and events is evident when initial framings legitimate some form of 
action but in turn transform the ideas and beliefs that make up the original frames so 
that such action is no longer efficacious.  Frame shifts are generally preceded by new 
or unanticipated events and occur when one frame, rather than being transformed, is 
displaced by another.  The susceptibility of a dominant frame to displacement is 
contingent on the extent to which it is falsifiable and may thus be prevalent in the 
health and medicine sector because of its reliance on empirical evidence (Snow and 
Lessor, 2010).  
2.3.3 Frame resonance: ‘half the battle’ yet only ‘half 
the story’ 
what texts ‘do’ we all ultimately realise, they do in the resonance achieved 
between the words themselves and the worlds that surround them, elicit them, 
and are reflected and transformed by them (Charon, 2006: 113)  
Frame resonance is understood as the ‘‘‘fit’’ between frames and audiences’ previous 
beliefs, worldviews, and life experiences’ (Kitzinger and Miller, 1992; Kitzinger, 2000; 
Williams, 2004: 105).  It incorporates the various strategic frame alignment processes 
and is seen as crucial in understanding why some frames and framing efforts are more 
successful than others (Snow and Benford, 1988; Benford and Snow, 2000).  Though 
there is a necessity for communicators to construct frames which ‘ring true’, ‘fit’, or 
‘hit home’ with an audience’s previous frames, there are risks as well as benefits in so 
doing.   
Achieving resonance is advantageous as it allows challenging actors to ‘peer 
into the actions and histories of other challenging groups’ (Steinberg, 1999: 752) and 
‘borrow’ their discourse in order ‘to articulate identities, grievances, and goals where 
there are gaps and silence in the discursive field in which they are fighting their own 
struggle’ (p. 752). Likewise, Turner describes how a sense of injustice ‘can become the 
leaven for vast social changes because (...) other organisable segments of society can 
see many of their own problems in the terms set forth by [other] activists’ (1969: 399).  
A new racist white supremacist, for example, described achieving resonance with 
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familiar civil rights language as ‘“half the battle”’ (Berbrier, 1998: 432) in legitimising 
‘the idea that whites have a right to organise, just like blacks, Hispanics and Jews’ (p. 
432.). Steinberg (1999) insists that it is very difficult for actors to construct truly new 
oppositional symbols and that oppositional discourse is more likely to be appropriated, 
or reproduced, from other familiar hegemonic discourses and inflected with the 
intended meaning of the new actors. In contrast, Polletta and Ho assert that activists 
‘sometimes invent new frames’ (2006: 194) arguing that neither women liberation 
activists seeking to radically challenge gender norms nor dissidents challenging the 
communist regime in Poland had social movement discourse to appropriate.  They 
subsequently indicate though that the political challengers in Poland invoked both 
moral frames from the Catholic Church and civil rights discourse, and that the women’s 
liberation activists appropriated, with a gender twist, civil rights discourse from the 
1950s.   
Though seeking resonance is ‘“half the battle”’ (Berbrier, 1998: 432) it is also 
‘only half the story’ (Ferree, 2003: 306)—this is at least because the familiar and 
‘common sense’ properties of resonant discourse potentially constitute it as 
hegemonic.  Ferree (2003) describes the structured and institutionalised nature of 
hegemonic discourses, or ‘discursive hegemony’ (Steinberg, 1999) as discursive 
opportunity structures (DOS): ‘institutionally anchored ways of thinking that provide a 
gradient of relative political acceptability to specific packages of ideas’ (Ferree 2003: 
309, emphases in original).  Such institutional structures include a media DOS (Ferree, 
2003; Koopmans and Olzak, 2004) and a judiciary DOS (McCammon et al., 2007). They 
may also include an epidemiological DOS, or a dominant epidemiological paradigm 
(DEP) (Brown et al., 2004), defined as ‘the pre-existing institutional [including science, 
government, private sector, media, and academia] beliefs and practices that shape the 
discovery and understanding of a disease [and] also shape the illness experience for 
the affected population’ (Brown et al. 2004: 61).  As such an epidemiological DOS/DEP 
may also be understood as a dominant public narrative around health, illness or 
disease which allows some ideas to reign as ‘common sense’ while marginalising 
others. 
In her study on abortion, Ferree (2003) argues that framemakers may instead 
opt for ‘nonresonant’ (p. 305) language, which ‘is by definition radical’ (p. 203), as an 
alternative and viable way both to achieve success and restructure hegemonic ideas. 
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She defines resonance and radicalism, respectively, as the mutually affirming or 
contradictory ‘interaction of a frame with a discursive opportunity structure supportive 
of the terms of its argument’ (2003: 310, emphases in original).  This then points to a 
potential combination of resonant and non-resonant language as an approach to 
successful framing. Also suggestive of this is Koopmans and Olzak’s (2004) 
understanding of  resonance as that which provokes either negative or supportive 
reactions—what they term consonance and dissonance—both ‘hitting  home’ but in a 
‘familiar’ and ‘alerting’ way respectively.  Along these lines Polletta (2006) argues, in 
relation to stories rather than frames, that though ‘stories must hew to familiar 
plotlines, a story that was so familiar as to be entirely predictable would be no story at 
all’ (p. 10).  Thus, it would indeed seem that though resonance may be ‘half the battle’ 
(Berbrier, 1998) in successful framing it still is ‘only half the story’ (Ferree, 2003).  
Something more is thus at stake in successful framing and looking more closely at what 
might constitute elements of resonance and non-resonance may shed some light on 
what this is. 
2.3.3.1 The role of emotion and repetition in resonance 
2.3.3.1.1 Emotion 
Emotions like those which accompany a sense of injustice, or others such as 
compassion, shame, guilt and anger, play a part in the ‘real reason[ing]’ (Lakoff, 2010: 
72) of everyday framing.  Rather than understanding ‘appeals to reason’ as 
unemotional, instead ‘real reason (...) requires emotion; uses the “logic” of frames, 
metaphors, and narratives’ (p. 72).  In their analysis of policymaking deliberations 
around resource allocations in primary health care, Russell and Greenhalgh (2011) find 
that a rhetorical approach to policy-making decisions does not ‘occlude emotions (...) 
as elements that get in the way of rational decision-making, but rather sees them as 
integral to persuasion of an audience’ (p. 60).  Russell and Greenhalgh thus identify a 
paradoxical tension between ‘appeals to reason’ through robust evidence and appeals 
to emotions in decision-makers’ arguments. Similarly, but outside of the policy arena,  
Kedrowski and Sarow (2007) suggest that ‘the masses are not interested in the 
particular details of policy or appeals to reason; rather they respond to emotion [and] 
language that appeals to the “moral codes” embedded in our understanding has the 
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greatest resonance’ (p. 165). Kedrowski and Sarow are concerned with what interests 
‘the masses’ (p. 165)—and, by extension, with what interests the media as a means of 
access to these masses.  I look now particularly at the particular emotions of ‘injustice’ 
and ‘interest’. 
Injustice, as a ‘‘hot’ emotion’ (Gamson, 1992: 7), has coloured all major social 
movements in each main historical era (Turner, 1969).   Injustice is not merely about 
recognising, or experiencing, a misfortune such as poverty or illness and petitioning for 
help.  Rather, it is ‘moral indignation’ (Gamson, 1992: 7), or ‘sense of outrage against a 
system productive of such misfortunes’ (Turner, 1969: 391) and action for their 
correction or eradication.  In other words, instead of relying on the goodwill of others 
to address a problem, you instead demand what you claim is right, your right or a 
right.  Significant social movements have both depended upon and promoted a 
‘normative revision’ (p. 390) in how a ‘substantial group of people look at some 
misfortune, seeing it no longer as a misfortune warranting charitable consideration but 
as an injustice which is intolerable in society’ (p. 390).  This involves changing ideas of 
what people view as unjust in any society; for example, the change in conceiving 
oneself as individually ‘unlucky’ in experiencing a particular event (or illness), to 
acquiring a consciousness of actors responsible for the perceived harm.   
A common view of ‘interest’ is as a collective motive for social action;  ‘interest 
groups’, like social movements, usually have goals which are similarly orientated 
towards either promoting or resisting change (Snow et al., 2004).  An alternative view 
of interest1 is that of ‘the curious emotion’, one of a number of knowledge emotions, 
by Silvia (2008).  Silva argues that ‘interest’ displays all the components normally 
associated with emotions: physiological changes in facial and vocal expressions; 
patterns of cognitive appraisal, subjective qualities; and an adaptive role across a 
lifespan (2008: 57).  He asserts that ‘emotions come from subjective evaluations of 
events: People appraise an event’s meaning and these appraisals bring about 
emotions’ (p. 58).  He suggests that interest results from two such appraisals: 
1. An evaluation of an event’s novelty-complexity:  ‘evaluating an event as new, 
unexpected, complex, hard to process, surprising, mysterious or obscure’ (p. 58)  
                                                     
1 I became aware of this understanding of ‘interest’ as a relevant concept to review in the literature only 
upon analysis of the data. 
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2. An evaluation of an event’s comprehensibility.  This less obvious coping-potential 
appraisal ‘involves people considering whether they have the skills, knowledge, 
and resources to deal with an event’ (p. 58) 
Thus with ‘interest’, ‘people are “dealing with” an unexpected and complex event – 
they are trying to understand it.  In short, if people appraise an event as new and as 
comprehensible then they will find it interesting’ (p. 58). Further, comprehension and 
novelty are hinges between interest and other knowledge related emotions such as 
boredom and confusion or uncertainty.  If an event is novel and comprehensible it is 
interesting but if it is novel and incomprehensible it is confusing (p. 58).  By extension, 
if an event is comprehensible but not novel then it is boring.   The addition of novelty 
onto the familiar is also evidence of how media producers ‘‘twitch’ the plot from time 
to time in order to retain audiences’ interest’ (Seale, 2002: 36, emphasis added) 
(§2.2.2).  An event’s comprehensibility, or the coping-potential required for an event, 
may also be related to its ‘familiarity’ and this is discussed alongside repetition below. 
2.3.3.1.2 Repetition  
Polletta proposes that ‘stories resonate through a combination of familiarity, 
pleasurable surprise, and emotional identification’ (1998b: 425). The above discussion 
around ‘interest’ and injustice begin to address the surprise and emotional elements of 
Polletta’s proposal. ‘Familiarity’ is argued to result from repetition, a discursive 
strategy at the heart of all discourse (Tannen, 2007: 49), and which gives talk ‘a 
character of familiarity, making the discourse sound right [and] is a verbal analogue to 
the pleasure associated with familiar pleasurable surroundings’ (p. 62).  Unlike 
Kedrowski and Sarow (2004) in their negation of the significance of ‘particular details’, 
Tannen instead shows how ‘the particularity and familiarity of detail makes it possible 
for both speakers and hearers to refer to their memories and construct images of 
scenes: people in relation to each other engaged in recognizable activities’ (2007: 134) 
and that this is essential in forcefully dramatising the emotional impact of an event (p. 
159). These images ‘fire the individual imagination’ (p. 134) precisely because they are 
constructed as recognisable through familiar details.  Tannen proposes that there are 
three ways of thinking about repetition:  
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• self-repetition or allo-repetition (the repetition of others) 
• a fixity-novelty continuum with a play between the fixed and the novel 
from exact repetition through to paraphrase 
• a temporal continuum from synchronic (immediate) to diachronic 
(delayed) repetition – between the near and distant verbal environment 
(Tannen, 2007: 63) 
These interrelating forms of repetition indicate that language is more pre-patterned 
than one may think or prefer.  Rather than this view of language favouring structure 
over agency, it instead addresses the ‘delicate balance between the individual and the 
social’ (Tannen, 2007: 99). Repetition thus has something to say about how the 
‘individual speaks through the group and the group speaks through the individual’ (p. 
100).  Perhaps it is the repetition of others’ language, through the accumulation of 
prior text that led Snow and Benford to argue, using the language of the Bakhtin circle, 
that frames are a ‘‘dialogical’ phenomenon; their essence resides “not within us but 
between us” [addressing] the interindividual, interactional and contested process of 
framing’ (Snow and Benford, 2005: 207).   
The common reporting of the thoughts, ideas or speech of others is typically 
referred to as ‘reported speech’.  However Tannen insists that this term is ‘grossly 
misleading as one cannot speak another’s words and have them remain primarily the 
other’s words’ (2007: 104).  She instead refers to this phenomenon as ‘constructed 
dialogue (...) a recontextualisation of words in a current discourse’ (p. 17) and is a 
discursive strategy which enhances the speaker’s ‘credibility as they present positive 
images of themselves and negative images of their opponents’ (p. 18).  Thus, 
utterances spoken by someone else and repeated in some form by another speaker 
cease to be those of the speaker to whom they are attributed and are appropriated by 
the speaker repeating them. Further, everyday language and its ‘accumulation of prior 
texts’ (Tannen, 2007: 49, 103) involves taking words which have existed ‘in other 
people’s mouths, in other people’s contexts, serving other people’s intentions’ 
(Bakhtin, 1981: 294) and making them serve our own intentions in our own contexts.   
The essence of such a line of theoretical enquiry is also reflected in the attention 
to the ‘cracks in the frame’ (Steinberg, 1998: 847 see also Snow and Benford, 2005), or 
shortcomings in practice if not in theory, of the framing literature (see Benford, 1997 
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for an insider's critique).  These at least include the tendency of frame analysis to yield 
more descriptive heat than analytical light (Benford, 1997) by producing lists of frames 
like lists of themes and also to ‘psychologise what is sociological’ (p. 420).  Steinberg 
shows how ‘tilting the frame with a discursive turn’ (1998: 862) addresses such ‘cracks’ 
and allows framing to be seen as a dialogic process (see also Bakhtin, 1981).  In 
addition to recognising the implied dialogue with at least one other voice, and 
potential ‘heteroglossia’ (Bakhtin 1981) or ‘multi-voicedness’, Steinberg argues a 
dialogic focus addresses the insufficient attention given to how actors use discursive 
skills to delegitimize other’s version of the truth by ‘snatching their words from their 
mouths’ (Steinberg, 1999: 772) and appropriating them with one’s own twist for one’s 
own purpose. 
In sum, this section has shown the usefulness of the framing concept for 
understanding how individuals and collectives interpret their world (Goffman, 1974; 
Entman, 1993).  This concept, as presented here, focuses on the activities of social 
movement actors and how they seek to produce or transform meaning around some 
aspect of reality (Benford and Snow, 2000).  It helpfully identifies a range of features 
that contribute to understanding how new social movement actors might seek to 
construct their desired messages to audiences—frame amplification, transformation, 
resonance; contested processes of framing; ideas around emotions like injustice and 
‘interest’; repetition and the dialogical nature of framing.  As such, and given that all 
‘meaning can be gleaned only by reference to a set of culturally familiar scenarios 
(scripts or frames)’ (Fillmore (1976, 1985) cited by Tannen 2007: 54), it offers a useful 
starting point for analysing how actors around a potential PCa HSM may seek to 
produce or transform messages around aspects of PCa.  Smith (2005) though suggests 
that understanding meaning through frame analysis has only ‘nuisance value’ and that 
the ‘fragmentary nature of frame analysis permits only guerrilla warfare against the 
dominant paradigm (….) what is required is some heavy artillery, not yet more 
scattered sniping’ (Smith, 2005: 10).  By this he means that it is structures within 
narrative which ‘are pivotal as the bearers of meaning’ (p. 14) and which make action 
‘legitimate and thinkable’ (p. 3)—‘people make sense of the world with stories and act 
accordingly’ (p. 18).  Likewise Polletta (1998a) suggests that the narrative ‘‘captures 
the action-compelling character of the discourse around the sit-ins better than does 
the concept of frames by virtue of narrative's combination of familiarity and 
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undecidability, convention and novelty, and truth (representing reality) and fiction 
(constituting reality)” (p. 152). 
2.4 Telling stories: narrative theory 
The poetic notion that ‘The universe is made of stories, not atoms (Rukeyser, 1994: 
135) recognises the universal tendency of human beings to tell stories about 
themselves or others (Bury, 2001).  Close analysis of stories allows examination of the 
connections between biography and culture (Riessman, 2008) and the recursive and 
repetitive nature of social practices common to both individual actors and social 
structures across space and time (Giddens, 1984).  My research aim in this thesis is to 
collect and analyse a variety of narratives—illness narratives which vary across time 
and type—to answer the research question of whether PCaOrgs or the UK print media 
have been a force for change in the UK regarding how PCa has been experienced by 
MWPCa.  My aim in this section is to describe different aspects of narrative theory 
including the debates around it, how narratives are defined, the different types of 
narratives and the forms and structures which they are composed of. 
2.4.1 Illness narratives 
The increasing focus on the lay perspective of illness—sometimes termed 
‘pathographies’ (Hyden, 1997; McKay and Bonner, 2002), ‘disease narratives’ (Brown 
et al., 2004) but more often ‘illness narratives’—began to emerge over the last thirty 
years or so (Hyden, 1997; Mishler, 2005) as a legitimate source of sociological enquiry 
into the ‘voice that was strong enough to stand up against the voice of medicine’ 
(Hyden, 1997: 49).  Thomas (2010) though suggests that any sociological enquiry into 
illness narratives sooner or later encounters the well-known ‘storm in the academic 
teacup’ (Morse, 2001: 587)—of which there are several elements. Examination of 
illness narratives is claimed to: privilege story-telling over story-analysing and the 
ostensibly authentic feelings and experiences of the participant over other forms of 
data; romanticise illness sufferers as heroes in contrast with villainous doctors; and 
lack methodological and analytical rigour (Atkinson, 1997 reproduced in 2006).  
The crux of this debate may reflect tension between public and professional 
sociologies (Thomas, 2010; Bury and Monaghan 2013a); the former concerned with 
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producing extra-academic knowledge for patient groups, the latter with producing 
academic knowledge for peers.  Public and professional sociologies are though 
interfacing ‘ideal types, each of which is internally complex’ (Burawoy, 2004: 1609).  
This is not least because professional knowledge is instrumental for public 
knowledge—an effective public sociology depends upon a professional sociology in 
providing ‘legitimacy, expertise, distinctive problem definitions, relevant bodies of 
knowledge, and techniques for analyzing data’ (p. 1610).  Correspondingly, Burawoy 
argues, the engagement of public sociologists in political and moral concerns beyond 
the academy makes the pursuit of methodological and theoretical coherence all the 
more worthy.   
Responding to Atkinson’s (1997, reproduced in 2006) claims, Frank (2000) argues 
that though ‘narrative’ suggests structures within stories which a knowledgeable story-
analyst may seek, story-tellers do not usually think of themselves as telling narratives 
and subsequently do not consciously adhere to any structures.  Focusing on narrative 
structures may then privilege the story-analyst standpoint and risk excluding what is 
most important to storytellers, for example argues Frank (2000), their self-
recuperation, self-preservation and remoralisation (p. 354).  Frank’s later work though 
suggests that while ‘people tell stories that are very much their own (…) they do not 
make up these stories by themselves (2010: 14)—thereby indicating that when illness 
sufferers offer, say, moral accounts of themselves, they may, albeit unconsciously, 
draw on available and acceptable ways, or structures, of telling and knowing.  Though 
‘narrative’ evades a definitive explanation (Riessman, 2008), Table 2.1 exemplifies 
some common components: 
Table 2.1 Common components in definitions of narrative 
Author Understanding Components 
Kleinman 
1988: 49 
‘The illness narrative is a story the 
patient tells, and significant others 
retell, to give coherence to the 
distinctive events and long term 
course of suffering.  The plot lines, 
core metaphors, and rhetorical 
devices that structure the illness 
narrative are drawn from cultural and 
personal models for arranging 
experiences in meaningful ways and 
for effectively communicating those 
1. Simultaneously positioning 
of  narrative and story  
2. Telling  stories 
3. Giving coherence to 
events 
4. Creating a plot 
5. Using metaphors and 
other figures of speech 
6. Drawing on cultural and 
personal resources  
7. Recognising audience 
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meanings’.  
Hyden, 1997: 
49 
‘we create frames for understanding 
and judgment and link them to the 
everyday circumstances of our lives 
by drawing on divers [sic] moral and 
political discourses. The narrative's 
importance lies in its being one of the 
main forms through which we 
perceive, experience, and judge our 
actions and the course and value of 
our lives’. 
1. Drawing on cultural 
resources to link with 
individual circumstances 
2. Simultaneously positioning 
of  frame and narrative  
 
Bury, 2001: 
264 
‘The telling of stories, whether about 
oneself or others, is universal. The 
development of language in human 
life, in both evolutionary and 
individual terms, leads to the 
elaborate use of metaphors and 
other figures of speech, and thus 
narrative form. All human cultures (or 
cultural segments) rely on such 
symbolic repertoires in order to 
achieve a minimum of social 
integration’. 
1. Telling stories 
2. Simultaneously positioning 
narrative and story  
3. Using metaphors and 
other figures of speech 
4. Drawing on cultural 
resources to integrate 
socially 
5. Creating, sustaining  and 
restoring meaning in 
everyday life 
Riessman, 
2008: 3, 105 
‘in everyday storytelling, a speaker 
connects events into a sequence that 
is consequential for later action and 
for the meanings that the speaker 
wants listeners to take away from the 
story.  Events perceived by the 
speaker as important are selected, 
organized, connected and evaluated 
as meaningful for a particular 
audience’ 
 
‘stories don’t fall from the sky (or 
emerge from the innermost “self”); 
they are composed and received in 
contexts – interactional, historical, 
institutional, and discursive – to 
name a view.  Stories are social 
artefacts, telling us as much about 
society and culture as they do about 
a person or group.’ 
1. Temporal ordering of 
events  
2. Creating plot 
3. Recognizing audience 
4. Selecting salient events 
5. Organizing, connecting 
and evaluating events 
Frank, 2010: 
25-26 
‘One thing happens in consequence 
of another (….) [tick tock] each tick 
creates an expectation for the 
corresponding tock to follow’ 
1. Recognizing audience 
2. Temporal ordering of 
events – tock follows tick 
Czarnisaskwa, 
2004: 5 
‘[people do not] tell stories as they 
please and, in so doing, shape their 
1. Telling stories less agency 
2. Drawing on cultural 
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lives as they see fit. (….) we are never 
the sole authors of our own 
narratives; in every conversation a 
positioning takes place (Davies and 
Harre 1991) which is accepted, 
rejected, or improved upon by the 
partners in the conversation’ 
resources 
3. Recognising audience 
4. Co-construction of story 
Table 2.1 shows the commonalities in how a variety of authors have understood 
narratives. These at least include: a temporal ordering of events; involving the 
audience in the co-construction of meaning; drawing on circulating cultural, political or 
moral ways of speaking; and creating a plot.  The often simultaneous positioning of 
‘narrative’ and ‘story’ shows that there is not a consistent distinction between these 
terms; I thus use these terms interchangeably throughout this thesis. 
2.4.2 Narrative types 
Hyden (1997) draws attention to the relationship between the narrator, the narrative, 
and the illness and proposes three types of illness narratives: 1) illness as narrative; 2) 
narrative about illness; and 3) narrative as illness.  First, an ‘illness as narrative’ is 
where the narrator, illness and narrative may be combined in one person depicting 
‘events that have been experienced personally and pose problems for the individual in 
one way or another’ (1997: 54). Second, in a ‘narrative about illness’, knowledge and 
ideas are conveyed by a narrator about an illness.  Third, a ‘narrative as illness’ refers 
to situations in which (an insufficient) narrative, or indeed an inability to create a 
narrative, indicates an illness, for example, a brain injured person unable to tie 
together particular experiences and events.  
2.4.3 Narrative forms and analysis 
I now draw on Bury’s (2001) three types of non-mutually exclusive narrative form: 
contingent, moral and core and use this as a basis for understanding how narratives 
are analysed.  I use the ideas of several other narrative and literary scholars to build 
upon this basis (for example: Bakhtin, 1986; Bury and Monaghan, 2013a; Frank, 2010; 
Hyden, 1997; Kelly and Dickinson, 1997; Polletta, 2006; Riessman, 2008; Tannen, 
2007). 
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2.4.3.1 Contingent narratives 
Contingent narratives address ‘beliefs and knowledge about factors that influence the 
onset of disorder, its emerging symptoms, and its immediate or ‘proximate’ effects on 
the body, self and others’ (Bury, 2001: 268).  They thus deal with the immediate 
temporal unfolding of the illness from its onset, the strategies used to manage its 
effects and the relationship between those ill and those they interact with (Bury and 
Monaghan, 2013a).   Bury (2001) suggests that Hyden’s (1997) ‘illness as narratives’ 
and ‘narratives about illness’ types may be constructed within the same narrative 
when respondents’ stories combine their lay beliefs with increasing familiarity with 
medical knowledge.  Bury goes on to suggest that contingent narratives are concerned 
with how an ill person manages the effects of the illness on family and friends and 
includes aspects of: 1) normalisation; 2) coping; and 3) the strategic management of 
illness.   
First, normalisation, Bury (2001) proposes, may be achieved either in the 
maintenance of one’s pre-illness identity or the incorporation of illness into a changed 
identity.  Maintaining one’s pre-illness identity means that when people tell stories of 
themselves they are unlikely to disclose aspects of their illness.  In contrast, people are 
more likely to disclose a variety of aspects of their illness when they seek to 
incorporate their illness into a changed identity.  Second, people’s talk about how they 
cope with illness deals with the practical management of interactional issues of 
disclosing illness to family and friends.  Bury (2001) suggests that coping talk may be 
performative in that it allows a preferred, likely virtuous, self to be presented to 
others. Though he does not reference it directly, Bury’s observation is similar to that 
which Wilkinson and Kitzinger (2000) argue is a moral imperative for women with 
breast cancer to ‘think positive’.  Wilkinson and Kitzinger (2000) show how the 
‘positive thinking’ talk of these women is ‘interactionally occasioned’ (2000: 809) in 
using a ‘taken-for-granted piece of cultural knowledge’ (2000: 802) to enable the 
disclosure and convenient ‘wrapping up’ (2000: 803) of troubles telling; in turn 
relieving the ‘listeners of a potential conversational burden’ (2000: 805).  Third, the 
strategic management of illness includes describing the pacing of work and home 
activities and the mobilisation of social support. 
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2.4.3.1.1 Disclosing illness and prostate cancer 
There are few studies which consider how MWPCa disclose their illness.  The most 
salient of these is a Canadian longitudinal study focusing on how MWPCa opting for 
surgery as treatment, and their spouses, manage decisions about telling or not telling 
others in their social and business networks (Gray et al., 2000).  These authors propose 
that, given the massive increase in media coverage1 and corresponding public 
awareness in the decade preceding the publication of their article, ‘prostate cancer has 
ceased to be hidden to public gaze’ (2000: 274).  If so, there are consequences for how 
MWPCa may feel about disclosing their illness to others and for the stigma associated 
with a cancer diagnosis (Muzzin et al., 1994). Muzzin et al. (1994) characterise people 
with cancer as having ‘a ‘living-dying’ experience’ (p. 1201), being ‘faced with the 
intolerable incompatibility of life and death’ (p. 1201).  These authors argue that this is 
at least because of the social stigma that others attribute to people with cancer and 
the subsequent problems that such people might have when interacting with others.  
People with cancer, they argue, might then choose to not disclose their diagnosis when 
they are interacting with particular groups of people.  Goffman (1963) understands 
stigma as a mark of disapproval; either visible and discrediting or invisible and 
discreditable.  Some marks of cancer are visible with the possessors of such marks 
discredited, for example hair loss as a result of chemotherapy; other marks though are 
invisible with the possessors instead discreditable, for example, impotence and 
incontinence resulting from radical prostatectomy or hormone treatment for PCa.  The 
challenge for the discredited is to ‘manage impressions’; for the discreditable to 
‘manage information’.   
Gray et al. (2000) hypothesise that MWPCa are beginning to be seen in a positive 
manner similar to that for women with breast cancer and that it may be less socially 
dangerous for men to acknowledge their health status to friends and acquaintances.  
This is despite their recognition that PCa potentially constitutes the double stigma of 
life threatening illness and sexual dysfunction related to treatment.   
Gray et al. (2000) conduct interviews with MWPCa and their spouses 
simultaneously and separately: pre-surgery; 8-10 weeks post-surgery; and 11-13 
                                                     
1 They explicitly reference Clarke (1999) in support of their argument that media coverage has greatly 
increased.  However, this is a misinterpretation of Clarke’s sample size who instead laments “the very 
few articles on prostate cancer in the media over the time period covered” (Clarke, 1999: 70) and their 
“paucity” (p. 70) when compared with articles on breast cancer. 
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months post-surgery.  The primary concern is on how men share information with 
others, besides their spouse, about their diagnosis and ongoing condition.  They find 
that most MWPCa avoid disclosure about their illness where possible to others other 
than their spouse.  The strategies men use for disclosing include concern with who 
needs to know; whether the men themselves need information from others; and an 
imperative to warn others.  Men, for example, feel obligated to be open with their 
family; to prepare them for their potential death during or after surgery; and to warn 
them of familial risk of PCa.  Among employed men, bosses or colleagues are also 
often perceived as needing to know for organisational purposes.  Some men feel that 
disclosing their illness introduces awkwardness into friend and work relationships as 
often people do not know how to be helpful, presenting an unwelcome disturbance to 
pre-illness relationships.  Men do not disclose their PCa to certain audiences: anyone 
outside of their circle of intimates; those who do not need to know; those they think 
would make a joke of it; and those whom they feel are vulnerable in some way, for 
example, frail mothers or those suffering themselves.  While acknowledging that 
others may want to be supportive there is a mixed response to its receipt with some 
men enduring the help for the benefit of those offering help.  Factors influencing this 
limited disclosure are a perceived low need of support; fear of the stigma associated 
with sexual dysfunction; the need to minimize threat of the illness to aid their coping; 
practical necessities in the workplace; and the desire to avoid burdening others.    
 Grunfeld et al., (2013), in their study of men’s experience of working after 
treatment for PCa, explored differences in how MWPCa disclose to their colleagues.  
They found that some men are reluctant to disclose to their colleagues because they 
are embarrassed and worried that they may be stigmatised.  Men are also concerned 
not to be seen as seeking sympathy or causing others to be embarrassed: ‘“[p]eople 
just don’t know what to think when you’ve got those things, cancer. As soon as people 
think that they think “Oh my God, you’re going to be dead within a few weeks” or 
something”’ (p. 78).  The authors though do not further discuss how men show their 
awareness of any interactional difficulty. 
2.4.3.2 Moral narratives 
Moral narratives have evaluative aspects as ‘sufferers seek to account for and perhaps 
justify themselves in the altered relations of body, self and society brought about by 
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illness’ (Bury, 2001: 274).  Narrators may attribute culpability to the self, shift blame to 
an external Other or, indeed, do both. Hyden describes how a suicidal man attempts to 
understand his illness by shifting blame from himself to his parents: the potential 
genetic predisposition for mental illness from his father and the high expectations 
upon him by his mother (1997: 58-9).  Moral narratives also include the pursuit of a 
virtuous presentation of self.  This may involve distancing oneself from the ‘dirty’ side 
of illness; from being seen as a burden to others; or seen as a failure in the face of 
illness. 
2.4.3.3 Core narratives and genres 
Core narratives are instrumental in both contingent and moral narrative forms in 
making available particular language to narrate the moral self and concepts of disease 
and illness. People construct core narratives ‘within cultural settings which provide 
specific forms of language, clichés, motifs, references and other elements of linguistic 
and symbolic repertoires which allow and constrain what is said and how it is 
expressed’ (Bury, 2001: 278). Bury (2001) ostensibly agrees with Frank (2000) that 
when people tell stories they may unconsciously draw on core narratives; people’s 
narratives may then be more ‘pre-patterned’ (Tannen, 2007) than they think.  Such 
pre-patterning can happen when people draw on culturally available ‘genres’ (Bury, 
2001: 278), or ‘‘genres of expression’ (Bury and Monaghan, 2013a: 81) through which 
the narrator ‘emplots’ herself in a more or less dramatic fashion’ (p. 81).  These may be 
epic, heroic, tragic, romantic, comic or ironic, or didactic (Bury, 2001) or apocalyptic 
(Smith, 2005).   
The suggestion that romantic genres are a struggle for personal meaning and 
identity (Kelly and Dickinson, 1997) is rather vague and seemingly redundant, not least 
given that narratives, generally, whatever the genre used, are considered to be sites 
for constructing and contesting identity (Riessman, 2008; Bury and Monaghan, 2013a).  
Drawing upon a heroic narrative is common, for example with media accounts typically 
describing those suffering from serious illness in terms of a ‘courageous ‘fight’ by the 
sufferer’ (Kelly and Dickinson 1997: 268) (see the media portrayal of children suffering 
from cancer in heroic terms (Dixon-Woods et al., 2003)).  Similar to the romantic genre 
though, at least as understood by Kelly and Dickinson, the heroic genre is somewhat 
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lacking in specificity, seeming to fit within both tragic and romantic genres.   More 
useful is Smith’s (2005) explanation of a romantic-tragic genre continuum: 
Where tragic frames exist the corresponding structure of feeling is not one that 
sustains activism or violent struggle. There is an amplified awareness of 
suffering, an atmosphere of pathos, and a belief that human motivations are 
misguided and can lead only to poor outcomes.  If tragedy involves a futile 
struggle against the fates, the ubiquity of bad choices, the inevitable failure of 
heroic actions, and the horror of consequent suffering, the essence of romance 
is the triumph of the hero over adversity. Not necessarily about love, this is a 
fundamentally optimistic genre marked by the belief that actions can make a 
difference and that change for the better is in the air. In romance the hero is 
motivated by high ideals and overcomes a series of obstacles, challenges, and 
enemies associated with powers deemed evil. (Smith, 2005:25-26) 
The romantic genre, continues Smith, is inspirational for social movements as it carries 
with it a hope that a wrong, or a wrongdoing antagonist, may be subject to successful 
negotiation to become good.  Bury notes that people are not necessarily consistent in 
their use of genres and move say from tragic to ironic or heroic to comic as they see fit.  
This will, he suggests, mainly ‘depend on the context in which the narrative is being 
constructed and presented, and on the intentional acts which they help to constitute’ 
(Bury, 2001: 280). 
Comedic or ironic genres may include mocking of the self or others (Kelly and 
Dickinson, 1997) with irony an aspect of both comedy and tragedy, and comedy 
sharing features of a romantic genre (Smith, 2005).  Kelly and Dickinson (1997) argue 
that humour is a narrative device which renders the suffering of the ill person 
commonplace and which functions to spare ‘the reader/listener pain, since the 
humour signals that the suffering is not to be taken seriously’ (1997: 268).  In this way 
the narrator creates a social distance from the suffering providing a practical 
intersubjective cue for the listener/reader to do likewise (p. 270).  To this extent then, I 
suspect that comedic and ironic genres are instrumental in contingent narratives of 
coping (Bury, 2001) and may likewise allow the convenient disclosure and ‘wrapping 
up’ of troubles (Wilkinson and Kitzinger, 2000).   
Epic genres involve an identification with or defence of existing social values 
(Kelly and Dickinson, 1997). The defence of a social value bears though, in my view, 
similarities to a moral narrative.  In their study of how personal storytelling functions 
as a mechanism of socialisation in families, Miller, Wiley, Fung and Liang (1997) show 
how didactic narratives are used to convey moral and social standards.  Inasmuch as 
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this is so, didactic genres, or forms, of narrative are at least instrumental in moral 
narratives. 
Whatever genre people use, it is always open to negotiation, always ‘“at risk”’, 
(Bury, 2001: 279) in the everyday interactions people face, particularly with their 
family (p. 279.).  To this extent then, narratives are ‘co-authored’ (Williams, 1984: 181) 
in that they are ‘bounded by and constructed in relationship with various individual 
people and organisations’ (p. 181.). Aspects of co-authorship are also seen when 
narrator and listener actively create ‘emplotment’ (Hyden, 1997: 61) when they seek 
‘to understand and articulate the illness and the illness events as a meaningful whole’ 
(p. 61). ‘Stories work to emplot lives’, argues Frank (2010: 10, emphasis in original), by 
making ‘some particular future not only plausible but also compelling’ (p. 10)—Polletta 
and Ho (2006) make a similar point regarding the work of frames in ‘advancing a 
compelling point of view’ (p. 186).  Although Hyden (1997) limits ‘emplotment’ to 
participants in oral narratives, Crossley and Crossley (2001) convincingly show, through 
written texts, how the mental health ‘voice’ changes over time with the changing 
anticipation of its audience’s reception.  Ideas of co-authorship and emplotment also 
suggest that stories are dialogical—there is always an implied dialogue with at least 
one other voice in any narrative and potentially a ‘heteroglossia’ (Bakhtin 1981; see 
also Riessman, 2008: 107).   Bakhtin (1986) points out that speakers, hearers, writers 
and readers all orientate to an actively responsive understanding and anticipate their 
audience’s agreement.  Similarly, Frank (2010) borrows the term ‘“recipient-designed”’ 
(p. 90) from conversation analysis in his observation that ‘storytelling is tailored to fit 
the expected response of the listener(s), including the listener’s apparent needs and 
purposes, sense of humour, likes and dislikes, and readiness to approve or distain’ 
(Frank, 2010: 90; see also Riessman, 2008: 106).   
In sum, Bury provides three useful means for thinking about how narratives 
might be analysed: contingent, moral and core narrative forms.  Core narratives are 
instrumental for the other narrative forms in that they provide pre-patterned common 
sense language, including genres, which the speaker draws on in the expectation that 
his/her intended audience does likewise in their interpretation.  Narrators are not 
though consistent in how they use this pre-patterned language with their use always 
open to audience negotiation in everyday interaction.  In this way, narratives are co-
authored or emplotted as speakers anticipate their audience’s reaction – sympathetic, 
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objectionable or otherwise – and respond accordingly in the story they tell.  Narratives 
are thus then also dialogic in that there is always an implied dialogue with at least one 
other voice.  The pre-patterned, or repetitious, language of core narratives is used in 
moral and contingent narratives.  Moral illness narratives seek to account for an 
illness, attribute blame, pursue a virtuous self and create distance from undesired 
aspects of the illness.  Contingent narratives, though paying attention to the 
immediate temporal unfolding of the illness and its implications for managing work, 
home and other activities, also contain moral aspects.  Narrators seek to normalise 
their pre/post illness identity and to manage interactional issues of disclosing illness to 
others and to create a social distance from being a burden, interactional or otherwise 
to others.  
2.4.4 Some shortfalls in the illness narrative literature 
Hyden (1997) proposes gaps that are insufficiently addressed in the literature: 1) 
studies comparing illness narratives in the mass media with illness narratives 
constructed by the afflicted; and 2) studies comparing how illness narratives may vary 
over time and social context.  Dixon-Woods et al. (2003) and Crossley and Crossley 
(2001) have since somewhat alleviated this deficiency.  Dixon-Woods et al. (2003) 
compare newspaper and parent’s accounts of childhood cancer1.  They analyse 42 
articles with significant coverage of a child with cancer which occurred during a specific 
week  in 1999 and compare accounts of childhood cancer therein with narrative 
accounts from 20 mothers in England asked to ‘tell the story’ of their child’s cancer.  
They find that though parents and newspaper accounts draw on common discourses 
about parenting, childhood and illness, they also differ significantly.  Crossley and 
Crossley (2001) explain how the ‘voice’ of those diagnosed as mentally ill changed 
between the 1950s and 1990s.  They show that when such ‘voices’ speak they 
accommodate an anticipated audience.  In the 1950s the mental health ‘voice’ 
anticipated, and was shaped by, an unsympathetic, hostile and critical audience.  In the 
1990s, largely due to the work of the anti-psychiatry and survivor social movements 
and spillover from feminism and black liberation movements, the audience of the 
mentally ill ‘voice’ was prepared to listen in a new way.  
                                                     
1 Although even here the parents are still surrogates for their children although the parents are giving 
their narrative of caring for their children 
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2.5 Summary 
In this chapter I have shown how illness and disease can no longer be considered to be 
distinct given that ‘social life matters for morbidity and mortality and vice versa’ 
(Timmermans and Hass, 2008: 661).  I show how a ‘social diagnosis’ (Brown et al., 
2011) considers how HSM actors might contribute to the diagnosis of a health 
condition inasmuch as they are actively involved in the production and transformation 
of meaning.  In the past twenty years, the public visibility of PCa has increased as 
PCaOrgs, as a potential HSM, have appeared in the UK.  Despite this, and an increase in 
social movement studies which have focused on aspects of health and disease, little 
attention has been paid to PCa with no studies of how the emergence of PCaOrgs in 
the UK may produce or transform meaning around PCa.  A social diagnosis also 
considers how the media might contribute to the diagnosis of a condition.  Print media 
are among the most relied on sources of information regarding disease, illness, death 
and medicine for people in general (Clarke, 2004), and MWPCa in particular (Halpin et 
al., 2009).  There are though relatively few studies of print media representation of 
PCa (Halpin et al. 2009) with as yet no study of such representation in the UK and thus 
none comparing how this representation may have changed since the emergence of 
PCaOrgs in the UK.  Furthermore, there are no studies about how changing 
representations of PCa by PCaOrgs and the media may impact on the experience of 
MWPCa. 
I have also shown that the tendency of people to tell stories is universal and the 
sociological examination of these stories sheds light on the repetitive nature of social 
practices over time.  The way people—or organisations or the media—tell stories 
about illness has been an increasing source of enquiry in the sociology of health and 
illness over the last thirty years.  There are though still gaps in this literature, for 
example, studies comparing illness narratives in the mass media with illness narratives 
constructed by the afflicted ad studies comparing how illness narratives may vary over 
time and social context (Hyden, 1997).  The sociological attention to illness narratives 
is despite contentious academic debate over the privileging of narrative data over 
other types of data.  The crux of this debate relates to the ostensible tension between 
producing knowledge which addresses public concerns and producing knowledge 
which advances academic theoretical and methodological expertise.   
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All of the literature reviewed in this chapter helpfully points to the range of 
influences that may shed light on how the research question asked in §1.3: how have 
PCaOrgs and the UK print media been a force for change in the UK regarding how PCa 
has been addressed and experienced by MWPCa?  And, more broadly, what might this 
reveal about the form and function of narratives?  This literature then offers a useful 
starting point for 1) how key individuals within PCaOrgs describe how they have sought 
to address the condition of PCa; 2) the changes in how MWPCa describe their illness 
experience in research interview over this time; and 3) the changes in how the UK 
national print media have represented the illness experience of MWPCa from the 
emergence of PCaOrgs in the UK in the mid-1990s. 
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 Methods and Chapter 3
methodology 
3.1 Introduction 
In this thesis I ask: how have PCaOrgs and the UK print media been a force for change 
in the UK regarding how PCa has been addressed and experienced by MWPCa?  In 
answering this question I aim to investigate: 1) how key individuals within PCaOrgs 
describe how they have sought to address the condition of PCa; 2) the changes in how 
MWPCa describe their illness experience in research interviews over this time; and 3) 
the changes in how the UK national print media have represented the illness 
experience of MWPCa since the emergence of PCaOrgs in the UK in the mid-1990s. The 
methods I used to answer the above research questions and address the research aims 
involved collecting and analysing a variety of illness narratives.  I proceed in this 
chapter to first describe my research design. I follow this by describing the 
methodology underpinning the methods.  I show the broad support in the literature 
for engaging with narratives in such a way that the research enquiry itself plays a 
major part in analytic decisions (Spicer, 2012).  Finally, I describe the methods I use to 
collect and analyse each of the three sets of data.  Here, I present the specific research 
questions and aims for the particular data set and lay out the various research steps 
for each of the data sets: recruitment or sampling, ethical approval, data collection, 
transcription and analysis.   
3.2 Development of research design  
The original methodological design for this thesis included investigation: 1) of the 
changing public image of PCa over time (through UK print media articles and health 
documents from NHS, government and PCaOrgs sources); 2) of the impact on the 
experience of PCa (through five focus groups with MWPCa and their intimate family 
members); and 3) of PCaOrgs (through interviewing leading figures within PCaOrgs) 
(Appendix 2).  A combination of opportunity and necessity led to three changes in this 
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design.  First, focus group interviews with MWPCa and intimate family members1 were 
changed to individual interviews with MWPCa around 2000-2001 and 2010-20122.  
This was due to an early collaboration with the Health Experiences Research Group 
(HERG) at Oxford University responsible for www.healthtalk.org which enabled access 
to 52 transcripts of narrative interviews with MWPCa in 2000.  Access to this 
secondary data prompted the research possibility that similar individual interviews 
with MWPCa could be carried out in 2010 and compared with those in 2000—resulting 
in data about the experience of MWPCa through research interviews over time.  While 
not ideal timing regarding the advent of PCaOrgs in the UK (in the mid-1990s), access 
to transcripts of MWPCa interviewed in 2000 was valuable in offering contemporary 
data on the experience of PCa close to this advent.  Thus, though focus group data—
where group members through agreement and disagreement ‘enthusiastically extend, 
elaborate, or embroider an initially sketchy account: for example through the 
consensual piling up of fine detail’ (Wilkinson, 2004: 180-1) would be lost—other 
interesting analytic comparisons were enabled.   
One such interesting analytic comparison was between the ‘(mass3) mediated 
nature of [the] personal experience’ (Seale, 2003: 513)  of MWPCa and that mediated 
through research interviews with MWPCa.  Though boundaries between ‘hard’ and 
‘soft’ media stories are blurred (Henderson and Kitzinger, 1999), sampling for ‘soft’ 
illness narrative articles over ‘hard’ articles—say about new drugs—offered a better 
comparative ‘fit’ with the rest of the research design.  This was because it allowed a 
‘human face’ (p. 570) to the media representation of PCa.  Thus, the second change in 
the original research design was to sample the UK media for illness narratives of 
MWPCa from 1990-2000 and from 2000-2010.  This corresponded to the two 10 year 
periods prior to each set of illness narrative interviews with MWPCa in 2000 and 2010.   
                                                     
1 The original design also envisaged that some focus group participants would be African or African-
Caribbean in order to explore how ethnically-based cultural differences may influence the degree to 
which the collective identity ‘offered’ to these individuals is taken up. A condition of the funding though 
was that this group should not be focussed on.   A statement from Clive Seale, the funding applicant; ‘I 
am happy to confirm that, although I wanted to include Afro-Caribbean [participants], the funders were 
quite insistent that a condition of funding was that we should not focus on this group. I was quite 
frustrated about this at the time and tried to persuade them, but they insisted on this’ (personal 
correspondence, 15 January 2014).       
     
2 For ease of reference I henceforth refer to the 2000-2001 and 2010-2012 fieldwork as ‘2000 and ‘2010’ 
respectfully 
3 Seale mainly focuses on “traditional popular ‘mass’ media” (p. 516) although he recognises that 
promotion of ‘scripts’ or ‘ways of thinking’ are increasingly found in ‘new’ media such as the internet.   
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Thus, the first change from conducting focus groups to conducting individual 
interviews and the second change from sampling all UK print media articles of PCa to 
sampling illness narratives of MWPCa sat alongside a third originally envisioned and 
unchanged source of data—narrative interviews with advocates around prostate 
cancer (PCaA) (Appendix 2).  These two changes were though consequential for the 
fourth originally envisioned source of data (Appendix 2) regarding the quantity and 
type of data in the study.  The first change meant an increase in data from 5 focus 
groups to 40 individual interviews (20 each from 2000 and 2010).  The second change 
meant a reduction in data from sampling all articles around PCa in the UK national 
print media to only those containing illness narratives.  Though this second change 
meant a reduction in the number of media articles analysed, the proposed method of 
analysis of these articles also changed from a straightforward comparative keyword 
analysis in context to one which paid additional qualitative attention to the narrative 
structure of these articles.  Thus, on balance, this still represented far more data and 
subsequent analysis than originally envisaged.  This then led to a third change—not to 
sample health policy documents concerning PCa from NHS, government or PCaOrg 
sources. Though a valuable research enquiry, it was not practical to proceed because 
of the extra time needed for data collection, analysis, discussion and the space needed 
in this thesis.  Table 3.1 summarises the research design and is indicative of the 
research data which will be fully described in §3.4.   
Table 3.1. Summary of research design and data  
Data No. of Narratives and Time Period 
Early Late 
Illness narratives of MWPCa in the UK 
national print media 
39 (1990-2000) 101 (2000-2010) 
Illness narratives of MWPCa in 
research interviews 
201 (2000) 20 (2010) 
Narratives by prostate cancer 
advocates 
0 21 (2010) 
1Interviews by HERG  for www.healthtalk.org matched along demographic variables (age at 
diagnosis/age at interview and socio-economic– see Table 3.9) of MWPCa interviewed in 2010 
Table 3.1 shows the quantity of narratives collected and analysed for this thesis.  It also 
indicates the diachronic and typological (Hyden, 1997) range of these narratives to 
include: different time periods; illness narratives constructed both in research 
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interview and by journalists writing in UK national print media; and narratives about 
illness constructed in research interview. 
3.3 Methodology 
Here I show the broad support in the literature to engage with narratives not in an 
‘undisciplined, anything goes atmosphere’ (Coffey and Atkinson, 1996: 194) but rather, 
where the research enquiry itself plays a major part in analytic decisions (Spicer, 2012).  
Although many researchers traditionally apply either a quantitative or qualitative 
methodology to data collection and analysis, the ‘ability to innovate [in combining such 
methods] lies at the heart of creative research practice’ (Spicer, 2012: 490).  It also 
responds to Riessman’s encouragement to ‘innovate and transgress the borders’ 
(2008: 18) of incumbent narrative analytic traditions such as thematic and structural 
analysis and newer methods such as dialogic analysis.  My research enquiry is to 
discover the extent to which PCaOrgs and the UK print media have been a force for 
change in the UK regarding how PCa has been addressed and experienced by MWPCa.  
I investigate this enquiry by examining: 1) how key individuals within PCaOrgs describe 
how they have sought to address the condition of PCa; the changes in how MWPCa 
describe their illness experience in research interviews over this time; and 3) the 
changes in how the UK national print media has represented the illness experience of 
MWPCa since the emergence of PCaOrgs in the UK in the mid-1990s. 
3.3.1 Sensitising concepts 
The literature review in Chapter 2 provides possible ‘sensitizing concepts’ (Blumer, 
1954; Bowen, 2006; Charmaz, 2006) with which to approach narrative data.  
Sensitising concepts ‘suggest directions along which to look’ (Blumer, 1954: 7) during 
the iterative process of reviewing literature and developing the analysis and provide 
‘initial ideas to pursue and sensitize you to ask particular kinds of questions about your 
topic’ (Charmaz, 2006: 16).  They are ‘points of departure for developing, rather than 
limiting, our ideas’ (p. 17).  One, rather unfounded, criticism though of using sensitising 
concepts is that they may disrupt an inductive approach to the data (Glaser, 1992)—
where ‘patterns, themes, and categories of analysis come from the data; they emerge 
out of the data rather than being imposed on them prior to data collection and 
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analysis’ (Patton, 1980: 306).  However, analysis is also an ‘inductive–deductive 
interplay (….) [where] [r]esearchers start with a topic of interest, collect data and allow 
relevant ideas to develop’ (McGhee et al., 2007: 335)—a process enabled by use of 
sensitising concepts.   
While the concepts in Chapter 2 provided initial ideas to pursue in investigating 
my thesis, and indeed iteratively helped to form it, in sensitising me to what questions 
to ask of the literature and my data (Charmaz, 2006), I remained open to the emerging 
relevance of other particular and unexpected literatures (Kelly, 2009).  This was 
particularly exemplified in my discovery of the importance of the concept ‘interest’ 
during analysis.  I used NVIVO (v9) software as a means to manage data from the 
MWPCa and PCaA interviews.  One tool within this software is a ‘query’ facility which, 
as I shall explain below, is useful to systematically search the entire dataset if one has 
an analytic hunch about, or is sensitised to, a particular word or concept.  Already 
sensitised to the idea that emotions may be important in my data (Turner, 1969; 
Gamson, 1992; Seale, 1993; Klawiter, 2004; Tannen, 2007; Lakoff, 2010), I inserted a 
list of emotions provided by Wikipedia1 into the NVIVO query facility.  When the PCaA 
data were so queried, of immediate note was the accumulation of data around 
‘interest’ across the 21 interviews, for example (emphasis added):   
I’d write for grants to the cancer charities for research money and get no, get 
nothing, and it seemed that there was no central government interest also in 
prostate cancer in the way that there was an interest in breast cancer (PCa-
MP/2)2 
I think what has changed is the angle that the media is interested in. (….) So 
although they are still very interested in prostate cancer as an issue, it’s not 
about the hidden nature of the disease. It’s not about the legacy of neglect. 
(….) so I think the issues have changed from the media perspective, what really 
interests them and what they’re going to run with (PCa-ORG/3/1) 
the media is not stupid and they start to question that kind of thing, and to 
sustain their interest you have to refresh the cause (PCa-ORG/3/2) 
those with a, what might or might not be a vested interest will continue to try 
and stimulate the idea that, there is some sort of there is a benefit to be 
gained, by detecting more prostate cancers (PCa-MP/1) 
                                                     
1 See Lupton’s blog (Lupton, 2013) on her recognition of academic’s use of Wikipedia as a reference 
source and her encouragement for academics to use this platform to contribute to their body of 
knowledge. 
2 See §3.4.2.1.1 for an explanation of this and other anonymised identifiers used in this section 
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This was surprising—not least because ‘interest’ was not immediately obvious as an 
emotion—and it prompted an investigation of the concept in the academic literature.  
This proved convincing regarding the status of ‘interest’ as an emotion; it also 
subsequently led to its theoretical and analytical importance in relation to ‘resonance’.  
My ensuing analytic attention on ‘interest’, and the discussion above on sensitising 
concepts in general, bears some similarities to what Frank describes as ‘artfulness’ 
(2010: 114), and what McGhee et al. (2007) might like to describe as inductive–
deductive interplay, by Williams (1984) in: “The Genesis of Chronic Illness: Narrative 
Re-construction”.  Frank proposes that Williams’s ‘artful’ use of ‘Bill’s’ question: ““How 
the hell have I come to be like this?”” (Frank, 2010: 114; Williams, 1984) implies that 
Williams’s analytic interest arose inductively from his interviews.  Instead, Frank 
continues, Williams’s decision to focus on the genesis of chronic illness likely derived 
as much from concepts about narrative and illness as spontaneously from his 
interviews.  
3.3.2 Comparative keyword in context analysis 
Inasmuch as sensitising concepts draw attention to important aspects of the literature 
and the data, they may also be considered to be somewhat akin to the notion of 
‘keyness’.  Qualitatively speaking, ‘key’ words are determined ‘after a scholarly, 
interpretive investigation of [their] resonance within a system of ideas’ (Seale et al., 
2006: 2581).  Key words have ‘available and developing meanings’ (Williams, 1976: 13) 
with people making both explicit and implicit connections in their meaning-making in 
their ‘ways not only of discussing but of seeing many of [their] central experiences’ (p. 
13.).  ‘Keyness’, is not only understood qualitatively but also quantitatively (Stubbs, 
1996; Baker, 2006) where it indicates the salience, or ‘proportional statistical 
frequency’ (O'Halloran, 2010: 215) of a word within a text.   
Comparative keyword in context (CKWIC) analysis is a way of inductively 
examining the words or phrases in one corpus, or body of data, which appear ‘key’, or 
statistically frequent (O’Halloran, 2010) when compared with another corpus.   It is a 
conjoint quantitative and qualitative analytic method which reduces ‘arbitrariness in 
what is selected as salient’ (p. 215) and which is ‘particularly suitable for use with large 
volumes of qualitative data where the systematic detection of differences between 
groups is a primary analytic purpose’ (Seale et al., 2006: 2577-8).  A word is 
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determined as quantitatively significantly ‘key’ by taking into account the size of each 
corpus, the frequencies of each word within them and then carrying out a statistical 
test of difference in frequency of words with the significance of this difference 
measured by a probability (p) value.  Two means commonly used to determine the 
significance of keywords are the chi-square test and log-likelihood statistic (Rayson et 
al., 2004); the choice of which one to use is indicated by their reliability for at least the 
size and ratio of the compared corpora.  The choice of p value is indicative of not only 
the amount of confidence that may be had that the word is key due to the conscious 
or unconscious choice of the author rather than by chance (Baker, 2006) but also by 
the number of keywords the investigator deems necessary for analysis.   
In as much as CKWIC is a quantitative analytic method it may be considered to be 
a specialised form of content analysis.  Content analysis is a quantitative method for 
analysing text for the ‘frequency of specific terms, narratives or concepts’ (Seale and 
Tonkiss, 2012: 460).  It may though not only be used for producing simple counts but 
combined with other methods to produce a more interpretive analysis of meaning in 
context (p.464).  It is frequently used for analysing print or television media content, 
policy documents and political speeches.  Studies using content analysis often use 
Nexis, or some other database, to search for data and some method of computer 
assisted data analysis software to examine a variety of substantive topics. Such studies 
include examining: how worldwide print media valorised men and women with cancer 
(Seale, 2002); obesity framing in the New York Times and prime time television news 
(Lawrence 2004); the effect of media portrayals of removal of human tissue from 
children for biomedical purposes on subsequent registrations with the UK Children’s 
Cancer Study Group tumour bank (Seale et al. 2005); coverage of Herceptin in UK 
national print news (Wilson et al., 2008); and changes in ‘cancer’ portrayal over time in 
major Canadian daily newspapers Henry et al. (2012). 
Like content analysis, studies using CKWIC analysis often use Nexis to search for 
data and computer assisted software to examine a variety of topics.  Also, like a more 
interpretive content analysis, CKWIC combines statistical quantitative and qualitative 
notions of keyness as it ‘reduces arbitrariness in what is selected as salient’ (O’Halloran 
2010: 215) and worthy of further investigation.  Thus CKWIC and content analysis may 
both be ‘a more purely inductive approach than that of the qualitative analyst who 
deploys inference at a much earlier stage’ (Seale et al., 2006: 2581).  Where CKWIC 
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differs from an interpretive content analysis is that it inductively examines words or 
phrases in one corpus which appear ‘key’ when compared with another corpus and is 
particularly suitable for research questions where the detection of differences 
between texts is a principal research enquiry (Seale et al., 2006).  CKWIC analysis is 
used in a variety of health and social contexts: the relevance of gender in online cancer 
support groups comparing breast and prostate cancer experience (Seale et al., 2006); 
differences in pro- and anti-hunt arguments in parliamentary debates (Baker, 2006); 
media constructions of sleep and sleep disorders (Seale et al., 2007); interaction of 
class and gender (Seale and Charteris-Black, 2008); changing media portrayal of 
anorexia (Shepherd and Seale, 2010); comparisons between formal and informal 
weaning advice to first time mothers (Moore, Milligan, Rivas, and Goff, 2012); and how 
people with osteoarthritis use ‘pain’ words in their experience of knee and hip pain 
and how men and women use ‘pain’ words differently (Gooberman-Hill, French, 
Dieppe, and Hawker, 2009).  
3.4 Methods 
The substantive focus of this section is on the methods used to collect and analyse a 
variety of narratives concerned with PCa (total n=200): illness narratives of MWPCa 
from the UK print media 1990-2010 (n=140); illness narratives from research 
interviews with MWPCa in 2000 (n=20) and in 2010 (n=20); and narratives about illness 
from actors around PCaOrgs in 2010 (n=21).  This section is laid out in two parts: first I 
describe the processes involved in collecting the data for these three sets of narratives; 
second I describe how I analysed each dataset. 
3.4.1 Data collection 
3.4.1.1 Data collection: media illness narratives of MWPCa 
1990-2010 
My research question asks how PCaOrgs and the UK print media have been a force for 
change regarding how PCa has been addressed and experienced by MWPCa since the 
emergence of PCaOrgs in the UK in the mid-1990s. I aim to answer this question by 
exploring changes in how the media have represented the illness experience of 
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MWPCa.  I now describe how I sampled the 140 illness narratives from the UK print 
media 1990-2010.      
3.4.1.1.1 Sampling illness narratives of MWPCa in UK print media  
A final sample of 140 media narratives was drawn across 2 time periods: 01/06/1990-
31/05/2000 and 01/06/2000-31/05/2010.  Of note is that I originally sampled by 4 five 
year time periods: 1) 01/06/1990-31/05/1995; 2) 01/06/1995-31/05/2000; 3) 
01/06/2000-31/05/2005; and 4) 01/06/2005-31/05/2010.  While the original sampling 
frame allowed a more nuanced examination of media framing of PCa when there was 
little, if any, activity from UK PCaOrgs1, the dual time period sampling frame provided 
a better fit with the overall research design.   
I used Nexis UK, a commercially available on-line database of newspaper 
articles, to retrieve all articles appearing in the English language UK national press from 
01/06/1990 to 31/05/2010 containing three or more mentions of the words ‘prostate 
cancer’ or ‘cancer of the prostate’ or ‘prostatic cancer’ with no section of the 
newspaper excluded.  To allow for misspellings of ‘prostate’, for example prostrate and 
postrate, I also searched for articles containing three or more mentions of these 
phrases with the misspelled words.  No graphics were included as Nexis UK reproduces 
text only.  This process retrieved 1,271 articles across 18 newspapers (or 21 if Sunday 
equivalents are distinct) and their distribution is shown in Table 3.2.  Of note, while 
broadsheet newspapers and their Sunday equivalents were accessible separately, for 
example Sunday Times and Times (rows 2-3), many non-broadsheets were combined 
with their Sunday equivalent, for example, Daily Mail and Sunday Mail (row 7). 
Table 3.2. All media articles drawn by newspaper across time  
 Newspaper 01/06/1990 -
31/05/2000 
 
01/06/2000 - 
31/05/2010 
Total 
1.  Guardian  32 51 83 
2.  Sunday Times  12 27 39 
3.  Times  56 129 185 
4.  Independent  24 57 81 
5.  Independent on Sunday  3 5 8 
6.  Observer  71 29 36 
7.  Daily Mail & Sunday Mail 541  300 354 
8.  People  11  4 5 
                                                     
1 The Prostate Cancer Research Foundation (PCRF) and The Prostate Cancer Charity (TPCC), for example, 
were established in 1993 and 1996 respectively - see first note in § 1.2 
78 
 
9.  Mirror & Sunday Mirror  261  117 143 
10.  Business 12  0 1 
11.  News of the World 02  4 4 
12.  Daily Express 22  132 134 
13.  Sunday Express 12  14 15 
14.  Sun 12  82 83 
15.  Daily Telegraph * 78 78 
16.  Sunday Telegraph * 8 8 
17.  Daily Star & Sunday Star * 8 8 
18.  Morning Star * 6 6 
 Total articles 220 1051 1271 
1not fully uploaded 01/06/1990-31/05/1995 but fully uploaded 01/06/1995-31/05/2000 
2not uploaded at all 01/06/1990-31/05/1995 and not fully uploaded 01/06/1995-31/05/2000 
*not uploaded at all 01/06/1990-31/05/2000 
Each of these 1271 articles were scan read in order to select those containing any 
coverage of the life or death of a named MWPCa.  Table 3.3 shows the distribution of 
the resulting 427 articles across 12 newspapers (combining newspapers where 
relevant with their Sunday equivalents) across time.  Therefore, of all the articles 
sampled in the UK national newspapers available online via the Nexis UK database 
containing three or more mentions of key phrases around PCa, slightly over one third 
referenced the life or death of a MWPCa.  
Table 3.3. Coverage of life and death of MWPCa across all online UK 
national newspapers (01/06/1990-31/05/2010) 
 Newspaper 01/06/1990- 
31/05/2000 
01/06/2000- 
31/05/2010 
Total 
1.  Times  & Sunday Times 23 51 74 
2.  Independent & Independent on Sunday 6 21 27 
3.  Guardian  & Observer 141 28 42 
4.  Daily Mail & Sunday Mail 341 82 116 
5.  The Mirror & Sunday Mirror 131 30 43 
6.  People  01 4 4 
7.  Business 12 0 1 
8.  The Sun & News of the World 12 40 41 
9.  Daily Express & Sunday Express 12 49 50 
10.  Daily  & Sunday Telegraph * 273 27 
11.  Daily Star & Sunday Star * 23 2 
12.  Morning Star * 03 0 
 Total 93 334 427 
1not fully uploaded 01/06/1990-31/05/1995 but fully uploaded 01/06/1995-31/05/2000 
2not uploaded at all 01/06/1990-31/05/1995 and not fully uploaded 01/06/1995-31/05/2000 
3not fully uploaded 01/06/2000-31/05/2005 
*not uploaded at all 01/06/1990-31/05/2000 
However, Table 3.2 and Table 3.3 show that not all newspapers were uploaded to the 
Nexis UK database in the earlier time periods.  Rows 1-2 show that only two 
newspapers (or four with Sunday equivalent) were uploaded at the start of the 
sampling period on 01/06/1990.  Rows 3-6 show that a further four (or seven with 
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Sunday equivalent) were uploaded to Nexis by 01/06/1995.  In order to examine 
changes in the media illness narratives of MWPCa in UK national print media over 
time, this study sampled only those six newspapers (or 11 with Sunday equivalent) 
which were at least to some extent uploaded 01/06/1990-31/05/1995 and fully 
uploaded thereafter.  Thus, the 121 articles containing three or more mentions of key 
phrases around PCa (rows 7-12 Table 3.3) are excluded from this analysis leaving a 
total of 306 articles (Table 3.5).  
3.4.1.1.2 Taking account of the excluded data 
Paying attention to the potential impact of the exclusion of these articles on the 
dataset, Table 3.4 shows that sampling Nexis UK for all articles in the UK national press 
for three or more mentions of key phrases around PCa, resulted in 934 articles across 
the six newspapers (combined with Sunday equivalent where relevant) which were at 
least to some extent uploaded to Nexis between 01/06/1990-31/05/1995.  Thus, of the 
original 1271 articles 337 articles were excluded as the relevant newspapers were not 
uploaded to Nexis UK to some extent in the earliest time period.   
Table 3.4. All sampled articles in newspapers uploaded to some extent 
01/06/1990-31/05/1995  
 Newspaper 01/06/1990-
31/05/2000 
01/06/2000- 
31/05/2010 
Total 
1.  Times & Sunday Times 68 156 224 
2.  Independent & Independent on Sunday  27 62 89 
3.  Guardian and Observer 391 80 119 
4.  Daily Mail & Mail on Sunday  541 300 354 
5.  Mirror & Sunday Mirror 261 117 143 
6.  People  11 4 5 
 Total articles  215 719 934 
1not fully uploaded 01/06/1990-31/05/1995 but fully uploaded 01/06/1995-31/05/2000 
 
Table 3.5 shows the distribution of these 934 articles containing any coverage of the 
life or death of a MWPCa across these newspapers. 
Table 3.5. All sampled articles in newspapers uploaded to some extent 
01/06/1990-31/05/1995 containing coverage of life and death of MWPCa  
 Newspaper 01/06/1990- 
31/05/2000 
01/06/2000- 
31/05/2010 
Total 
1.  Times & Sunday Times 23 51 74 
2.  Independent & Independent on Sunday  6 21 27 
3.  Guardian and Observer 141 28 42 
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4.  Daily Mail & Mail on Sunday  341 82 116 
5.  Mirror & Sunday Mirror 131 30 43 
6.  People  01 4 4 
 Total 90 216 306 
1not fully uploaded 01/06/1990-31/05/1995 but fully uploaded 01/06/1995-31/05/2000 
Therefore, Table 3.4 and Table 3.5 show that of the articles sampled across the 6 UK 
national newspapers uploaded to Nexis UK at least to some extent during the earliest 
time period (01/06/1990-31/05/1995) and containing three or more mentions of key 
phrases around PCa, approximately one third (306/934) of these made at least some 
reference to the life or death of a MWPCa.  Similarly, rows 7-12 Table 3.3 indicate that 
just over one third (121/337) of the articles excluded through their relevant 
newspapers not being uploaded to Nexis UK in the earliest time period also contained 
content of the life or death of a MWPCa.  In addition to this similarity, another 
noteworthy point regarding this excluded data is that only 3/121 articles (rows 7-9 
Table 3.3 column 2) were from the first time period of 01/06/2000-31/05/2010 and 
thus provide minimal comparative interest for the research interviews with MWPCa in 
2000.  Further, given what is discussed below regarding the 46% reduction of these 
306 articles to 140 illness narratives (or 15% or total articles), it is reasonable to 
assume that a similar proportion of these 121 articles would have contained illness 
narratives.  Thus, the analysis in this thesis potentially excludes approximately 56 
articles predominantly containing illness narratives of MWPCa and these would be 
almost exclusively from 01/06/2000-31/05/2010. 
3.4.1.1.3 Refining sample for illness narratives 
While each of the 306 articles indicated in Table 3.5 included at least some coverage of 
the life or death of a MWPCa, the extent to which this was informative about the 
experience of MWPCa varied widely.   Some articles contained only one sentence of 
the life or death of a MWPCa, for example, “Major Ron is one of the lucky ones” 
(Mirror, 11/12/1998), while others contained several thousand words, for example 
“The Awesome Mr Ripley” (article title, Sunday Times, 23/10/2005).  Using Hyden’s 
(1997) typology, these 306 articles were read again to determine which could be 
categorised as an ‘illness narrative’.   The articles fell, to varying extents, into the first 
two of Hyden’s threefold typology.  For the article to be included in the sample as an 
‘illness as narrative’, I required it to predominantly (50% or more of its word content) 
depict ‘events that have been experienced personally and pose problems for the 
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individual in one way or another’ (Hyden, 1997: 54); and/or to be ‘a story the patient 
tells, and significant others retell, to give coherence to the distinctive events and long 
term course of suffering’ (Kleinman, 1988: 49).  Table 3.6 shows the distribution of 
these ‘illness as narratives’ and ‘narratives about illness’ across the six sets of 
newspapers and across all time periods. 
Table 3.6. Total number of articles containing ‘illness as narratives’ and 
‘narratives about illness’ across time  
Time period Newspaper 
Predominantly 
Illness as 
narrative1 
Narrative 
about 
illness2 
Other3 Total 
01/06/1990-
31/05/2000 
Times  & Sunday Times 9 14 0 23 
Independent & Independent on Sunday 1 5 0 6 
Guardian  & Observer 5 6 3 14 
Daily Mail & Mail on Sunday  19  15  0 34 
Mirror & The Sunday Mirror  5  5 3 13 
The People 0 0 0 0 
Total  39 45 6 90 
 
01/06/2000-
31/05/2010 
Times  & Sunday Times 16 28 7 51 
Independent & Independent on Sunday 8 10 3 21 
Guardian  & Observer 13 10 5 28 
Daily Mail & Mail on Sunday  47 31 4 82 
Mirror & The Sunday Mirror  17 13 0 30 
The People 1 3 0 4 
Total  102 95 19 216 
 
Total across both time periods 141 140 25 306 
150% or more ‘illness as narrative’ (11 contain less than 250 words (5 & 6 from each time period respectively) 
2less than 50% ‘illness as narrative' and may contain narratives about prostate cancer or other health or illness narratives or 
fundraising or campaigning 
3Political contexts (which are less than 50% illness as narrative) or letters/obituaries 
Having now identified those articles which are predominantly ‘illness as narratives’, 
henceforth I dispose of Hyden’s terminology and refer to these simply as illness 
narratives.  McKay and Bonner (2002) suggest that there are marked differences 
between celebrity and non-celebrity illness narratives in that the former may be used 
to revive the flagging career, explain absences or announce forthcoming concerts.  I 
suggest a similar argument could also be put forward for the illness narratives of 
politicians.  While this may be so, my sampling procedure ensures that even those 
articles about celebrities or politicians are predominantly about their experience of 
PCa.  Therefore, my sample includes articles which are predominantly illness narratives 
of MWPCa regardless of any celebrity or political status.  Further Fakhri excludes 
narratives of less than 250 words in order to ‘screen out short texts which might not 
include features of connected discourse’ (1998: 451).  I have though chosen to retain 
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these shorter narratives (5 and 6 in the respective time periods) if the illness narrative 
represents more than 50% of the word count in the article in which they appear.  
In sum then, this sampling procedure has resulted in a final sample of 140 
articles (note the one further exclusion in Table 3.7) which are predominantly about 
the illness narratives of MWPCa out of an original 934 articles containing key phrases 
around prostate cancer in 6 UK national newspapers between the specified dates in 
1990-2010.  Therefore, approximately 15% of the originally sampled articles, or 46% of 
the 306 articles containing coverage of the life or death of a MWPCa, were 
predominantly about the illness experience of MWPCa.  Table 3.7 shows the 
distribution of these articles across the 6 newspapers and time. 
Table 3.7. Total number of articles containing MWPCa illness narratives 
across time  
 Newspaper 01/06/1990- 
31/05/2000 
01/06/2000- 
31/05/2010 
Total 
1.  Times & Sunday Times 9 16 25 
2.  Independent & Independent on Sunday  1 8 9 
3.  Guardian and Observer 5 1 13 18 
4.  Daily Mail & Mail on Sunday  19 1 47 66 
5.  Mirror & Sunday Mirror 5 1 16* 21 
6.  People  0 1 1 1 
 Total 39 101 140 
1not fully uploaded 01/06/1990-31/05/1995 but fully uploaded 01/06/1995-31/05/2000 
*1 article (375 words) excluded due to it being in the Eire edition and thus not accessible to MWPCa in the UK 
3.4.1.2 Data collection: ‘narratives about illness’ by PCa 
advocates 
In this thesis I ask how PCaOrgs and the UK print media have been a force for change in 
the UK regarding how PCa has been addressed and experienced by MWPCa.  I aim to 
answer this question by investigating how key individuals within PCaOrgs describe how 
they have sought to address the condition of PCa since the emergence of PCaOrgs in 
the UK in the mid-1990s.  I now describe the data collection process for this data. 
3.4.1.2.1 Recruitment 
Recruitment negotiations with these participants began in mid-October 2010 with the 
first interview in mid-November 2010 and the last in mid-April 2011.  My first contact 
was a freelance commentator on men and women’s health issues and previous head of 
policy and research in a PCaOrg.  My access to this person was prompted by an opinion 
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piece they had written about PCa in several prominent newspapers.  Another initial 
contact was with a public affairs consultant and lobbyist who worked on behalf of a 
PCaOrg.  I then ‘snowballed’ (Biernacki and Waldorf, 1981) these interviewees by 
asking them to tell me of others whom they thought suitable to participate in my 
research and they each indicated several, sometimes common, potential contacts.  
‘Snowballing’ contacts, a legitimate way of gaining access to the field, ‘yields a study 
sample through referrals made among people who share or know of others who 
possess some characteristics that are of research interest’ (Biernacki and Waldorf, 
1981: 141).  The researcher must ‘develop and control the sample’s initiation, progress 
and termination’ (p. 143) and is, at least, responsible for initiating the referral chain by 
contacting participants and verifying the eligibility of those people identified by their 
current participants.  This process proved unproblematic, perhaps because of the 
combination of my small sample size and the high number of potential eligible 
participants.   
There were 21 participants recruited for this part of the research.  These 
included two public commentators/consultants around PCa; seven medical 
professionals who were influential in PCa awareness and often were also involved in 
PCaOrgs; and twelve participants from 5 PCaOrgs.  There was one public consultant 
and one public commentator each concerned with PCa.  These were given the 
common pseudonym of PCa-PCa and a number relating to the order in which they 
were interviewed.  For example, PCa-PC/2 indicates that this was the second 
commentator/consultant interviewed. 
The seven medical professionals included three consultant urologists (from 
Barts and The London and Belfast City hospitals) and two consultant oncologists (from 
Hammersmith and Belfast City hospitals).  There were five professors in total including 
three of the aforementioned consultants.  All but one of these medical professionals 
also had very significant involvement in either PCa or men’s health organisations as 
founders, presidents, or trustees (The Prostate Cancer Charity, Men against Cancer, 
European Men’s Health Forum, Prostate Cancer Research Foundation, Prostate Action) 
or as organisation members (Men against Cancer, The Prostate Centre).  These 
participants were given the common pseudonym of PCa-MP and a number relating to 
the order in which they were interviewed.  For example, PCa-MP indicates that this 
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participant was a medical professional and was the second such professional 
interviewed. 
Finally, the five PCaOrgs which participated in this research were: The Prostate 
Cancer Charity (now Prostate Cancer UK); The Prostate Cancer Support Federation; The 
Association for Prostate Awareness; Prostate Action; and Men against Cancer.  The 
twelve participants in these PCaOrgs included two chief executives; two chairmen; one 
secretary; one head of media and public relations; one head of policy and campaigns; 
and five managers concerned with volunteer development; information; marketing 
communications; helpline; and African-Caribbean policy and development.  These 
participants were given the common pseudonym of PCa-ORG; a number related to the 
particular PCaOrg; and where appropriate, a number relating to the number of 
participants interviewed in that organisation.  For example, PCa-ORG/3/4 indicates 
that this participant worked for a PCaOrg, which was the third such organisation 
represented in this research and they were the fourth participant from this 
organisation. 
3.4.1.2.2 Ethical approval 
Research ethical approval was granted for this part of the research by Queen Mary 
University of London Research Ethics Committee (Ref: QMREC2010/27) in April 2010 
(Appendix 4).  Due to their public visibility there were particular potential risks for 
some of these participants.  First, during interview they could describe publicly visible 
activities where anonymity may not be easy to ensure.  Second, they could say 
something in their interview which, if published, could damage their own or someone 
else’s reputation.  In order to avert these potential risks I informed these participants 
in the information sent to them (Appendix 9) that I would send them a copy of the 
interview transcription for them to highlight passages that caused them concern and 
which they would prefer not to be published.  In addition, they could require changes 
to particular passages in order that they may be written in a way that preserved their 
anonymity.  Thus, they would have opportunity to check, amend and veto anything 
they said in the interview which they would prefer not to be included in reports arising 
from the study.   
A further issue regarding ethics was my proposal to ask my participants 
“further questions on themes relevant to the research agenda”.  When I was informally 
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seeking advice from the research ethics committee administrator on how to complete 
my ethics application I was advised that it would be beneficial to include 
supplementary information with my ethics committee application regarding what 
these ‘further questions’ might be.  Though it is methodologically unjustifiable to 
develop precise questions in a ‘tell me the story about…’ narrative interview, what was 
methodologically justifiable was to develop potential interview prompts which related 
to what I knew was relevant in the literature I had reviewed to that point.  I thus 
submitted these potential interview prompts (Appendix 6) as supplementary material 
as indicative of what I may ask in interview if the participant did not already talk about 
them in the course of their narrative and if it seemed interactionally appropriate to do 
so.  There was neither requirement for me to ask these questions nor to seek further 
ethical approval for any other question that I decided to ask. 
3.4.1.2.3 Data collection 
All participants gave their consent to participate in the research (Appendix 7).  They 
were then invited to ‘tell the story’ of how they became involved with PCa and the 
organisations associated with it and their reflections on the history and future 
prospects of PCa awareness. The supplementary questions were used only if 
appropriate to the particular participant.  The interviews lasted between 24 minutes 
and 2 hours with most lasting either around 30 minutes or 1 hour.  Most interviews 
were held in the office of the interviewed participant although four were held in a cafe 
and one in the participant’s home.  All interviews were audio-recorded.  In one 
instance I was asked to turn the recorder off as the participant wanted to say 
something ‘off-the-record’.  In another instance, the participant expressed confidence 
in saying something ‘off-the-record’ while the interview was being recorded; perhaps 
confident of the assurances given orally at the start of the interview and in the written 
information sheet regarding their review of the transcription.  Many participants were 
confident they would not say anything in the interview that would identify themselves 
or others in a non-preferred way.  In some instances the reason for this confidence 
was made explicit; that they were professional public orators.  With one exception all 
participants wanted to review their transcription.  The exception was the participant 
who expressed an ‘off-the record’ comment.  Contextual notes were made of the 
interview for some of the participants and alongside the transcription of all.   
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3.4.1.2.4 Transcription 
All interview recordings were initially transcribed to a stage similar to a ‘“first pass” 
transcription (without intonation, emphasis, breathing, overlaps, etc.)’ (Hepburn and 
Potter, 2007: 175) by a professional transcription organisation1.  The transcriptions, 
while providing most of the content of the interview talk, still required checking for 
accuracy of this content and the addition of some other non-verbal indicators of 
interaction such as laughter; pauses of more than a few seconds; noticeable emphasis 
on words; and ‘ehm’s’, ‘er’s’ and the like and this constituted a stage 2 transcription 
(see Appendix 8 for the transcription notation).  The words of both interview 
participants, that is, interviewer and interviewee, were recorded given the co-
authored nature of the narrative.  Of the 21 participants interviewed, 20 transcriptions 
were returned in August 2011 for review with an accompanying letter (Appendix 9).  
Of these 20, 6 neither acknowledged receipt of the transcription nor indicated any 
desired changes;  2 made no changes; 5 made minor changes only (defined as 
correction of typing errors or transcriber mishearing or removal of laughter or 
ehms/ers or the like); and 7 made major changes (defined as rewording or veto of 
talk). 
3.4.1.3 Data collection: illness narratives of MWPCa  
In this thesis I ask how PCaOrgs and the UK print media have been a force for change in 
the UK regarding how PCa has been addressed and experienced by MWPCa.  In 
answering this question I aim to investigate changes in how MWPCa describe their 
illness experience in research interview from a time approximate to the emergence of 
PCaOrgs in the UK in the mid-1990s.  Early on, the research saw collaboration with the 
Health Experience Research Group (HERG) at the Department of Primary Care Health 
Sciences, Oxford University, England.  The HERG2 is responsible for the research which 
appears on www.healthtalk.org, an  award winning website, which along with 
www.youthhealthtalk.org allows public access to over 2,000 people’s experiences of 
more than 60 health related illnesses and conditions.  Interviews take place in 
                                                     
1 www.transcriptionsulike.co.uk.  This was my own business enterprise during my PhD and so I 
personally completed all transcriptions. 
2The HERG is formerly the DIPEx (Database of Individual Patient Experience) Research Group and 
www.healthtalk.org is formerly www.healthtalkonline.org  
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participants’ homes or another preferred location. Interviews are audio-recorded for 
analysis, though they may also be filmed with participant consent. 
This collaboration enabled access to 52 transcriptions of interviews with MWPCa 
in 2000-01 and in return I provided HERG with access to my interviews completed in 
2010 to update www.healthalk.org. Thus, the data were collected over two time 
periods: 1) 2000 by HERG; and in 2010 by me.  Once the 2010 fieldwork period was 
completed, 20 of the interviews completed in 2000 were matched along significant 
variables (age at diagnosis/age at interview and socio-economic status – see Table 3.8) 
with those completed in 2010.  Video, audio or transcription excerpts of some of the 
interviews with MWPCa over these two time periods are accessible on 
www.healthtalk.org (Appendix 10).  The 2010 fieldwork with MWPCa took place in 
London and Belfast where I worked and lived respectively. 
3.4.1.3.1 Recruitment 
Table 3.8. Recruitment summary of MWPCa in 20101 
Recruitment Site Participant 
Packs 
Reply slips Interviews 
Initial 
recruitment 
Belfast City Hospital 129 7 6 
Barts Hospital 80 2 2 
APA1 London 40 1 0 
Casual contact 5 5 5 
Subsequent 
snowball 
recruitment 
From MWPCa interviews 3 0 0 
Advocate interview 5 0 0 
Advocate interview/ 
PCaSO2 SE England 
25 3 1 
Advocate interview 5 0 0 
TPCC Voices * 9 7 
Total   292 27 21 (Belfast: 8 & London: 13) 
1APA – Association for Prostate Awareness; 2PCaSO Prostate Cancer Support Organisation 
*recruitment information on TPCC website; web messages board; and email and print monthly bulletin Jun-Aug 
2011 (Appendix 12) 
Table 3.8 summarises the recruitment for MWPCa in 2010.  The recruitment strategy 
for the 2010 fieldwork was adapted from that of the original www.healthtalk.org 
interviews in 2000 (Chapple and Ziebland, 2002).  Access began in early May 2010 by 
first identifying specialist nurse gatekeepers at both Barts and The London Hospital 
and Belfast City hospitals and also a gatekeeper at the Association for Prostate 
Awareness (APA) in east London.  Access letters (Appendix 9) and sample participant 
information packs (PIPs) were sent to these gatekeepers in early May 2010 asking if 
                                                     
1 See note 1 p.70 
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they would act as participant identification centres and distribute PIPs to MWPCa 
attending the hospital or support group.  PIPs contained four documents: an 
introductory letter to the MWPCa (Appendix 9), a participant information booklet 
produced by HERG and adapted for this research; a document describing 
www.healthtalk.org; a reply slip (Appendix 11) and an addressed envelope1.  Men 
were invited to return the reply slip to me and I would subsequently contact them.  In 
mid-May 2010 I began distributing PIPs to these gatekeepers and was very expectant 
regarding recruitment success given the number of packs distributed (Table 3.8); their 
willingness to take part; and also the support of their attendant consultants (two of 
who would also be interviewed as PCaA participants).   
I made five casual contacts through friends and friends of friends and sent 
these men PIPs.  I also ‘snowballed’ (Biernacki and Waldorf, 1981) these participants 
with those willing to do so taking PIPs for others.  However, this was with limited 
success with the exception of those distributed through the Prostate Cancer Support 
Organisation (PCaSO).  The most successful recruitment was through Prostate Cancer 
‘Voices’; a TPCC network aiming to facilitate user involvement in research and projects 
aimed at improving the experience of MWPCa (Appendix 12).  This resulted in nine 
men contacting me and receiving PIPs and returning reply slips leading to seven 
MWPCa being interviewed. 
3.4.1.3.2 Overcoming recruitment problems 
My expectant success turned gradually to disappointment as between May-November 
2010 I had received only eight reply slips and interviewed seven men.  One reason for 
this was the delay in recruitment at Belfast City Hospital where the associated health 
trust had requested local ethical approval (Appendix 4) which was finally granted in 
November 2010.   
In mid-November 2010 I met with the specialist nurse at Barts and The London 
after having asked her to reflect on whom she gave the PIP to.  She found this an 
interesting task and said she only gave it to those men whom she thought would like to 
take part and whom she thought could describe their experience adequately.  I replied 
that I understood this because, as a qualitative researcher, I seek people who are able 
                                                     
1 The first 160 addressed envelopes were also stamped but I decided to stop this as it did not seem to be 
encouraging response and was using up valuable resources.   
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to reflect upon and describe their experience of illness (Morse, 2002).  However, such 
a person is not always immediately apparent and so to the extent that she was giving 
the PIP only to ostensibly ‘good’ participants, she was potentially missing other 
reflective participants.  We discussed the possibility, and problems, of giving packs out 
to all the men attending her clinic.  Possibilities included putting a PIP with each set of 
notes but problems meant asking other nurses also to distribute packs as she would 
miss other men when attending to another patient.  Also, some MWPCa attending her 
clinic did not speak good English and would not be able to adequately describe their 
experience.  In addition, she expressed her uncertainty over how to introduce the 
pack.  I had already given her a very short guiding script (Appendix 13) but she said she 
did not like to read it out.  I assured her that she did not have to read this but merely 
use it as a guide to how she might introduce the research and PIP. 
Between April-May 2011 I completed seven further interviews.  These came 
from one casual contact, three from PCaSO (to which I recently sent information packs 
having already interviewed its chairman as part of the PCaA interviews) and three from 
Belfast City Hospital.  The latter may have been as a result of a recent visit there to 
interview the consultant as a PCaA participant, deliver more PIPs, and speak briefly to 
the specialist nurse.  When I informed this nurse of the recent increase in reply slips 
she responded, “I'm now adding in that you really appreciate their participation, 
maybe that's doing the trick!” (personal email communication) This response perhaps 
illustrates that persuading men to take part in this (or any?) research depends on 
personal interaction with somebody that they know and who can act as a mediator 
(Oliffe and Mróz, 2005).  This is also exemplified in that all five of the casual contacts 
resulted in interviews (Table 3.8).   
I gave two recruitment presentations to PCa support groups which also had the 
benefit of opportunities to practice communicating my research to a lay audience.  The 
first was to an audience of approximately 30 (mostly men) at the annual general 
meeting of the APA support group in mid-November 2010.  While my presentation was 
ostensibly well received and I personally distributed 15 PIPs, no man returned a reply 
slip.  The second was to an audience of approximately 25 (almost exclusively men) at a 
PCa support group in September 2011 at a hospital near Belfast at the suggestion of 
the specialist nurse at Belfast City Hospital.  Throughout the presentation there were 
both questions by the facilitator and members of the group and also discussion 
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between the men.  In a way it reminded me of the interactive benefits of a focus group 
where group members through both agreement and disagreement ‘enthusiastically 
extend, elaborate, or embroider an initially sketchy account: for example through the 
consensual piling up of fine detail’ (Wilkinson, 2004: 180-1).  One man in particular, 
probably aged in his mid-fifties and recovering from a recent operation to remove his 
prostate, shared his great distress from the treatment side effects.  The other group 
members gave him advice, agreeing and disagreeing with each other over what was 
best.  Many men mentioned their PSA level with one man talking of his ‘watchful 
waiting’ treatment approach and how he was controlling his PSA by diet.  I had 
brought along several PIPs, but only one man took one and I did not subsequently 
receive a reply slip. 
It may be the case that the decision to take part in my research was more 
daunting than taking part in a typical research interview.  This was because potential 
participants were also asked to consider whether they would like the audio (or video if 
they consented) recording of their interview to be publically accessible on 
www.healthtalk.org.  
3.4.1.3.3 Ethical approval 
This part of the study was approved by the Berkshire Research Ethics Committee 
(Reference: 09/H0505/66) under ‘Narratives of health and illness for 
www.healthtalkonline.org and www.youthtalkonline.org’ (Appendix 4). The Belfast 
Health and Social Care Trust requested additional local Research Ethics Committee 
submission and this was approved before the Belfast fieldwork (Reference: 10142SZ-
SP) (Appendix 4).   
3.4.1.3.4 Data collection 
This section relates to interviews with MWPCa completed in 2000 and 2010.  21 
MWPCa participated in the 2010 fieldwork and interviews took place in men’s homes 
(eight men living around Belfast) or in a meeting room at my London office (13 men 
living around London); were all interviewed by me; lasted on mean average 59 minutes 
(range 36-85 minutes); and gave consent for their interviews to be video-recorded (18 
men) or audio-recorded (three men) (Appendix 7).  These interviews were then 
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matched with 201 MWPCa interviewed in 2000 on age at diagnosis/age at interview 
and socio-economic variables (Table 3.9).  The interviews in 2000 mostly took place in 
men’s homes; lasted on mean average 62 minutes (range 23-128 minutes); all but one 
were interviewed by Alison Chapple of Healthtalkonline; and gave consent to be video-
recorded (twelve men) or audio-recorded (eight men).  Most men in both periods (all 
remaining 20 in 2010) were interviewed alone.  All but two men interviewed in the 
2010 fieldwork were of White European ethnicity2 with one Black Caribbean and one 
Bangladeshi.  I do not have specific data on the ethnicity of the men interviewed in 
2000.  The aggregate metadata of the original 52 men interviewed in 2000 indicates 
the majority of these were of White European ethnicity (49) and one each of Black 
Caribbean, Black Nigerian and Indian ethnicity (Chapple and Ziebland, 2002). 
Table 3.9 shows the pseudonym, age at interview, age at diagnosis and socio-
economic classification of each of the participants interviewed in 2010 and their 
matched participants interviewed in 2000. In the presentation of the findings and 
discussion all participants, and any other identified people or places, are given 
pseudonyms.   
Table 3.9. Pseudonym and age characteristics of participants 
Interviews in 2010   Interviews in 2000   
Pseudonym AgeI/AgeD NS SOC 2010 Pseudonym AgeI/AgeD NS SOC 2010 
Alan 72/69 5 Aaron 70/66 5 
Brian 64/64 2 Barry 66/66 2 
Charlie 67/66 2 Calvin 65/63 2 
Don 66/65 2 David 63/62 2 
Ernie 73/67 1 Eddie * 72/65 2 
Fred 51/50 3 Finlay 57/54 3 
Graham 58/56 2 Gary 58/57 1 
Hugh 62/57 2 Harry 63/56 2 
Ivan 88/82 2 Ian 80/77 2 
Joe 61/52 1 James 65/59 1 
Keith 57/54 2 Karl* 59/59 3 
Liam 70/65 2 Lawrence 70/67 2 
Michael 68/65 2 Mark 69/67 2 
Neil 53/47 2 Nathan* 51/50 2 
Oscar 66/58 1 Oliver 63/59 1 
                                                     
1 One MWPCa in 2010 withdrew on receipt of his transcript.  
2 Men self-identified as white/caucausian or white British/Irish/European/Latvian.  I have no ethnic data 
for the 20 MWPCa interviewed in 2000 although 48 of the original 52 were White British 
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Peter 62/60 2 Paul 65/65 3 
Quinn 67 /61 3 Quentin* 68/66 2 
Robert 68 /54 2 Ralph 66/57 2 
Sean 81/80 2 Sam* 83/81 5 
Thomas 57/54 3 Taylor* 55/54 ? 
MWPCa 2010 interviews are matched with interviews in 2000 by AgeI/AgeD and then by occupation by ONS 
Standard Occupational Classification (SOC) 2010; *not a direct match either by occupation or AgeI or AgeD 
Men in both time periods were asked to ‘tell the story’ of their illness from when they 
first suspected they may have PCa to the present day.  Further questions were asked 
to encourage more details of specific events in their narrative or to correct any 
misunderstanding.  In addition, if not already elaborated on in their narrative, other 
questions were asked regarding, for example, diagnosis, treatment and side effects.  
To ensure some similarity with prompting questions asked in the earlier interviews I 
randomly selected 6/52 of the interview transcripts from 2000 and reviewed and 
categorised the questions asked by the interviewer.  Table 3.10 summarises the 
similarities and differences of the sample of MWPCa in 2000 and 2010. 
Table 3.10. Similarities and differences of MWPCa sample 2000 and 2010 
Characteristics of MWPCa 
and interview 
2010 2000 
www.healthtalk.org 
No. of MWPCa  20 20 
Age at 
interview  
50-59  5  5  
60-69  10  10  
70-79  3  3  
80-89  2  2  
Ethnicity  White European  18  Most 
Black Caribbean  1  -  
Bangladeshi  1  -  
Location of interview  and 
interviewer  
  
7 in homes of MWPCa in 
Belfast & 13 in AM’s 
London office (AM1)  
Throughout the UK in 
homes of MWPCa (almost 
all AC2) 
Interview method Interviews start with a ‘tell the story’ narrative followed 
by semi-structured questions on e.g. diagnosis, 
treatment & side effects if not mentioned. Random 
selection and categorization of questions asked in 2000 
to give some similarity of questions asked in 2010  
Purpose of interview To provide other MWPCa with up-to-date information 
about what PCa experience with some interviews 
contributing to www.healthtalk.org  
Mean length of interview  59 mins (range 36-85)  62 minutes (23-128 mins)  
Video/audio recording  17 V & 3A  12 V & 8 A  
Interviewed alone/partner  Alone Alone (most?) 
Transcription  AM  All rechecked by AM  
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1Anne Montgomery; 2Alison Chapple 
3.4.1.3.5 Video recording 
As noted earlier (§3.4.1.3), the www.healthtalk.org interviews with MWPCa in 2000 
though audio-recorded for analysis, were also sometimes videoed with participant 
consent.  Video, audio or transcription excerpts of interviews with MWPCa were then 
made accessible on www.healthtalk.org.  As some of my interviews would be used to 
update www.healthtalk.org with the experience of MWPCa in 2010, I also asked my 
participants for consent to video their interview—for the explicit purpose that some 
video excerpts may be used on this website.  Table 3.10 shows that 17 men gave 
consent for their interview to be videoed.  Though there is increasing sociological 
attention to the role that visual aspects of interaction plays in the practical 
accomplishment of a social activity (Heath, 2004)—such as describing one’s experience 
of PCa—my research question did not require these visual aspects of interaction to be 
transcribed and analysed (Bailey, 2008).  What was of methodological interest was that 
taking part in a video recorded interview was a different experience from an audio 
recorded interview.  As discussed earlier, all narratives are implicitly co-authored as 
speakers anticipate the response of their co-present or non-present audience. The 
video recorder potentially served as a more explicit observable reminder to my 
participants of their non-present audience.   
3.4.1.3.6 Transcription 
All recordings from the 2010 MWPC fieldwork were similarly transcribed to the PCaA 
recordings (§3.4.1.2.4).  As per standard policy for www.healthalk.org all transcriptions 
were returned to the participant for their review. Of the 21 transcriptions, 8 were 
returned with no revisions, 8 with minor revisions and 4 with major.  One participant 
withdrew during my follow up telephone call to him after his long delay in returning 
his transcription.  In withdrawing he said that his illness was “a long time ago” and he 
no longer wanted to take part.  The minor revisions mostly included corrections of my 
mis-hearings, mis-transcribing or mis-spellings, for example, one participant corrected 
my mis-transcribed “enema scan” to “MRI scan”.   Revisions also categorised as minor 
were 2 participants who made small deletions of ehms or ehs; small corrections to 
their grammar; or small corrections to what they wanted to have said, for example, 
94 
 
“switch me to the zoladex, which blocks the +production+ (receptors)” or “I was laying 
there stark +naked+”1.    
While the minor revisions were a useful, very often correcting, exercise there 
were aspects of the major deletions which were of concern to the research and to 
which brief attention needs to be paid.  2/4 major revisions were from the oldest 
participants in the study.  One retired high ranking professional spoke for about 15 
minutes at the start of his interview about his wife’s illness and death and this text he 
deleted along with small amounts of other text regarding his wife and other family 
members.  While this text was useful and interesting for me to serve as a context for 
this man’s experience, it was not necessarily relevant to the analysis and so excluding 
it was not problematic.  A second elderly man, whom I experienced as a very difficult 
participant to the extent that I considered excluding his interview, expressed confusion 
with his transcript and significantly delayed its return.  He made many 
additions/deletions to the first 1 ½ pages of his transcription and I suspect he may 
have liked to have completely rewritten it.  I have reflected elsewhere on difficult 
moments in interviews (Montgomery, 2012) and so it is likely that I will similarly reflect 
on this difficult interview at a later time.  One other participant made smaller and not 
so important deletions.  A fourth participant made very significant deletions around his 
experience to the extent that I wrote to him to ask if he would reconsider these 
changes so that I might consider them in my analysis though they could still be 
excluded for www.healthtalk.org.  He agreed that I could re-include some text while 
keeping other text excluded.    
Returning the transcripts to participants is both a useful and ethical activity.  It 
is useful as it enables appropriate corrections to be made to the transcript.  It is ethical 
as it may help address the power imbalance between ‘interviewee’ and ‘interviewer’ in 
research interviews (Edwards and Mauthner 2002; Sinding and Aronson 2003; 
Liamputtong 2007).  Returning the transcript to the participant may contribute to a 
joint creation of ‘liveable stories’ (Sinding and Aronson 2003: 115), that is stories which 
can be lived with after the researcher has gone.  Perhaps the withdrawal of my one 
MWPCa and the problems that I’ve noted around one elderly MWPCa (at least around 
his perusal of the transcript) has something to do with having a story that can be lived 
with.   
                                                     
1 +text+ was added text and text was text deleted by participants 
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It is also the policy of HERG to write short biographies of the participant and 
‘more about me’ summaries which also appear on the website.  While initially I began 
writing these and sending them to the participants with the transcriptions I stopped 
this as it proved too laborious particularly given that not all recordings would be 
chosen for www.healthtalk.org.  I decided then to wait until HERG had chosen those 
participants whose recordings they wished to use to update their website before 
writing these biographies and summaries and sending them to the participants for 
their review and agreement (see the weblinks in Appendix 10). 
With respect to the illness narratives of MWPCa interviewed in 2000, HERG 
enabled my access to 52 transcripts of MWPCa with corresponding demographic data 
from which I matched 20 MWPCa interviews with the 20 MWPCa interviewed in 2010.  
I subsequently asked HERG for access to the recordings of these 20 interviews so that I 
could check the transcriptions for accuracy and incorporate the interactional features 
that I included in the transcriptions from 2010.  A data transfer agreement was 
obtained. 
3.4.2 Data analysis 
Here I describe how I analysed each of the three datasets of narratives. 
3.4.2.1 Data analysis: comparative keyword in context 
analysis of media narratives 
I now describe the CKWIC analysis of the sampled media illness narratives (§3.4.1.1.1).  
The CWIKC analytic framework allowed me to ask key practical questions of my media 
illness narrative data: 1) which words were significantly more frequently used by 
journalists when writing about MWPCa in 1990-2000 and 2000-2010; and 2) what 
‘aerial view’ (Seale and Charteris-Black, 2008: 456) did this give of how the UK national 
print media represented the illness narratives of MWPCa since the emergence of 
PCaOrgs into the UK in the mid-1990s?  There were five main steps in the CKWIC 
analysis: 1) creating word lists of each corpus of text; 2) identifying words significantly 
more frequent in one corpus when compared with another (p<0.01); 3) constructing 
preliminary ‘keyword sets’ (O’Halloran 2010: 218), or themes (Seale et al., 2006), and 
assigning keywords to these; 4) doing an initial concordance analysis of identified 
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keywords to refine the sets; and 5) doing a further detailed concordance analysis of 
identified keywords in context.    
3.4.2.1.1 CKWIC analysis: steps 1 – 2  
Steps 1 and 2 involved inserting both corpora into Wordsmith Tools software (Scott, 
2013).  This allowed respective lists of words along with their frequencies and 
keywords to be created.  The first column in Table 3.11 indicates the corpus under 
examination with the reference corpus it is compared with in parenthesis. The second 
and third columns respectively indicate the number of articles and words which 
constitute these corpora.  The second column shows that there were 39 and 101 
media articles containing illness narratives of MWPCa in 1990-2000 and 2000-1010 
respectively, giving a total of 140 articles overall.  The third column shows a respective 
41,487 and 108,107 words in each corpus, giving a total of 149,594 words.  Of note is 
the difference, though not problematic (Rayson et al., 2004), in the size of the two 
corpora.   
Table 3.11. Characteristics of the 1990-2000 and 2000-2010 corpora 
Corpus of print media 
narratives of MWPC 
No. of articles Words in 
corpus 
Words in 
wordlist 
Keywords1 
p<0.01 (p<0.001) 
1990-2000 
(RC 2000-2010) 
39 41487 4915 138 (84) 
2000-2010 
(RC 1990-2000) 
101 108107 8894 118 (41) 
Total 140 149594 13809 256 (125) 
1Log-likelihood statistic 
Column 4 in Table 3.11 shows the number of words in each word list.  The frequencies 
of the words in each wordlist were compared with each other to see which ones were 
‘key’, that is, occurring statistically more often than would be expected by chance.  The 
fifth column indicates the number of keywords identified at specified significance 
levels (p<0.01 and p<0.001) using the log-likelihood statistic.  I chose the log-likelihood 
statistic over the chi-square test as it is used with accuracy for various combinations of 
size and of corpora (Rayson et al., 2004) and the chi-square test gave a much lower 
number of keywords than was useful for analysis when p<0.01.  Row 1 column 5 in 
Table 1 shows that comparing the 1990-2000 in reference to the 2000-2010 corpus 
identified 138 keywords when p<0.01, 84 of which were also significant when p<0.001.  
Row 2 column 5 shows that comparing the 2000-2010 corpus with reference to the 
1990-2000 corpus identified 118 positive keywords when p<0.01, 41 of which were 
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also significant when p<0.001.  The minimum frequency of keywords was set at 5 and 
11 respectively in order to cover 0.01% of each corpus. 
Appendix 3 shows all keywords identified in this process.  Baker (2006) suggests 
that keyword lists tend to show up three types of words: 1) proper nouns; 2) 
grammatical or functional words; and 3) ‘aboutness’ words.  The latter, being lexical 
words—nouns, verbs, adjectives and adverbs—are Baker suggests, the most 
interesting to analyse.  Of note was, as Baker indicates, the high number of proper 
nouns, evident in male names.  Also notable was the relative lack of functional words 
identified as key in each corpus; this may be because both corpora were from the 
similar genre of written narratives of MWPCa in print media.   
3.4.2.1.2 CKWIC analysis: steps 3 – 4  
Steps 3 and 4 in the CKWIC analytic process involved a move from a purely quantitative 
to a more qualitative analysis.  Drawing on the constant comparative method 
(Charmaz, 2006) I constructed short and simple codes which stayed close to the data.  
These were first categorised into preliminary themes (Seale et al., 2006): the keywords 
GBP (Great British Pounds), million and spent intuitively seemed to be about money; 
brachytherapy, procedure, anaesthetic, treatment, drug, Zoladex, Casodex, and 
operations seemed to be about treatment; risk about risk; wear about clothing; score 
about sport; PSA about testing and so on.  I constructed preliminary codes and 
compared the keywords with each other and the codes until as many as possible were 
categorised.  I then examined the keywords in their context through the concordance 
provided by the software.  This allowed me to see whether my intuition was right, 
needed refined or mistaken. Figure 3.1 shows the GBP concordance—each line shows 
GBP (1990-2000) with several words of context on either side.  
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Figure 3.1 Sample 'GBP concordance 1990-2000 
 
Examining the keywords in their concordance was often enough to refine my 
categories, but if not then particular concordance lines were also viewed in their larger 
context.  This process mainly resulted in two outcomes: the complete removal of a 
word from one theme to another; and/or the placing of a word in more than one 
theme if it was associated with two or more meanings.  These words were marked 
with a * to indicate their ‘split’ status (Seale et al., 2006: 2582).  An example of this 
process was with the keyword wear (2000-2010), originally categorised as ‘Clothing’.  
Examining wear in its context showed that seven of its ten relevant instances referred 
to issues around treatment side-effects: “I was also left incontinent and had to wear 
pads for three years” (Daily Mail, 01/11/2005); and “that removed most of the cancer, 
but it damaged my ability to stay sexually aroused. I prayed it was just a temporary 
effect, that it would eventually wear off and everything would be normal” (Daily Mail, 
06/11/2001).  In one instance it referred to a drug beginning to ‘wear off’; in another 
to Megrahi, the man convicted of the Lockerbie bombing, who offered “to wear an 
electronic tag if freed” (Daily Mail, 15/11/2008).  Only once did it refer to an item of 
N Concordance
1 GBP 350 million empire. He was lived for the company and built it into a 
2 GBP 3.5 million, paid out GBP 1 million year before he died.' His Trust, valued at 
3 GBP 400. It looks as though I've got worried because each scan costs 
4 GBP 47,000 last year, compared to spent on finding a cure is derisory - 
5 GBP 47,000 last year, compared with spent on finding a cure is derisory - 
6 -GBP 47,000 last year. That is why the spent on finding a cure is derisory 
7 GBP to the Daily Mail Prostate Cancer Manchester M60 3JD I am donating 
8 GBP raised by Mail readers the . HERE'S HOW TO DONATE For every 
9 GBP raised by Mail readers the . HERE'S HOW TO DONATE For every 
10 GBP 47,000. I hope the money will help charity received a cheque - for exactly 
11 GBP 1million fundraising campaign - in get there.' The Daily Mail launched its 
12 GBP 47,000 a year on research into out that the Government spent just 
13 GBP 15, and it is appalling that it is not insurance. The blood test costs only 
14 GBP 47,000 last year, compared to spent on finding a cure is derisory - only 
15 GBP 47,000 was spent researching it in 8,000 men in the UK a year but only 
16 GBP 47,000 a year goes on prostate of cancer prevention and cure. Yet only 
17 GBP 1 million a year ago to the , valued at GBP 3.5 million, paid out 
18 GBP 47,000 was spent last year - 10,000 die every year - yet a pitiful 
19 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
20 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
21 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
22 GBP 1 million. Sidney Swan was Mail has launched an appeal to raise 
23 GBP 1 million. Here, 58-year-old Mail has launched an appeal to raise 
24 GBP 47,000 for prostate research and I vowed that, when I was better, I'd raise 
25 GBP 47,000. Through my job in UK. I had one mission: to raise 
26 GBP 18 million was spent on Aids, the disease. At the same time, 
27 GBP 18 million spent on Aids. The GBP 47,000 last year, compared to 
28 GBP 18million spent on Aids, which - GBP 47,000 last year, compared to 
29 GBP 500,000 another pound will be by generous Mail readers - up to 
30 GBP 500,000. The money raised will go Charitable Trust will match it up to 
31 GBP 500,000. The money raised will go Charitable Trust will match it up to 
32 GBP 500,000 - another pound will be by generous Mail readers - up to 
33 GBP 18 million spent on Aids, which - GBP 47,000 last year, compared with 
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clothing in relation to Andy Ripley, a celebrity MWPCa, many years earlier.  Thus, wear 
was removed from ‘Clothing’ and placed in ‘Treatment side-effects’.   
 Likewise, score (2000-2010) was initially classified in ‘Sports’ but examining it in 
its context demonstrated that it was almost exclusively used to indicate either a 
Gleason or PSA score (§1.1.1).  One of two instances of score in a sporting context did 
though indicate a pertinent gendered use:  
Ladies easily discuss breast cancer, but you don't see a gathering of men in a 
pub talking about their prostates. They are talking about the latest page three 
girls or the cricket score because they think that any problem "down there," as 
they'd put it, is a nonmacho situation (Daily Mail, 27/07/2002) 
I thus removed score ‘Sports’ and placed it in ‘Tests and diagnosis’.  Similarly, all but 
two instances of race (1990-2000) were associated with political contests in the USA, 
mostly regarding Rudolph Giuliani but also Bob Dole.  One exception referred to a 
MWPCa comparing his outlook on life before and after PCa; the other was regarding a 
half marathon ran by a MWPCa to raise £47,000.  Thus, though the meaning of race 
was as a sports word in all instances, this was as a metaphor for a political contest; it 
was thus categorised in, the subsequently excluded, ‘Political practice’.  Of note, race 
did not refer to ethnicity in any instance.  Examples of ‘split’ words in 1990-2000 were 
Mail*, raise* and Mail’s*, due to their meaning around both raising awareness and 
raising money.  Launch* in 2000-2010 was used to describe launching a show or a book 
in the context of employment of MWPCa and launching awareness campaigns.   
3.4.2.1.3 CKWIC analysis: step 5 
The keywords were then examined in detail in their concordance using Wordsmith 
Tools (Scott, 2013) in order to discover analytic patterns.  Collocation, informally 
defined as ‘the company a word keeps’ (Firth (1957) cited by Stubbs 1996: 173), 
provided a way of exploring the statistical tendency of words ‘to co-occur with other 
words’ (Stubbs 1996: 173).  Figure 3.1 above shows the concordance for GBP.  In order 
to help identify patterns in the concordance, these lines were, in the first instance, 
sorted alphabetically one space left of the keyword and then one space right, with any 
deviation from this sort noted.  Sometimes particular patterns were only somewhat 
visible and a re-sort was needed to make them more visible.  For example, “47,000” 
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was repeated often in Figure 3.1; a re-sort one space right then one space left (Figure 
3.2) allowed all lines containing “47,000” to appear consecutively: 
Figure 3.2 Partial 'GBP' keyword concordance 1990-2000: '47,000' 
 
Table 3.12 shows the final thematic categories of keywords in UK print media when the 
media narratives of MWPCa in 1990-2000 were compared with those in 2000-2010.  It 
begins to offer insights into how journalists wrote stories about the illness experience 
of MWPCa: 
Table 3.12 Thematic categories of keywords 
 Keywords and themes across time
1 (p<0.01) 
 1990-2000  2000-2010  
1.  Raising money for PCa: (GBP, million, spent, 
Mail*, raise*, Mail’s*)  
 
No keywords 
 
 
 
 
 
No keywords 
 
 
Treatment side-effects: (sexuality, risks, 
greater) 
No keywords 
 
 
Treatment types and procedures: 
(brachytherapy, procedure, robot, SPES, 
anaesthetic, keyhole, treatment, drug, trial, 
seeds, monitor, needles*, operations, work*, 
inoperable*, herbal, join, LRP, receive,  robotic) 
 
Treatment policy and insurance: (Guildford, 
cover, PCT, policy)  
 
Treatment side-effects: (love, nerves, 
depression, again*, Zoladex, testicles, wear, 
Casodex) 
2.  Being reluctant to talk: (taboo, quiet) 
 
Raising awareness: (Mail*, idea, raise*, 
Mail’s*) 
 
Knowing about the prostate and prostate 
cancer (prostatic, studying, shaped, BPH, 
Being reluctant to talk: (reasons) 
 
Raising awareness: (radio, launch*, diary) 
 
 
No keywords 
N Concordance
12 GBP 47,000 last year, compared with GBP 18 yet the amount spent on finding a cure is derisory - 
13 GBP 47,000 last year, compared to GBP 18million of money spent on finding a cure is derisory - 
14 -GBP 47,000 last year. That is why the Daily Mail of money spent on finding a cure is derisory 
15 GBP 47,000. I hope the money will help research week the charity received a cheque - for exactly 
16 GBP 47,000 a year on research into prostate when I found out that the Government spent just 
17 GBP 47,000 a year goes on prostate research. other forms of cancer prevention and cure. Yet only 
18 GBP 47,000 last year, compared to GBP 18 million the money spent on finding a cure is derisory - only 
19 GBP 47,000 was spent researching it in 1998. It is cancer kills 8,000 men in the UK a year but only 
20 GBP 47,000 was spent last year researching the killer for men - 10,000 die every year - yet a pitiful 
21 GBP 47,000 for prostate research and education, moment I vowed that, when I was better, I'd raise 
22 GBP 47,000. Through my job in international Campaign UK. I had one mission: to raise 
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tumour, surrounds, analysed, doughnut, 
slower, upper, enlarge, killer, develops, disease, 
capsule, hyperplasia, cancer) 
3.  Risks 
Age risk: (escalate, occur, age, young) 
Genetic risk: (genetic, history, link, gene) 
Nutrition risk: (vegetables, fruit, zinc, fats, oil, 
tofu, exposure, eat, vitamin, diet, meat, 
chemicals) 
 
Symptoms (urine, symptoms, water, 
frequently, stream, passing, signs, 
enlargement) 
No keywords 
 
 
 
 
 
 
No keywords 
 
 
4.  Tests and diagnosis: (examination, transrectal, 
medical, identifies, biopsy, rectal, reveal, 
digital, ultrasound, remains) 
Tests and diagnosis; (again*, score, needles* 
inoperable*, PSA*)  
5.  Lifestyle 
Employment (biology) 
 
No keywords 
 
No keywords 
Lifestyle 
Employment (presiding, launch*, return,  TV, 
work*, Manchester* ) 
Sports (England, rugby, game, Manchester*. 
rowing) 
Emotion (emotional) 
6.  Actants (Margaret, Cliff, it, MFI, Magda, Myra 
goon, shadows, sister, family, I’d, Duchess, 
figure, pathologists, charitable, society, men, 
institute)  
Actants (UK, she, Val, Maureen, Jackie, de, 
court, university, he, nurse, you’re, Caroline, 
Liz, Bono, professor, doc, charity’s, club, his)  
7.  Other (charmed, even, almost, as, only, joke, 
all, happen, powerful, fortunately, soon) 
Other (Stuff, park, November, testicular, 
allowed, around, final, later, on, either,  road, 
tea, over, said, yes) 
1Two categories of keywords are not included here (Political practice - 21 & 13 keywords in 1990-2000 and 2000-2010 
respectively and  NAMES OF MWPCa  - 20 & 24 keywords in 1990-2000 and 2000-2010 respectively) 
*indicates a ‘split’ keyword (Seale et al., 2006: 2582) when contextual examination shows association with two or more themes  
Table 3.12 is arranged to show keywords in the 1990-2000 corpus when compared 
with 2000-2010 and vice versa.  Column 1 shows all significant keywords (p<0.01) 
when the 1990-2000 corpus was compared with 2000-2010; column 2 shows the same 
information for 2000-2010.  Of note are the different categories of keywords more 
prevalent in one time period than another.  Two categories of keywords in each period 
were not included in this table: ‘Political practice’ and ‘Names of MWPCa’.  All 
keywords are listed in Appendix 3 and all were significant when p<0.01.   
In sum, there were three benefits of CKWIC as a method in analysing the illness 
narratives of MWPCa in the UK print media in 1990-2000 and 2000-2010.  My research 
question asks how the UK print media have been a force for change regarding how PCa 
has been addressed and experienced by MWPCa since the emergence of PCaOrgs in 
the UK in the mid-1990s. My first analytic step in answering this question was to 
investigate changes in how the media have represented the illness experience of 
MWPCa.  This resulted in two large data sets—39 illness narratives in 1990-2000 with 
41,487 words and 101 illness narratives in 2000-2010 with 108,107 words.  The first 
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benefit therefore was the suitability of CKWIC for analysing large quantities of 
qualitative data where the research concern is regarding differences between datasets 
(Seale et al., 2006).  The second benefit was that CKWIC was useful in impartially 
identifying those words more statistically salient, or key, in one corpus—here of media 
illness narratives of MWPCa—with another and vice versa. In this way, it attended to 
the criticism that sensitising concepts disrupt an inductive approach to the data 
(Glaser, 1992) where patterns of analysis are presumed to emerge out of the data 
(Patton, 1980).  Third, it allowed an ‘inductive–deductive interplay’ (McGhee et al., 
2007) between what I was sensitised to as potentially salient in my data through the 
literature review in Chapter 2 and what was inductively revealed in the data.  In sum, 
the cumulative benefit was that CKWIC analysis gave me a quantitative ‘aerial view’ 
(Seale and Charteris-Black, 2008: 456) of patterns not seen from the ground which 
then enabled a more detailed qualitative analysis of these patterns in their narrative 
context using sensitising concepts from Chapter 2 (Table 3.13).  
3.4.2.2 Data analysis: narratives of PCaA and MWPCa  
Though Kelly and Dickinson describe genres as ‘devices for structuring and giving 
meaning to stories’ (1997: 266), they also suggest that genres have an ‘undesirable 
impression of categorization’ (p. 266).  While I agree that genres may be a form of 
categorisation I view this as less undesirable than do Kelly and Dickinson. Similarly, 
Frank (2010: 119) argues that though ‘putting stories in boxes’ is risky, typologies of 
narratives are advantageous in that they recognise: 
the uniqueness of each individual story, while at the same time understanding 
how individuals do not make up stories by themselves.  Each story is singular; 
none is a mere instance.  Yet, stories depend on other stories: on recognizable 
plots, character types, conventional tropes, genre-specific cues that build 
suspense, and all the other narrative resources that story tellers utilize (….) all 
storytellers work with these types as resources for telling and expectations for 
hearing. Experience is understood as residing as much outside persons as inside 
them; it is borrowed even as it is felt. (Frank, 2010: 119, emphasis in original) 
Frank shows that it is through the categorisation of a variety of narrative elements that 
we can examine ‘how individuals do not make up stories by themselves’ but work with 
these narrative elements and their co-authoring audience in making up their own 
story.  Many of these narrative elements are included as a selection of sensitising 
concepts in Table 3.13.  These sensitising concepts became apparent as useful ideas to 
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think with and ask questions about and discover relationships between in the course of 
reviewing the literature and thinking about the emerging data.  
Table 3.13 Selected Sensitising Concepts 
Sensitising 
Concept 
Brief Description 
Narrative concepts 
Contingent 
narratives 
Concerned with temporal unfolding of illness from onset, 
managing its effects and the relationship between those ill and 
those they interact with. 
Normalisation: Achieved either in maintaining one’s pre-illness 
identity or incorporating illness into a changed identity—likely to 
not disclose illness in former and to disclose illness in latter 
Coping: Practically  managing interactional issues of disclosing 
illness to family and friends—performative in allowing a 
preferred presentation of self; relieving others of interactional 
burden 
Strategic management of illness: Pacing of work and home 
activities and access to social support 
Moral narratives Justify self in the altered relations of body, self and society—
usually pursuing a virtuous presentation of self; may attribute 
culpability to self or  external other 
Core narratives People draw upon specific available language e.g. clichés, 
symbolic repertoires which constrain or allow what can be said. 
Genres Particular language resources which allow/constrain what is said: 
epic or heroic; tragic; comic or ironic; romantic; and didactic.  
People not necessarily consistent in using and may shift from 
tragic to ironic or heroic to comic as they see fit depending on 
context, intention of speaker, and response of audience 
Emplotment Communicators anticipate audience’s response and work 
together to produce a meaningful story 
Co-authorship Narratives are constructed in relationship with various people 
and organisations implying a dialogue with other voices 
Framing concepts  
Frames Highlight, or diagnose, some aspect of social life as problematic 
and/or unjust in need of change; propose a solution, or make a 
prognosis, for the diagnosed problem specifying what needs to 
be done; make diagnostic attributions of blame by identifying a 
culpable adversarial ‘they’ of individual, collective or structural 
agents responsible for the problem; and make prognostic 
attributions by identifying a ‘they’ who will bring change by 
engaging in corrective action to resolve the problem. 
Frame resonance Speakers ‘fit’ their talk with their audience’s beliefs, worldviews 
and experiences.  Challenging actors can peer into histories of 
other challenging groups and borrow their language when there 
is silence in the arena where they are fighting their own struggle. 
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Frame 
transformation  
 
Redefines events or biographies already meaningful from one 
viewpoint to another and often adopting an injustice frame and 
shift in blame 
Frame 
amplification 
The idealisation or embellishment of existing values and beliefs, 
for example, around family and fairness 
Framing hazards E.g. counterframimg undermines other’s frame; dialectic tension 
when an initial frame legitimates an action at one point but then 
transforms belief so that such action is later no longer legitimate; 
framing errors when action is based on erroneous beliefs 
Dissonance 
/radicalism 
A story which is too familiar is no story at all (Polletta, 2006) and 
novel/radical/dissonant elements are also needed (Ferree, 2003) 
Emotions Injustice as ‘moral indignation’ or a ‘sense of outrage’ is ‘leaven’ 
for social change when people/organisations can see many of 
own problems in terms set forth by others. 
Interest as the subjective evaluation of an event’s novel-
complexity (for example, its unexpectedness, surprise, or 
mysteriousness) and its familiarity or comprehensibility 
Literary and concepts 
Repetition Repetition gives talk the characteristic of familiarity which makes 
talk sound right or ‘fit’. Stories, or narratives, resonate through a 
combination of familiarity, pleasurable surprise and emotional 
identification.  Pre-patterning of talk 
Heteroglossia and 
dialogical 
Stories are dialogical in that there is always an implied dialogue in 
any utterance and potentially many voices or ‘heteroglossia’. 
The concepts in Table 3.13 interrelate at several points, examples of which are: 
• Core narratives as instrumental in moral and contingent narratives—people 
draw on core ways of speaking to tell moral and contingent stories 
• Heteroglossia, dialogism and co-authorship, repetition, and resonance in their 
recognition of the voices of others within stories 
• Frame transformation, injustice, and moral narratives when storytellers seek to 
shift blame from self to another or from one object to another 
• The novel-complex component of ‘interest’ and radicalism as unexpected and 
unpredictable elements in stories 
• The familiar component of ‘interest’ and resonance, or repetition, as 
predictable elements in stories 
Line-by-line coding of the kind advocated by Charmaz (2006), though it allows 
familiarity with content of the data, only somewhat hints at its form and breaks the 
data into too small segments than compared with what is usually advocated for 
narrative analysis (Bury, 2001; Riessman, 2008; Frank, 2010; Bury and Monaghan, 
2013a).  The constant comparison between codes and categories that line-by-line 
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coding entails is though, perhaps surprisingly, similar to how Frank (2010) identifies 
forms of narratives in his constant comparing, and re-sorting and renaming  of forms 
until the type emerges: 
Types become identifiable as they are named, and a typology compels or 
collapses depending on the descriptive force of its names.  Names can describe 
the stories (for example, “diagnosis stories”), or they can borrow some phrase 
that reoccurs in that type of story, or names can be descriptively evocative, like 
my types of restitution, chaos or quest.  Some names are immediate and 
obvious fits; some clusters of types seem resistant to naming.  The process of 
naming a type proceeds iteratively with changing understandings of which 
stories fit that type.  Stories that do not fit within proposed types require 
decisions whether to expand a type that has already taken shape and may have 
a name, or to create a new type (….) resorting and renaming bring the typology 
into being.  No rule says when to stop; eventually, the analyst and enough 
others recognise the types as expressing something significant about the 
stories they describe. (Frank, 2010: 120-121) 
The narrative elements as sensitising concepts in Table 3.13 and the ways of 
categorising such elements as advocated by Frank (2010) were used in my analysis of 
each of the empirical data sets.  They were also useful in examining  deviant, or 
negative, cases—where ‘“things go differently”’ (Peräkylä, 2011) from an expected 
analytic pattern. Deviant cases at times provided additional support for my 
interpretation by showing how the participant also orientated to the pattern I 
expected; sometimes it led to my abandoning a particular interpretation; or at times I 
found particular contingencies of an individual case (see Peräkylä, 2004; Seale, 2012). 
I interviewed all the PCaA and the MWPCa (2010) participants and transcribed all 
of the audio recordings1.  Transcribing the recordings took approximately five hours 
per one hour of recording, a process which served to begin to familiarise me with the 
data.  This familiarisation continued as I reread each transcription before I imported all 
transcriptions into NVIVO 9 software.  Though CKWIC analysis proved very useful in 
identifying patterns of changes in the representation of illness narratives of MWPCa in 
the print media, it was not conducive to analysing the MWPCa and PCaA interviews.  
This was because there was no comparative element in the PCaA interviews for CKWIC 
to be of benefit and my eventual analytic enquiry into changes in how MWPCa 
disclosed their PCa to various audiences was not one easily accommodated by CKWIC 
analysis. 
                                                     
1 See note 1in §3.4.1.2.4 
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3.4.2.2.1 Analysing the narratives of PCaA from 2010 
On further close reading of the PCaA interviews I began to identify how PCa was 
presented as a ‘problem’ (Gamson et al., 1992; Snow and Benford, 1992) and identified 
three potential ‘problem’ stories around PCa: PCa as a neglected condition; a lack of 
information around PCa; and potential misinformation around PCa. Attracting funds 
for PCa research was described as “very very difficult” (PC-MP/2), and the early 
diagnosis of PCa was described as one of “several kinds of key issues (...) we needed to 
tackle” (PC-PC/1).  I then used a thesaurus to identify words which indicated a 
‘problem’ such as: issue, concern, question, matter, difficult, trouble, dilemma, 
predicament, quandary, complex and danger and used the query facility of NVIVO to 
search the data for these words. Examining these words in their narrative context 
allowed me to identify a nuanced story of injustice around PCa as not only neglected 
but also with inequalities in other ways such as the differential delivery of services or 
treatment by postcode lottery and access to information on screening.  In addition it 
allowed me to see evidence of temporal and contentious elements to the ‘neglect’ 
story. 
My queries in the PCaA interviews continued for contexts around particular 
phrases: cause/movement/issue; signs and symptoms; power; care; support; PSA, 
screening and testing; breast cancer; evidence; treatment; injustice; fundraising; 
humour; decision making; responsibility and blame; and family words.  I then 
examined each of these queries in their narrative context to see which were relevant 
for my thesis and continually added to my categories as necessary.  My coding was 
continually modified to ensure an adequate ’fit’ with the data, while also accounting 
for ‘deviant cases’ or ‘negative instances’ (Seale, 2012). It was also an iterative process 
between the developing analysis, new data and emerging literature. 
3.4.2.2.2 Analysing the narratives of MWPCa from 2000 and 2010 
There was a lot of ‘dialogic’ talk by participants in both time periods—MWPCa 
repeating, or reconstructing familiar voices from past conversations with others 
around all sorts of issues related to their PCa.  Inspired by Rapley’s (2008) work on how 
decision-making is never just an individual cognitive activity, or even a dyadic activity 
between doctor and patient, but rather distributed over a range of settings, people 
and technologies, I examined how these men distributed their voice over a variety of 
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settings and people.  Men’s talk around issues, for example of disclosing their 
condition, testing, masculinity, awareness or treatment, was categorised as ‘voicing’—
‘voicing disclosure of PCa’, ‘voicing treatment choices’, ‘voicing masculinity’ and so on.  
These ‘voicing’ categories were organised into coding frameworks using NVIVO (v9) 
software.  The idea of ‘voicing’ emphasises how the ‘private’ voice of MWPCa 
integrates with other voices.  These other voices were ‘collective’, for example, that 
offered by the media or accepted as a ‘common sense’ way of thinking.  Or, they were 
another ‘private’ voice, that offered by a medical professional, a partner, child, or 
friend.  When people reconstruct the voices of others they provide evidence not only 
of what they have actively heard from past conversations, and which is resonant, or 
‘rings true’, with their experience, but also how they want those words to be heard in 
the present conversation (Bakhtin 1981; Volosinov 1986; Tannen 2007).    
The data from the MWPCa interviews was analysed after the analysis of the 
media and PCaA data and the findings from the analysis of the media and PCaA data 
then prompted my analytic enquiry for Chapter 6 MWPCa data.  A finding from the 
media analysis demonstrated that PCa as a “taboo disease that no one dares talk 
about” was more explicitly and frequently articulated in the media illness narratives of 
MWPCa in 1990-2000 than those in 2000-2010 (§4.4).  A finding from the analysis of 
the PCaA data demonstrated that though towards the end of the 1990s “prostate 
cancer was just beginning to come out of the shadows of neglect” and that when men 
“would have their illness, they would not talk about it, they would die quietly”, this 
was less the case towards 2010. In addition, my thesis focuses on changing narratives 
of PCa over time.  Though I draw on ideas from several narrative and literary scholars, I 
use as a basis Bury’s (2001) three non-mutually exclusive narrative forms: contingent, 
moral and core narratives (§2.4.3).  Though all three are useful, contingent narratives 
of coping in particular address the practical management of interactional issues of 
disclosing illness to family and friends.  Given these findings and my research enquiry, I 
was prompted to investigate whether there were differences in how MWPCa disclosed 
their illness over time to various audiences.  I thus chose to focus on ‘voicing disclosure 
of PCa’ to various audiences over other substantive types of ‘voicing’.   
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 Changing narratives of Chapter 4
MWPCa: the UK national 
print media 1990-2010  
4.1 Introduction 
Print media is among the most relied on of sources of information regarding disease, 
illness, death and medicine for people in general (Clarke, 2004), and men with prostate 
cancer (MWPCa) in particular (Halpin et al., 2009). It is also considered, along with 
health social movements (HSM), to contribute to the social diagnosis of a disease 
(Brown et al., 2011).  Although PCa is the research ‘flagship of men’s cancer’ (Wenger 
and Oliffe, 2013) there are relatively few studies of print media representation of PCa 
(Halpin et al. 2009).  As yet, no study has compared how this representation may have 
changed since the emergence of PCaOrgs into the UK in the mid-1990s.  This chapter 
begins to address this deficit by drawing on the conceptual frameworks of narrative 
and framing theory described in Chapter 2 and a comparative keyword in context 
(CKWIC) analysis described in Chapter 3 to analyse changes in how the illness 
narratives of MWPCa have been represented in the UK print media.  These analytic 
frameworks allowed me to ask key practical questions: which words were significantly 
more frequently used by journalists when writing about MWPCa in 1990-2000 than in 
2000-2010 and vice versa; and what insights did this give into how the UK national 
print media represented the illness experience of MWPCa since the emergence of 
PCaOrgs in the UK in the mid-1990s.   
4.2 An ‘aerial view’ of the illness narratives of 
MWPCa in the UK print media  
Sampling of the UK print media through Nexis UK, an on-line database of newspaper 
articles, resulted in 140 articles predominantly about the illness narrative of MWPCa 
(§3.4.1.1).  Table 4.1 (reproduced from Table 3.7) shows the distribution of these 
articles across six newspapers and time.   
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Table 4.1 Sampled articles predominantly containing illness narratives of 
MWPCa  
 Newspaper 01/06/1990- 
31/05/2000 
01/06/2000- 
31/05/2010 
Total 
1.  Times & Sunday Times 9 16 25 
2.  Independent & Independent on Sunday  1 8 9 
3.  Guardian and Observer 5 1* 13 18 
4.  Daily Mail & Mail on Sunday  19 1 47 66 
5.  Mirror & Sunday Mirror 5 1 16 21 
6.  People  0 1 1 1 
 Total 39 101 140 
1not fully uploaded 01/06/1990-31/05/1995 but fully uploaded 01/06/1995-31/05/2000 
*only one article from 1990-1995 (in the Guardian) contained the illness narrative of a MWPC  
Table 4.1 indicates that since the emergence of PCaOrgs into the UK in the mid-
1990s—the Prostate Cancer Research Foundation in 1993 and The Prostate Cancer 
Charity1 in 1996—there has been greater attention to the illness experience of MWPCa 
in the UK national print media, with 39 illness narratives in 1990-2000 and 101 in 2000-
2010.  Though there was only one article predominantly about the illness experience 
of a MWPCa during 1990-1995—in the time period approximately just prior to the 
emergence of PCaOrgs into the UK—rows 3-6 show that some newspapers were not 
fully uploaded to the Nexis database in this period.  
The  CKWIC analysis (§3.4.2.1) was useful in giving an inductive ‘aerial view’ 
(Seale and Charteris-Black, 2008: 456) of changes in how the UK print media 
represented the illness experience of PCa over time. It first identified words which 
were statistically more frequent when the print media illness narratives of MWPCa in 
1990-2000 were compared with those in 2000-2010 and vice versa.  These ‘keywords’ 
(Stubbs, 1996; Baker, 2006; O’Halloran, 2010) allowed patterns of analysis to emerge 
inductively from the data (Patton, 1980; Glaser, 1992) and these patterns were 
organised into keyword themes (Table 4.2).  These keywords and themes then served 
as inductive “points of departure” (Charmaz, 2006: 17) for further deductive analysis; 
affording then an analytic “inductive-deductive interplay” (McGhee et al., 2007: 335).  
This was by examining the keywords in their concordances—which showed the 
keyword in its brief context—and by allowing the narrative and framing concepts 
described in Chapter 2 to sensitise me to which analytic paths to pursue (Charmaz, 
2006). 
 
                                                     
1Now Prostate Cancer UK  
110 
 
Table 4.2 Keywords and themes in a CKWIC analysis of illness narratives 
of MWPCa in UK print media 1990-2000 and 2000-2010 
 Keywords and themes across time (p<0.01)1 Aerial view 
of PCa 
stories 
 1990-2000  2000-2010  
1.  Raising money for PCa: (GBP, million, 
spent, Mail*, raise*, Mail’s*)  
 
No keywords 
 
 
 
 
 
 
 
No keywords 
 
 
Treatment side-effects: (sexuality, risks, 
greater) 
No keywords 
 
 
Treatment types and procedures: 
(brachytherapy, procedure, robot, 
SPES, anaesthetic, keyhole, 
treatment, drug, trial, seeds, 
monitor, needles*, operations, 
work*, inoperable*, herbal, join, LRP, 
receive,  robotic) 
 
Treatment policy and insurance: 
(Guildford, cover, PCT, policy)  
 
Treatment side-effects: (love, 
nerves, depression, again*, Zoladex, 
testicles, wear, Casodex) 
Stories of 
injustice 
2.  Being reluctant to talk: (taboo, quiet) 
 
Raising awareness: (Mail*, idea, raise*, 
Mail’s*) 
 
Knowing about the prostate and prostate 
cancer 
prostatic, studying, shaped, BPH, tumour, 
surrounds, analysed, doughnut, slower, 
upper, enlarge, killer, develops, disease, 
capsule, hyperplasia, cancer 
Being reluctant to talk: (reasons) 
 
Raising awareness: (radio, launch*, 
diary) 
 
No keywords 
Stories of 
taboo 
3.  Risks 
Age risk: (escalate, occur, age, young) 
Genetic risk: (genetic, history, link, gene) 
Nutrition risk: (vegetables, fruit, zinc, fats, 
oil, tofu, exposure, eat, vitamin, diet, 
meat, chemicals) 
 
Symptoms 
urine, symptoms, water, frequently, 
stream, passing, signs, enlargement  
No keywords 
 
 
 
 
 
 
No keywords 
 
 
Stories of 
problematic 
waterworks 
and age 
4.  Tests and diagnosis: (examination, 
transrectal, medical, identifies, biopsy, 
rectal, reveal, digital, ultrasound, remains) 
Tests and diagnosis; (again*, score, 
needles* inoperable*, PSA*)  
Stories of 
tests & 
diagnosis 
1See Table 3.11  for a summary of the 138 and 118 keywords (p<0.01) identified in 1990-2000 and 2000-2010 respectively.  All 
keywords are shown in Appendix 3.  Five categories of keywords are not included for analysis (Political practice, Names of MWPC, 
Actants and expressivity, Lifestyle, and Other) (§ 3.4.2.1.1 & §3.4.2.1.2) 
*indicates a ‘split’ keyword (Seale et al., 2006: 2582) when its contextual examination shows that it should be associated with two 
or more themes (§3.4.2.1.2) 
There are four rows and three columns in Table 4.2.  Each row shows those words used 
statistically more frequently by journalists when writing about the illness experience of 
MWPCa in 1990-2000 (column 1) than in 2000-2010 (column 2) and vice versa.  The 
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keyword themes in each row point towards differences in how journalists narrated the 
illness experience of PCa across time (column 3). 
4.3 Shifting stories of injustice around PCa 
The keyword themes in row 1 in Table 4.2—‘Raising money for PCa’ and the three 
themes around ‘Treatment’—provided an inductive analytic launch pad (Charmaz, 
2006) for further exploration of narratives around PCa which seemed to suggest a shift 
from stories of injustice around the funding neglect of PCa in 1990-2000 to other 
injustices around treatment in 2000-2010.   
4.3.1 The story of ‘neglect’ of PCa 1990-2000 
There were six keywords associated with ‘Raising money for PCa’ in the 1990-2000 
corpus (GBP [Great British Pounds], million, spent, Mail, raise and Mail’s) and none in 
2000-2010 (Table 4.2). The raw and relative frequencies of these words in each time 
period are summarised in Table 4.3: 
Table 4.3 ‘Raising Money for PCa’ Keywords 1990-2000 
‘Raising money for PCA’ 
Key word 1990-2000 
Raw Freq. 
1990-2000 
Freq./100,000 
2000-2010 
Raw Freq. 
2000-2010  
Freq./100,000 
P 
GBP1 
(GBP/POUNDS/$/£) 
33 
(61) 
79.5 
(147) 
15 
(71) 
13.9 
(65.7) 
 p<0.001 
MILLION 22 53.0 6 5.6  p<0.001 
SPENT 22 53.0 17 15.7  p<0.001 
MAIL* 18 43.4 13 12.0  p<0.001 
RAISE* 16 38.6 13 12.0  p<0.01 
MAIL'S* 5 12.1 1 0.9  p<0.01 
1Nexis UK variously represents the British monetary symbol as ‘£’/‘GBP’/‘pounds’.  Row 1 also shows the raw and relative 
frequencies for the combined GBP/pounds/£/$ ($ as the US monetary symbol) 
*’split’ keyword (Seale et al., 2006: 2582) where contextual examination of the keyword in its concordance shows it is 
associated with two or more meanings.   
 
There are six columns in Table 4.3 and in each of the subsequent summary keyword 
tables in this chapter.  The first (Keyword) lists each keyword contributing to the 
category.  The second and fourth columns (1990-2000 Raw Freq.) and (2000-2010 Raw 
Freq.) give the raw frequencies of the keywords in the two time periods.  As the 
corpora differ in size, it was often more useful to consider the frequency per 100,000 
words rather than raw frequencies.  The third and fifth columns, (1990-2000 
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Freq/100,000) and (2000-2010 Freq/100,000) give the raw frequency as a ratio per 
100,000 words.   Though the software also indicated a keyness value, this is not 
included in the table as what is important to note is that as the list descends the log-
likelihood statistic, as measured by the probability (p) value given in the sixth column, 
increases as keyness decreases.  The greater the keyness, the greater the salience or 
‘proportional statistical frequency’ (O’Halloran, 2010: 215) of the keyword.  All 
keywords were statistically significant when p<0.01.  As an example, row 1 in Table 4.3 
shows that GBP occurred 33 times in 1990-2000 and 15 times in 2000-2010 
corresponding to 79.5 and 13.9 words per 100,000 words respectively.   
 Figure 4.1 shows the GBP concordance, and lists all instances of GBP in its 
context; as expected this keyword was associated with money in every occurrence: 
 
Figure 4.1. ‘GBP’ keyword concordance 1990-2000 
The most frequent collocate—the word company that GBP kept (Stubbs 1996: 173) 
(§3.4.2.1.3)—one place left of GBP was raise.  Raise was also a ‘Raising money for PCa’ 
1990-2000 keyword and examining all its instances in the GBP concordance and its 
N Concordance
1 GBP 350 million empire. He was lived for the company and built it into a 
2 GBP 3.5 million, paid out GBP 1 million year before he died.' His Trust, valued at 
3 GBP 400. It looks as though I've got worried because each scan costs 
4 GBP 47,000 last year, compared to spent on finding a cure is derisory - 
5 GBP 47,000 last year, compared with spent on finding a cure is derisory - 
6 -GBP 47,000 last year. That is why the spent on finding a cure is derisory 
7 GBP to the Daily Mail Prostate Cancer Manchester M60 3JD I am donating 
8 GBP raised by Mail readers the . HERE'S HOW TO DONATE For every 
9 GBP raised by Mail readers the . HERE'S HOW TO DONATE For every 
10 GBP 47,000. I hope the money will help charity received a cheque - for exactly 
11 GBP 1million fundraising campaign - in get there.' The Daily Mail launched its 
12 GBP 47,000 a year on research into out that the Government spent just 
13 GBP 15, and it is appalling that it is not insurance. The blood test costs only 
14 GBP 47,000 last year, compared to spent on finding a cure is derisory - only 
15 GBP 47,000 was spent researching it in 8,000 men in the UK a year but only 
16 GBP 47,000 a year goes on prostate of cancer prevention and cure. Yet only 
17 GBP 1 million a year ago to the , valued at GBP 3.5 million, paid out 
18 GBP 47,000 was spent last year - 10,000 die every year - yet a pitiful 
19 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
20 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
21 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
22 GBP 1 million. Sidney Swan was Mail has launched an appeal to raise 
23 GBP 1 million. Here, 58-year-old Mail has launched an appeal to raise 
24 GBP 47,000 for prostate research and I vowed that, when I was better, I'd raise 
25 GBP 47,000. Through my job in UK. I had one mission: to raise 
26 GBP 18 million was spent on Aids, the disease. At the same time, 
27 GBP 18 million spent on Aids. The GBP 47,000 last year, compared to 
28 GBP 18million spent on Aids, which - GBP 47,000 last year, compared to 
29 GBP 500,000 another pound will be by generous Mail readers - up to 
30 GBP 500,000. The money raised will go Charitable Trust will match it up to 
31 GBP 500,000. The money raised will go Charitable Trust will match it up to 
32 GBP 500,000 - another pound will be by generous Mail readers - up to 
33 GBP 18 million spent on Aids, which - GBP 47,000 last year, compared with 
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remaining instances in the raise concordance (Appendix 14: ‘Raising money for PCa’) 
showed that it was almost exclusively used in the context of raising money, for 
example regarding the launch of a Daily Mail appeal to raise one million pounds.  
Figure 4.1 shows other semantic equivalents of the Daily Mail raising money through 
earlier donations or announcements of the launch of this appeal.  Mail/Mail’s were 
also mostly used in the context of the Daily Mail either launching an appeal or/and 
campaign to raise funds or/and awareness.  The keyword spent was predominantly 
used in the context of money and the keyword million occurred in an almost exclusive 
context of money; many of the instances of these keywords are also seen in Figure 4.1. 
Overall, the GBP concordance in Figure 4.1 and other relevant concordances (Appendix 
14: ‘Raising money for PCa’) indicated concern with raising money for PCa either 
through the Daily Mail campaign or through other fundraising action.  Thus, the CKWIC 
analysis gave an ‘aerial view’ (Seale and Charteris-Black, 2008: 456) of a narrative 
around PCa which was statistically more frequent in 1990-2000 than 2000-2010—PCa 
was an illness for which money needed to be raised.  What narrative or framing 
devices were used in this story?   
 The figure “47,000” was repeated often in Figure 4.1 as the “derisory” or “pitiful” 
amount of money spent “last year” and in terms suggesting it was very limited—“just”, 
“but only” and “yet only”.  Such repetition indicated a ‘Derisory £47,000 PCa Spend’ 
‘boilerplate’ (Cotter, 2010: 171) (underlined in Extract 4.1).  Although a boilerplate is 
‘seemingly throwaway material (....) repetitious, unattributed (...) and is potentially 
expendable as text (....) its role in framing a news story may also end up influencing 
public debate’ (p. 171):  
Extract 4.1  
I am one victim, but I've raised more cash on my own for prostate cancer than 
the Government did all of last year 
PROSTATE cancer has become the disease no one wants to talk about.  Every 
hour a British man dies from it, yet the amount spent on finding a cure is 
derisory - GBP 47,000 last year, compared with GBP 18 million spent on Aids, 
which kills 400 a year. That is why the Daily Mail has launched an appeal to 
raise GBP 1 million.  Here, 58-year-old businessman Ted Clucas, from Jersey, 
tells VICTORIA FLETCHER of his struggle to end the secrecy surrounding 
prostate cancer after he was told he needed surgery within hours of being 
diagnosed.  
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The ‘Derisory £47,000 PCa Spend’ boilerplate was one of two boilerplates evident in 
the data and which, to varying extents, were often (as in Extract 4.1) included as 
context for the illness narrative of a MWPCa.  This boilerplate is included at the start of 
the very long illness narrative of Ted Clucas, a 58 year old businessman diagnosed with 
PCa.  The first part of Ted’s narrative (shown in Appendix 15: Daily Mail, 10/11/1999) 
may be considered to have a contingent form (Bury, 2001; Bury and Monaghan, 
2013a), as it focused on the temporal unfolding of his illness from its onset and the 
relationship between Ted and his family and others he interacted with.  The latter part 
of Ted’s long narrative is shown here (Extract 4.2), as the CKWIC analysis demonstrated 
that some of the words within it were used significantly more frequently by journalists 
when writing about the illness experience of MWPCa in 1990-2000 than in 2000-2010.  
Ted’s narrative ends, after Extract 4.2, with another boilerplate (shown in Extract 4.17)   
Extract 4.2 
The next few days were a whirlwind, but in that time I decided to learn all I 
could about the disease. All I kept thinking was: Why had my GP not known all 
of this? How had he missed the telling signs? And why was there so little 
information available to men, if so many suffer from prostate cancer?  My 
shock soon turned to anger when I found out that the Government spent just 
GBP 47,000 a year on research into prostate cancer. No wonder I'd never heard 
about it; no wonder my GP wasn't knowledgeable about it.  No one was taking 
it seriously, and at that moment I vowed that, when I was better, I'd raise GBP 
47,000 for prostate research and education, to prove to the Government that 
just one man was capable of equalling their pitiful donation.  After the 
operation, my recovery was quite quick - I knew I had to beat the disease. I had 
radiotherapy until February and then started to get fit.  I'd decided to do a half 
marathon in July to raise money for the Prostate Research Campaign UK. I had 
one mission: to raise GBP 47,000.  Through my job in international financial 
services, I know some wealthy clients, and with a bit of persuasion I knew I 
could reach my goal. I finished the race, and last week the charity received a 
cheque - for exactly GBP 47,000.  I hope the money will help research into the 
disease.  But more than that, I hope that it will be used to educate GPs and 
encourage the public to get themselves checked.  Next year I am going to raise 
even more for research. We all have to beat this disease.  (Daily Mail, 
10/11/1999) 
Ted’s narrative in Extract 4.2 demonstrates aspects of framing theory specific to social 
movement framing (§2.3.1): presenting aspects of life as problematic and/or unjust 
and in need of change; attributing blame to culpable actants; proposing a solution to 
the injustice; and identifying actants who/which will engage in corrective action 
(Gamson et al., 1992; Snow and Benford, 1992). Ted transformed his diagnosis of PCa 
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from a tragic personal shock to an unjust event (Snow and Benford, 1986) with several 
actants identified as culpable: his GP’s lack of knowledge about PCa; the general lack of 
information available to men; and ultimately the “pitiful” funding of PCa by the UK 
government.  Ted proposed his own action as that which would address the lack of 
information available to men and GPs.  His rationale of “I knew I had to beat the 
disease”, ended with a collective plea for action—“We all have to beat this disease”.  
“We” indicated not just “the [male] public” given that males are the only “public” who 
can “get themselves checked” but also potential others: the female public who might 
‘nag and drag’ the male public to get checked; the “no one was taking it seriously” 
societal public; the unknowledgeable medical public of “GPs”; the PCa organisational 
public such as the “Prostate Research Campaign UK”; and the pitifully donating 
“Government”.   
 Ted’s identification as a ‘victim’ in the title of his narrative (Extract 4.1) seemed 
somewhat surprising given that this term implies that one has succumbed to the 
disease when instead it is survivorship which is often understood as key to activism 
(Kedrowski and Sarow, 2007).  Smith (2005) argues that when a tragic genre is used it 
demonstrates an ‘amplified awareness of suffering (p.25) and a ‘futile struggle against 
the fates’ (p.26); things which do not sustain activism.  Conversely, a romantic genre—
where a hero triumphs over adversity—inspires activism as it carries a hope that a 
wrong, or a wrongdoing antagonist, can be subject to successful resolution or 
negotiation.  This shift from Ted as a tragic ‘victim’ to one who triumphs over adversity 
does though fit with Bury’s (2001) observation that narrators are not necessarily 
consistent in using the narrative genres, or pre-patterned ways of talking and making 
sense, available for narrators and their audience (Tannen, 2007).   
In addition to Figure 4.1 demonstrating the Daily Mail’s launch of an appeal, 
other ‘Raising money for PCa’ concordance displays (Appendix 14) also show how 
individual MWPCa, or those associated with them, took action to raise money:  
Extract 4.3 
But prostate cancer is the "Cinderella" of cancers. Even when they have been 
diagnosed, men wait twice as long for surgery as breast cancer sufferers.   And 
while pounds 16 million a year goes into breast cancer research, a mere pounds 
1 million is spent on finding a cure for this killer disease.  Roger Kirby, Doug and 
Andrew are running the London Marathon to raise money for the Prostate 
116 
 
Research Campaign. To sponsor them, send a cheque to: Prostate Research 
Campaign (The Mirror, 06/04/2000) 
The metaphor “Cinderella” draws attention to PCa as a neglected disease when 
compared to waiting times for treatment for breast cancer.  Blame for this was 
attributed to the disparity of research funding between these diseases.  This suggested 
a gender-based neglect story and prompted further investigation of the GBP 
concordance (Figure 4.1) along such comparative lines.  In addition to ‘raise’, another 
frequent GBP collocate in Figure 4.1 was ‘to’ and while most of its instances have 
already been highlighted, a further two compared the funding of PCa unfavourably 
with the disease of AIDS (see also “with” in line 33). This comparative aspect was also 
explicitly shown in other concordance displays (see the ‘Pounds/$/£’ 1990-2000 
concordance in Appendix 14: ‘Raising money for PCa’) and extended to breast cancer 
and heart disease.  Other emotive words in Figure 4.1 were “appalling” and 
“scandalous” which helped to tell a story of neglect of PCa in relation to other 
illnesses. 
The unjust neglect of PCa and also of “men’s lives and deaths” more generally, 
was also told alongside familiar hegemonic discourse regarding men’s reluctance to 
seek help on health issues (Gough 2006).  “Suffering in silence” and “hoping it won’t 
happen” is understood as risky behaviour through the “Russian roulette” metaphor: 
Extract 4.4 
Suffering in silence or hoping it won't happen is like playing Russian roulette. 
There's also an issue of fairness here. Vast sums are spent on other forms of 
cancer prevention and cure. Yet only GBP 47,000 a year goes on prostate 
research. Does that mean men's lives and deaths don't matter?  Is society 
saying: 'Men don't complain so we can ignore their illnesses?' (Daily Mail, 
04/11/1999) 
In contrast to the silence of men, Extract 4.4 shows that “society” was given a voice 
which spoke about the ease of neglecting the illnesses of uncomplaining silent men.  
This focused attention on the potential lack of value that society placed on the lives 
and deaths of men.  This was also demonstrated by examining the keyword million in 
1990-2000 which occurred not only in an almost exclusive context of money (many 
seen in Figure 4.1) but also again with an unfavourable comparison made between the 
relatively small amount of money spent on PCa and that spent on AIDS, heart disease 
and breast cancer in both the UK and America.  Additionally, million was also used to 
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quantify how many men may have PCa, with this also in the context of an 
unfavourable and emotive comparison between British and European death rates: 
Extract 4.5 
At 10,000 deaths a year, Britain has Europe's second-highest mortality rate 
from prostate cancer. The figure has doubled in the past 20 years and some 
experts predict that it will reach 'epidemic proportions' over the next few 
decades. An estimated 2 million men in Britain over 50 probably have the 
disease, though only a small percentage will die from it. (Daily Mail, 
14/12/1996) 
Extract 4.5 shows a tentative attempt to describe PCa as an “epidemic”.  It is tentative 
because of the particular phrases used around it, suggesting it was like or almost an 
epidemic; ‘“epidemic proportions”’ (Extract 4.5), ‘“an epidemic in waiting”’ (Guardian, 
26/11/1996), and on “the verge of an epidemic” (Extract 4.6): 
Extract 4.6
One of the main aims of the Institute of Cancer Research Everyman appeal, 1 
which Richard Bentine is spearheading, is to raise $6 million to build and equip 2 
Britain's first dedicated male cancer research centre, which will be headed by 3 
the ICR's Professor Colin Cooper. 'One man in ten can expect to get prostate 4 
cancer in his lifetime yet research into male cancers has been minimal,' 5 
Professor Cooper says. 'We spend $16 million a year on breast cancer, for 6 
example, $40 million on heart disease and $15 million on Aids, but only $1 7 
million on prostate cancer.  '(sic) I think it's been so neglected because it's seen 8 
as a disease of old men.  But men as young as 40 can die of it and many older 9 
men could live for an extra ten, even 20 years, if they were cured.   '(sic) We are 10 
on the verge of an epidemic.  Within the next 20 years the incidence could be 11 
as high as one in four, partly due to an ageing population.  '(sic) But we're not 12 
very good at treating it yet. Lack of research funds means that 70 pc of patients 13 
will die of it. And the risks of side-effects are high. The Americans say better a 14 
live husband than a dead lover, but it's a high price. It is an awful disease and 15 
because we don't know the cause we cannot prevent it.' (Daily Mail, 16 
12/05/1999)17 
 
There were three instances of “epidemic” in 1990-2000 and none in 2000-2010.  
Although it was excluded as a keyword as only those of five or more instances were 
sought (§3.4.2.1.1), articulating PCa as an epidemic resonated with the idea of neglect 
above and thus to a qualitative notion of keyness (Williams 1976; Seale et al., 2006).  It 
is important as it potentially constituted PCa as a major health problem requiring 
government action.  That two ‘epidemic’ phrases were in quotation marks drew 
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attention to the use of this word in other contexts. ‘Epidemic’ may have been a 
familiar term to journalists since breast cancer as an ‘epidemic’, with unacceptable 
rates of incidence in the young and old, was used in public claimsmaking around breast 
cancer in the USA in the  1980s (Kolker, 2004).  Extract 4.6 also demonstrates (lines 6-
8) how a ‘dollar’ version of the ‘Derisory £47,000 PCa Spend’ boilerplate was used as 
context for the neglect of PCa.  Notable also (lines 8-9) was an indication of an ageist 
element to the gender-based neglect story—PCa has “been so neglected because it’s 
seen as a disease of old men”.  This perhaps familiar notion though was placed 
alongside what might be considered as rather more novel information: PCa was a 
disease that “men as young as 40 can die of” (line 9).  The above example ends with 
the implication that the lack of medical knowledge around PCa was a consequence of 
institutional neglect.   
 Though there were no ‘Raising money for PCa’ keywords in 2000-2010, 
examining the GBP and pounds/$/£ concordances in 2000-2010 (Appendix 14: ‘Raising 
money for PCa’) showed differences in how these words were used in each time 
period. The most common use of GBP in 2000-2010 was regarding insurance—all of 
which were from the same article and concerned with problems caused for insurers 
paying out on huge numbers of policies resulting from increasing numbers of MWPCa 
being detected early and cured.  The next most common use of GBP in 2000-2010 was 
around costs or affordability of treatment.  Only three instances of GBP in 2000-2010 
referred to the previous Daily Mail campaign to raise money and one to the “only GBP 
47,000” spent in 1999. Similarly, the most frequent context for pounds/£/$ in 2000-
2010 was regarding the costs of treatment.  The next most frequent articulation was 
around funding or raising money, followed by unfavourable comparisons between 
spending on PCa and other spending, and lastly the low cost of the PSA test.   
In sum, many of the ‘Raising money for PCa’ keywords in 1990-2000 were in the 
context of an appeal by the Daily Mail to raise £1million to “rectify [the] scandalous 
situation” of the “derisory” £47,000 of funding that PCa received compared to other 
illnesses including AIDS, breast cancer and heart disease.  This, and other emotive 
language in the context of these keywords such as “appalling” and PCa being described 
as ‘the “Cinderella” of cancers, suggested that PCa was problematised as a neglected 
disease.  This neglect was mostly gender-based although there were also ageist 
elements.  Blame for this neglect was attributed to various actants, including men 
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themselves who were stereotypically presented as “suffering in silence”.  Other 
attributions of blame were towards a society that placed little value on the lives and 
deaths of its men, the medical profession and government.  There was also evidence 
that PCa was tentatively framed as an ‘epidemic’ in 1990-2000 while not at all in 2000-
2010.  In contrast to 1990-2000, examination of GBP in 2000-2010 showed less 
concern with the funding neglect of PCa than with insurance and costs of treatment.   
4.3.2 Stories of injustice about treatment in 2000-2010 
Row 1, column 2 in Table 4.2 shows three categories of keywords around treatment in 
2000-2010: ‘Treatment types and procedures’ (brachytherapy, procedure, robot, SPES, 
anaesthetic, keyhole, treatment, drug, trial, seeds, monitor, needles, operations, work, 
inoperable, herbal, join, LRP, receive and  robotic); ‘Treatment side-effects’ (again, 
Zoladex, nerves, depression, testicles, wear and Casodex); and ‘Treatment policy and 
insurance’ (Guildford, cover, PCT and policy).  Of note is the mere three ‘treatment’ 
keywords in 1990-2000 (row 1, column 1): ‘Treatment side-effects’ (sexuality, risks and 
greater).  The raw and relative frequencies of these keywords in each time period are 
summarised in Table 4.4 and Table 4.5.  With the sole exception of the keyword 
treatment, journalists made no or minimal use of 2000-2010 keywords in 1990-2000.   
Table 4.4 Treatment Keywords 2000-2010 
Treatment types and procedures  
2000-2010 
Keyword 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000  
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000  
P 
BRACHYTHERAPY 0 0.0 60 55.5 6.40463E-12 
PROCEDURE 1 2.4 52 48.1 2.68906E-07 
ROBOT 0 0.0 26 24.1 3.9456E-05 
SPES 0 0.0 23 21.3 0.00011 
ANAESTHETIC 0 0.0 18 16.7 0.00063 
KEYHOLE 0 0.0 17 15.7 0.00089 
TREATMENT 81 195.2 313 290.0 0.00101 
DRUG 6 14.5 51 47.2 0.00143 
TRIAL 4 9.6 38 35.2 0.00348 
SEEDS 3 7.2 33 30.5 0.00358 
MONITOR 0 0.0 13 12.0 0.00365 
NEEDLES* 0 0.0 13 12.0 0.00365 
OPERATIONS 0 0.0 13 12.0 0.00365 
WORK* 17 41.0 89 82.3 0.00444 
INOPERABLE* 0 0.0 12 11.1 0.00523 
HERBAL 0 0.0 11 10.1 0.00750 
JOIN 0 0.0 11 10.1 0.00750 
LRP 0 0.0 11 10.1 0.00750 
RECEIVE 0 0.0 11 10.1 0.00750 
ROBOTIC 0 0.0 11 10.1 0.00750 
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Treatment policy and insurance  
2000-2010 
Keyword 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000  
2000-2010 
Raw Freq. 
2000-2010 Freq 
100,000 words 
P 
GUILDFORD 0 0.0 15 13.9 0.00180 
COVER 0 0.0 12 11.1 0.00523 
PCT 0 0.0 11 10.1 0.00750 
POLICY* 1 2.4 19 17.6 0.00828 
Treatment side-effects  
2000-2010 
Keyword 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000  
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000  
P 
AGAIN* 6 14.5 52 48.1 0.00113 
ZOLADEX 0 0.0 15 13.9 0.00180 
NERVES 1 2.4 22 20.3 0.00330 
DEPRESSION 0 0.0 13 12.0 0.00365 
TESTICLES 0 0.0 11 10.1 0.00750 
WEAR 0 0.0 11 10.1 0.00750 
CASODEX 0 0.0 11 10.1 0.00750 
*’split’ keyword  
Table 4.5 Treatment Keywords 1990-2010 
Treatment: side-effects Keywords 1990-2000 
1990-2000 
Keyword 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000  
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000  
P 
SEXUALITY 5 12.1 0 0.0 0.00034 
RISKS 10 24.1 7 6.5 0.00745 
GREATER 9 21.7 6 5.6 0.00917 
The ‘Treatment types and procedures’ keywords mostly represented new forms of 
treatments available in 2000-2010.  Brachytherapy treats PCa with radiation from 
inside the prostate either through radioactive seeds or high dose radiactive material 
inserted by needles into the prostate.  LRP, or laparoscopic radical prostatectomy, 
through keyhole operations and use of a monitor, removes the entire prostate.  
Medical professionals may also monitor PCa after treatment or the health of the 
prostate gland by regular PSA testing.  Join  is used mostly in the context of the 
procedure of a radical prostatectomy.  A newer type of keyhole radical prostatectomy 
is a robot or robotic prostatectomy where the surgeon uses a machine to assist in 
removing the prostate.  Herbal treatments included the Pfeiffer Protocol and (PC-) 
SPES, the latter previously available over the counter in the USA from 1996 but 
withdrawn in 2002 by the US Food and Drug Regulation Agency as samples contained 
warfarin.  Anaesthetic was associated with various surgical treatments including 
prostatectomy, brachytherapy and cryotherapy. Though procedure was used 
predominantly regarding treatment procedures it also referred to appeal procedures 
for men unhappy with funding decisions around treatment.  Trial was predominantly 
used in the context of trials of drugs or treatment with other instances referring mostly 
to various judicial trials. Figure 4.2 shows the 2000-2010 brachytherapy concordance: 
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Figure 4.2. ‘Brachytherapy’ concordance 2000-2010 
 
N Concordance
1 brachytherapy. The treatment is widely used in America home and searched the internet where he found out about 
2 brachytherapy. What we need now is honesty in the have to fight for treatment once his clinicians have advised 
3 brachytherapy n implanting radioactive pellets to kill chemotherapy, radiotherapy, hormone therapy, and 
4 brachytherapy, using radioactive seeds implanted in the is frozen; radiotherapy, which uses radiation X-rays; and 
5 brachytherapy. This involves planting around 100 for him - a relatively modern procedure known as 
6 brachytherapy is a more expensive procedure than slicing my PCT would need to approve the funding because 
7 brachytherapy. Instead of radiation being applied by an is one of a growing number of men being treated by 
8 brachytherapy, a procedure in which radioactive material of daily doses of radiation; or something called 
9 brachytherapy, a relatively new treatment in which pellets the cancerous cells. There is internal radiotherapy called 
10 brachytherapy, which is suitable for men who have early into the prostate. After consulting widely, Burton chose 
11 brachytherapy would be right for me. 'I had assumed were malignant cells, and Professor Langley said he felt 
12 brachytherapy costs approximately Pounds 1,300 more teased various facts out of my local trust. First, they figure 
13 brachytherapy compared with 10 to 15 per cent after 1 per cent of men suffer incontinence problems following 
14 brachytherapy a treatment involving the implanting of of his prostate so he would be eligible as a 'guinea pig' for 
15 brachytherapy - a form of radiation treatment. He said the at the University Hospital of Wales, in Cardiff, to Leeds for 
16 brachytherapy, a form of treatment that involves implanting me. I asked my urologist if I would have been suitable for 
17 brachytherapy funding for local men have been submitted . Meanwhile, I understand that four new applications for 
18 brachytherapy funding. So while she begins a slow , one of many thousands of frightened men fighting for 
19 brachytherapy n a treatment now being offered in Scotland prostate so that he would be eligible as a eguinea pig' for 
20 brachytherapy privately - it costs pounds 12,000 - Mr seeking legal advice. But without the means to pay for 
21 brachytherapy treatment in England. The , 54, is not an exceptional case to receive NHS funding for 
22 brachytherapy when my work commitments had finished a told me there was no need to panic. So I said I'd opt for 
23 brachytherapy in England for 56 prostate cancer patients NHS services for Welsh patients, said it would now fund 
24 brachytherapy, and said that it had always looked at it on to The Observer that it had a blanket ban on funding 
25 brachytherapy. I am stunned. So what exactly, I ask, am I grounds but simply because they were no longer funding 
26 brachytherapy its approval in 2005. The funding for it, National Institute for Health and Clinical Excellence gave 
27 brachytherapy, it is now hearing of cases in Nottingham it was originally Wales alone which refused to give 
28 brachytherapy in England. Mr Powell, a contracts managerit will pay for some men with pros- tate cancer to have 
29 brachytherapy in England. Last week the government bodyWales had stopped paying for any patients to have 
30 brachytherapy. They told me later that they never deal have the courtesy to write to me about why I couldn't have 
31 brachytherapy are treated as day cases, despite ensures their most effective distribution. Patients having 
32 (brachytherapy), high-intensityfocused ultrasound (HIFU) such as radiotherapy, radioactive seed implants 
33 "Brachytherapy has a lot to commend it," Steel says. , or surgery which can lead to incontinence or impotence. 
34 brachytherapy. If I waited for his return he would carry it was going to New York a few days later to qualify in 
35 brachytherapy it was surprising, to say the least.' What for cancer, and that Langley himself is an expert in 
36 Brachytherapy is a treatment first developed 20 years ago,. Why, then, am I having to fight tooth and nail for it?' 
37 brachytherapy, a specialised form of internal radiotherapy. . He saw a radiation oncologist privately. She mentioned 
38 brachytherapy funding. He reiterated that I could now me that Guildford & Waverley PCT had rejected my 
39 brachytherapy, October 18. The seeds have to be ordered is still where we want it to be and we set a date for my 
40 brachytherapy. While I'm under a general anaesthetic, the sessions and is very weak. I start on stage one of my 
41 brachytherapy - an alternative to surgery where radioactive Langley who performed the biopsy. He tells me I need 
42 brachytherapy. The treatment, which involves planting tiny PCT which initially said it would not pay for a course of 
43 brachytherapy. The National Institute for Health and may be external beam radiotherapy and a higher dose of 
44 brachytherapy in the UK and another six will soon open. work within a week. There are now eight centres offering 
45 brachytherapy, I meet all the clinical criteria for this , according to Health Commission Wales' draft policy on 
46 Brachytherapy is recommended only if the cancer is at an brachytherapy in the UK and another six will soon open. 
47 brachytherapy, the insertion of tiny radioactive seeds into radical surgery, conformal external beam radiotherapy or 
48 brachytherapy - when little radioactive seeds are put in the , there is no cure. All treatments, whether radiotherapy or 
49 brachytherapy, which involves having radioactive pellets chemotherapy; radiotherapy; hormone therapy; or 
50 brachytherapy -- a form of radiotherapy where radioactive He was given the option of surgery to remove the prostate, 
51 brachytherapy costs just £ 2,000 more than the radical had a policy of not funding the treatment. Given that 
52 brachytherapy had not only zapped my prostate, it had X-rays. In his opinion, the radiation that was a part of the 
53 brachytherapy tomorrow. 'It's a two-tier service we have that if he paid £ 11,000 and went private he could have the 
54 brachytherapy treatment," she says. "But we've been very was quite knocked back when he was unable to have the 
55 brachytherapy treatment but someone pushing a pen . 'Two consultants have told me that I should have this 
56 Brachytherapy involves the insertion of radioactive iodine , I meet all the clinical criteria for this treatment. 
57 Brachytherapy, suitable for early stage prostate cancer, slightly by the prospect of a revolutionary new treatment. 
58 brachytherapy, which involved having radioactive pellets all the cancer would be eradicated. The other option was 
59 brachytherapy treatment is recommended, should be unacceptable that any man with prostate cancer for whom 
60 brachytherapy is more successful than using seeds alone.give external radiation as data shows combining this with 
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The most significant brachytherapy collocate in Figure 4.2 was ‘radioactive’, describing 
the type of treatment that is brachytherapy. Its next most significant collocate was 
‘funding’: brachytherapy was a treatment that “many thousands of men [were] 
fighting for” (line 18), the funding for which was likely to be “rejected” (line 38) 
because of “a blanket ban on funding” (line 24).  Looking through Figure 4.2 revealed 
almost half of the concordance lines were in a context suggesting that funding for PCa 
was problematic.  Though Bill Elliot and his wife Val were diagnosed with PCa and 
breast cancer respectively within an hour of each other, the stories they had to tell 
were very different (See Appendix 15: The Observer, 09/07/2006  for full narrative): 
Extract 4.7 
For [Val’s] husband, the story is different. Still working as The Observer's golfing 1 
correspondent, [Bill] has been turned down on cost grounds for the treatment 2 
which his consultant, Professor Stephen Langley, recommended for him - a 3 
relatively modern procedure known as brachytherapy. This involves planting 4 
around 100 radioactive seeds, about the size of rice grains, within the prostate 5 
gland in order to kill off the cancer through radiation.  The alternative is to have 6 
a radical prostatectomy, the surgical removal of the prostate which has a 7 
higher risk of two major side effects - impotence and incontinence.  'I had been 8 
having tests for the last three years, just to make sure there was no risk,' Bill 9 
said. 'I'd been having the usual warning signs, such as getting up a lot in the 10 
night to have a pee. Although my PSA [prostate-specific antigen] count was 11 
relatively low, I had a biopsy which showed that there were malignant cells, 12 
and Professor Langley said he felt brachytherapy would be right for me.  'I had 13 
assumed everything would be fine, until the professor received a letter from 14 
the Primary Care Trust, saying they had turned down the request for the 15 
procedure. Given that Guildford is the major centre of excellence for cancer, 16 
and that Langley himself is an expert in brachytherapy it was surprising, to say 17 
the least.  What angers Bill so much is that the PCT has refused to explain its 18 
decision for the rationing.  'They didn't even have the courtesy to write to me 19 
about why I couldn't have brachytherapy. They told me later that they never 20 
deal directly with patients. Why not? Is that because they want to remain 21 
unaccountable?'  The Prostate Cancer Charity is worried that covert rationing of 22 
treatment is starting to spread. Although it was originally Wales alone which 23 
refused to give brachytherapy, it is now hearing of cases in Nottingham and 24 
Bath. The charity’s chief executive, John Neate, said: ‘It is a disgrace and 25 
completely unacceptable that any man with prostate cancer for whom 26 
brachytherapy treatment is recommended, should be denied access to it. 27 
(Observer, 09/07/2006) 28 
There are several notable narrative elements in Extract 4.7.  Lines 8-14 demonstrate 
Bill’s pursuit of a virtuous self in a moral narrative (Bury, 2001) in endeavouring to 
lessen his perceived risk of PCa by having regular [PSA] tests; paying attention to what 
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he perceived to be symptoms of PCa; having a biopsy even though his PSA count was 
low; and trusting his consultant on treatment advice.  In addition to this justification of 
his actions, his implicit blaming of the “unaccountable” (line 22) PCT for putting him at 
higher risk of impotence and incontinence also fits the form of a moral narrative (Bury, 
2001).  The metaphor “starting to spread” (line 23) bears similarities to that of 
“epidemic” used by journalists writing about PCa in 1990-2000.  Here it refers to the 
“covert rationing of treatment” (lines 22-23), originally in Wales but now spreading to 
other PCTs.  The idea that MWPCa should not be “denied access to” (line 27) 
treatment which has been recommended to them was common throughout the 
brachytherapy concordance.  That this was a “disgrace and completely unacceptable” 
(lines 25-26) was also similar to the ‘derisory’ and ‘scandalous’ words used by 
journalists to tell a story of neglect around PCa in 1990-2000.  This then suggests that 
the story of neglect told by journalists when writing about the illness experience of 
MWPCa in 1990-2000 shifted to other tales of injustice around treatment in 2000-
2010. In addition to some of the narrative elements shown in Extract 4.7, Extract 4.8 
shows that a MWPCa was given a family-based identity:  
 Extract 4.8 
A grandfather has been refused funding for a new prostate cancer treatment 
for a second time - just a week after other patients were told they could have 
it. A special panel has ruled that David Powell, 54, is not an exceptional case to 
receive NHS funding for brachytherapy treatment in England. The grandfather-
of-four has accused Health Commission Wales of infringing his human rights by 
denying him the treatment and is now seeking legal advice. But without the 
means to pay for brachytherapy privately - it costs pounds 12,000 - Mr Powell 
could have to undergo a different form of treatment with more side effects - or 
even surgery. (Mirror, 19/06/2006) 
The family-based identity of ‘grandfather-of-four’ attributed to David Powell, a 
MWPCa, bears similarities to the identities of wives and mothers given to breast 
cancer sufferers in the US in the 1980s (Kolker, 2004).  This helped to move breast 
cancer from that which not only threatened women but also American families with 
the result that ‘the pool of victims impacted by the disease expanded significantly to 
include the entire family’ (Kolker 2004: 831)—something also potentially the case for 
MWPCa.  
Bill’s narrative in Extract 4.7 (line 8) demonstrates that at least one reason why 
men fought for brachytherapy was to lessen their risks of incontinene and impotence.  
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This concern was also demonstrated in the analysis of the ‘Treatment side-effects’ 
keywords.  The exclusive context of all instances of the keyword nerves relating to 
side-effects was concerned with the risk of damage from keyhole robot or laparascopic 
radical prostatectomy to the nerves responsible for continence and sexual function: 
Extract 4.9 
Mr Gillatt said the prostate was in a tricky location and he would try not to 
damage the nerves surrounding it which govern sexual function. But at that 
stage, whether or not I'd ever perform sexually again seemed irrelevant. I went 
in for my prostatectomy on May 3. I was the youngest man on the ward by 15 
years (Daily Mail, 24/09/2002) 
The relevant instances of wear showed that it predominantly referred to concerns 
around incontinence and impotence: “I was also left incontinent and had to wear pads 
for three years” (Daily Mail, 01/11/2005) and “That removed most of the cancer, but it 
damaged my ability to stay sexually aroused. I prayed it was just a temporary effect, 
that it would eventually wear off and everything would be normal” (Daily Mail, 
06/11/2001). Though love was mainly used in a context of family love and support and 
Lloyd Webber’s production ‘Love Never Dies’, it was also used around  ‘making love’ or 
one’s love-life.  Although Zoladex and Casodex, trade names for Goserelin and 
Bicalutamide respectively, are types of hormone therapy acting on testosterone levels, 
their concordance (Figure 4.3) shows they were used in relation to their side-effects: 
Figure 4.3. ‘Zoladex/Casodex’ concordance 2000-2010 
 
N Concordance
1 Zoladex (the brand name for the drug Goserelin) which inhibits the prostate gland. His doctors prescribed radiotherapy and 
2 Zoladex works by reducing testosterone in the body to levels or problems with attention and memory as side effects. But 
3 Zoladex, which inhibits the production of the hormone Breakfast chef in the early Eighties, was given a drug called 
4 Casodex, which reduces the production of testosterone but Nigel would try radiotherapy plus a hormonal drug called 
5 Zoladex have been reported to the Medicines and Healthcare a suspected high incidence of cases of depression concerning 
6 Casodex was probably to blame. The best treatment for such to me. Scans showed I was clear of cancer and he confirmed 
7 Zoladex produces depression. And although a suspected high taken seriously, but in a written response his urologist denied 
8 Casodex and two months' radiotherapy. Casodex blocks the if the disease is caught early. The treatment was the drug 
9 Casodex. This is an anti-androgen that blocks the effects of oncologist Robert Laing puts me on the hormone drug 
10 Zoladex was administered to Glynn by two injections. A few treatment would reduce my libido and give me hot flushes.' 
11 Zoladex stops the production of leuteinising h o r m o n e and playground.. leuteinising hormone in the brain's pituitary gland. 
12 Zoladex injections. Graham finished his treatment in November . This was followed by another six- month course of 
13 Casodex, which prevents testosterone getting to the tumour are treated by hormones alone. He was put on a course of 
14 Casodex, a pill which blocks the action of testosterone and almost immediately. First there was a 30-day course of 
15 Zoladex, a hormone therapy, to reduce the size of the tumour. at Ashford Hospital, Middlesex, and had monthly injections of 
16 Zoladex, which stops the production of testosterone and was to play an important role - and then I started an injection of 
17 Zoladex, a hormone which stops the body producing being given a plan to tackle this thing.' Graham was started on 
18 Casodex for two months. 'It had a dramatic effect. My PSA survival.' Before Nigel started radiotherapy, he was put on 
19 Casodex, his breasts will not regrow; the mastectomy should , once the wound has healed. Even if John has to go back on 
20 Casodex blocks the male hormone testosterone, which feeds was the drug Casodex and two months' radiotherapy. 
21 Casodex has allowed him to get on with his life, but admits take the first treatment offered to me.' Nigel says that taking 
22 Casodex drug makes me feel as though I am jetlagged. It be delayed and I will need to take drugs to try to reduce it. The 
23 Zoladex, which is administered by six-monthly injection. This drug began to wear off, so last November he was switched to 
24 Zoladex - for three months. Prostate cancer feeds off the , Maxton was prescribed a hormone-injection treatment - 
25 Zoladex, a drug that blocks production of testosterone (which first consultant I saw believed it was cancer and wanted to use 
26 Zoladex being a chemical form of this, I felt sure there was a about castration causing symptoms of depression and, with 
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The predominant story around Zoladex/Casodex (Figure 4.3) was regarding the mostly 
debilitating side-effects.  These included depression, impotence, lack of libido, lack of 
confidence, tiredness, breast enlargement, pain and tenderness, hot flushes, and 
weight gain.  Many of these were experienced by Glynn Christian, a celebrity chef with 
PCa who, because of hormonal treatment for PCa, became “like a menopausal 
woman” (Daily Mail, 24/02/2009): 
Extract 4.10 
WHEN TV chef Glynn Christian began to suffer from debilitating depression and 
co-ordination difficulties, his doctors could provide no explanation.  Unable to 
work, drive or shop, he faced a frustrating battle to discover the cause of his 
symptoms. Only after five years of suffering did he work out what was wrong -- 
the depression was a side effect of [Zoladex] treatment he had received for 
prostate cancer. (....) 'I had read about castration causing symptoms of 
depression and, with Zoladex being a chemical form of this, I felt sure there was 
a connection. I told my doctors, but they sent me to a psychiatrist.'  This 
treatment failed to help Glynn. He stopped working and lived on his savings 
and credit card. Eventually, his psychiatrist agreed that it might be worth 
finding out if the hormone treatment was partly responsible. She referred him 
to an endocrinologist, who recommended hormone replacement therapy.  As 
soon as he started this, Glynn's libido returned, his depression eased and his 
memory improved (….) I really do feel I should have been warned (Daily Mail, 
24/02/2009) 
Though Glynn began his narrative with a tragic genre of suffering regarding the 
debilitating side-effects of Zoladex, he proceeded to tell about his triumph over the 
adversity, not only of PCa but also of its side effects.  His felt injustice was that he 
ought to have been warned of these unwanted side-effects—perhaps he would not 
had chosen Zoladex as treatment.  The desire to avoid impotence and incontinence 
was demonstrated even in the one article which described how Casodex preserved one 
man’s sex life. After treatment with Casodex and radiotherapy, Nigel said:  
Extract 4.11 
‘Although I'm divorced with two grownup sons, I wasn't prepared to trade in 
my sex life just yet.  Men who have surgical or chemical castration are more 
likely to survive longer, but you have to weigh up quality-of-life issues. (….) One 
of the things that tipped me away from castration was an article in the British 
Medical Journal, where patients were surveyed and said they would prefer 
quality-of-life over increased survival. (….) I still hope to meet someone again. 
Impotence is not something most men could cope with. I know from my 
experience as a surgeon that patients want to find out about their treatment, 
and to have a say in what is decided.  I'm so glad I didn't take the first 
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treatment offered to me.' Nigel says that taking Casodex has allowed him to get 
on with his life, but admits there are some side effects.  'It leaves you incredibly 
tired, and causes male breast enlargement. But I'm still prepared to live with 
these side-effects rather than have my sex life taken away,' he says (Daily Mail, 
30/11/2004) 
Unlike Glynn, Nigel’s narrative did not start by drawing upon a tragic genre for his own 
suffering and moving to a romantic one of overcoming adversity.  Nigel did though 
indicate competing versions of tragic genres—potential early death versus living with 
impotence—and corresponding competing romantic genres—longer survival versus a 
good quality, though potentially short, life.  His choice of romantic optimistic genre, 
like Bill’s (Extract 4.7 ) and Glynn’s (Extract 4.10), was that which allowed him to 
overcome the threat to his valued sex life.  Mens’ narratives also demonstrated 
triumph over the threat of incontinence and impotence in other ways.  The 
predominant context of testicles was regarding hormone treatment for PCa with most 
refering to side-effects:  
Extract 4.12 
My testicles also appeared to be shrinking, and I didn't have to shave every day. 
But it wasn't all bad, I joked, there were definite pluses to getting in touch with 
the kinder, more feminine me (Daily Mail, 20/12/2005). 
Extract 4.12 shows how a MWPCa used a comic genre (Bury, 2001) to mock both 
himself (Kelly and Dickinson, 1997) and hegemonic masculinity (Courtenay, 2009) in a 
way which potentially created social distance from the suffering of these side-effects 
(Kelly and Dickinson, 1997: 270).  Hilton (Extract 4.13) drew upon a variety of pre-
patterned ways of talking (Tannen, 2007), or narrative genres (Bury, 2001), to tell his 
story of PCa: 
Extract 4.13 
“I was booked in for the treatment at the Royal Marsden in Surrey when they 1 
asked me if I would like to go on their active surveillance programme. The 2 
cancer was very small and they said that if at any time it showed signs of 3 
growing or spreading they would operate”. Now Hilton has a PSA test every 4 
three or four months and a biopsy every two years. So far there is no sign that 5 
the cancer is growing - so he has escaped potentially damaging treatment. "I 6 
reckon I am going to die with the cancer, not of it. There are men who have 7 
been treated because of the [PSA] test and are impotent and incontinent. It is a 8 
fact that the cure is worse than the disease”. He is appalled by the damage that 9 
has been done by over-treatment. “If you were given the option of living with 10 
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cancer or having your sex life removed and being given a nappy to wear, which 11 
would you choose?"  Many men would be appalled by the idea of living with a 12 
cancer inside them, but he is unworried by it. "I feel like a fraud. I go to the 13 
Royal Marsden for my check-ups and there are people undergoing 14 
chemotherapy who have lost their hair and have yellow, waxy skin, and I think I 15 
shouldn't be saying I have the same disease as these people".  His experience 16 
illustrates the unique feature of prostate cancer: it is curable but may not need 17 
treatment. In many men it is slow-growing - so slow that they can live with it 18 
and die of something else.  (The Independent, 20/09/2004) 19 
There are several notable elements in Hilton’s narrative. He used emotive words 
similar to those used by journalists writing in 1990-2000 to describe the injustice of 
neglect of PCa: this time though it was regarding injustice around the appalling 
damage of overtreatment (lines 9-10).  This tragic genre of unjust suffering (Smith, 
2005) was though also juxtaposed with another ostensbily tragic genre: the “appalling” 
(line 12) idea of living with a cancer inside you.   Dying with PCa and not of it (line 7, 
18-19) is known in at least the academic literature (Neal and Donovan, 1998); likewise 
for the idea that  the cure of PCa with its risks of incontinence and impotence may be 
worse than the disease (lines 9-12) (Parker, 2004).  Finally, Hilton contrasted what he 
saw as his fraudulent identity as a person with cancer with those who were really sick, 
at least as a result of their treatment for the same disease he had.   
Of the ‘Treatment side-effects’ keywords in 1990-2000, sexuality was used 
mostly in the context of regaining potency: “At first my check-ups were every three 
months, but now it's every six. My PSA level is below normal and my sexuality has 
returned” (Daily Mail, 12/05/1998).  The predominant context of greater was 
regarding treatment, and most of these referred to recovery from side-effects such as 
the ‘greater chances of regaining potency’.  Likewise, the almost exclusive context of 
risks in 1990-2000 was regarding the risks of incontinence and impotence from a 
prostatectomy.  Thus, the keywords around ‘Treatment side-effects’ in 1990-2000—
though much fewer than in 2000-2010—also indicated men’s concern around 
impotence and incontinence. 
Of the ‘Treatment policy and insurance’ keywords in 2000-2010 all but one 
instance of cover referred to insurance and this was almost exclusively used alongside 
policy.  The predominant context of policy was insurance cover for illness.  This was 
followed by a treatment policy context, many of which were regarding problematic 
funding of brachytherapy and cryotherapy, one regarding a policy of ‘watchful waiting’ 
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and one regarding the lack of a national screening policy for PCa.  In all but one 
instance PCT referred to a MWPCa battling for funding for brachytherapy in a series of 
articles in The Observer (for an example see Extract 4.7), with the remaining instance 
referring to the refusal of Bolton PCT to fund cryotherapy. 
In sum, keywords around treatment for PCa were more evident in 2000-2010 
than in 1990-2000.  These mostly represented new forms of treatments and 
procedures available in 2000-2010 such as brachytherapy, Zoladex and Casodex 
hormone treatment, laparascopic or robotic radical prostatectomy, herbal remedies 
and trials for new drugs.  The “disgraceful” and “unacceptable” injustice around 
funding for brachytherapy and attention to NICE and PCT policies were of concern in 
2000-2010. In addition, and in contrast to 1990-2000 where journalistic concern was 
mainly for the risks of impotence and incontinence post-prostatectomy, concern in 
2000-2010 also centred on the “debilitating” and feminising side-effects of hormone 
treatment.  There was also attention to the problems caused for insurance companies 
given the increasing numbers of MWPCa being diagnosed early and cured.  Thus, the 
‘aerial view’ from the CKWIC analysis showed a narrative around PCa which was 
statistically more frequent in 2000-2010 than 1990-2000—PCa was an illness for which 
there was injustice around funding for treatment and concern over debilitating side-
effects.  So far then, the CKWIC analysis has indicated a shift from the injustice around 
the funding neglect of PCa in 1990-2000 to injustice around treatment in 2000-2010. 
4.4 A story of ‘taboo’ around PCa 
Row 2, column 1 in Table 4.2 shows three categories of ‘Awareness’ keywords: ‘Being 
reluctant to talk’ (taboo, quiet); ‘Raising awareness’ (Mail, raise, Mail’s);  and ‘Knowing 
about the prostate and prostate cancer’ (studying, prostatic, shaped, BPH [benign 
prostatic hyperplasia], tumour, surrounds, analysed, doughnut, slower, upper, enlarge, 
killer, develops, disease, capsule, hyperplasia, cancer, idea). There were four 
‘Awareness’ keywords in 2000-2010: ‘Being reluctant to talk’ (reasons) and ‘Raising 
awareness’ (radio, launch, and diary).  The raw and relative frequencies of these 
keywords are summarised in Table 4.6 and Table 4.7: 
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Table 4.6 Awareness Keywords 1990-2000 
‘Being reluctant to talk’  
1990-2000 
Key word 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000 
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000 
P 
TABOO 6 14.5 0 0.0 8.76E-05 
QUIET 8 19.3 2 1.9 0.00059 
‘Raising awareness’  
1990-2000 
Key word 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000 
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000 
P 
MAIL* 18 43.4 13 12.0 0.00042 
RAISE* 16 38.6 13 12.0 0.00196 
MAIL'S* 5 12.1 1 0.9 0.00451 
‘Knowing about the prostate and prostate cancer’  
1990-2000 
Key word 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000 
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000 
P 
STUDYING 9 21.2 0 0.0 1.55E-06 
PROSTATIC 14 33.7 3 2.8 2.71E-06 
SHAPED 11 26.5 1 0.9 2.76E-06 
BPH 12 28.9 2 1.8 5.68E-06 
TUMOUR 44 106.1 47 43.5 3.13E-05 
SURROUNDS 9 21.2 1 0.9 3.31E-05 
ANALYSED 5 12.1 0 0.0 0.00034 
DOUGHNUT 5 12.1 0 0.0 0.00034 
SLOWER 5 12.1 0 0.0 0.00034 
UPPER 9 21.2 3 2.8 0.00068 
ENLARGE 7 16.9 2 1.8 0.00182 
KILLER 16 38.6 13 12.0 0.00196 
DEVELOPS 8 19.3 3 2.8 0.00197 
DISEASE 95 229.0 165 152.6 0.00204 
CAPSULE 5 12.1 1 0.9 0.00451 
HYPERPLASIA 7 16.9 3 2.8 0.00557 
CANCER 567 1366.7 1288 1191.4 0.00678 
IDEA 16 38.6 15 13.9 0.00511 
*‘split’ keyword 
Table 4.7 Awareness Keywords 2000-2010 
‘Being reluctant to talk’  
2000-2010 
Keyword 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000 
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000 
P 
REASONS 0 0.0 14 13.0 0.00256 
‘Raising awareness’  
2000-2010 
Keyword 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000 
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000 
P 
RADIO 0 0.0 16 14.8 0.00126 
LAUNCH* 0 0.0 15 13.9 0.00180 
DIARY 0 0.0 11 10.2 0.007 
*‘split’ keyword 
The combined taboo and quiet concordance (Figure 4.4) demonstrates that all 
instances of taboo and most of quiet were in a context indicating that keeping one’s 
experience of PCa “quiet” and PCa as a condition which “no one dares talk about” (line 
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14) was more common in 1990-2000 than 2000-2010.  There were no instances of 
taboo and only two of quiet in 2000-2010: 
Figure 4.4. ‘Taboo’ and ‘quiet’ concordance 1990-2000 
 
The Oxford English Dictionary defines taboo as ‘a social or religious custom prohibiting 
or forbidding discussion of a particular practice (...) or thing’. As such, articulating PCa 
as a taboo suggests that blame for men’s reluctance to talk was attributed to a society 
which prohibits them from doing so and which the society has an obligation to 
address. There was knowledge around PCa, but such was this knowledge that it both 
constructed “isolating silence” (line 13 Figure 4.4,) for men and also the illness as 
taboo for society: 
Extract 4.14 
For too long prostate cancer has been a taboo.  It has been ignored by 
politicians and greeted by too many people with giggles, embarrassment or a 
shocked silence.  Too many men are reluctant to admit there could be anything 
wrong and don't bother going to the doctor for checks. It's also a disease every 
woman who loves a man must address. Indeed, the scale of this 'forgotten 
disease' was revealed yesterday as Government figures showed a huge rise in 
cases during the past decade.  The only good news was a slight fall in death 
rates due to early diagnosis.  This message reinforces the Mail's campaign to 
raise money for the Prostate Cancer Charity, Britain's only group dedicated to 
raising public awareness and encouraging research. (Daily Mail, 03/11/1999) 
N Concordance
1 quiet moment in the house would always bring , and that made me feel more positive. But a 
2 quiet as possible. I felt that it was no one's my cancer. My initial impulse was to keep it as 
3 quiet from everyone else, including my three of death cross my mind. I kept the condition 
4 quiet in there.' We exchanged glances and and said: 'You'd better come into my office, it's 
5 quiet about my cancer for almost a year before checked out. And it could save their life. I kept 
6 quiet about the name of their benefactor. The his money on the one condition that they kept 
7 quiet killer IF ANYONE can bring glamour to the treatment and, right, gives the lowdown on the 
8 quiet and didn't want the Press or the showbiz the panto season. At the time I kept it very 
9 taboo. It has been ignored by politicians and . For too long prostate cancer has been a 
10 taboo subject. Medical sociologist Clare prostate cancer is that for many it remains a 
11 taboo subject. HOW TO SPOT THE DANGER then will we stop making prostate cancer a 
12 taboo among American voters, and with no in its most treatable form, still carries a heavy 
13 taboo and talk. Boldy, he chose the latter. isolating silence of his own fears, or break the 
14 TABOO DISEASE THAT NO ONE DARES MONEY AND AWARENESS FOR THE 
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Extract 4.15 
It's always struck me how different men are to women. For men, it's all about 
upholding this tough, macho image, regardless of the consequences. But 
women are far more aware of potential problems.  With the Mail promoting 
the issues, maybe the Government and medical profession will follow suit.  
Only then will we stop making prostate cancer a taboo subject.  (Daily Mail, 
11/11/1999) 
Men’s culpability in making PCa a taboo subject was demonstrated in their drawing 
upon hegemonic masculinity discourse (Courtenay, 2009) in their seeking to uphold a 
macho image and reluctance to seek help on health issues.  Other actants though were 
also identified as both responsible for the construction of PCa as a taboo and as agents 
in its solution.  These included “politicians”; the “too many people”; the “every woman 
who loves a man”; the “Government”; “the Mail’s campaign”; “the Prostate Cancer 
Charity”; the “medical profession”; and the “we” who made PCa a taboo subject. As 
raising money was articulated as a solution to the problem of the funding neglect of 
PCa, so raising awareness was articulated as a solution to the problem of prostate 
cancer as a taboo.   
There was one ‘Being reluctant to talk’ keyword in 2000-2010. In most instances 
reasons is used by George Carman, a celebrity MWPC, who announced his retirement: 
Extract 4.16 
saying he needed treatment for a "little local difficulty" but did not expand on 
the description until yesterday.  "On reflection, I feel it important to say, to 
dispel rumour, and for other reasons, that in fact I have suffered from prostate 
cancer for over three years".  (Times; Guardian; and Daily Mail all 04/09/2000) 
 
A further two instances of reasons indicated that the reasons why PCa did not have a 
high profile was at least because men found it difficult to talk about PCa: “‘it’s difficult 
for men to deal with strong emotions. This is one of the reasons why prostate cancer 
has not had a high profile, because men have found it difficult to talk’” (Independent 
on Sunday, 10/09/2005).  One instance of score also indicated this difficulty in talking: 
“Ladies easily discuss breast cancer, but you don't see a gathering of men in a pub 
talking about their prostates. They are talking about the latest page three girls or the 
cricket score because they think that any problem "down there," as they'd put it, is a 
nonmacho situation (Daily Mail, 27/07/2002). This use of reasons and sport somewhat 
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indicated that PCa and its treatment was that which men might prefer to keep quiet 
about.   
Mail*, raise* and Mail’s*, split keywords discussed earlier, were also categorised 
as ‘awareness’ due to their meaning around ‘Raising awareness’.  There were three 
such keywords (radio launch*, and diary) in 2000-2010.  Radio was used in seven of its 
14 relevant instances to describe how this medium was used to inform others both 
about new treatments for the disease and of the necessity to get checked out.  Though 
launch was a split keyword and used mainly to describe launching a show or a book in 
the context of employment of MWPCa, it was also used regarding the launch of 
awareness campaigns.  Diary, in most of its instances, referred to Andy Ripley, a 
celebrity sportsman with PCa, who wrote a diary about his battle against PCa which 
was later published by The Prostate Cancer Charity in line with Ripley’s wishes to “‘get 
one more man to go and get checked out’” (Independent on Sunday, 25/11/2007).   
Most instances of the keyword idea in 1990-2000 were around men having “no” 
or “little” idea regarding the prostate or PCa.  Apart from idea, many of the ‘Knowing 
about the prostate and prostate cancer’ keywords were likely keywords because of 
their use in the boilerplate (Cotter, 2010): ‘Your guide to the prostate’ (Extract 4.17): 
Extract 4.17 
*WHAT is the prostate? A doughnut-shaped gland the size of a walnut that 
surrounds the upper part of the urethra - the tube that carries urine from the 
bladder to the penis. When cells in the gland grow, a tumour develops.  Cancer 
cells then spread to other parts of the body.  * WHEN does it occur? With age, 
it is normal for the prostate to enlarge.  This condition is Benign Prostatic 
Hyperplasia (BPH) and can occur in men as young as 30.  BPH can be easily 
treated.  * WHAT is prostate cancer? There are two types - an aggressive form 
and a slower one. Pathologists determine the type by studying the cells.  * 
WHAT are the symptoms? You need to urinate frequently.  The urine stream is 
poor. You have lower back pain. There is blood in your urine.  * HOW is it 
diagnosed? There are four types of test. Digital Rectal Examination: A doctor 
feels the prostate and identifies an enlargement.  Prostate Specific Antigen 
(PSA) test: A blood test that measures levels of a protein called PSA. Transrectal 
ultrasound: A probe is placed in the rectum and pictures are taken of the 
prostate. Biopsy: A sample of prostate tissue can be analysed to see how 
aggressive the cancer is.  * WILL you get it? The odds escalate with age: 70 pc 
of men in their 70s will have it, rising to 80 pc in their 80s.  *WHAT are survival 
rates? Within five years of being diagnosed, the survival rate in Britain is less 
than 50 pc. (for example, Daily Mail, 10/11/1999) 
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BPH, surrounds, doughnut, studying, analysed, slower, upper, enlarge, develops and 
hyperplasia are used in this boilerplate either exclusively or almost so; tumour, 
disease, prostatic, and shaped less so.  Develops was used almost exclusively with 
tumour, and tumour principally around the presence or aggressiveness of the tumour 
or what was happening to the tumour post-treatment.  Killer did not appear in any 
boilerplate and was used almost three times as often in 1990-2000 as 2000-2010.  All 
1990-2000 instances referred to the ‘killer disease’ of PCa and five also referred to it as 
a silent or quiet killer or that which was ignored or neglected.  This boilerplate (Extract 
4.17) was used in seven Daily Mail articles over two weeks in November 1999 during 
the launch of its campaign to raise money and awareness.  Like the boilerplate in 
Extract 4.1, it was often inserted before or after the narrative of a MWPCa and 
articulated biomedical information about PCa in a way to construct men’s awareness 
of this condition and so fulfil the awareness aims of the Daily Mail’s campaign. 
In sum, PCa as a “taboo” disease that “no one dares talk about” and about which 
men kept quiet was more explicitly and frequently articulated in 1990-2000 than 2000-
2010.  PCa was allowed to be a taboo by society in that “it has been ignored by 
politicians and greeted by too many people with giggles, embarrassment or a shocked 
silence.”  Though there were no instances of ‘taboo’ in 2000-2010, the limited use of 
the keyword reasons by journalists in 2000-2010 indicated that PCa remained 
somewhat difficult to talk about.  In 1990-2000, raising awareness was proposed as a 
solution to PCa as a taboo with particular actants identified both as culpable for this 
problem and also as those who must act to change it including “every woman who 
loves a man” and the “we [who] will stop making prostate cancer a taboo subject”.  
Additionally, MWPCa in 1990-2000 were more frequently described as having ‘no idea’ 
about the prostate and PCa than in 2000-2010. Increasing awareness of PCa was still of 
concern in 2000-2010, with awareness-raising media such as radio and diaries used to 
inform men and urge them to get themselves checked.   
4.5 Stories of symptoms and risks 
Row 3, Table 4.2 shows two categories of keywords more frequent in 1990-2000 than 
in 2000-2010: ‘Risks’ (including age, nutrition and genetic risk); and ‘Symptoms’—there 
were no such keywords in 2000-2010.  These keywords are summarised in Table 4.8: 
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Table 4.8 ‘Symptoms’ and ‘Risk’ Keywords 1990-2000 
‘Symptoms’  
1990-2000 
Key word 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000 
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000 
P 
URINE 47 113.3 43 39.8 1.01E-06 
SYMPTOMS 67 161.5 93 86.0 0.00013 
WATER 14 33.7 8 7.4 0.00046 
FREQUENTLY 11 26.5 7 6.5 0.00318 
STREAM 10 24.1 6 5.6 0.00380 
PASSING 13 31.3 10 9.3 0.00387 
SIGNS 18 43.4 19 17.6 0.00711 
ENLARGEMENT 10 24.1 7 6.5 0.00745 
‘Age risk’ 
ESCALATE 6 14.5 0 0.0 8.76E-05 
OCCUR 13 31.3 7 6.5 0.00053 
AGE 46 110.1 63 58.3 0.00121 
YOUNG 22 53.0 23 21.3 0.00269 
‘Genetic risk’  
GENETIC 9 21.2 2 1.9 0.00019 
HISTORY 14 33.7 9 8.3 0.00093 
LINK 6 14.5 2 1.9 0.00555 
GENE 7 16.9 3 2.3 0.00557 
‘Nutrition risk’  
VEGETABLES 8 19.3 0 0.0 5.91E-06 
FRUIT 7 16.9 0 0.0 2.26E-05 
ZINC 7 16.9 0 0.0 2.26E-05 
FATS 5 12.1 0 0.0 0.00034 
OIL 5 12.1 0 0.0 0.00034 
TOFU 5 12.1 0 0.0 0.00034 
EXPOSURE 5 12.1 0 0.0 0.00034 
EAT 15 36.2 9 8.3 0.00039 
VITAMIN 9 21.2 3 2.8 0.00068 
DIET 14 33.7 10 9.3 0.00174 
MEAT 9 21.2 5 4.6 0.00447 
CHEMICALS 6 14.5 2 1.9 0.00555 
Many of the ‘Symptoms’ keywords were used in the ‘Your guide to the prostate’ 
boilerplate (Extract 4.17) (21 instances of urine; seven each of symptoms, frequently 
and stream; five of enlargement; and four of signs).  Urine was almost three times 
relatively more frequent in 1990-2000 than in 2000-2010.  Overall, 36/47 raw 
instances of urine in 1990-2000 were in the context of symptoms of PCa; referring 
either to blood in urine or to lower urinary tract symptoms (LUTS).  The remaining 
instances referred to urine tests or to some aspect of the prostate or organs around it.  
In addition, the almost exclusive use of the keywords water and passing were 
regarding some or other LUTS: 
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Extract 4.18 
THE only clue that anything was wrong was that I noticed I was getting up once 
or twice during the night to pass water, which had never happened before.   At 
first, I didn't take it seriously, because there was no pain and it wasn't difficult 
to urinate. I thought it was a minor bladder problem and put it to the back of 
my mind.   But it didn't get any better, so I went to see my doctor. He told me 
he wanted to check my prostate and examined me.   Although he could find 
nothing wrong, he referred me to a specialist for a PSA (Prostate Specific 
Antigen) reading.  (Daily Mail, 03/11/1999) 
Extract 4.19 
After he had performed the [flu] inoculation, he said, matter-of-factly: 'How's 
the old water works?' 'Fine,' I lied, my hand on the door handle. 'Perhaps we'd 
better have a look anyway.' (Daily Mail, 12/01/1999) 
Similarly, the exclusive use of stream and the almost exclusive use of frequency in 
1990-2000 refer to LUTS.  All instances of enlargement in 1990-2000 referred to 
prostate enlargement in the context of PCa.  Five of these were in the ‘Your guide to 
the prostate’ boilerplate (Extract 4.17) and the remaining five were regarding the 
difficulty in distinguishing between malignant and benign prostate enlargement: 
Extract 4.20 
The symptoms of the benign enlargement of the prostate which is an inevitable 
part of ageing are well known; but these same symptoms, usually to a lesser 
extent, also cause suspicion of cancer of the prostate. (The Times, 09/10/1997) 
All but two instances of enlargement in 2000-2010 also referred to this difficulty; with 
the remaining two instances instead referring to breast enlargement as a side-effect of 
Casodex.  The keyword signs was used over twice as frequently in 1990-2000, 
predominantly as a semantic equivalent of symptoms.  Symptoms was used by 
journalists almost twice as frequently in 1990-2000 than 2000-2010 and Figure 4.5 
shows its 1990-2000 concordance:  
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Figure 4.5. ‘Symptoms’ concordance 1990-2000 
 
N Concordance
1 Symptoms include: difficulty with or delays in urinating; attacks around one in ten men, mostly aged over 65. 
2 Symptoms: (most of these symptoms are more likely one close relative with prostate cancer at a young age 
3 symptoms: EACH YEAR 10,000 men die of prostate at you is not unbearable." Know the enemy: site and 
4 symptoms. But we still don't know whether offering prostate cancer in men who have not developed any 
5 symptoms,' he said. 'They discovered it only through other people with prostate cancer, I didn't display any 
6 symptoms such as difficulty passing water, don't And my advice is always, if you are worried or have any 
7 symptoms, but this is generally carried out only if men. A simple blood test can detect it before it causes 
8 symptoms, which disturb the patient, there is a 50 per prostate is an insidious disease; by the time it causes 
9 symptoms, but his GP here hadn't diagnosed anything. Michael Bentine discovered it. 'He'd had all the classic 
10 symptoms and then opt for treatment at that stage.' . Alternatively, they can wait and see if they develop 
11 symptoms, and that his cancer was the 'tiger' kind . He was unusually unlucky because he had very few 
12 symptoms. He did go to the bathroom once a night, was one of a tiny minority who only experience very few 
13 symptoms that could foretell the need for urgent , do not have regular PSA blood tests should watch for 
14 symptoms were obvious - I had a frequent need to go to experiencing problems in my early forties. The initial 
15 symptoms, advances in treatment, and their success Dr Thomas Stuttaford reports on prostate cancer: its 
16 symptoms, there is only mild or moderate relief. Third, one in my case. For people with mild or moderate 
17 symptoms checked out in the summer of 1997. I was in doctor. So I left it dangerously late before getting my 
18 symptoms. Going to the lavatory was becoming really . How right she was. I went to my GP and explained my 
19 symptoms my GP sent me immediately to a specialist with the flow of urine. As soon as I had described my 
20 symptoms were only moderate. I do not mind getting up factors persuaded me against the operation. First, my 
21 symptoms. A lot of men who get prostate cancer find worrying thing in my case is that I had absolutely no 
22 symptoms and the bleeding would not have been blood was found in his urine; apart from this he had no 
23 symptoms. And his cancer, too, was detected at a banker Andrew, 63, from Kensington, London, had no 
24 symptoms at all, apart from impotence.' When a to admit that I had a problem. Also, I had absolutely no 
25 symptoms but my daughter had wanted me to have the in my left groin, but I couldn't feel anything. I'd had no 
26 symptoms, but I know that men often find themselves wives play in detecting the cancer is crucial. I had no 
27 symptoms of the killer disease which claims more than to 1983, is still astonished at the fact that he had no 
28 symptoms to alert me. Now I'm paying a heavy price for the cancer in my prostate gland, but there were no 
29 symptoms until the disease is advanced Problems with for their book, Prostate Problems: The Facts. . Often no 
30 symptoms. Yet this insiduous disease, which kills 11,he would never have to worry about - he simply had no 
31 symptoms are peeing too much - or getting up in the , I'm not feeling very invincible. "I gather the normal 
32 symptoms. By this time treatment options have aches and pains in the bones and joints are the obvious 
33 symptoms I tell them: 'For goodness sake get it prostate cancer? If ever I have friends who complain of 
34 symptoms. Rectal examinations reveal only 40 per cent . Neither my friend George nor I had much in the way of 
35 symptoms. I feel lucky. I'd recommend all men of my and my sexuality has returned. And I've had no other 
36 symptoms. I felt fine but I had no idea what was going aspect of this cancer is that there are no real outward 
37 symptoms," she says. "Prostate cancer is a very slow is that he looked so well and there weren't any outward 
38 symptoms, usually to a lesser extent, also cause inevitable part of ageing are well known; but these same 
39 symptoms for three months before he finally got a had screened him earlier, because he was showing 
40 symptoms of the disease. This is because most screened for prostate cancer unless you have specific 
41 symptoms of prostate cancer, including a frequent urge putting on too much weight. He had none of the tell-tale 
42 symptoms, though they may take longer to become is also not without politically inconvenient long-term 
43 symptoms can be dealt with as they arise. The Institute nothing until there is evidence of spread. Thereafter the 
44 symptoms developed by his wife Elsie. She had was Dementia Care because dementia was one of the 
45 symptoms (less powerful flow, more frequent urination, : 25 per cent in one study. So if you suffer from the 
46 symptoms of the benign enlargement of the prostate have expected to live for another 15 or 20 years. The 
47 SYMPTOMS? THE prostate is a male sex gland about and make them go to the doctor.' WHAT ARE THE 
48 symptoms, to know that there is a test which costs  Richard Bentine says: 'I want people to know about the 
49 symptoms unmistakeable. Once the cancer has until the spread of the disease had made the 
50 symptoms were. She listed about five, such as having likely to get, including prostate. I asked her what the 
51 symptoms, which can include impotency, difficulty in by the year 2018. Very few men are aware of the 
52 symptoms? You need to urinate frequently. The urine as 30. BPH can be easily treated. * WHAT are the 
53 SYMPTOMS? You need to urinate frequently. The urine the type by studying the cells. * WHAT ARE THE 
54 symptoms? You need to urinate frequently. The urine as 30. BPH can be easily treated. * WHAT are the 
55 SYMPTOMS? You need to urinate frequently. The urine the type by studying the cells. * WHAT ARE THE 
56 symptoms? You need to urinate frequently. The urine the type by studying the cells. * WHAT are the 
57 SYMPTOMS? You need to urinate frequently. The urine the type by studying the cells. * WHAT ARE THE 
58 symptoms? You need to urinate frequently. The urine the type by studying the cells. * WHAT are the 
59 symptoms are more likely to be due to benign disease) cancer at a young age Symptoms: (most of these 
60 symptoms before they have a PSA test (see left) may on the way to the loo. Patients who wait for these 
61 symptoms sees a doctor as soon as possible. Leaflets Research says it is vital that a man with any of these 
62 symptoms from a non- cancerous enlargement of the is advanced Problems with passing urine (similar to 
63 symptoms doctors always ask their patients three of cancer of the prostate. When discussing urinary tract 
64 symptoms. Only when the diagnosis had been it because he felt so fit and had no urinary tract 
65 symptoms developed it could have been too late. I was growing silently inside me. If I had waited until 
66 symptoms, which men are embarrassed about and , the enlarged prostate often causes abnormal urinary 
67 symptoms of prostate trouble - I didn't keep getting up been diagnosed early, because I had none of the usual 
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The most frequent collocate one place left of symptoms is ‘the’, followed by ‘no’ and 
then ‘my’.  Lines 52-58 of Figure 4.5 show that seven of ‘the’ form part of the ‘Your 
guide to the prostate’ boilerplate (Extract 4.17) and indicate that the “need to urinate 
frequently” is a symptom of PCa.  Another 27 lines in Figure 4.5 also indicate that 
problematic urination was a symptom of PCa.   Examining the collocate ‘no’ (lines 21-
30) shows that though men knew that problematic urination was a symptom, they did 
not experience it themselves: “I had no symptoms, but I know that men often find 
themselves getting up three times a night to pass water” (Daily Mail, 16/11/1999).  
Further examination of Figure 4.5 reveals 24 lines indicating this pattern: 
Extract 4.21 
When discussing urinary tract symptoms doctors always ask their patients 
three salient questions. Do you get up at night to pass water? Is your urinary 
flow slow? Are you in any way bothered by bladder function? Further questions 
often reveal that the patient may have intermittent urination, that their flow is 
very slow and they can't dawdle on the way to the loo.   Patients who wait for 
these symptoms before they have a PSA test (see left) may be waiting too long. 
Neither my friend George nor I had much in the way of symptoms. (The Times, 
09/10/1997) 
In contrast, examining ‘my’ in Figure 4.5 (lines 17-20) indicates that some MWPCa did 
have such symptoms.  Further examination shows a total of eight lines indicating this 
pattern.  Also, thirty lines in Figure 4.5 are in the context of a PSA test, most of which 
indicate the usefulness of the PSA test in finding PCa when there were no symptoms: 
Extract 4.22 
Dr Tim Key, epidemiologist at the Imperial Cancer Research Fund, explains: 'We 
know that the PSA blood test can help to detect prostate cancer in men who 
have not developed any symptoms'. (Guardian, 23/09/1997) 
The predominant use of the ‘nutrition risk’ keywords (vegetables, fruit, zinc, exposure, 
fats, oil, tofu, eat, vitamin, diet, meat and chemicals) was in one Daily Mail article.  The 
predominant use of ‘genetic risk’ keywords (genetic, gene, history and link) was around 
inherited risk of PCa.  The ‘age risk’ keywords were age, young, occur and escalate.  
Escalate was used exclusively, and occur almost so, in the ‘Your guide to the prostate’ 
boilerplate (Extract 4.17).  In contrast, only approximately one quarter of the instances 
of the keywords age and young were used in this boilerplate.  Figure 4.6 shows the 
concordance for the 1990-2000 keyword age:   
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Figure 4.6. ‘Age’ concordance 1990-2000 
N Concordance
1 age of 70, and tends to be more aggressive, so the sooner family history, the cancer often strikes earlier than the average 
2 age. The mean age for a prostate operation is 70. Many men at ranged from 30 to 70 per cent). The figures are complicated by 
3 age. He started to suffer bowel and bladder problems and had prostate cancer, as it is extremely rare in someone of Conlan's 
4 age.' In cases where there is a family history, the cancer often , we can start targeting them for screening at a much earlier 
5 age. He rides his daughter Alice's eventer through the , Major Ferguson remains more active than most men half his 
6 age, having one or more family members who contracted it at a chances of getting prostate cancer,' Key says. 'Increasing 
7 age for a prostate operation is 70. Many men at this age may to 70 per cent). The figures are complicated by age. The mean 
8 age. Even the most conservative doctor would agree that he by his particular growth. The mayor, at 55, is still in middle 
9 age. Recent celebrity sufferers include former James Bond star ." Prostate cancer is common among men in mid to late middle 
10 age, to take an interest in their health. "This cancer was me realise how important it is for men, as we move into middle 
11 middle-age to do is don't be complacent, don't ignore the I'm optimistic. Above all, the one thing I would urge all men in 
12 age was no protection, his brother was tested and found to one and he's just 47," the patient replied. Advised that middle 
13 age. However, I'd never say I'm free of prostate cancer. I have a fact, they were down to a level considered safe for a man of my 
14 age. 'It was at this point that alarm bells went off. I told him to worry about because this was quite normal in a man of my 
15 age to have regular check-ups. It was discovered as a result of brought home to me is how important it is for people of my 
16 age to have a check-up. The man who dared to speak out no other symptoms. I feel lucky. I'd recommend all men of my 
17 age to make sure the same does not happen to them. Already prostate removed and made a full recovery. I urge all men of my 
18 age of the other men who were also waiting. That was the at the posters about prostate cancer and the wide range of 
19 age. As well as cancer of the prostate running in families, it trouble. Cancer is usually a disease of late middle or old 
20 age. Initially, the doctors thought might have a urinary infection . But like so many others, I thought it was a disease of old 
21 age, one in ten is under 65, and 5 pc of deaths occur among of the 14,000 men diagnosed each year are post-retirement 
22 age and on the same day. Even now, when I think about that father and his brother died from prostate cancer, at the same 
23 age of 50, it starts to enlarge. By pressing on the bladder, the and they are unaware of its existence until, around the 
24 age of 50, or over 40 for those with a family history of the prostate examination is recommended for all men over the 
25 age of 65 and I have the impression that treatment was not upper lip. He was first diagnosed with prostate cancer at the 
26 age of 80. There is a genetic link in cancer of the prostate. The surgery and my father, too, died of prostatic disease at the 
27 age of 40, I've been having a check-up at least once a year. like this, it's clear you have to react swiftly. Since the 
28 age, their general health and the importance to them of has to be tailored to the individual and take into account their 
29 age. In my favour, I was reasonably fit. I played golf a couple of not contemplate performing the operation in men around this 
30 age may want to stop sexual activity. I'm 56 and do not wish to. The mean age for a prostate operation is 70. Many men at this 
31 age you are, doctors and specialists need to be constantly so sad that it wasn't detected sooner. So it doesn't matter what 
32 age: 70 pc of men in their 70s will have it, rising to 80 pc in the cancer is. * WILL YOU GET IT? The odds escalate with 
33 age: 70 pc of men in their 70s will have it. 7 WAYS TO SAVE can be analysed. * WILL YOU GET IT? The odds escalate with 
34 age: 70 pc of men in their 70s will have it, rising to 80 pc in the cancer is. * WILL you get it? The odds escalate with 
35 age: 70pc of men in their 70s will have it, 80 pc in their 80s. * get it? The odds of developing prostate cancer escalate with 
36 age: 70pc of men in their 70s will have it, 80 pc in their 80s. * get it? The odds of developing prostate cancer escalate with 
37 age: 70pc of men in their 70s will have it, rising to 80pc in their the cancer is. * WILL you get it? The odds escalate with 
38 age. Despite its high incidence, surveys show that men remain also living longer, and the disease grows more common with 
39 age, it is normal for the prostate to enlarge. This condition is gland grow, a tumour develops. * WHEN does it occur? With 
40 age, it is normal for the prostate to enlarge. This condition is spread to other parts of the body. * WHEN does it occur? With 
41 age, it is normal for the prostate to enlarge. This condition is gland grow, a tumour develops. * WHEN does it occur? With 
42 age, it is normal for the prostate to enlarge. This condition is . Cancer cells then spread. * WHEN does it occur? With 
43 age, it is normal for the prostate to enlarge. This condition is to other parts of the body. * WHEN DOES IT OCCUR? With 
44 age, it is normal for the prostate to enlarge. This condition is to other parts of the body. * WHEN DOES IT OCCUR? With 
45 age, and the population you come from. Black Americans have one or more family members who contracted it at a young 
46 age Symptoms: (most of these symptoms are more likely to be cancer, or one close relative with prostate cancer at a young 
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Age occurred almost twice as often in 1990-2000 as 2000-2010.  The most frequent 
collocate one place left of age was “with” and these were used almost exclusively in 
the ‘Your guide to the prostate’ boilerplate (Extract 4.17): “with age” the risks of 
benign changes in the prostate or PCa escalate.  Another frequent collocate left of age 
was ‘middle’ (lines 8-12) and this indicated that PCa was that which men should 
consider as they “move into middle-age”.  Overall, almost half of the concordance lines 
in Figure 4.6 refer to younger men.  These often contained either an imperative to act 
in relation to PCa or were regarding the risk of impotence and incontinence to younger 
men from side-effects of treatment for PCa: 
Extract 4.23 
Daunted by the risks of becoming incontinent or impotent, I returned to 
Brendan Devlin, an old friend who is director of the medical-audit unit of the 
Royal College, and his colleagues who conducted the prostate survey. "Don't 
have it [a radical prostatectomy]," was their unanimous verdict. (...) The figures 
are complicated by age. The mean age for a prostate operation is 70. Many 
men at this age may want to stop sexual activity. I'm 56 and do not wish to. 
(Guardian, 03/11/1995) 
The keyword young occurred over twice as often in 1990-2000 as in 2000-2010.  It was 
used six times in the ‘Your guide to the prostate’ boilerplate (Extract 4.17) referring to 
BPH occurring “in men as young as 30”.  Its remaining 16 instances showed that it was 
almost exclusively used regarding the risks and concerns to younger men though three 
are in the exceptional circumstance of a 19 year old man who died of PCa.  In three 
instances MWPCa are placed in a familial setting with grown-up children:  
Extract 4.24 
Young people like me aren't meant to suffer.  GRAHAM BREEZE, 46, was 
diagnosed with prostate cancer a year ago, and recently underwent surgery to 
remove his prostate gland. Graham is an editor at the North Wales Newspaper 
Group and is married to Yolande. They have two sons, Paul, 23, and Neil, 20, 
and live in Welshpool, Wales. (....) I thought it was something that affected only 
elderly men. Men in their 40s don't expect this to happen to them (....) The next 
stage was an appointment to discuss treatment options. The main two were 
radiotherapy or surgery to remove the prostate gland.  There are two main 
possible side-effects of the surgery, incontinence and impotence.  Being so 
young, both of those possibilities were terrifying. (Daily Mail, 03/11/1999) 
Examining ‘age risk’ in 2000-2010 showed that although age and young were relatively 
less frequently articulated than in 1990-2000 there were some qualitative similarities. 
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While the predominant context of age in 2000-2010 was also of the risk to younger 
men, in contrast to 1990-2000, this was more often in the context of much younger 
men to include those in their thirties.  This was often in the context of relative 
knowledge that while PCa was “just an old man’s disease” and “half of all cases involve 
the over-75 age group”, PCa “hit me at 37 and now I'm living on borrowed time” (Daily 
Mail, 17/05/2005) and “a significant and growing number of men in their thirties and 
forties are developing malignant tumours” (Daily Mail, 29/04/2002).  Similarly, the 
predominant context of young in 2000-2010 is regarding ‘young’ men either already 
diagnosed with PCa or who ought to be made aware of it.  As in 1990-2000, men are 
also positioned in a familial context with older children and grandchildren but also 
more frequently as “young family men” and having young children/daughter/kids 
themselves.   
In sum, language around symptoms was significantly more frequent in 1990-
2000 than 2000-2010.  Urinary symptoms were those most frequently articulated in 
1990-2000 and these were predominantly frequent/nocturnal/intermittent urination 
followed by blood in urine.  MWPCa in both 1990-2000 and 2000-2010 were more 
frequently articulated as having no symptoms rather than experiencing symptoms. 
There was concern in both 1990-2000 and 2000-2010 regarding the difficulty in 
distinguishing benign from malignant enlargement of the prostate as each cause the 
same symptoms.  While language around ‘age risk’ was used relatively approximately 
twice as frequently in 1990-2000 as in 2000-2010, there were qualitative similarities 
across time.  In 1990-2000, the most common, though not predominant, context of 
age, and predominant context of young, was around the risks of PCa to younger men.  
In 1990-2000 men were sometimes positioned in a familial context with brothers or 
fathers with PCa or with a wife, older children and grandchildren.   In 2000-2010 the 
risk of PCa was in much younger men to include those in their thirties and with young 
children themselves. 
4.6 Stories of Tests & Diagnosis 
Table 4.2 shows ten ‘Tests & diagnosis’ keywords in 1990-2000 and five in 2000-2010 
and the raw and relative frequencies of these words are shown in Table 4.9 and Table 
4.10: 
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Table 4.9 Tests & diagnosis Keywords 1990-2000 
‘Tests and diagnosis’  
1990-2000 
Key word 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000 
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000 
P 
EXAMINATION 26 62.7 20 19.0 4.39E-05 
TRANSRECTAL 6 14.5 0 0.0 8.76E-05 
MEDICAL 50 120.5 69 63.8 0.00084 
IDENTIFIES 6 14.5 1 0.9 0.00133 
BIOPSY 46 110.9 64 59.2 0.00154 
RECTAL 15 36.2 12 11.1 0.00246 
REVEAL 7 16.9 3 2.8 0.00557 
DIGITAL 7 16.9 3 2.8 0.00557 
ULTRASOUND 15 36.2 14 13.0 0.00653 
REMAINS 10 24.1 7 6.5 0.00745 
Table 4.10 Tests & Diagnosis Keywords 2000-2010 
‘Tests and Diagnosis’ 
2000-2010 
Keyword 
1990-2000 
Raw Freq. 
1990-2000 
Freq/100,000 
2000-2010 
Raw Freq. 
2000-2010 
Freq/100,000 
P 
AGAIN* 6 14.5 52 48.1 0.00113 
SCORE 0 0.0 14 13.0 0.00256 
NEEDLES* 0 0.0 13 12.0 0.00365 
INOPERABLE* 0 0.0 12 11.1 0.00523 
PSA* 63 151.9 240 222 0.00535 
*‘split’ keyword 
 
All but medical and reveal of the ‘Tests & diagnosis’ keywords in 1990-2000 were to 
some extent used in the “Your guide to the prostate” boilerplate (Extract 4.17) with 
transrectal, identifies and digital almost exclusively so.  Ultrasound was used 5/15 
times in this boilerplate and the remainder referred to further diagnostic tests.  Five 
instances of reveal were in the context of what examinations reveal and four of 
remains indicated controversy around the lack of specificity of the PSA test.  Though 
the predominant use of medical was synonymous with examination as in “my cancer 
was discovered during a routine medical” (Daily Mail, 16/11/1999), most instances of 
examination referred to a digital rectal examination (DRE).   
Of the ‘Tests & diagnosis’ keywords in 2000-2010 (again*; score; needles*, 
inoperable* and PSA*), all but score were ‘split’ between this category and 
‘Treatment’.  Inoperable, needles and score were not used at all in 1990-2000.  Six 
instances of needles were in a biopsy context with the remainder regarding technical 
aspects of treatment, mostly around brachytherapy.  Half of the instances of 
inoperable were in a PCa diagnosis context with the remainder referring to initially 
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diagnosed inoperable PCa which later responded dramatically to experimental 
treatment.   
Score was predominantly used in the context of the Gleason and PSA score. The 
Gleason score, a measure of malignancy of prostate tumours using needle core 
biopsies, is often used in combination with PSA to predict pathological stage and 
clinical outcome of prostate cancer (Osunkoya 2012).  Though the immediate context 
of score was the diagnosis of PCa, almost all concordance lines associated with 
‘Gleason’ and ‘PSA’ also indicated treatment options for MWPCa.   
Extract 4.25 
Luckily, my Gleason score (which grades the tumour on a scale of two to ten: 
two to six being termed non aggressive; seven moderately aggressive; and 
eight to ten aggressive and, therefore, likely to spread faster) was a six.  
HOWEVER, I was relatively young to have prostate cancer, since the average 
age for diagnosis is 75. So even though mine was a slow-growing one, the 
doctors felt it was better to take the prostate out in a radical prostatectomy 
(removal of the entire prostate gland) rather than simply monitor the disease. 
(Daily Mail, 12/09/2006) 
The predominant use of again was in a treatment context followed by diagnosis and 
often either indicated the use of PSA tests in the diagnosis of PCa or to check whether 
the cancer had returned again after treatment.  
Analysis of the keyword PSA indicates two main but contrasting stories.  First, 
PSA was a reliable indicator for PCa and associated both with a basis for further testing 
for PCa and also with the success or failure of treatment:  if PSA was raised then 
treatment was begun; PSA lowering after treatment; and PSA rising post-treatment: 
Extract 4.26 
I had no symptoms, but my PSA continued to rise and, about a year later, a 
biopsy confirmed it was cancer.  The cancer was treated with radiotherapy. 
Although this was originally successful, my PSA levels started to creep up again.  
In July last year, it was confirmed that my cancer had returned. Amazingly, I still 
had no symptoms. I felt fine but I needed more treatment. (Daily Mail, 
28/09/2004) 
Secondly, PSA was also described as an unreliable indicator for PCa, and may also be in 
a ‘grateful’ context: 
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Extract 4.27 
Not all men in the UK are offered the PSA test routinely because it's not always 
completely reliable as an indicator of cancer, according to Cancer BACUP. But in 
my case, I believe it saved my life.  The normal PSA upper limit for my age at 
the time, which was 53, should have been 3.5, so my first result of 5.3 was high 
enough to be a warning. (Daily Mail, 12/09/2006) 
In sum, words around tests and diagnosis for PCa were more plentiful and used more 
frequently in 1990-2000 than in 2000-2010.  Journalists used the phrase ‘digital rectal 
examination’ (DRE) more frequently in 1990-2000 than in 2000-2010 when talking 
about tests and diagnosis of PCa.  The 1990-2000 keywords were used almost 
exclusively in the context of the tests needed for diagnosis.  In contrast, the 2000-2010 
words are mostly regarding the treatment men might receive because of their 
diagnosis.  PCa was more frequently described as an inoperable disease in 2000-2010 
than in 1990-2000 and score is used regarding Gleason and PSA readings to predict 
pathological stage of this disease.  Although PSA appeared in the ‘Your guide to the 
prostate’ boilerplate (Extract 4.17) in 1990-2000, it was significantly more frequent in 
2000-2010 and thus a keyword.   
4.7 Discussion 
The analysis in this chapter begins to address the gap in the literature examining how 
UK print media representation of PCa may have changed since the emergence of 
PCaOrgs into the UK in the mid-1990s.  PCaOrgs may be considered to be a form of 
health social movement (HSM); HSMs are generally considered to be a force for 
change in society in the way health issues are addressed (Crossley and Crossley, 2001; 
Brown et al., 2004; Kedrowski and Sarow, 2007).  Actors around social movements are 
argued to be actively engaged in the production or transformation of meaning for their 
various audiences (Snow and Benford, 1992) which includes print media.  Though 
framing theory has often been used to understand the meaning-making of social 
movement actors, Smith (2005) suggests that framing has only ‘nuisance value’ (p.9) 
and ‘permits only guerrilla warfare’ (p.9) in understanding such meaning.  Instead, the 
‘heavy artillery’ (p. 9) afforded by narrative structures has more explanatory value.  
The analysis in this chapter has used an inductive-deductive interplay (McGhee et al., 
2007) with CKWIC analysis and narrative and framing concepts to compare two 
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datasets of illness narratives of MWPCa in the UK print media: 39 narratives in 1990-
2000 and 101 narratives in 2000-2010.  This analytic approach allowed me to 
determine first, which words were significantly more frequently used by journalists 
when writing about MWPCa in 1990-2000 than in 2000-2010 and vice versa and 
second, what insights this gave into how the UK national print media represented the 
illness experience of MWPCa since the emergence of PCaOrgs in the UK in the mid-
1990s.   
My findings suggest that there have been changes in the representation of the 
illness experience of MWPCa since the emergence of PCaOrgs into the UK in the mid-
1990s.  They show that the UK print media told stories of injustice around PCa.  This 
may though be unsurprising—at least to social movement theorists though not 
perhaps to those interested in the substantive topic of PCa.  Injustice, as a ‘hot’ 
emotion (Gamson 1992: 7), has been used as ‘leaven’ (Turner, 1969: 399) for social 
change by all social movements in each main historical era (Turner, 1969; Snow, 2004).  
Journalists writing for the UK print media, as an audience for the meaning-making 
activities of PCaOrgs, may then also be expected to include injustice when writing 
about the illness experience of MWPCa.  What may be surprising is that the 
substantive focus of this injustice changed over time—from PCa as “neglected” and 
“taboo” in 1990-2000 to injustices around treatment in 2000-2010.   
When journalists wrote about the illness experience of MWPCa in 1990-2000 
they used certain words more frequently than in 2000-2010 to tell a story of PCa as a 
neglected ‘Cinderella’ disease when compared with breast cancer, AIDS and heart 
disease.  Many of these words were in the context of an appeal by the Daily Mail to 
raise £1million to “rectify [the] scandalous situation” of the “derisory” £47,000 of 
funding that PCa received compared to other illnesses.  Other emotive words included 
‘appalling’ and ‘epidemic’.  This neglect was mostly said to be gender-based although 
there were ageist elements mentioned.  Blame for this neglect was distributed across: 
men themselves as those stereotypically “suffering in silence”; a society which placed 
little value on the lives and deaths of men; the medical profession; and government.   
Why though was the neglect story picked up by journalists in the 1990s?  One 
answer is that in a ‘world of narrative, [where] very little is ever new’ (Frank, 2010: 
123), journalists were able to draw upon a pre-patterned (Tannen, 2007) way of 
talking, or genre (Bury, 2001), already familiar to their audiences.    The ‘neglect’ story 
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was likely already familiar to journalists and their audiences through its successful use 
in several other social movements (see Kolker, 2004).  Familiarity for media audiences 
was also provided by the repetition of a ‘Derisory £47,000 PCa Spend’ (Extract 4.1) 
‘boilerplate’ (Cotter, 2010: 171), often included as context for the illness narrative of 
MWPCa.  A boilerplate, argues Cotter, may end up influencing public debate through 
repetition; this boilerplate repeated the figure “47,000” as the “derisory” or “pitiful” 
amount of money spent by the UK government on PCa “last year”, in terms suggesting 
it was very limited—“just”, “but only” and “yet only”. This boilerplate formed part of 
the Daily Mail’s campaign to raise money and awareness for PCa; the potential efficacy 
of which was demonstrated in the publication of the NHS Prostate Cancer Programme 
in 2000, and subsequent Prostate Cancer Risk Management Programme (PCRMP) in 
July 2001.   
Stories of the neglect of PCa seemed no longer to be told when journalists were 
writing about the illness experience of MWPCa in 2000-2010.  Instead, journalists 
wrote about the “disgraceful” and “unacceptable” injustice around funding for new 
treatments such as brachytherapy, the risks of impotence and incontinence post-
prostatectomy and the “debilitating” and feminising side-effects of hormone 
treatment.  But why the switch from one type of injustice to another?  Seale (2002) 
argues that journalists ‘“twitch” the plot from time to time in order to retain 
audiences’ interest’ (p. 36).   
PCa as a “taboo” disease that “no one dares talk about” and about which men 
kept quiet was more explicitly and frequently written about by journalists in 1990-
2000 than in 2000-2010.  PCa was allowed to be a taboo by society in that “it has been 
ignored by politicians and greeted by too many people with giggles, embarrassment or 
a shocked silence.”  Though there were no instances of ‘taboo’ in 2000-2010, PCa 
remained, at least somewhat, difficult to talk about.  In 1990-2000, raising awareness 
was proposed as a solution to PCa as a taboo with particular actants identified both as 
culpable for this problem and also as those who must act to change it, including “every 
woman who loves a man” and the “we [who] will stop making prostate cancer a taboo 
subject”.   
My findings also show that words around symptoms were used significantly 
more frequently by journalists in 1990-2000 than 2000-2010 when writing about the 
illness experience of MWPCa.  Lower urinary tract symptoms (LUTS) — frequent, 
146 
 
nocturnal or intermittent urination—followed by blood in the urine were those urinary 
symptoms most frequently articulated. Particular phrases included “difficulty passing 
water” and having problems with “the old waterworks”.  MWPCa in both 1990-2000 
and 2000-2010 were more frequently articulated as having no symptoms rather than 
experiencing symptoms.  That this language was less used by journalists in 2000-2010 
than in 1990-2000 may be due to evidence indicating that LUTS are not indicative of 
PCa (Collin et al., 2008).  Such a way of talking may be perceived as less valid, as for 
example, less validated by extant evidence by journalists in 2000-2010 than in 1990-
2000.  Validity though is not necessarily a requirement of successful storytelling as 
viability, or resonance with existing cultural ideas, is more important.  Kolker (2004) 
shows that despite its lack of validity, the ‘epidemic’ frame around breast cancer in the 
early 1990s was viable. 
This is controversial ground for the potential medicalisation of old age with the 
‘natural processes of aging’ (Armstrong, 2014: 15), such as physical changes in men’s 
bodies which result in benign enlargement of the prostate normatively revised (Turner, 
1969) or ‘reinvigorated and incorporated into a model of pathological disease’ 
(Armstrong, 2014: 16).  Here, there is a redefining of symptoms ‘that are already 
meaningful from the standpoint of some primary framework [urinating problems 
experienced by large numbers of men as they age], in terms of another framework 
[the pathological disease of PCa]’ (Snow et al., 1986: 474).  This also shows the 
compounding and intricate interaction between disease and illness (Timmermans and 
Hass, 2008).  Armstrong (2014) argues that the diagnostic labels of any period, as here 
in the transformation of symptoms for benign prostate problems to PCa, may not in 
reality reflect an underlying biological reality but rather reflect a medical perception 
contaminated by contemporary world views.  That autopsy studies show very young 
men with PCa (Powell et al., 2010) suggests potential for an underlying biological 
reality of PCa.  Given also that PCa is being looked for harder than ever before (Welch 
et al., 2012), as more men are persuaded themselves or by other audiences—partners, 
families, friends, or GPs—that LUTS should be further investigated, this underlying 
biological reality may increasingly be found.  Many of these men are likely to be glad 
that their cancer has been found “early” and to avail of treatments. 
While language around ‘age risk’ was used approximately twice as frequently in 
1990-2000 as in 2000-2010, there were qualitative similarities across time.  In 1990-
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2000, the most common, though not predominant, context of age, and predominant 
context of young, was around the risks of PCa to younger men.  In 1990-2000 men 
were sometimes positioned in a familial context with brothers or fathers with PCa or 
with a wife, older children and grandchildren.   Likewise, although relatively less 
frequently articulated than in 1990-2000, the predominant context of ‘age risk’ 
keywords in 2000-2010 is also of the risk to younger men.  However, in contrast to 
1990-2000, this is more often in the context of much younger men, where “a 
significant and growing number of men in their thirties and forties are developing 
malignant tumours”.  As in 1990-2000, men are also positioned in a familial context 
with older children and grandchildren but also more frequently as “young family men” 
and having young children/daughters/kids themselves.  Thus, there are two aspects of 
PCa that are made salient here and relevant to the framing of MWPCa in UK print 
media: 1) that younger men are increasingly being diagnosed with PCa; and 2) that 
‘family’ is likely to be of concern to these men.   
As men get older they are more likely to be diagnosed with PCa although this 
may change as more and more younger men are diagnosed with PCa  (Cancer Research 
UK, 2013c).  In addition,  the autopsy studies referred to above show a surprisingly 
high level of premalignant and malignant disease is found in the prostates of men aged 
in their 20s, 30s and 40s (Soos et al., 2005; Powell et al., 2010).  Framing ever younger 
men at risk of PCa may thus make this framing both valid and viable (Kolker 2004).  As 
with the discussion around symptoms above, this is simultaneously interesting, 
controversial and consequential in several ways in understanding how the social life 
around PCa matters for at least its morbidity and vice versa (Timmermans and Hass, 
2008).   It may be that much of the diagnosed cancer in younger men may be ‘destined 
merely to be an incidental histological event’ (Parker, 2004: 101).  Naming these pre-
malignant and malignant conditions as PCa, and diagnosing men as such, especially 
with pre-malignant or ‘early’ PCa (Aronowitz 2009; Faulkner 2012) substantially 
increases the risk of detecting non-clinically relevant PCas and moves many more men 
onto a risk/disease spectrum (Aronwitz 2009) of PCa.   
This has consequences for both the overdiagnosis of PCa, that is ‘the diagnosis 
of men who would not have clinical symptoms during their lifetime’ (Schroder et al., 
2009: 1327) and its overtreatment (Wolters et al., 2012).  In turn, this has 
corresponding consequences for morbidity around PCa in that these men may be more 
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likely to adopt decision-making styles typically used for more advanced states as is 
currently potentially the case for women with breast cancer (Aronowitz, 2009; 
Henderson, 2013; Wise, 2013).  In addition, it has consequences for the public face of 
PCa, which may become healthier as those with a poor prognosis become relatively 
fewer (Aronowitz 2009).  Moving many more younger men onto the risk/disease 
spectrum of PCa also has consequences for creating a larger and more mobilised 
disease/at risk population, giving a greater audience for disease advocates.  This, in 
turn, has consequences for the success of health social movements or grassroots 
survivor organisations (Kedrowski and Sarow 2007).  
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 Changing narratives of Chapter 5
prostate cancer 
advocates 
5.1 Introduction 
In the UK, in the past twenty years the public visibility of PCa has increased as prostate 
cancer organisations (PCaOrgs), as a potential health social movement (HSM), have 
emerged to promote awareness of the condition and lobby for funding of services and 
research. Actors in HSMs are argued to be actively involved in the production and 
transformation of particular aspects of reality and ways of understanding the world 
(Benford and Snow, 2000).  As yet there are no studies of how PCaOrgs in the UK may 
produce or transform aspects of PCa.  My aim in this chapter is to address this deficit 
through an analysis of narratives of advocates around PCaOrgs collected through 
research interviews in 2010.   Drawing on the conceptual framework informed by a 
combination of narrative, framing and literary concepts (Bakhtin, 1986; Bury, 2001; 
Smith, 2005; Polletta, 2006; Riessman, 2008, Tannen, 2007; Frank, 2010;) described 
earlier, I ask: 1) how have advocates around PCa sought to produce or transform 
meanings around PCa and 2) what narrative forms or elements have they used in doing 
so.  I present my findings in two sections: 1) using the neglect story of prostate cancer 
and 2) losing the neglect story of prostate cancer and finding other pockets of 
injustice. 
5.2 Using the neglect story of prostate cancer  
In answer to my opening question, ‘So tell me how you became associated with 
prostate cancer and the organisations associated with it?’, a chief executive of a 
PCaOrg began to tell the story of his recruitment to the post and how his own personal 
lack of awareness of the prostate gland or PCa gave him an indication of the challenge 
the organisation faced in raising awareness: 
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Extract 5.1 
Participant: The charity was set up in [year] and really from the outset, it had a 
dual objective to increase research investment, but also to raise public 
awareness of the disease and to provide support and information to men 
affected by it. 
Interviewer: And how have you managed to do that? 
Participant: (…) so there’s been a radical transformation in our income and our 
resources and the extent to which we’ve been able to influence the external 
world and the agenda [since 2002]. I think it’s fair to say that back in 2002, 
prostate cancer was just beginning to come out of the shadows of neglect. 
There had been a fairly major, or a very major, media campaign run by the 
Daily Mail, I think in 1999, which had really been a seminal point in the growing 
up of the charity. They were raising money for, I think, a research unit at 
Hammersmith Hospital, and pretty much around that time, in 2000, the 
government published its prostate cancer programme. So there was general 
stirring of realisation in government and NHS circles and in the media that this 
was a neglected disease and something needed to be done about it. So there 
were lots of levers for change that started to appear around the end of the 
1990s into the beginning of the 2000s. (PCa-ORG/3/1) 
Telling the story about PCa as a “neglected disease” hidden in the “shadows” and 
about which “something needed to be done” was a story which effected action in the 
late 1990s shortly after the emergence of the first PCa organisations into the UK.  This 
action was achieved not only through the Daily Mail campaign in 1999 to raise money 
(§4.3.1) but also by the “general stirring of realisation”, which led to the publication of 
the NHS Prostate Cancer Programme (NHS, 2000), to which this participant refers, and 
the subsequent Prostate Cancer Risk Management Programme (PCRMP) (Burford et 
al., 2010) in July 2001.  Why did the neglect story effect such action back in the late 
1990s?  The answer, I suggest, in a ‘world of narrative, [where] very little is ever new’ 
(Frank, 2010: 123), partly lies in the extent to which actors around PCaOrgs were able 
to draw upon a pre-patterned (Tannen, 2007) way of talking, or genre (see for example 
Bury, 2001), already familiar to audiences.  However, a story which is ‘entirely 
predictable (…) [is] no story at all (Polletta, 2006: 10) and thus the success of the 
‘neglect’ story in effecting action, I suggest, also lies in the extent to which this 
appropriated language was inflected with new meaning (Steinberg, 1999). 
The ‘neglect’ story had already been successfully used in the early 1990s when 
public claimsmaking by breast cancer movement activists defined breast cancer not as 
a problem of access to screening and treatment but one of gender-based neglect 
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(Kolker, 2004).  A sense of injustice, such as that engendered by ideas of ‘neglect’, has 
been used as ‘leaven’ (Turner, 1969: 399) for social change by all social movements in 
each main historical era.  Advocates around PCa were able to use the ‘tried and true 
method’ (Steinberg, 1999: 752)  of seeing ‘their own problems in the terms set forth by 
[breast cancer] activists’ (Turner, 1969: 399).  This is one beneficial consequence of 
social movement ‘spillover’ (Meyer and Whittier, 1994) where new movement actors 
align their messages with what they know is already familiar, or resonant, to their 
potential audiences.  Resonant language ‘fits’ or ‘rings true’ in some way with 
audiences’  already existing beliefs, values, ideologies or experiences (Williams, 2004: 
105).  Viewing the language of ‘neglect’ as culturally resonant begins to explain why 
the ‘neglect’ story from the breast cancer movement could be used to influence the 
illness sufferers and other attentive audiences around PCa.  The difficulty in, or 
aversion to, constructing explicitly oppositional discourse (Steinberg, 1999) is seen in 
the concern of a public consultant around PCa to avoid “the tendency to kind of revert 
to the kind of oppositionist, ‘we’re outsiders, everything’s terrible’ approach, which is 
very easy, and is very understandable as well” (PCa-PC/1) for the “condition and 
cause” (PCa-PC/1) of PCa. 
 The appropriated story of neglect was then a mechanism which offered hope 
from history to successfully articulate the problems facing both MWPCa and those 
concerned with treating them.  The following medical professional was involved in very 
early attempts to publically articulate these problems and find solutions for them.  He 
begins this section of narrative in an ostensibly tragic genre, with an ‘amplified 
awareness of suffering’ (Smith, 2005: 25), to articulate the hopelessness around a 
forgotten disease which had no institutional interest and the shame and fatalistic 
behaviour of its sufferers when nobody knew “what to do in those days”: 
Extract 5.2 
Interviewer: Okay, and the campaigning issue then, what was it, can you 
remember? 
Participant: That this was a disease that was forgotten about and not talked 
about, where management and treatment was not optimal, where there was 
no research, where, because there was no central interest and no cancer 
charity interest, where there was no information source for the patients, there 
was nothing, so you couldn’t find out about the disease if you were a patient 
and how you should be treated 
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Interviewer: so the campaigning was then to? 
Participant: To increase public awareness of the disease and to provide proper 
academic research, to lobby central government, to make men not ashamed 
about talking about what they had 
Interviewer: Do you think that they’ve been successful in that or? 
Participant: Oh yeah, it’s knockout, it’s been really brilliant  
Interviewer: In that men are not ashamed? 
Participant: Well whether it’s just to do with societal aspects in the way that 
men are now as compared with how they were in the 1980s and 90s, yeah, I 
mean it’s true society has changed, but the men (didn’t sort of) stand up in the 
way that the women stood  
Interviewer: They didn’t? 
Participant: No, they would have their illness, they would not talk about it, they 
would die quietly, and unlike breast cancer, where there was tremendous fuss 
and noise, where women were talking about mutilating surgery, where women 
got lots of money into research, there was nothing, you couldn’t, didn’t know 
what to do in those days. 
Interviewer: Yeah, yeah, so, was there anything that, in those early days, made 
a particular impact, was particularly successful in… 
Participant: The Daily Mail campaign was amazing  
 (PCa-MP/2) 
The tragic genre of suffering was, however, not consistently adhered to even in this 
short section of narrative.  Peering into the actions and history (Steinberg, 1999) of the 
breast cancer movement to tell a neglect story of PCa effected “brilliant” and 
“amazing” action.  Such successful action implies the hope of triumph over adversity 
and thus this narrative also shows elements of a romantic genre (Smith, 2005).   This 
though is in line with Bury’s (2001) observation that speakers may move from one 
genre to another as they see fit.  Though the borrowing of language around breast 
cancer activism was ‘“half the battle”’ (Berbrier, 1998: 432) in successfully narrating 
PCa as a neglected disease, it was still only ‘half the story’ (Ferree, 2003: 306).  A story 
is not a story unless it contains elements of unpredictability (Polletta, 2006) or ‘radical’ 
non-resonant language (Ferree, 2003); it is not an ‘interesting’ story unless it contains 
elements of novelty (Silvia, 2008). So how then were novel, unpredictable or radical 
aspects included in the story of neglect of PCa?  
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One answer is that actors around PCa were able to inject this neglect story with 
elements of the “story about men versus women” (PCa-MP/6) and in this way 
transform it to articulate their own specific sense of injustice and moral authority 
(Steinberg, 1999: 751).  In some ways though, this gender-based inflection was also 
resonant—and thus not novel—as it was used by breast cancer activists in the US a 
decade earlier (Kolker, 2004).  In other ways it was novel in that men, rather than 
being the usual perpetrators of discrimination, were now the ones being discriminated 
against.  The medical professional quoted below began his story of how he became 
involved with PCa and its organisations by contrasting at length the lack of historical 
struggles of men against discrimination with the several and varied such struggles of 
women. He particularly observed how women’s health issues were successfully 
“bolted on” to existing institutional mechanisms for dealing with these struggles: 
Extract 5.3 
It was a mixture of [discrimination, isolation and abuse] and demand for better 
health care and things like screening for breast cancer and so on, which drove 
the women’s health movement.  This mix with feminism and political agitation 
for better rights for women, a lot of it working with trade unions to a very large 
extent, deeply committed to all these kind of things, and then bolted on to 
whatever the issue was to do with health.  So what you found is, with the 
women’s health movement it didn’t really matter which one you looked at, 
there was always an element of, the political side which was very strong, along 
with the health messages that they were putting across.  So it did tend to 
attract women in political spheres and the media and entertainment and so on, 
they tended to come out of the woodwork very quickly to support it, not just in 
the health sense but also the political objectives which they were trying to 
achieve. Men’s health came from a completely different animal, men didn’t 
need to worry about discrimination and isolation cos they were the ones who 
were doing the discrimination in the first place.  So the discrimination against 
women was a male attribute, so men didn’t have to worry about fighting the 
political battle cos that was already won, or lost whichever way you look at it, 
so the animal came very much from simply the needs of men for health, and it 
and it came around two areas really.  One was the men themselves and the 
(amount of) insight they had and their use of services, and the other one was 
the political side, which was the delivery of the services within the health 
service itself, and what happened was that the early workers did a bit of 
digging and found things like for instance that there was only something like 
forty thousand pounds a year spent on prostate cancer research.  When you 
compared that to breast cancer research it was like countless millions and 
millions into breast cancer research, and their argument was that this was 
actually (inequality based), and of course they were quite right, it was. (PCa-
MP/4) 
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Notably then for this participant, women were able to ‘piggyback’ (Kedrowski and 
Sarow, 2007: 153) their health issues onto other issues of discrimination in a way 
which men, at least up to that point, were not.  Such ‘piggybacking’ is similar to social 
movement spillover (Meyer and Whittier, 1994) where at least one consequence of 
spillover is the creation of sympathetic allies for the cause of concern; for women in 
the above account these included at least trade unions, the media and the 
entertainment industry.  All of these allies though were lacking for those advocating 
around PCa.  Not lacking though was the culturally resonant story of neglect which 
could be appropriated to ‘articulate identities, grievances, and goals where there 
[were] gaps and silence in the discursive field in which they [were] fighting their own 
struggle’ (Steinberg, 1999: 752).  The discovery by the early advocates around PCa of 
the huge discrepancy in funding for breast cancer and PCa served as a supporting and 
motivating element in this story; a narrative element also used in media illness 
narratives of MWPCa in the late 1990s (§4.3.1), the approximate time to which this 
participant referred. 
Kolker (2004) notes how breast cancer activists constructed themselves as part 
of ‘an angry disenfranchised group that would not stay silent in the face of 
governmental neglect’ (2004: 839).  What is evident in the following narrative by a 
medical professional is that rather than being ‘angry’, ‘disenfranchised’ and a ‘group’ 
who ‘would not stay silent’ and who made a “tremendous fuss and noise” (Extract 5.2), 
men are instead described as “passive” and not making “a fuss” in a society where “no-
one made a fuss” about men suffering and dying from PCa.  Such hegemonic discourse 
regarding men’s passive behaviour (Connell and Messerschmidt, 2005; Courtenay, 
2009) is intrinsically familiar and therefore, ostensibly, not novel.  Nonetheless, when 
used in striking contrast to the language describing the behaviour of women, it 
potentially works to inject novel, unpredictable or radical language into the neglect 
story:  
Extract 5.4 
It became my job to try and attract funds for the treatment of people with 
prostate cancer and for research into that area, and it was very very difficult to 
do so, because prostate cancer was not a fashionable illness, and breast cancer, 
by contrast was.  So the women’s movements in the sixties had been great, and 
radicalising lesbians had taken a banner and taken breast cancer as a campaign 
issue and the women’s liberation movement did wonderful things for breast 
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cancer, but here was prostate cancer, and men got the disease and they 
suffered and they died and they didn’t make a fuss.  No-one made a fuss.  It just 
was remarkable.  Men were very passive in dealing with prostate cancer (...) so 
I got rather frustrated about the fact that I’d write for grants to the cancer 
charities for research money and get no, get nothing, and it seemed that there 
was no central government interest also in prostate cancer in the way that 
there was an interest in breast cancer, so (...) I set up a charity to try and bring 
to the public’s attention the fact that prostate cancer was a, a significant 
illness, to lobby the government for change in the way that they view prostate 
cancer and to provide information for prostate cancer patients cos there was 
absolutely nothing there, and as a token of that the amount of central 
government money coming to prostate cancer in 1996 (...) was forty-eight 
thousand pounds, which compared with about five million that went to breast 
cancer.  So derisory figure for breast cancer but negligible amount of money for 
prostate. (PCa-MP/2) 
This medical professional described his frustration at the “absolutely nothing there” 
with regard to research funding and information particularly detailing the “negligible” 
“forty-eight thousand pounds” so prominently featured in media illness narratives in 
the late 1990s (§4.3.1).  This moved him to “set up a charity” to change the way the 
public and government viewed PCa.  That this helped to produce a change is seen with 
“fuss” beginning to be made within the Department of Health: 
Extract 5.5 
The Department of Health made, I think made a big effort to listen to the story 
about men versus women, I think there was a change about ten years ago 
when, there was quite a lot of fuss in the Houses of Parliament about the 
amount of money spent on prostate cancer research compared to breast 
cancer research.  The Department of Health responded to that by setting up 
these advisory groups [the Prostate Cancer Risk Management Programme and 
Prostate Cancer Reference Group, Scientific Reference Group], and they’ve 
worked quite hard together with the charities.  So on the Prostate Cancer 
Advisory Group, there’s someone from the charities on that group as well.  So 
they’ve worked quite hard to listen, and to try and come out with a sort of 
national cancer strategy, because when they did the national audit they 
discovered that prostate cancer was not being well managed in the UK in terms 
of a lot of variability in waiting times and surgical availability, surgical skills and 
when they talked to men they got rather sad reports really, of men not feeling 
they were being managed very well, having to wait a long time, not being told 
very sympathetically what the diagnosis is.  So I think they’ve listened to that 
and as a response to that, we produced a document which was, advice on the 
PSA test that went out to thirty-six thousand GPs, probably seven years ago 
now, and we rewrote that document last year, and it went out to the same 
number of GPs last year. (PCa-MP/6)  
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The “men versus women”, or gender-based, ‘neglect’ story of PCa thus resonated in 
the Houses of Parliament at the end of the 1990s, with action effected with lasting 
consequences.  So far then, this analysis has indicated that a gender-based ‘neglect’ 
story worked as a story, at least because it combined the familiar and unpredictable 
(Polletta, 2006; Silvia, 2008)—the ‘half battle’ (Berbrier, 1998) and the ‘half story’ 
(Ferree, 2003).  Why did this combination of resonance and dissonance work so 
successfully?  The answer, I suggest, paradoxically lies in considering how the neglect 
story became an unacceptable story, at least to some audiences. 
5.3 Losing the neglect story of prostate cancer 
and finding other “pockets of injustice” 
While the data mostly showed the success of the ‘neglect’ story in effecting action in a 
historical context, there were examples which were used in a contemporaneous 
context and these were important to consider as deviant cases (Seale, 1999; Silverman, 
2004, 2005).  Just as “prostate cancer is a condition whose time has come” (PCa-PC/1), 
there was also evidence of temporal and contentious elements to the success of the 
‘neglect’ story in that, at least to some but not all audiences, it was one whose time 
had come and gone.  These temporal and contentious elements centred on sustaining, 
constructing, or opposing a variety of ‘interests’: 1) sustaining media interest; 2) 
sustaining the interest of “the man in the street”; 3) constructing the interest of the 
“family”; and 4) opposing “vested” interests. 
5.3.1 Sustaining media interest 
Of first note in the accounts below is that the neglect story of PCa, in a contemporary 
context, is no longer a “universally true story”.  This is noteworthy as it indicates that it 
is the “heavy artillery” (Smith, 2005: 9) of ‘injustice’ that is perhaps a better 
explanation for compelling stories around PCa than the “scattered sniping” (p. 9) of 
‘neglect’.  Losing “the legacy of neglect” and finding other “pockets of injustice”, such 
as inequalities in PSA testing and screening, was necessary in order to provide an 
‘entertaining disruption of expectations’ (Seale, 2002: 36) for the media audience of 
those advocating around PCa; entertainment which the media could subsequently 
transfer to its own audience:   
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Extract 5.6 
I think what has changed is the angle that the media is interested in, whereas 
ten years ago, and certainly maybe twenty years ago,  it was possible to talk 
generally about the hidden nature of prostate cancer, long neglected, and it 
was a kind of universally true story. The media angle was this terrible hidden 
story. Now the media feels that it is no longer a hidden cancer and I think 
increasingly that's becoming more true. So although they are still very 
interested in prostate cancer as an issue, it’s not about the hidden nature of 
the disease. It’s not about the legacy of neglect. It's much more now about 
research stories. It’s about inequalities. It’s about PSA testing and screening 
and that kind of stuff, so I think the issues have changed from the media 
perspective, what really interests them and what they’re going to run with. 
(PCa-ORG/3/1) 
Extract 5.7
The media is not stupid and they start to question that kind of thing, [not 
understanding where the cause is at] and to sustain their interest you have to 
refresh the cause, so we should know where the pockets of injustice are, we 
should know what, if and when it has increased we should admit to that, but 
show the media there’s still a long, long way to go, so we had this campaign last 
year which was talking about prostate cancer being the hidden cancer, and it I 
think it worked (across) marketing materials because they just wanted to give a 
more simple message to the man in the street but it really didn’t work for the 
media, there was a big backlash around it, so I had like four national journalists 
saying, “but it’s not hidden any more, why are you saying that”, so and I spoke 
to our chief exec about that and just said “you know just be aware that the 
cause has moved on you can’t keep giving out the same old message that it’s 
the hidden disease or no one talks about prostate cancer, I don’t believe that 
any more”, (...) the other challenge, is really understanding exactly where the 
cause is at and keeping it fresh for journalists.  (PCa-ORG/3/2) 
These narrative segments indicate a dialectic tension confronting social movement 
actors: an initial story ceases to be successful in effecting action as it transforms the 
original beliefs that prompted the action, so that similar stories are no longer 
efficacious.  Narrating PCa as a neglected disease resulted in the successful Daily Mail 
campaign in 1999 (§4.3.1) and the publishing of the PCRMP in 2002.  This subsequently 
changed the belief, at least to some audiences, that PCa was a neglected disease.  
Rather than resulting in comparable collective action, contemporary use of the neglect 
frame invoked the response, reported in the voice of “four national journalists”: “but 
it’s not hidden any more, why are you saying that” (Extract 5.7) which, in turn, invoked 
the response from this participant to the chief executive “I don’t believe that any 
more” (Extract 5.7). The need to “show the media there’s still a long, long way to go” 
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(Extract 5.7) indicates the realisation of a continual need to ‘twitch’ (Seale, 2002: 36) 
the PCa plot to retain the interest of the media.  PCa as a neglected illness was no 
longer an acceptable story to tell or hear.  Was this though true for all audiences? 
5.3.2 Sustaining the interest of the “man in the 
street” 
Another aspect of this dialectic tension is seen when “the same old message that it’s 
the hidden disease or no one talks about prostate cancer” (Extract 5.7) was no longer 
believed as a viable frame for one audience, that of the media, but did still serve as “a 
more simple message to the man in the street” (Extract 5.7).  This indicates evidence 
of a problem associated with the concept of frame resonance (Ferree, 2003) where 
actors in the same movement have reasons for framing issues differently—essentially, 
in this example, entering an intra-organisational framing contest.  Here, the short-term 
strategic effectiveness of the “simple” message to the “man in the street” by the 
marketing department differs from those concerned with strategically refreshing the 
media’s interest.  Though seemingly incongruous, good stories are argued to be ‘good’ 
because they are indeed open to different interpretations as particular audiences 
collaborate with the storyteller in their interpretation (Polletta, 2006). The gender-
based ‘neglect’ story of PCa was also told by a participant, himself diagnosed with PCa 
several years earlier, who was active in setting up a leading grassroots PCa patient’s 
support network: 
Extract 5.8 
I'm still a member [of support network] and I still go to meetings when I can, 
one of my wife’s comments is that there’s too much prostate cancer around 
particularly when I'm cured, which brings me, I suppose it touches on my 
motivation because I still feel really quite angry that prostate cancer patients, 
well actually men in general, get a very raw deal, in comparison with women, I 
know this is a politically, generally regarded as an unacceptable view, but if you 
look at the lobbying and the amount of money that is put into women’s cancer 
when compared with, let’s add testicular cancer in as well for instance, with the 
male cancers, it’s about, it’s nearly ten times as much, ten times as much 
attention, ten times as much money. (PCa-ORG/1) 
Here again, like the participants from Extract 5.6 and Extract 5.7, is the observation 
that the ‘neglect’ story is not universally true but rather one which is politically and 
generally unacceptable.  It still did though work as a motivating factor for this 
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participant. Why was this?  One answer is that an unpopular political belief may itself 
be enough of a novel injection into a resonant story to make it interesting (Silvia, 
2008).  Another answer is that this participant may be the “man in the street” (Extract 
5.7) to whom the ‘neglect’ story still resonates.    
5.3.3 Constructing the interest of the “family” 
Another contemporary use of the ‘neglect’ story is used in a context which seeks the 
‘family’ as audience.  Part of the point being made by in Extract 5.9 is that although 
men with PCa and women with breast cancer share the experience of being diagnosed 
with cancer, their reactions to it are ‘shaped by their history, personal experiences, 
and the gendered nature of these diseases’ (Kedrowski and Sarow, 2007: 19): 
Extract 5.9 
If I contrast the women’s health movement and particularly breast cancer, and 
men, I think that one of the great things about the breast cancer movement has 
been that women are amazingly good at networking and that sort of collective 
action. Their ability to apply political pressure to the system is quite 
remarkable. I think men, by contrast, don’t network in the same sort of way 
generally and so trying to replicate the same kind of movement for men as we 
have for women I think is actually not what we’ve been about. It’s much more 
about saying that what we have to do with men is to take a more holistic, 
family based approach. So  we need to be thinking about the impact of prostate 
cancer on sons and daughters and partners and how can we get sons and 
daughters and partners involved in some of the things we do, to show support 
for prostate  cancer. So very often it will be about showing support for dad or 
whatever and our emphasis has been much more looking at the impact of 
prostate cancer on significant others and on building family involvement as the 
means by which we can generate this movement for change. Women, by 
contrast, are actually quite capable of - just on a women only basis - building 
their networks. When it comes to messaging, it’s partly hard edge messaging 
around the signs and symptoms to look out for, what are the preventative 
things you might be able to do, do you know what the gland does, and so on. 
So factual stuff, for sure, but it’s also about getting across the message that this 
has been a neglected disease, this is about precious men in your life, what can 
you do as a family member to help dad or whoever it is to take the right steps 
to make him aware of the options and the choices.  (PCa-ORG/3/1) 
The appropriation of the ideological ‘family’ frame resonates with a prior use of this 
frame in the United States where, in addition to the public construction of breast 
cancer sufferers as victims of gender-based neglect, family-based identities of wives 
and mothers were added to breast cancer sufferers (Kolker, 2004).  This resulted in the 
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portrayal of breast cancer as not only as a threat to women but also to American 
families meaning that ‘the pool of victims impacted by the disease expanded 
significantly to include the entire family’ (Kolker, 2004: 831).  What was of note in the 
narrative above was how the inclusion of ‘family’ not only increased ‘the pool of 
victims’ (p. 831) by “looking at the impact of prostate cancer on significant others” but 
also, in contrast to its use around breast cancer, included increasing family activism for 
change.  A likely tension here though is that casting women and families as guardians 
of and campaigners for men’s health may perpetuate an alternative story—men’s lack 
of agency and passivity around their health. 
5.3.4 Opposing “vested” interests 
The final example of the contemporaneous use of the neglect story of PCa is 
particularly notable as it is used in an adversarial way which attempts to undermine 
other “vested” interests (Gamson and Modigliani, 1989; Benford, 1997):  
Extract 5.10 
Those with a, what might or might not be a vested interest will continue to try 
and stimulate the idea that there is some sort of, there is a benefit to be 
gained, by detecting more prostate cancers and they will use all the influence 
that they have to make that argument and the influence will be in terms of 
putting forward patient’s stories.  It will be the politics of big P saying “this is, 
men’s health is being neglected, women’s health is being very prominent and 
this is a scandal”, and they will try and influence the people who make policy.  
And the people who make policy will be influenced to some extent by these 
appeals to them, but will be grounded by the fact that resource is limited, 
particularly now, and will be unwilling to embark on costly new initiatives, 
unless there is good evidence.  On the one hand there is very good evidence 
that these new initiatives will produce benefit, which is not the case at the 
moment, or, the political impulse produced by those other things  becomes so 
strong that they become less able to resist it.  So there’ll be a tension, between 
the forces which are trying to push through a particular way of looking at 
things, and the forces of, that want to make sure, partly for good reasons, that 
things don’t change.  And I guess (it’s overall is a good reason) they don’t, that 
we as a society should not waste our money doing things which we can’t show 
we’ve got a benefit. (PCa-MP/1) 
Lakoff’s (2010) argument that ‘negating a frame just activates the frame, as when 
Nixon said, ‘‘I am not a crook’’ and everyone thought of him as crook [sic]’ (p. 72) 
suggests that repeating a particular story strengthens it.  This indicates then that the 
repetition of the speech of the “vested interest” of big P politics—‘“men’s health is 
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being neglected, women’s health is being very prominent and this is a scandal”—
strengthens the gender-based ‘neglect’ story.  I propose though that this appropriation 
is essentially ironic (see Bloomaart, 2005: 199-201) and instead serves to undermine 
and discredit the ‘neglect’ story.  Thus, when this participant takes these gender-based 
neglect words which have existed ‘in other people’s mouths, in other people’s 
contexts, serving other people’s intentions’ (Bakhtin, 1981: 294), he instead inflects 
them with his own meaning (Steinberg, 1999: 751), and makes them serve his own 
intention in his own context.  Such an accomplishment is the crux of ‘constructed 
dialogue’ (Tannen, 2007) which is a discursive strategy used by a speaker not only to 
recontextualise words into a current discourse but also to augment their own 
credibility while diminishing the credibility of their opponents. 
This medical professional highlights the virtues of his own position relative to 
‘society’, namely “that we as a society should not waste our money doing things which 
we can’t show we’ve got a benefit”.  His ‘benefit’ of choice is not the “benefit to be 
gained by detecting more prostate cancers” of the potential vested interests in their 
use of “patient’s stories” as a ‘trump card’ (Russell and Greenhalgh, 2012: 50) in 
“influenc[ing] the people who make policy”.  Those “people who make policy” will at 
least include the UK National Screening Committee (NSC) who so far have not been 
sufficiently influenced to introduce a screening policy given that the ‘harms from 
prostate cancer screening using PSA are currently likely to outweigh the benefits’ 
(Mackie, 2010: 13).  While currently there is no known benefit of screening for PCa by 
PSA testing, DRE or any other method (Andriole et al., 2009) there is widespread 
agreement that national screening programmes have been introduced due to such 
“vested” interest advocacy rather than clinical or epidemiological evidence (Brown et 
al., 2004; Jutel, 2009; Armstrong and Eborall, 2012; Faulkner, 2012; Welch et al., 2012).   
5.3.5 Finding other “pockets of injustice” 
Extract 5.6 and Extract 5.7 show the necessity of shifting the “terrible hidden story (....) 
[of] the legacy of neglect” (Extract 5.6) to other “pockets of injustice” (Extract 5.7) to 
keep the cause of PCa “fresh for journalists” (Extract 5.7).  I asked PCa-ORG/3/1 what 
he meant by “inequalities” and these are also elaborated on by PCa-PC/1: 
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Extract 5.11 
Oh, so either regional inequalities, postcode lottery type differences, different 
mortality rates by primary care trust areas, for example, differential provision 
of clinical nurse specialists in different parts of the country and then socio-
economic differences around awareness in particular. We know almost without 
exception, that when you measure awareness of some aspect or another of 
prostate cancer, you know that awareness would drop off by social gradient, so 
whatever problem you have at an overall population level gets amplified once 
you start to look at people in less fortunate social backgrounds. (PCa-ORG/3/1) 
Extract 5.12 
Our role now is much more about uncovering data which can then be used to 
create a discussion about prostate cancer, so for example last year we were 
involved in uncovering some data on variations in mortality rates for prostate 
cancer so doing that by PCTs so you know, looking at what was the () variation 
in mortality, now in of itself that tells you nothing but what it does do is give 
you an opportunity to introduce that story to the media and then get them 
thinking about “well what are the inequalities in prostate cancer, why do they 
exist, what are the variations in access to treatment” etcetera etcetera. (….) I 
think the care and support aspects are absolutely critical.  We have many 
hundreds of thousands of men who live with and beyond their prostate cancer, 
many of whom don’t necessarily have the right support to meet their needs 
and we need to do more about that. I think there are issues around equality 
and prostate cancer, in terms of the way that different men are treated, I mean 
you’ve got a couple of big equality issues.  One, the (roles of older) men and we 
know there are issues around “ageism”, in inverted commas, in the NHS.  We 
also have men of African descent are three times more likely to develop 
prostate cancer than white men, there are therefore issues around how we 
provide advice, what form of advice we provide, how we make sure services 
are culturally sensitive.  There are issues around deprivation and making sure 
we get access, so that all men get access to the right services, I’m still struck by, 
I forget what the statistic is, but it’s something like, the prostate, the PSA 
testing rate is something like nine times as high in Hampshire as it is in 
Northern Ireland, now I’m not sure what the right rate is, but what I know is 
that is a clear function there of affluence and information, and you know, there 
are those sorts of issues which we really need to know and work very very hard 
to address. (PCa-PC/1) 
There are several ‘pockets of injustice’ storylines evident in the above narratives.  First 
are ‘postcode’ inequalities around mortality rates and support with the latter 
specifically regarding the provision of clinical nurse specialists.  Narrating PCa around 
mortality rates is potentially relevant in the framing of PCa as an aggressive ‘tiger’ 
which one may die of rather than with, rather than as an indolent ‘pussycat’ PCa that 
one is likely to die with rather than of (Neal and Donovan, 1998).   
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 A second ‘pocket of injustice’ is regarding socio-economic inequalities in 
awareness measured by “some aspect or another of prostate cancer” (Extract 5.11).  
The differences in awareness levels in the informed ‘affluent’ man and the uninformed 
man of “less fortunate social background” (Extract 5.11) leads to “what we have in the 
UK is a situation where the informed, just get themselves screened, and the 
uninformed, don’t” (PCa-MP/3).  However, this supposedly “clear function” (Extract 
5.12) between “affluence and information” is instead rather murky: 
Extract 5.13 
Part of the reason why we’re seeing so much more about prostate cancer now 
is that affluent men are living longer, so therefore they’re living long enough to 
develop prostate cancer, and the most vocal people in society when it comes to 
health issues are the affluent, the dispossessed and the poor have very little 
voice in health (...) the men whose votes don’t count are the guys in Glasgow 
whose life expectancy is only fifty-four years, those men won’t develop 
prostate cancer, to them prostate cancer is not an issue, never will be probably 
(...) the issues now are very much to do with delivery of services and men’s use 
of services, but because it’s the affluent who are pushing this, it’s very much 
based upon early diagnosis, screening programmes. (PCa-MP/4) 
While the “dispossessed and the poor (...) to [whom] prostate cancer is not an issue” 
(Extract 5.13) may be understood as those who are uninformed and who don’t get 
themselves screened (PCa-MP/3); being uninformed they cannot then be 
‘misinformed’. The potential paradox here is that the affluent and ostensibly informed 
men who “just get themselves screened” (PCa-MP/3) may instead be ‘misinformed’:   
Extract 5.14 
They’ve gone to see their doctor about a few symptoms that other men in the 
population wouldn’t bother about, or they’ve seen an advert suggesting that 
they should have their PSA done, or they’ve seen a telly programme that’s 
worried them about prostate cancer, so and what, potentially would happen if 
you, if every man was screened, is that you would throw up a lot of small 
harmless prostate cancers, which would then, probably put a proportion of 
those people into forms of treatment which were destructive.  (….)  One of the 
things that you need to realise is that, most of the symptoms of prostate 
cancer, are symptoms which are present, to some degree, in all men over a 
certain age, so if it so happened that prostate cancer was associated with 
baldness or greying of the hair, then alerting people to the fact that if they’ve 
got baldness or greying of the hair, they might have prostate cancer, isn’t going 
to help very many people.  And the same applies to passing your water slightly 
more frequently, or getting up at night, or your sexual function deteriorating.  
Almost everybody, when they get over a certain age, these are symptoms that 
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are a common experience, and  are associated, mostly with benign disease and 
the distinction between the symptoms produced by benign disease and the 
symptoms produced by malignant disease, is, is nothing, there is no difference.  
So the bladder symptoms you get with prostate cancer are precisely exactly the 
same as the symptoms you get with benign disease of the prostate, and it’s 
only if you’ve got life-threatening metastatic prostate disease that you get 
other, additional symptoms specific to the cancer, and then it’s too late.  So, 
because it’s very difficult to distinguish from, what is, if you like, normal aging, 
you end up by having posters like I’ve noticed they’ve got at [a London Tube 
Station], saying, “are you getting up a couple of times a night, if so, go and see 
your GP”.  So, the person would go and see their GP, they’ll have a PSA done, 
probably, they’ll be found to have a, a slightly raised PSA, they will or will not 
have a biopsy, that will or will not be positive, and they’ll end up at the end of 
it, having to make decisions about themselves which will be extraordinarily 
difficult, and will raise all sorts of anxieties and unhappiness, and yet they 
started off from a position which was probably barely distinguishable from the 
rest of the population of their age. (PCa-MP/1) 
Although as men get older they are more likely to be diagnosed with PCa, the rates of 
incidence of PCa for the most elderly are declining; for those aged 85+ from the mid-
1990s and for those aged 75-84 from the early 2000s (Cancer Research UK, 2013c).  
One explanation for this is as more and more men are diagnosed younger there are 
increasingly fewer men who have not been diagnosed by the time they reach their 70s.  
In his revisionist account of chronic illness, Armstrong (2014) suggests that ‘natural 
processes of ageing’ (p. 15) are pathologised into new diagnoses of chronic illness.  
These natural processes of ageing most certainly include the physical changes in men’s 
bodies such as benign enlargement of the prostate and lower urinary tract symptoms 
(LUTS) to which the medical professional in Extract 5.14 refers. LUTS are present in 
more than 50% of men aged over 60 and nearly 100% of men aged 90 (Weight, 
2013)—statistics likely to be similar for the “baldness or greying of the hair” (Extract 
5.14) in men of this age.  The resulting diagnoses from the pathologisation of these 
natural processes, Armstrong (2014) argues, are not ‘uncontaminated by 
contemporary world views or theoretical frameworks’ (p. 16)—which at least include 
information on the likes of posters at London tube stations with the seemingly simple 
suggestion to go to the GP who will likely offer a PSA test, a point also made by the 
public consultant below:  
Extract 5.15 
Life expectancy is extending, the more that goes on, the more men get old 
enough to “achieve”, in inverted commas, a diagnosis of prostate cancer 
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because prostate cancer is so typically a disease of older men, so you have this 
problem that in terms of the demographics, you’re adding, more men, to the 
pool of men who could get prostate cancer, by virtue of getting older, so how is 
that built into how you understand the perception of prostate cancer, if you 
keep saying “it’s not just old men that get prostate cancer” and concentrating 
on the men in their fifties and sixties, perhaps by suggesting to them in a very 
simple fashion that the PSA test for example is something they should know 
about, because I think once you give people the idea that there is some sort of 
intervention that might work, is that they take a qualitative understanding of 
that, which is “oh it’s an intervention that might work.” (PCa-PC/2) 
Also notable in Extract 5.14 is that the pathologisation of these natural ageing 
processes may increase the chance of detecting non-clinically relevant PCas and induce 
overtreatment (Wolters et al., 2012).  Men diagnosed with “small harmless prostate 
cancers”, this participant suggests, may end up making “extraordinarily difficult” 
decisions around treatment—a situation not unlike the ‘semantic slippage’ (Aronowitz, 
2009: 435) in naming certain diseases as ‘cancer’ rather than an underlying risk state 
and which results in those diagnosed adopting decision-making styles typically used in 
more advanced cancer states.  Making seeming simple suggestions to men about what 
they should do about their LUTS may then be seen by some, though not all, as 
misinformation.  This may then be a, likely contested, type of injustice around PCa  
Aronowitz (2009) also argues that, especially regarding chronic diseases, new 
screening and diagnostic technologies and disease definitions lead to ‘the recruitment 
of larger numbers into chronic disease diagnoses’ (p. 417).  What this leads to is a 
‘larger and highly mobilised disease/risk population, resulting in an expanded market 
for interventions and greater clout for disease advocates’ (Aronowitz, 2009: 417-8):   
Extract 5.16 
[MWPCa] are advocating for themselves, in general compared to the rest, other 
cancers, they’re a healthy bunch of men, they normally aren’t smokers, 
because otherwise they would have got their stroke or their heart attack in 
their fifties or sixties and not lived to have got their prostate cancer (...) they 
tend to be men of an age where they’ve either made it in their career or 
they’re comfortable financially, or they’re sorted in some shape or form, 
they’re unlikely to be you know, thirty-five years old, living on benefits and 
wondering where the next ten pounds is coming from, in general they’re sorted 
out in some shape or form, they’re living on a pension, or they’re, after a 
successful career, so they’re better able to advocate for themselves, I think, 
you know, they’re in a better position to stand up and say, you know, “I’ve got 
prostate cancer, and here’s what it means, and here’s the treatment I want.” 
(PCa-MP/5) 
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Affluent and self-advocating MWPCa may form part of the “many hundreds of 
thousands of men who live with and beyond their prostate cancer” (Extract 5.12) in the 
context of what is in effect, after treatment, a chronic illness (Doyle-Lundred 2007; 
Oliffe and Thorne 2007; Oliffe, 2009).  An increased mobilisation of a PCa population 
and greater clout for disease advocates (Aronowitz, 2009) more fully meets the seven 
characteristics of a successful grassroots survivors’ organisation (Kedrowski and Sarow, 
2007: 52-60).  These: 1) form around long term health hazards; 2) adopt and use the 
organisational structures and practices of existing activist organisations; 3) offer their 
own experiences as evidence; 4) depend on an empowered and educated activist 
support base; 5) depend on the media and courts for keeping issues alive and in the 
public’s agenda; 6) depend on women as activist leaders; and 7) need financial and 
promotional support from business and industry to ensure long term viability.   
Whether MWPCa are misinformed or uninformed, they may still need someone 
to fight their corner as victims of prior neglect and in present need of protection and 
caring.  Extract 5.4 shows that unlike the women’s movement or the breast cancer 
movement there was no equivalent of “radicalising lesbians” for prostate cancer, made 
explicit by another participant: 
Extract 5.17 
People didn’t feel that there was anyone fighting the good fight for prostate 
cancer, now, frankly it doesn’t really matter who does that as long as someone 
does it and someone does it effectively. (PCa-PC/1) 
This is not to say that there were no voices around PCa; there were a number of 
PCaOrgs at this time but instead of fighting the good and effective fight, they “fought 
like cats and dogs, and (...) very often undermined each other’s cause by contradicting 
each other, saying different things, the most obvious, but not the only example, being 
around the PSA test” (PCa-PC/1).  That there is disagreement over aspects of potential 
reality of PCa is not surprising as the very existence of social movements around health 
suggests differences around the meaning of some aspect of reality and a struggle 
between actors to invest this with their preferred meaning (Benford and Snow, 2000). 
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5.3.6 Age inequalities 
The “(equality) issues around ‘ageism’” envisioned by the participant in Extract 5.12 
was also reflected on by others: 
Extract 5.18 
Old men are seen to be, almost a nuisance, and that’s where the expression 
“dirty old men” probably comes from, you don’t hear of “dirty old women”, you 
know, “dirty old man”, and it’s and it’s this sort of ageist approach to the whole 
damn thing, age and modern society, (), older men are not seen as being, as 
relevant for health care either for prevention, promotion. (PCa-MP/4) 
Extract 5.19 
the huge problem, I don’t think the prostate cancer brotherhood understands, 
is that the average age from, of death from prostate cancer is significantly 
higher, than all the other cancers, that doesn’t mean, you don’t approach it, it 
does mean, to my mind, that you approach it in a different way, you are trying 
to solve a different problem, and I’m not sure they see that,  because you will 
come across phases like, “it’s not just a disease of older men” (...) just because 
you know that’s what makes people pay attention, but in my, inside my heart 
I’m screaming “even if it was just disease of older men why do you then think 
that that’s good enough to let a man die of cancer?  Because he’s older?”  Is 
that all old people do? (PCa-PC/2) 
Narrating PCa as “‘not just a disease of older men’” to make “people pay attention” or 
to capture their ‘interest’ thus has the potential to ignore the needs of older men and 
not help in addressing the lack of attention to potentially common idioms such as 
“dirty old men”: 
5.4 Discussion 
This analysis shows how advocates around PCa have sought to produce or transform 
meanings around PCa and the narrative forms or elements they have used in doing so.  
What is of initial relevance is that a story of ‘neglect’, already successfully used in the 
early 1990s by breast cancer movement activists in the US (Kolker, 2004), was used in 
the late 1990s by actors around PCa in the UK.  Critically, however, the neglect story 
became no longer acceptable as a story to be told and heard, at least to the media 
producing audience.   
168 
 
The success of the neglect’ story of PCa was due to the combination of novelty and 
familiarity—necessary elements in making a story a story (Polletta, 2006) and which 
created ‘interest’ (Silvia, 2008) around PCa in the years following the advent of 
PCaOrgs into the UK.  Borrowing this neglect story in the late 1990s was a discursive 
strategy which made this frame ‘sound right’ (Tannen, 2007: 62) and ‘fit’ or resonate 
with audiences’ previous experiences.  The ‘silence in the discursive field in which 
[advocates around PCa] were fighting’ (Steinberg, 1999: 752) meant they lacked a prior 
familiar history to draw upon to cope with their novel status as victims.  This 
combination of novelty and lack of familiarity and comprehensibility led to uncertainty 
and confusion (Silvia, 2008) and the situation where one “didn’t know what to do in 
those days”.  There was, however, a ‘spilled-over’ familiarity from women’s activism 
around breast cancer in the gender-based neglect frame and it was this borrowed 
familiar story alongside the novelty of men as victims which juxtaposed the resonance 
and dissonance necessary to stir realisation and create interest.  The broadening of 
blameworthy agents of injustice from government to society may constitute a basis for 
a necessary ‘normative revision’ (Turner, 1969: 391) in how a person, or group of 
people, comes to look at a problem.  The problem is no longer that men suffering and 
dying from PCa is a result merely of their own passivity but rather that they are also 
neglected by both society and central government; the former not making “a fuss” and 
the latter giving worse than a “derisory” amount of money to PCa.  Thus, in summary, 
the neglect story was familiar and novel in several ways:  
1. It was familiar as it had previously been used by breast cancer activists in 1990s 
2. It was novel as men rather than women were neglected—this particular novelty 
also was familiar as it was gender-based like its use in the breast cancer context 
3. It was familiar as it articulated hegemonic discourses about men’s passive health 
behaviour  
4. It was novel as it contrasted the silence of men with the noise of women 
5. It was novel as it broadened the attribution of blame from government to all 
society 
There was a need for media producers to ‘“twitch” the plot from time to time in order 
to retain audiences’ interest’ (Seale 2002: 36, emphasis added).  A strong ‘twitch’ takes 
the form of a ‘reversal, in which polarities previously set up may suddenly be reversed, 
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so that evil and good swap places to provide an entertaining disruption of 
expectations’ (p. 36).  The same may be said here about how advocates around PCa 
‘twitch’ the plot for their media producing audience.  While there are some interesting, 
and very relevant, instances of a contemporary use of the neglect story, there is also a 
shift from the injustice around the “legacy of neglect” to “other pockets of injustice” in 
contemporary messaging around PCa.  These include ‘postcode’ inequalities around 
mortality rates and support, socio-economic inequalities in awareness, and age 
inequalities.  There are few studies around socio-economic deprivation and risk for PCa 
(for one exception see McVey et al. 2010).  The findings above are evidence that there 
is disagreement over how MWPCa may be socio-economically framed: as affluent and 
self-advocating survivors; as uninformed; or as misinformed. What is more, successful 
frames may combine contradictory ideas to meet the different strategic needs of the 
frame-makers (Polletta and Ho 2006).   
What is important in this study is that there are increasing numbers of men being 
diagnosed with PCa and correspondingly ‘recruited’ onto the PCa disease spectrum 
(Aronowitz, 2009).  If these men are indeed “a healthy bunch of men (...) [who have] 
made it in their career (...) [and are] better able to advocate for themselves (...) they’re 
in a better position to stand up and say, you know, “I’ve got prostate cancer, and 
here’s what it means, and here’s the treatment I want”” (PCa-MP/5) then this will 
‘result in an expanded market for interventions and greater clout for disease 
advocates’ (Aronowitz, 2009: 417-8).  It also makes this a constituency which more 
fully meets the seven characteristics of a successful grassroots survivors’ organisation 
(Kedrowski and Sarow, 2007).  Likewise, those men who are uninformed and victims of 
prior neglect need someone to fight the “good fight for prostate cancer”, as do those 
who are ‘misinformed’.    
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 Changing narratives of Chapter 6
disclosure by MWPCa 
6.1 Introduction 
My aim in this chapter is to explore the changing disclosure behaviour of MWPCa by 
analysing research interviews with MWPCa carried out in 2000 and 2010. Though the 
term ‘disclosure’ has been used to describe how cancer patients may openly discuss 
their diagnosis and thoughts and feelings about the disease  (Hilton et al., 2009), it is 
used in the main here to refer to the initial telling of a PCa diagnosis from a man with 
this condition to his family and others (Gray et al., 2000).  It may also refer to 
situations when men discuss being involved in disclosure conversations with other 
MWPCa.  It is thus not here considered as the announcement of diagnosis of PCa from 
a medical professional (see Mróz et al., 2013).  
I focus on disclosure for three reasons.  First, my research question in this thesis 
asks how PCaOrgs and the UK print media have been a force for change in the UK 
regarding how this condition has been addressed and experienced by MWPCa.  A 
finding from Chapter 4 demonstrates that PCa as a “taboo disease that no one dares 
talk about” (Figure 4.4) was more explicitly and frequently articulated in the media 
illness narratives of MWPCa in 1990-2000 than those in 2000-2010 (§4.4).  A finding 
from Chapter 5 demonstrates that though towards the end of the 1990s “prostate 
cancer was just beginning to come out of the shadows of neglect” (Extract 5.1) and 
that when men “would have their illness, they would not talk about it, they would die 
quietly” (Extract 5.2), this was less the case towards 2010.  Though these findings were 
not known when the MWPCa were interviewed in 2000 and 2010—and thus disclosure 
was not an a priori research enquiry—men in both periods were asked about how they 
told others about their illness.  Secondly and relatedly, this thesis focuses on changing 
narratives of PCa over time.  Though I draw on ideas from several narrative and literary 
scholars, I use as a basis Bury’s (2001) three non-mutually exclusive narrative forms: 
contingent, moral and core narratives (§2.4.3).  Though all three are useful, contingent 
narratives of coping in particular address the practical management of interactional 
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issues of disclosing illness to family and friends.  Finally, there are few studies which 
consider how MWPCa disclose their illness.  These reasons provide validity for my 
focus here on how MWPCa disclose their illness to a variety of audiences. 
I specifically ask: 1) are there differences in how MWPCa disclose their illness 
over time and to various audiences; and 2) what narrative forms and elements do 
MWPCa draw upon when disclosing their illness to various audiences. I present my 
findings in four sections: disclosing to ‘partners’; disclosing to ‘children and wider 
family’; disclosing to ‘friends and others’; and disclosing to ‘colleagues’.  I suggest that 
many of the same narrative forms and elements occur across these audience types.  
While one might expect less interactional difficulty for MWPCa in disclosing their 
illness when a tragic genre of ‘taboo’ may be less available to draw upon, my study 
suggests that with some audiences this is often not the case. I close this chapter by 
briefly discussing the reasons for this increase in interactional difficulty in more detail 
and some potential consequences of it.     
6.2 Disclosing to partners 
In large part, men interviewed in both 2000 and 2010 told how they made a prompt 
disclosure of diagnosis of PCa to their partners and how they received welcome 
support: “my wife's been a wonder with me all the time and she's been my right arm 
all the way through it” (Taylor 2000).  Men mainly disclosed in the expectation of 
hearing worry from their ‘partners’ and either pre-empted this or responded to it by 
indicating an anticipated or desired good treatment and recovery.  In wondering how 
to disclose, Harry (2000) implicitly anticipated the worry of his family and sought to 
counter this worry with reassurances of his recovery: 
Extract 6.1 
I think the impact of the diagnosis mainly was as I said coming home, I could 
recall nothing whatsoever about the journey; how do I explain it to my wife and 
my family in particular because there was a large family involved and I suppose 
as much as anything I wanted to offer those people the reassurance, even at 
that time perhaps silly, of there was life thereafter. (Harry, 2000) 
Sometimes the diagnosis, in both time periods, was made with an accompanying 
partner.  Ernie, one of the oldest participants and from South Asia, unusually received 
his diagnosis in the company of both his wife and children.  Ernie reconstructed a 
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conversation with his wife and children and described his expectation of “worry” and 
“shock” from his wife and children in their mutual knowledge of the death of his father 
from PCa some years previously:   
Extract 6.2 
Ah yes my whole family, my son was with me, my wife, my two daughters yes 
(....) Aw probably it was a big shock for them like you know so, but I told them 
“it’s nothing to worry about”, well I was the brave one, I said nothing to worry 
my wife but “my father died of it so I got it and these days this modern 
equipment and the technology so high, the success rate so high so I’ll be, 
alright”. (Ernie, 2010) 
Ernie’s narrative demonstrates how he transformed this worry with an anticipation of 
his likely “alright” recovery given the high success rate associated with modern 
treatment.  Likewise, Neil (2010) described how his wife, on hearing “the word 
‘cancer’”, and thinking of it as fatal, “was anxious that I get the treatment quickly, get 
rid of the cancer and just start the recovery process”.  One man reported his prompt 
disclosure to his partner with an explicit moral imperative as “the right thing to do” 
(Fred, 2010) (emphasis added).  Fred wanted to model his disclosure on his wife’s 
disclosure of her breast cancer to him some years previously; he was sorry though that 
it “brought back some of those early stages for her” (Fred, 2010).  Keith (2010) 
reconstructed his disclosure conversation with his wife while simultaneously 
reconstructing his consultant’s confidence in his treatment and recovery: 
Extract 6.3 
Well, I, yeah well obviously I discussed it with [wife] that evening, and I said to 
her “well, I’ve to go to the scan, but the consultant is confident that if I have my 
prostate removed, that will sort the problem out”, and you know, that’s the 
way it was, and at the same time, we, well probably when I say we, but the way 
that I was going to deal with it, was that nobody else apart from [wife] and I 
would know about it until, until we had to tell them. (Keith, 2010) 
Contingent narratives of coping are made possible through core narratives—culturally 
available genres or ways of talking ‘which allow or constrain what is said and how it is 
expressed’ (Bury, 2001: 278).   The above narrative extracts demonstrate that upon the 
disclosure of illness to their partners, MWPCa expected to hear worry and concern 
regarding potential poor outcomes and suffering and fitting with a ‘tragic’ genre 
(Smith, 2005).  Genres though, argues Bury (2001), are always open to negotiation, 
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always ‘“at risk”’ (p. 279) in the everyday interactions people face, especially, suggests 
Bury, with their families.  Likewise, in his analysis of a news delivery sequence, 
Maynard (2003) suggests that rather than thinking of a certain type of news delivery, 
for example disclosing PCa, as inherently bad, participants in such a disclosure event 
‘must interactively establish the valence of the news and just how good or bad it is’ 
(2003: 89, emphasis in original).  Similarly, Maynard (2003) proposes, that participants 
in an interaction may each choose to respond to an ‘intended valence’ (2003: 116) in a 
way which assesses it ‘positively or negatively, usually but not always in accord with 
displayed anticipations’ (p. 106.).  Though MWPCa anticipated the tragic genre of 
worry from their ‘partners’, the above extracts demonstrate that these men did not 
respond in accord with this displayed anticipation.   
Instead, MWPCa disclosed their illness to their ‘partners’ with an ‘intended 
[positive] valence’ (Maynard, 2003: 116) which included an anticipated treatment and 
recovery.   In this way then, they countered the tragic genre and instead advanced a 
romantic narrative genre.  A romantic genre—not inevitably about love—indicates that 
a ‘change for the better is in the air’ (Smith, 2005: 26).  The above narratives 
demonstrate the triumph of a good treatment and recovery over the adversity of 
illness.  They also demonstrate the ‘co-authored’ (Williams, 1984: 181) nature of these 
disclosures in that they are bounded by and constructed in negotiation with this 
audience.  This co-authorship though also includes those not present in the immediate 
interaction such as when Keith (2010) in Extract 6.3 reconstructed the voice of his 
consultant in his disclosure to his wife.  Frank (2010: 10; see also Hyden, 1997) 
suggests that stories work to emplot so that a particular future is not only plausible but 
compelling.  All of the above stories work to ‘emplot’ a compelling romantic genre 
using an anticipated recovery to counter the expected or explicit tragic genre of worry 
from this audience.    
That genres are open to negotiation (Bury, 2001) was also seen in a reverse way 
in Calvin’s (2000) narrative (Extract 6.4).  Calvin’s heightened awareness of potential 
death indicated an “amplified awareness of suffering” (Smith, 2005: 25) typical of a 
tragic genre.  He reconstructed in detail his wife’s countering of his displayed genre: 
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Extract 6.4 
Suddenly it's like somebody saying you know you're going to die and you'd 
never thought of dying.  And I was disturbed by it, rather quiet I suppose, 
pensive, worried.  And we're walking back to where we had parked the car, 
passing a café and my wife said "Well let's go into the café, let's talk about it."  
So we went into the café and we sat down and we had a cup of coffee and she 
says, well I think I said "Where are we going from here?" to her or something 
like that and she says "Well what are you worried about?" I said "Well you 
know it's a disaster, I'll have to give up work, I'll have to do this, I'll have to do 
that."  And she says "Well why, you know, you're here today, you're in perfectly 
good health, you're going to be here tomorrow aren't you?"  I said "Well yes," 
"And you'll be here the next day."  She said "Well there's three days, what are 
you worried about you know we could be knocked over by a bus going for our 
car or something you know so why is this suddenly the big disaster.  Because 
it's not happening tomorrow, it's not happening next week, the next month, 
okay it's not very good but you know let's be positive about it. (….) And 
suddenly I thought ‘well yes I am here today, there is a tomorrow, there is a 
day after that’ and that was very encouraging. And she has been tremendously 
positive and supportive right the way through.  But having said that, at times it 
has got to her.  There have been tearful moments because she doesn't want to 
lose me; I wouldn't want to lose her so moments have become a little bit 
difficult.  (Calvin, 2000) 
Calvin’s wife negotiated with him in his choice of genre in his disclosure narrative to 
advance instead the ‘fundamentally optimistic’ (Smith, 2005: 26) romantic genre; this 
included anticipating a good, albeit perhaps temporary, recovery.  This negotiation is 
understood as a ‘genre war’ (Smith, 2005: 28) where interactants compete over how 
to interpret aspects of reality.  In addition to genres being ‘“at risk”’ (Bury, 2001: 279) 
in everyday interactions, Bury suggests that people are not consistent in their choice of 
genre and may move between, say, romantic and tragic as they see fit.  Though Calvin 
indicated his glad acceptance of his wife’s proffered romantic genre at that point of 
time, it is evident that this genre was also ‘“at risk”’ (p. 279) in difficult “tearful 
moments” since. 
 There were though assorted deviances in that some disclosures were delayed or 
the anticipated worry was not in the end effectuated.  Three men in 2010 spoke about 
how they intentionally delayed disclosure to their partners.  Don delayed disclosing to 
his wife until compelled to do so when she saw him feverish after his biopsy:  
Extract 6.5 
I was referred to the hospital, around about [date], and throughout this time I 
was subject to MRI scans, ultrasounds, numerous blood tests and the biopsy, 
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and up until the biopsy I’d not told my wife or a living soul, a word of my 
circumstance. I drove myself to hospital each time, drove home again, and 
drove home, a little discomfort after the biopsy, and got in my house and found 
that I was feverish, I was shivering, shaking.  My wife was out, and I got a 
blanket, and sat in the lounge trying to shake the fever off knowing she would 
come into the house shortly, but she came, found me, shivering, with a fever, 
which didn’t last more than two hours after the biopsy, it was just a reaction.  
And I told her then, and being firm with her, I says ‘look this is not a matter of 
your sympathy for me, it’s a matter for me dealing with, so don’t start 
blubbing, just do the things that I ask of you and just trust me to deal with this’.  
But if I could have gone the whole, nine yards, without telling, I would have 
done, and that way, the worry’s contained, the anxiety’s all mine, and I don’t 
share it and people don’t have to worry about me, which is a, part of, I prefer, 
but again it’s a character thing, I’m pretty much a secretive person, and would 
object to somebody else keeping me in the dark, how about that for hypocrisy? 
(....) I went for a year and only told my wife. I went from diagnosis, prognosis, 
referral, prognosis, diagnosis, right up to treatment and then, four months after 
treatment and getting what please God is a cure.  So I went for sixteen months 
and never told a soul, except my wife, and she, credit to her, she never blurted 
it out to anybody either. (Don, 2010) 
Don’s narrative is exceptional in its seemingly ostentatious display of hegemonic 
masculinity (Courtenay, 2009). Maynard (2003) suggests though that a ‘stoic response 
[is] an interactional and not just psychological phenomenon.  Deliverers [of news] (...) 
sometimes intentionally, often inadvertently encourage stoicism on the part of their 
recipients’ (p. 121). Don’s forbidding of his wife to either “start blubbing” or to ‘blurt’ 
out his diagnosis of PCa would seem to be an intentional imperative, rather than 
encouragement for a corresponding stoicism on the part of his wife.  As such, stoicism, 
though advanced by Don and described by him as “a character thing”, may well also be 
a co-authored feature of this narrative demonstrated in his reconstruction of his wife’s 
collaboration with him.  Don’s disclosure though delayed, and thus not prompt like the 
others described above, still indicated an expected hearing of worry and concern from 
his wife. To this extent, Don’s narrative also drew on the romantic genre but one 
perhaps less open to negotiation (Bury, 2001). 
Two other men in 2010 intentionally temporarily delayed disclosing to their 
wives due to particular circumstances.  Joe talked about how he made a “terrible 
mistake” in disclosing his PCa to a friend just before they went off together on a cycling 
holiday before he told his wife: “so I just said, “I’ll not tell her, she’ll only be worrying 
about it, and I’m going to go anyway” (Joe, 2010).  Hugh, who worked overseas, 
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planned in detail how he would tell his wife when he returned home three weeks after 
his diagnosis: 
Extract 6.6 
I says “oh right, can you come in a wee second”, ((laughs)).  I knew the moment 
I told her to sit down for a second she went on guard immediately, suspicion 
was too strong a word but she knew something was coming that was out of the 
ordinary.  So, I had practised what I thought I would say, to lead into it, but 
there isn’t any way of, being kind with the word cancer, at the end of the day, I 
thought I’m actually just going to get her more and more upset if I beat around 
the bush, and I could see that she was beginning, “what, what’s coming?” So, 
the only way to deal with that was, I just said, very very simply, “I’ve got 
cancer”.  And you know, she reacted the same way I did, immediate shock.  She 
was actually very good.  She’s been tremendous throughout all of this.  We’d a 
bad day that day, so we did, but you learn, you cope, she’s been brilliant. 
(Hugh, 2010) 
Hugh and Joe’s narratives of disclosure indicate that they expected to hear worry from 
their wives.  In Joe’s case his decision not to proceed with any negotiation with this 
tragic genre resulted in regret.  In Hugh’s case, though his negotiation of genre began 
some weeks before his disclosure as he practiced what he might say to his wife, this 
was then re-negotiated in the immediate interactional setting of his disclosure. 
 Another type of deviant disclosure was when Charlie (2010) told how his 
expectation of shock and concern from his wife and children did not happen:   
Extract 6.7 
Interviewer: And then what about telling others, your wife was with you 
whenever you heard? 
Charlie: I don’t know whether what you see in soap operas and the like is the 
real world, where somebody near to you goes into a state of shock when they 
receive this information, at no stage, did either my wife or my daughters show 
shock and horror, maybe it was that in a previous illness, I should have 
succumbed to the problem and I survived and whether they keep this in the 
back of their minds, that things aren’t desperate, I don’t know, but I wouldn’t 
say that there was, there was shock or panic, maybe they disguised it well. 
(Charlie, 2010) 
Charlie’s disclosure narrative made explicit his knowledge of the culturally available 
genre available through “soap operas and the like”: family members go “into a state of 
shock” when they hear a disclosure of illness from their husband/father. His attempt 
to explain this missing tragic genre—“maybe they disguised it well” or maybe it 
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resulted from their background knowledge of his good recovery from a previous 
illness—demonstrated his surprise that this expected genre was not advanced.  His 
narrative may though still be understood to correspond to the examples above as it 
still shows a negotiation between a tragic and romantic genre.  In this case it was the 
implicit romantic genre by his wife and daughters of an expected good treatment and 
recovery that worked to counter the ‘soap opera’ tragic genre that Charlie expected. 
The final deviant example was Graham’s (2010) brief summary (the only 
reference in his interview of disclosing to his wife) which was in the context of his 
receiving his diagnosis from his consultant: 
Extract 6.8 
‘well Graham, you’ve got cancer’, (...) he said the good news was that I think it 
was only two out of the ten samples contained cancer, the other eight were 
clear, so it was quite possible that we’d got it in its very early stages which he 
said was a very, was very good news, so he spent I think the rest of the twenty-
five or thirty minutes, very quickly going over a whole list of options, as to 
where we go from here, and sent me home to think about it, for three or four 
weeks to arrange another, to go back and talk about what we decided to do, so, 
it was quite a shock and I remember phoning my wife and telling her that that’s 
what had come out of it.  (Graham, 2010) 
Graham’s summary disclosure to his wife from his diagnosis conversation with his 
consultant, though prompt, ostensibly suggests that he did not anticipate a tragic 
genre of worry on her part.  What is evident however is that the ‘bad’ news given by 
the consultant of “well Graham, you’ve got cancer” is combined with the consultant’s 
“very good news” that his PCa was caught “in the very early stages” with “a whole list 
of [treatment] options”.  It is thus reasonable to infer that Graham’s brief reported 
statement of disclosure to his wife was a reconstruction of his diagnosis conversation 
with his consultant and that this drew upon a romantic genre of an anticipated 
triumph over the adversarial illness. 
In sum, MWPCa interviewed in 2000 and 2010 disclosed to their ‘partners’ in 
very similar ways.  Though there were deviant examples, men in both periods made 
prompt disclosures and received a welcome supportive response.  All the narratives, 
even deviant cases, demonstrated the negotiation between a tragic and romantic 
genre. In the main, these narratives commenced with an at least anticipated tragic 
genre and were subsequently countered by a romantic genre.  In one instance, though 
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a tragic genre was anticipated it was not—somewhat surprisingly to the MWPCa—
voiced in the disclosure interaction. All narratives were co-authored with this 
audience. 
6.3 Disclosing to ‘children and wider family’ 
Seemingly similar to disclosing to ‘partners’ was that when MWPCa disclosed to 
‘children and wider family’ they expected to hear worry and receive support.  What 
was different to disclosing to ‘children and wider family’ though was concern by the 
MWPCa over the additional anxiety their disclosure caused this audience.  Also, unlike 
that received from ‘partners’, the support from ‘children and wider family’ at times 
seemed to be unwelcome, for example in the “excessive” support received by Barry 
(2000).  One potential consequence of this was, unlike the prompt disclosure to 
‘partners’, disclosures to ‘children and wider family’ were sometimes delayed.  That 
Don (2010) “went for a year and only told his wife” was also the case for other men in 
each time period who initially told only their wives and ‘kept it quiet’ from others.  
Taylor (2000) delayed telling his mother until almost the time of his operation as he 
“did not want to worry [her] because my father had died only nine months before, so I 
was a bit concerned”.  This expectation by MWPCa of hearing worry demonstrated 
that these men anticipated that their ‘children and wider family’ would draw upon a 
tragic genre of suffering upon hearing their disclosure of illness.  
Also ostensibly similar to disclosures to ‘partners’ was how MWPCa sought to 
counter this tragic genre with an optimistic romantic genre based on a hoped for good 
treatment and recovery.  Mark’s (2000) family “just said ‘get on with it’ you know, I 
think they were relieved at least there was something wrong and that I was taking a 
very positive attitude about it”.  Finlay and Graham, though speaking ten years apart, 
told of the relief felt by their respective families when they could present an at least 
attainable treatment and recovery: 
Extract 6.9 
I kept it to myself.  I told my daughters, [youngest daughter] is a nurse, my 
youngest daughter she's another very positive person “Oh you'll be alright 
dad”, [oldest daughter] had a little weep (....) I think, I think my attitude rubbed 
off on the family, they took it that I was happy, that something was happening, 
something was getting done.  My personality went back to itself again, I got 
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back my bubbly self and said “Well I'm going in for an op, that's it and they're 
going to fix me” ((laughs)) so I think that rubbed off on everyone, including 
[wife]. (Finlay, 2000) 
Extract 6.10 
I think even in terms of family, my own parents were still alive; I was able to 
talk to them about it quite openly.  It’s slightly worrying because they get very 
anxious and so you know that you’re putting an additional anxiety on people 
when you tell them that you have cancer, and, but then on the other hand they 
want, I mean, they want to support you and go through it with you, so but that 
they were quite relieved when it was all solved in the end.  But no, I can’t think, 
you know, certainly within immediate family, even to some extent, my sister, 
siblings, I wasn’t, I didn’t go broadcasting it, but certainly the people that I’d 
been in any sort of reasonably close relationship with I felt I had to let them 
know, and that this was something we were going to have to confront. 
(Graham, 2010) 
That Finlay’s positive attitude “rubbed off on everyone” is indicative of how welcome a 
positive disclosure is in enabling a convenient ‘wrapping up’ (Wilkinson and Kitzinger, 
2000: 803) of the conversational burden involved in disclosing illness.  Though his 
eldest daughter “had a little weep”, all others accepted his displayed valence in their 
work to establish just how good or bad this disclosure news was (Maynard 2003) and 
did not renegotiate a tragic genre (Bury, 2001).  Notable also in Finlay’s narrative was 
his work to maintain his pre-illness “bubbly self” identity—fitting with a contingent 
narrative of normalisation (Bury, 2001).  
Keith’s (2010) disclosure to his children, delayed until “a very short time before 
[he] went into hospital”, again reconstructed his consultant’s words that a radical 
prostatectomy “will sort the problem out”: 
Extract 6.11 
we just arranged for all the family to be here, when I say all the family I mean 
our children, and we had them here, and I told them, the problem, and I said 
“but listen, this, this should be okay, the consultant has told me, ‘removal of 
the prostrate [sic] will sort the problem out’”, and that’s the positive way that I 
looked at it, and you know needless to say, I suppose they were shocked, 
because they had no suspicions whatsoever, and I suppose they all felt sorry for 
me, as such, but we all remained very positive about the thing. (Keith, 2010) 
Fred (2010), who modelled his disclosure of his PCa on his wife’s disclosure of her 
breast cancer to him, knew that his children also had knowledge of their mother’s 
previous successful treatment.  He delayed his disclosure to his children until he was 
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able to tell about an optimistic treatment and recovery outcome.  Notable in Fred’s 
narrative (like Finlay’s in 2000, see Extract 6.9) was his work to maintain his pre-illness 
identity—again fitting with a contingent narrative of normalisation (Bury, 2001).  Of 
interest, though not explored further here, is that Fred (2010) and Finlay (2000) were 
MWPCa matched along age at diagnosis/age at interview and socio-economic variables 
(Table 3.9).  Of further note is that when his son told him concerns about his own 
genetic risk of cancer, Fred also negotiated with this tragic genre to posit a more 
hopeful outcome:   
Extract 6.12 
We didn’t actually speak to the children about it, until I’d, I’d been diagnosed 
and sort of the treatment was being lined up (...) but when I was able to say to 
them “well, you know I also have to have treatment but it’s not spread and it’s 
going to be fairly straightforward and it’s probably not going to make, you 
know, a huge difference to how I am”, then,  they, they sort of took it in their 
stride (...) my oldest son did ask that about whether because both my partner 
and I had had cancer whether he would, that meant he was more likely to have 
cancer, later in his life, and, I think we sort of, we reassured him that quite a lot 
of causes of cancer were environmental, and although there was a genetic 
factor, the other thing to say was that treatment was advancing so fast. (Fred, 
2010) 
Though temporarily delaying disclosure to ‘children and wider family’ was a feature of 
men’s disclosure narratives, some men significantly prolonged the delay and in some 
cases chose not to disclose at all.  Such lengthy delays were done in both time periods 
to avoid worrying elderly parents, vulnerable adult children, and young children.  
Nathan (2000) limited disclosing his illness to his wife and kept quiet about his PCa to 
his children until he “couldn’t really keep it a secret any more”: 
Extract 6.13 
I think that it's been very traumatic [for my family], I did keep it back from the 
children for a long time when they came to visit, actually they came to visit me 
in [American city] and they stayed in this [accommodation] and there's a big 
sign that said ‘American Cancer Society’ so I think the cat was more or less out 
of the bag.  We went to a kind of, there was a kind of a prayer meeting that we 
went to and somebody mentioned prostate cancer and then they became 
aware of it. (Nathan, 2000) 
Lawrence (2000) said that he did not tell his 88 year-old mother as it was “a worry that 
I would not put on her shoulders, I mean I've had it now for nearly four years, she 
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doesn't know and I just want to leave it that way, I think it's better that way”.  Both 
Robert and Don in 2010 also made lengthy delays in telling their children: 
Extract 6.14 
I think, it was obvious I went in for the operation but I said, or we just said it 
was a man’s problem, you know, didn’t say it was cancer, and I remember I was 
I took her out for lunch and told her some time afterwards (....) She was 
pleased I didn’t tell her ((brief laugh)), cos I was able to tell her “I’m on the 
mend”, you know, “that’s it”, you know, I didn’t say I was cured, but “I’m on 
the mend and it’s been done, nothing to worry about”. (Robert, 2010) 
Extract 6.15 
I never told a soul except my wife, until I’d been to the specialist on [date], 
when he’d comforted me by telling me “it’s under control and you’re looking at 
a cure”, it was at that stage I could tell everybody but while I was still 
threatened with prostate cancer I didn’t want my daughter to know, I didn’t 
want her to be terrified, so she was kept in the dark throughout that year’s 
treatment.  (Don, 2010) 
Although Don did not mention that his daughter was particularly vulnerable, Robert’s 
daughter was pregnant and bipolar.  Both Don and Robert, though tentative in 
Robert’s case, drew upon a romantic genre of cure and recovery in their disclosures. 
 Thus, the above narratives demonstrate the negotiation between tragic and 
romantic genres in disclosing to ‘children and wider family’.  MWPCa sought to counter 
an implicit or explicit tragic genre in at least two ways: delaying their disclosure 
temporarily, significantly or permanently; and by indicating an optimistic treatment 
and recovery.  However, as with disclosures to ‘partners’, there were deviances to the 
negotiation from the tragic genre to a romantic one.  In contrast to an expectation of 
worry, two men in 2010 spoke of the lack of worry from their mothers: 
Extract 6.16 
My mother, ((laughs)) she said, “oh that’s what my old boss died off”, I said, 
“oh thank you mother, that’s very reassuring”, ((laughs)) she doesn’t believe 
I’ve got it really (...) She imagines that I’m you know, I’m going to be cured, if 
I’ve got it, it’s not that serious and I’m going to be cured any minute (…) I just 
laugh and say, “oh, if only” ((laughs)). (Quinn, 2010) 
Extract 6.17 
When I told my mother she was, she used to be a nurse, so she knew that it 
was recoverable, so she, I was surprised how well she took it, she wasn’t, she 
didn’t seem too worried. (Neil, 2010) 
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In different ways, both mothers drew upon a romantic genre of an optimistic 
treatment and recovery—both Quinn and Neil though expressed their surprise at the 
lack of worry showed.  Quinn told how he expected reassurance rather than disbelief 
that he had PCa.  His “oh, if only” demonstrates his work to renegotiate the optimistic 
“it’s not that serious and [he’s] going to be cured any minute” romantic genre choice 
of his mother into a tragic one.  Though not made explicit, one reason for this re-
negotiation might be to obtain the sympathy he originally expected. 
In sum, men interviewed in 2000 and 2010 disclosed similarly to ‘children and 
wider family’.  Like disclosures to ‘partners’, men anticipated a tragic genre of worry of 
this audience but sought to transform it with an optimistic treatment and recovery.  
What was different in disclosing to this audience than to ‘partners’ was that men often 
achieved this by delaying their disclosure—temporarily, significantly or permanently.  
Some men in 2010 though, like Charlie (2010) in his disclosure to his wife and 
daughters (Extract 6.7), did not receive the response of worry, or tragic genre, they 
expected but rather an optimistic expectation of a good treatment and recovery akin 
to a romantic genre. In one case this prompted further work by the MWPCa to re-
negotiate a tragic genre. 
6.4 Disclosing to ‘friends and others’ 
Unlike disclosures to ‘partners’ and ‘children and wider family’, MWPCa in 2000 and 
2010 did not talk about their expectation of worry from ‘friends and others’.  Similar 
numbers of men in 2000 and 2010 talked about receiving support from this audience.  
This support though was often alongside interactional difficulty as when Lawrence 
(2000) talked of how “when people know that you've got a cancer, there's always an 
awkwardness when they meet you for the first time having heard it”.  This 
“awkwardness” appeared to result from an uncertainty of which genre should be 
drawn upon in a disclosure conversation—for both the speaker and the hearer: 
Extract 6.18 
Interviewer:  Anybody you’ve chosen not to tell? 
Calvin: (….) No we didn't have any, any particular person we didn't tell.  I 
haven't, I haven’t gone up to people, sort of tapped them on the shoulder 
saying “Hey guess what I've got?” I haven't been in that sort of vein but when it 
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has cropped up in conversation, yes, I don't see any point in going around and 
saying what's happened unless it crops up, unless you're asked and then there's 
no hesitation.  But the support from people has been very, very good. The only, 
the only thing I find is that some people find it a little bit difficult in reacting to 
you.  You can be very positive about it and maybe they're not too sure what to 
say.  It's like in some ways I suppose when there's a bereavement, you know 
the person who's left very well and you find it a very difficult subject to broach 
because you don't know the attitude of the person.  You sometimes find the 
strange attitude in that direction and again you find that some people say “How 
are you?” you know wondering how your cancer is, and it's almost you know 
“You do look well”, and it's almost the sort of big surprise as to “Oh you're still 
with us!”  (Calvin, 2000) 
Calvin’s comparison between “bereavement” and his disclosure of PCa serves well to 
shed some narrative light on this “awkwardness”.  It suggests that talking about 
bereavement may be interactionally difficult, perhaps because one does not know 
whether the person bereaved will draw upon, for example, a tragic genre where death 
is “a futile struggle against the fates” (Smith, 2005: 26), or a romantic genre believing 
that some type of “change for the better is in the air” (p. 26). Until you “know the 
attitude of the person”, it is difficult to know what to say—or which genre to draw 
upon.  Likewise, when describing how ‘friends and others’ reacted to his PCa, Calvin 
seemed to recognise the work they were doing to establish just how good or bad his 
news was (Maynard, 2003)—moving between a romantic genre of “You do look well” 
and a tragic expectation of death.   This expectation of death reflected in the surprised 
“‘Oh, you’re still with us!’” and others not being “too sure what to say” was also 
indicated in 2010 when Alan told how people “just said ‘I'm very sorry to hear’, shook 
hands with me and all, and said, ‘sorry to hear, hope you’re alright in the future and 
the best of luck’”.  This combination of 'shaking hands', often done with bereaved 
relatives, and wishing Alan the best for the future presents a paradox; cancer as a 
‘living-dying’ experience’ (Muzzin et al., 1994: 1201).   
Though this paradox is well described in the literature, it is further complicated in 
this data.  Quinn and Charlie, both interviewed in 2010, demonstrated the intricacies 
of genre negotiation when they disclosed their PCa:   
Extract 6.19 
They don’t quite know how to approach the subject, you say, “oh I’ve got 
prostate cancer”, people say “oh well that’s quite curable now isn’t it, you just 
need an operation”, which is what I used to think, and you say, “well yes, in a 
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lot of cases yes, but some, where it’s, where it’s spread, it’s a bit more of a 
problem, and it can be un-, you know, it can be incurable.” (Quinn, 2010) 
Extract 6.20 
Interviewer:  So what about others, did you tell anybody else that you had 
prostate cancer? 
Charlie: I, have a very very wide social circle, and whilst many of them knew, 
they never conveyed to me neither sympathy or wanted to discuss the matter 
in fact one person with a medical background who I mentioned it to, and she 
didn’t know, she said, “well, they can treat these things can’t they”, and I 
thought well, “how’s that for sympathy” but then perhaps I wasn’t looking for 
sympathy, ((laughs)) I don’t want to paint it as a matter of fact experience but 
there was nothing really that stuck out as, in fact, to be honest with you, I was 
surprised that the general, the general reaction to it was as subdued as it was. 
Interviewer:  Right, why were you surprised? 
Charlie: Because here again, you, you turn on the television and you hear 
stories about, “oh and he heroically fought this” and all the rest of it, and there 
was great rejoicing all round that you’ve come out of it, somehow I never went 
in to that type of feeling, or mode, nobody’s ever said to me, “oh well done, 
because you’ve fought it, and you’ve won”, I don’t know whether I’ve won or 
not, it’s just, just one of those things perhaps they also know that my previous 
illness was more critical, and that, then there was considerable concern, but 
the fact that I came through it, maybe has conditioned their way of thinking, I 
don’t know, but then I will never go up to anybody and say, well, “what do you 
think about me being, having cancer”, it would seem a silly question to ask 
anyway, and I’m not so sure they would know how to reply ((laughs)). (Charlie, 
2010) 
Upon disclosure by Quinn and Charlie of their PCa, their audience advanced a 
surprising and unexpected, to Charlie and Quinn at least, romantic genre of an 
optimistic recovery where “you just need an operation” (Quinn) and “well, they can 
treat these things can’t they” (Charlie).  A disclosure of PCa did not then, for their 
audience, necessitate a tragic genre of suffering and potential death.  This genre was 
though ‘“at risk”’ (Bury, 2001: 279) in the disclosure interaction in different ways by 
these men. Though Quinn drew his audience’s attention to the appropriateness of a 
romantic genre in some circumstances, he also told them how, for his own case, a 
tragic genre might be better deployed.  Though Charlie did not explicitly renegotiate 
the romantic genre with his audience, his narrative demonstrates his work to explain 
to himself the discrepancy between the romantic genre he received and the tragic 
genre and sympathy he expected. 
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In contrast to the experience of Quinn and Charlie in 2010, more men in 2000 
than in 2010 told how cancer discredited men as those near death and to be pitied 
(though see Keith [2010] in Extract 6.21).   Eddie (2000) said it used to be “that if 
anyone got cancer it was a sort of goodnight nurse situation, but now I think we're 
having much more success with cures”.  David (2000) said that while “people didn’t 
like to ask”, he “didn’t mind telling people about it at all” and when playing bowls one 
day “it came up and I happened to tell somebody and he couldn't believe it ((laughs)) 
“You can't be, you look normal”, “well of course I look normal””. Harry (2000) said that 
“the main reaction to [his disclosure] was “Poor Harry” and that isn't me 
unfortunately.  I think I met it square on”.  This discrediting and pity continued even 
after men recovered: 
Extract 6.21 
When you mention the word cancer, it, it conjures up in people’s minds, you 
know, a certain thing, and so many people when they hear the word cancer, 
just think, you know, in terminal terms, so a lot of people just, I think, felt very 
sorry for me (...) people  still sort of think “well you know that fella has had 
cancer, you know, is he alright”, type thing, ((brief laugh)) but that’s, that’s just 
the way it is.  (Keith, 2010) 
Extract 6.22 
You mention cancer, people don't react very well to it they just clam up and 
don't talk about. I think prostate cancer is probably even more sensitive 
because it's that area which is personal, private and it's the area that you don’t 
generally talk about.  So having been diagnosed with prostate cancer I found it 
very difficult initially to talk about it. (….) It's not a matter of not admitting 
you've got cancer, it's knowing the reaction when you tell people.  And a 
certain, if you've got cancer, a certain number of people, probably a high 
percentage, will write you off, that's not because you're not going to recover 
but when you recover they say “Oh well yeah well he had cancer”.  Now it's not 
a final diagnosis in today's society because it's very curable and most cancer 
cases are cured, and it's long term cure.  But it's still difficult when you've been 
one of the people who's seen other people say “Oh I've got cancer”, and you 
always think the worst.  It's not very easy to then become one of the victims 
and to face it the same as you would if you'd be one of the people who were 
just viewing from afar.  It's a very difficult subject to talk about, I find it easier 
now to talk about it than I did initially, and I don't have the same 
embarrassment, (….) But it is still one of those subjects that people find, is 
taboo, you don’t speak about it. (Karl, 2000) 
Though such discrediting was not necessarily heard as ‘death’, it was still resisted as a 
tragic genre and was then ‘“at risk”’ (Bury, 2001: 279) in the disclosure negotiation. 
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MWPCa sought to counter the tragic genre with a romantic one of a hopeful 
overcoming of adversity (Smith, 2005). Karl was the only man, interviewed in either 
2000 or 2010, to speak about PCa explicitly as a taboo; this idea however is implicit in 
the talk of men in both periods, some making repeated reference.  Oliver (2000) told 
how men found it difficult to talk about anything to do with the prostate and Don 
(2010) how he and his golfing pals paid little attention to the disclosure of PCa by four 
other golf friends:  
Extract 6.23 
They won't talk about it because they're frightened that it's going to knock their 
macho image. (….) in America especially men are really keen on this big macho 
thing about being manly and the fact that, going back over the years, way, way 
back, right into Morecambe and Wise and that, you know, prostate has always 
been a subject for joke and humour, you know, men running off to the toilet 
and things like that.  (Oliver, 2000) 
Extract 6.24 
No it was a kind of an intimacy thing that people only make a quick reference 
to, and probably a couple of jokes would be floated to the prejudice of the 
sufferer, but there was never no discussion other than just a loose talk in terms 
of, “oh I must get a PSA” (Don, 2010) 
These narratives indicate the use of a comic genre (Bury, 2001) as that which involves 
mocking of the self or others (Kelly and Dickinson, 1997). Kelly and Dickinson (1997) 
argue that humour is a narrative device—used by a narrator—to lessen the suffering, 
create social distance from it and provide a practical cue for the listener to do likewise 
(p. 270).  In Don’s example it appears that it was the listeners who created social 
distance from the narrator and one reason for this might be to ease their own 
discomfort upon hearing of others’ PCa. Men across time also talked explicitly, often 
with several references, either about other’s embarrassment (Barry, 2000, Oscar 2010, 
Quinn, 2010) or their own (Karl, 2000).  Barry’s neighbour also had PCa and Barry 
compared his neighbour’s embarrassment and his own such lack saying “I think there's 
a lot of embarrassment, he's a tremendously fit person too and so, but I didn't feel the 
embarrassment, I don't know why but I didn’t” (Barry, 2010).  He went on to grapple 
with what ‘embarrassment’ might mean and also referred to humour: 
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Extract 6.25 
Barry: I don't know what this embarrassment is really.  I remember a guy 
talking to me who'd lost a testicle on something and he was deeply 
embarrassed about even mentioning that to anybody on earth you see.  But 
over a cup of tea we were talking about and the sort of relief you know came 
out of him, so I think, you know, why not, yeah.  It's as if it's caught up with the 
macho thing, probably, I don't know.   
Interviewer:  Have you ever felt that it sort of offends your sense of masculinity 
to talk about health problems or 
Barry: Not at this stage of life no.  I think it might've done earlier on but I don't 
think so.  But I think it could, for many men it could really yes, yeah and it 
becomes something of a joke perhaps I don't know. (Barry, 2000) 
Oscar (2010) also elaborated on the nature of embarrassment—and also perhaps the 
nature of comic genre—when he described the response of men witnessing ‘The Great 
Drag Race’, an event aiming to “drag [prostate cancer] into the limelight” (Oscar, 
2010).  Oscar dressed up in women’s wigs and clothing and gave leaflets about PCa 
symptoms and treatment to men in various public places including a Millwall football 
match:   
Extract 6.26 
it became very obvious that guys who would not talk to another man about 
embarrassing things like visits to the loo late at night, frequency, anything in 
the nether regions, in normal everyday clothes, they were quite open, if I was 
in a dress and a wig, very strange but we actually got mobbed by people, 
wanting to tell us about their, their problems, and that, that’s an interesting 
thing, I’ll have to look into the psychology of that, but I suppose it’s, “well if 
you’ll go that far, I’ll talk to you about it” (Oscar, 2010) 
Dressing in ‘drag’ then also potentially drew on a comic or an ironic genre where 
though the macho image was dramatically and visually mocked, it served to signal to 
those observing and talking to Oscar that the affront to their masculinity was not to be 
taken seriously (Kelly and Dickinson, 1997). 
Similar numbers of men in each time period talked about either themselves or 
others ‘keeping it quiet’.  Ralph (2000) had been “trying to keep it to myself” while Don 
(2010) went for “sixteen months and never told a soul” except his wife.  One potential 
reason for this was men’s reluctance to talk about health issues in general: 
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Extract 6.27 
Interviewer:  And why do you think men aren’t ((Graham laughs)) more open 
about it? 
Graham:  It’s probably the macho thing, you know that certainly in our culture 
men, men don’t cry, men don’t display any weakness, men are never 
vulnerable, they’re always the top dog, they’re always in charge, in control and 
in command, and, men’s issues in general, particularly health issues in general, 
I think men don’t go there, as readily, it’s probably, you know, it might be type 
casting to an extreme but I certainly, from a prostrate [sic] cancer point of view, 
hadn’t talked to anybody about it beforehand. (Graham: 2010) 
Graham (2010) drew upon what is normally considered to be a discourse of hegemonic 
masculinity (Connell and Messerschmidt, 2005; Courtenay, 2009).  It may be though 
that such a form of masculinity is a romantic genre where the actions of the hero 
overcome various adversities.  Such a genre is though also likely to be ‘at risk’ to the 
extent that men draw upon this form of masculinity. 
Hugh (2010) discussed how “prostate cancer and all that it entails is extremely 
sensitive and very close to the male psyche”.  He described being out socially with his 
brother and observing another man’s attempt to tell others about his PCa and his 
knowledge about how such stories are usually received by other men: 
Extract 6.28 
The only person in that particular group that knew I had had prostate cancer 
was my brother, and [brother] was very funny, he was actually watching me, to 
see how I was reacting to this guy telling his story.  Anyway, I just watched the 
behaviour.  They [the audience] didn’t want to hear (....) they interrupted or “so 
and so’s over there” ((reconstructing what this audience was doing and 
saying)).  The guy didn’t, I don’t think there was a single person in the group 
who heard the whole story.  The guy got telling his story but the group kept 
changing and looking away, they weren’t listening, they weren’t listening, [they 
had a closed] mind-set, “it’s not going to happen to me” ((reconstructing what 
may be the verbal or non-verbal indication of this audience)), not half. (....) And 
[brother] said, “Why didn’t you say anything”? And I said, “Well I knew what 
was going to happen”, I says, “I’ve seen it happen”. (Hugh, 2010) 
Though there was no indication by Hugh of the narrative elements of the other man’s 
disclosure of PCa, he observed important aspects of the hearers’ response.  The men in 
this audience interrupted the speaker; they did not listen; they not only looked away 
but also looked around for validating distractions that would excuse them from the 
conversation; and they indicated (at least non-verbally) that they did not expect PCa to 
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happen to them.  Though this cannot be explored more from my data, Hugh told how 
this was a familiar scenario.  It may then be indicative, in addition to the use of humour 
discussed above, of how men might create social distance from the suffering 
associated with PCa. 
There were seemingly ‘unsayable’ disclosures to ‘friends and others’ by MWPCa 
interviewed in each time period—by this I mean disclosures prefaced by one or more 
versions of ‘I’m not going to broadcast/promote/broach the fact that I’ve got prostate 
cancer’ and ‘you just can’t say ‘hello, I’ve got prostate cancer’’.  Seemingly ‘sayable’ 
disclosures, such as when men in each period told how ‘there’s nobody that I wouldn’t 
tell’, were sometimes combined with what was ‘unsayable’ as when Joe (2010) 
asserted: “no, there’s nobody that I wouldn’t tell, but, I just don’t bring it up really in 
conversation”.  Sometimes peripheral friends were not told as when Peter described 
how although he had told his close friends, “there have been other friends who I only 
see now and again, who I’ve simply not told”. PCa was “obviously a very personal 
thing” (e.g. Liam, 2010), potentially something “to hide” (e.g. Calvin, 2000 and Ivan, 
2010), and that some people are going to be “embarrassed if you tell them, sort of 
straight out”: 
Extract 6.29 
I wouldn’t sort of broach the subject, I’m more than willing to tell people all 
about it, but I’ve found that some people are embarrassed if you tell them, sort 
of straight out, and say, “how’re you doing?”, you know, “oh hello, how are 
you?”, I say, and you say, “well I’ve got incurable cancer”, and you think well, 
it’s a bit of a, not a way to sort of start a conversation is it, ((laughs)) but my 
wife would tell them, you know, “well don’t you know he’s got such and such”, 
and then they’ll say “oh well that’s not too bad is it, it’s curable”, and she’ll say, 
“well not in his case”.  (Quinn, 2010) 
Though this embarrassment, awkwardness and ‘unsayableness’ in interaction was 
described in both time periods, what was demonstrated as different in 2010, as Extract 
6.29 shows (see also Extract 6.19 and Extract 6.20), was that some men had to counter 
an unexpected romantic genre of recovery and cure with a tragic genre of PCa as an 
incurable condition.  In Quinn’s case above, his wife was also involved in this 
negotiation.   
In sum, unlike disclosures to ‘partners’ and ‘children and wider family’, MWPCa in 
2000 and 2010 did not talk about their expectation of worry from ‘friends and others’ 
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and there was no evidence of an imperative to disclose to ‘friends and others’.  Similar 
numbers of men in 2000 and 2010 talked about receiving support from this audience.  
This support though was often alongside interactional difficulty; difficulty more 
apparent to this audience than the audiences of ‘partners’ and ‘children and wider 
family’. Though there were similarities across time, there were also nuanced 
differences. Similar numbers of men in each time period talked about either 
themselves or others ‘keeping it quiet’ because of fear of damage to their macho 
image or their own or other’s embarrassment.  More men in 2000 than in 2010 told 
how PCa discredited men as near death and to be pitied—these men sought to 
counter this tragic genre with a romantic genre of recovery.  In contrast, more men in 
2010 than in 2000 told how they had to counter an unexpected romantic genre of 
recovery and renegotiate a tragic genre of PCa as an incurable condition.  Though the 
narrative elements mostly drawn upon in men’s disclosures to ‘friends and others’ 
were that of tragic and romantic genres, there was also evidence of use of a 
comic/ironic genre. 
6.5 Disclosing to ‘colleagues’ 
Different across time in disclosures to ‘colleagues’, was that more men in 2000 than in 
2010 spoke about receiving concern or support.  Finlay (2000) was “virtually” told: 
‘“Well go home and come back when you're ready’”.  Ralph’s (2000) colleagues were 
advised to treat him “as normal”:  
Extract 6.30 
Ralph: I also told them at work, they were very understanding at work.  I 
worked in [particular part of organisation], they held a meeting unknown to me 
that they were, I was to be treated as normal because there's no doubt about it 
you mention cancer to people and some people think you're, ((laughs)) you 
know you've sort of got the plague or something.  And though I worked 
amongst [particular staff] there was one or two, there was a few, more than 
one or two actually, who found it hard to talk to me about it.  But they had a 
meeting, the Head of the Department called a meeting which I found out later, 
that they were to treat me as normal. 
Interviewer:  Why do you think people find it so difficult to talk to cancer 
patients? 
Ralph: Fright, they don't actually understand the modern treatment and they 
think that’s the end. (Ralph, 2000) 
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The first response then of Ralph’s colleagues appeared to be to draw upon a tragic 
genre of an awareness of suffering and futile hope (Smith, 2005).  Negotiation with this 
genre began though before Ralph’s first interaction with his colleagues, through the 
meeting between the head of department and his colleagues, in the hope that he 
would be treated as normal.  His colleagues still though tended to give what Ralph 
perceived as unnecessary support: 
Extract 6.31 
Sometimes I found it, I found it at work ((laughs)) you know [the support] 
wasn't necessary, “You sure you can do this?” you know “are you sure you can 
do that?” And there was nothing wrong me with me you know nothing wrong 
with me at all except this prostate cancer which is inside you and is giving you 
no pain while I'm working. (Ralph, 2000) 
After receiving test results from his consultant three weeks after his diagnosis Finlay 
(2000) reconstructed a conversation with his work colleagues:  
Extract 6.32 
The only thing I heard [my consultant] saying, he was explaining all about the 
prostate cancer, but he said “It is contained”.  Now to me, it was just like saying 
you haven't got it and when I told them in work they were “Well you've still got 
cancer”, I said “yeah but it's contained”, it was like getting a, the only way I can 
explain it's like getting a second bite of the cherry, so I felt so relieved. (Finlay, 
2000) 
Finlay demonstrates how he drew on the romantic genre and the voice of his 
consultant to put forth the fundamentally optimistic romantic genre of a hoped for 
recovery.  This was though immediately renegotiated in his conversation with his 
colleagues. 
Only three men spoke of organising their workload—in a contingent narrative 
around the strategic management of illness (Bury, 2001); one man, Graham (2010) as 
an imperative in how he “had to let [the guys in work] know” (emphasis added) as he 
was going to be out of action for several months. Likewise, Harry (2000) wanted 
neither to ‘promote’ his PCa nor “frighten” anyone: 
Extract 6.33 
Interviewer: Was there anybody you chose not to tell about the cancer at that 
point? 
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Harry: No I'm not that kind of person, not that I want to involve other people to 
frighten other people but I believe personally that if you can talk freely about it, 
and talk to anyone within your family and your friends and even your work 
mates to say “well look this is the situation”, I can look back on all those 
aspects of the was that I dealt with it in not being promoting it in any form but 
saying to people “well look I won't be into work for the next couple of weeks”, 
or “I won't be refereeing this sort of game, or that sort of game”. (Harry, 2000) 
Men in 2010 discussed a variety of outcomes of disclosure to ‘colleagues’: having 
closer relationships; finding others relieved when they could disclose using a romantic 
optimistic genre; giving insights to others about PCa; and warning others.  Fred (2010) 
said “my colleagues at work were very supportive, which was great, in fact it probably 
led to me having sort of closer relationships with some of them than I had before 
really”.  To the extent that men gave insights to or warned their colleagues about PCa, 
it may be that they drew on a didactic genre (Miller et al., 1997; Bury, 2001) used to 
convey moral or social standards.  Joe’s (2010) purpose in disclosing to his first set of 
colleagues “was more to tell the other men that were there, you know, ‘don’t ignore 
this guys, have a think about it’”.  Graham (2010) used his disclosure to warn those “in 
a certain age group” that “the sooner you confront it and get on with it, the better, 
you know, the more likely you are to be around long term”.  Graham (2010) told  how 
being able to say “it’s solved, [I’m] cured” enabled his colleagues to approach him for 
insights into prostate cancer in particular, and death in general: 
Extract 6.34 
Everybody’s quite relieved when you can tell them that it’s solved, that you’re 
cured, and well I never had a conversation with anybody till I was able to say 
that, cos I think people maybe don’t want to go there, to contemplate what 
might be a horrible end, but having come through the thing successfully, I can 
think immediately of at least two guys who I had a more in depth conversation 
with, about what it was that led me there, why I thought I had it, and what had 
happened and what the consequences of it were, so obviously some of these 
guys are thinking about it, and are maybe glad of the opportunity to speak to 
somebody or somebody will talk to them about it (....) so there’s a few 
relationships like that which are probably different and deeper as a 
consequence of it, but the vast majority of people, just glad it’s over, and get 
on with life as normal, that includes family. (Graham, 2010) 
Although men did not often explicitly talk about delaying their disclosure to 
‘colleagues’, some men told how they limited details of their disclosure and other men 
told how they both delayed and limited their disclosure to work colleagues.  Nathan 
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(2000) again said that “the cat was out of the bag” when after telling a few people at 
work others also found out.  Joe (2010) told his colleagues after one meeting when 
“they were all in one room at the same time, and there weren’t any of the women 
present”.  While his colleagues appeared “slightly shocked, or taken aback, but 
appreciative more than anything” it was never “mentioned again”.  When asked if he 
also told his colleagues about the treatment side effects in his disclosure Joe replied:  
Extract 6.35 
No, not really, no I mean, I just keep it pretty light hearted to be honest, I don’t 
go into the details, I mean if they really wanted to know I would tell them, the 
conversation’s just never been in that much depth, I mean these are people 
that I know professionally rather than as friends. (Joe, 2010) 
At the time of his interview Joe had a different set of colleagues and said “I don’t 
actually know whether they know or not, I don’t have a problem with them knowing, 
but I don’t go out of my way to tell them about it”.  Keith (2010) delayed telling his 
work colleagues until the last few days before treatment as they: 
Extract 6.36 
didn’t need to know all those details until they needed to know, and you know 
really ((brief laugh)) I suppose if I could have went into hospital and got this 
matter dealt with, without actually telling anybody, I might have actually done 
it that way ((brief laugh)). (Keith, 2010) 
Two men chose to retire from work with one, Paul (2000), stressed from his work 
anyway, telling his managing director “immediately” before going on the “sick” until 
his due retirement; and Michael (2010), the only man to specifically talk about not 
telling his colleagues, said: 
Extract 6.37 
I didn’t really sort of tell people at work because I didn’t consider it was 
relevant to them anyway, and when I had the cancer confirmed at the end of 
the year I just said, “I’m not going back to work, I’m going to concentrate on 
getting this, getting through this” as such and I didn’t return to work at all. 
(Michael, 2010) 
In sum, there were differences over time in how men disclosed to ‘colleagues’.  When 
men disclosed in 2000 they mostly placed their disclosure in a context of receiving 
support or concern, organising the workload, and treatment and recovery.  The 
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disclosures of men in 2010 instead led to closer relationships, finding others relieved 
when men could put their disclosure positively, giving insights and warnings to others.   
6.6 Discussion 
In this chapter I have explored changes and differences in how MWPCa interviewed in 
2000 and 2010 disclose their condition to the audiences of ‘partners’, ‘children and 
wider family’, ‘friends and others’ and ‘colleagues’.  In addition I have considered the 
extent to which Bury’s (2001) insights into narrative form can explain the practical 
management of interactional issues in disclosing PCa to such audiences.  I asked: 1) are 
there differences in how MWPCa disclose their illness over time and to various 
audiences—especially given that changes in a tragic “taboo” genre suggest the 
potential for changes in interactional difficulty in disclosing PCa; and 2) what narrative 
forms and elements do MWPCa draw upon when disclosing their illness to these 
audiences. My analysis shows that though one might expect less interactional difficulty 
for MWPCa in disclosing their illness when a tragic genre of ‘taboo’ is ostensibly less 
available to draw upon, with some audiences this may not be the case.  It also 
demonstrates that, with some exceptions, the same narrative forms and elements 
occur across these audience types. 
MWPCa and their audiences across time demonstrated their use of narrative 
genre. There was no evidence to indicate that these genres were consciously drawn 
upon.  This corresponds then to the suggestion by Bury (2001) and Frank (2000) that 
when people tell stories of illness they do so by unconsciously drawing on culturally 
available genres ‘which allow and constrain what is said and how it is expressed’ (Bury, 
2001: 278).  The genres drawn upon were mostly tragic and romantic genres.  A tragic 
genre allows talk which suggests at least ‘a futile struggle against the fates’ (Smith, 
2005: 26), ‘an amplified awareness of suffering’ (p. 25) and ‘the inevitable failure of 
heroic action’ (p. 26).  A romantic genre—not necessarily about love—is instead 
‘fundamentally optimistic (…) marked by the belief that actions can make a difference 
and that change for the better is in the air’ (p.26).  The tragic genre most drawn upon 
in men’s disclosures of PCa was that of worry about potential suffering and death from 
PCa; the typically drawn upon romantic genre was that of an optimistic overcoming of 
the illness through treatment, recovery and cure. There was though also evidence of 
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comic/ironic (Kelly and Dickinson, 1997; Bury, 2001) and didactic genres (Miller et al., 
1997; Bury, 2001).  Comic/ironic genres were drawn upon when men, across time in 
their disclosures to ‘friends and others’, told how they or others drew upon some form 
of humour to widen or lessen social distance from the suffering associated with PCa.  
Didactic genres were used by men in 2010 to put forth a moral imperative to 
‘colleagues’ in warning them to pay attention to their health to increase their 
likelihood of being around long-term (Graham, 2010). 
When men were making their disclosures to the audiences of ‘partners’ and 
‘children and wider family’ they expected these audiences to draw upon a tragic genre 
of anticipated suffering and death.  Most often, men resisted this genre and instead 
put forth an optimistic outcome with treatment that would, for example, “sort the 
problem out” (Keith, 2010).  There was also evidence of one man drawing upon a 
tragic genre only for this to be renegotiated by his ‘partner’ to a romantic one which 
he then accepted.  On the whole though there was no difference across 2000 and 2010 
in the expectation of the tragic genre and its countering with a romantic genre in 
men’s disclosures to ‘partners’ and ‘children and wider family’.  There were though 
differences in the timeliness of the disclosure to these audiences and whether 
audiences did in actuality draw upon the tragic genre that the men expected them to.  
Though men, almost exclusively, made prompt disclosures to ‘partners’, they very 
often delayed—temporarily, significantly or permanently—to ‘children and wider 
family’, especially so if the family member was perceived as vulnerable; there was no 
difference across time.  There were though differences across time regarding whether 
these audiences did in fact draw upon the tragic genre expected by the men.  Instead 
of drawing upon a tragic genre, three men in 2010 talked about their surprise when 
their audience—the wife and children together for one man and the mothers of two 
other men—used a romantic genre of an optimistic good recovery.  In one case this 
prompted further work by the man to renegotiate a tragic genre. 
In contrast to ‘partners’ and ‘children and wider family’, MWPCa in 2000 and 2010 
did not talk about their expectation of worry from ‘friends and others’ or ‘colleagues’ 
and there was little evidence of an imperative to disclose to these audiences. Similar 
numbers of men in 2000 and 2010 talked about receiving support from ‘friends and 
others’ though this was often alongside interactional difficulty; difficulty not evident in 
men’s disclosures to ‘partners’ and ‘children and wider family’.  One consequence of 
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this “awkwardness” was that men found it “a very difficult subject to broach” (Calvin, 
2000) and their audience found it hard to respond to.  Though there were similarities 
across time, there were also nuanced differences in this “awkwardness”. Men, across 
time, similarly indicated that PCa was an illness about which they or others kept quiet 
because of fear of damage to their macho image or their own or others’ 
embarrassment.  Those who were not embarrassed often contrasted their openness to 
talk with that of their knowledge of others embarrassment and reluctance to talk.  
More men in 2000 than in 2010 told how PCa discredited men as near death and to be 
pitied—these men sought to counter this tragic genre with a romantic genre of 
recovery.  In contrast, more men in 2010 than in 2000 told how they had to counter an 
unexpected romantic genre of recovery and renegotiate a tragic genre involving PCa as 
an incurable condition.   
My findings suggest that disclosing PCa to ‘friends and others’ was at least as 
interactionally difficult for men interviewed in 2010 as it was for those in 2000.  This is 
the case despite indicatively optimistic evidence from Chapter 4  and Chapter 5: PCa as 
a “taboo disease that no one dares talk about” (Figure 4.4) was less frequently written 
about by journalists in 1990-2000 than in 2000-2010; and towards the end of the 
1990s PCa came out of the “shadows of neglect” (Extract 5.1) where men “would not 
talk about [their illness] (…) [and] would die quietly” (Extract 5.2).  These findings do 
though concur with Gray et al. (2000) when they note that ‘there is no evidence to 
suggest that concerns about stigmatization are unwarranted, despite recent, optimistic 
signs’ (p. 280).  The ‘optimistic signs’ to which they refer was the ‘dramatic shift in 
public awareness of prostate cancer within the last decade’ (p. 274), in their Canada 
context, and where ‘prostate cancer has ceased to be hidden to public gaze’ (p. 274)—
the same ostensibly optimistic situation in the UK at present.  
My findings demonstrate that genres were continually ‘“at risk”’ (Bury, 2001: 279) 
in men’s disclosure interactions with the various audiences—meaning that though a 
particular genre was drawn upon by one party in the disclosure interaction it was not 
necessarily accepted by another. That the genres were ‘at risk’ and negotiated 
throughout the disclosure interaction demonstrates the ‘co-authored’ (Williams, 1984: 
181) nature of these disclosures. This negotiation was most often shown when a tragic 
genre of potential suffering and death was drawn upon by an audience and this was 
renegotiated to a romantic genre of a cure and recovery by the MWPCa.  It was though 
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also demonstrated when an audience unexpectedly drew upon a romantic genre of 
cure and recovery and the MWPCa renegotiated into a tragic genre.  Such negotiation 
(Bury, 2001) is also understood as a ‘genre war’ (Smith, 2005: 28) where interactants 
compete over how to interpret aspects of reality.  Negotiation over aspects of reality is 
also common ground in the everyday business of actors around social movements 
(Benford and Snow, 2000) who strategically seek to make their messages ‘fit’ or 
resonate with their audiences’ understandings of reality (Williams, 2004).  Along 
similar lines, Maynard’s (2003) work suggests that participants in a news event, such as 
a disclosure of PCa, not only interactively establish just how good or bad the news is, 
but also may not always respond in accord with the genre drawn upon.   
As discussed above, my findings suggest that a romantic genre includes the 
triumph of the MWPCa over his illness through treatment, cure and recovery.  My 
findings though also hint at the possibility that some aspects of hegemonic masculinity 
(Connell and Messerschmidt, 2005; Courtenay, 2009) may also be called upon as a 
romantic genre where the “hero is motivated by high ideals and overcomes a series of 
obstacles, challenges and enemies” (Smith, 2005: 26). One aspect of hegemonic 
masculinity is stoicism, defined by the Oxford English Dictionary as ‘the endurance of 
pain or hardship without the display of feelings and without complaint’.  In my data 
Don (2010) ostentatiously displayed stoicism in his forbidding of his wife to either 
“start blubbing” or to ‘blurt’ out his PCa to anybody (Extract 6.5).  Maynard (2003) 
suggests though that a ‘stoic response [is] an interactional and not just psychological 
phenomenon.  Deliverers [of news] (...) sometimes intentionally, often inadvertently 
encourage stoicism on the part of their recipients’ (2003: 121).  Don’s wife, at least in 
how he told his story to me, seemed to collaborate with him in his stoicism and did not 
seek to renegotiate another genre.   
Though Don was unique in his blatant display of stoicism, my findings suggest that 
men across time used the romantic genre of a hopeful cure and recovery to transform 
the worry of the ‘partner’ and ‘children and wider family’ audiences over their 
potential suffering and death.  At least in the stories told to me, there was no evidence 
that these audiences sought to renegotiate back to a tragic genre, thus suggesting an 
ostensible mutual collaboration with the optimistic romantic genre.  Men’s use of this 
romantic genre in transforming the worry of these audiences may then, though less 
blatant than Don’s, be a display of stoicism with little change little over time.  
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I suggest that such a collaboration constitutes a performance of hegemonic 
masculinity (Connell and Messerschmidt, 2005; Courtenay, 2009) with all actors in the 
disclosure interaction collaborating in the construction of the MWPCa as having his 
illness under control with nothing to worry about. This finding is interesting because 
criticisms of the concept of hegemonic masculinity include its lack of attention to how 
masculinities change across the lifespan (Connell and Messerschmidt, 2005). While the 
plurality of masculinities available to a man may indeed change as he gets older, this 
finding shows that these men perform at least this aspect of hegemonic masculinity. 
However, such stoicism in the transformation of worry about suffering and death 
to an optimistic hoped for cure and recovery may not be limited to hegemonic 
masculinity.   Wilkinson and Kitzinger (2000) show how women with breast cancer are 
morally exhorted to ‘think positive’ to enable the disclosure and convenient ‘wrapping 
up’ (p. 803) of troubles telling and to relieve ‘listeners of a potential conversational 
burden’ (p. 805).  Thus, the findings here that across time men use the romantic genre 
of a hopeful cure and recovery to transform the worry of various audiences over 
potential suffering and death may indeed be a feature of broader culture in a 
hegemonic imperative for men and women to draw upon a romantic genre for the 
convenient ‘wrapping up’ (p.803) of ‘troubles’ such as disclosure of illness.  
 My findings also have implications for the healthy public face of PCa 
(Aronowitz, 2009).  PCa is being looked for harder than ever before (Welch et al., 2012) 
and as autopsy studies show PCa in the prostates of men as young as aged 20-29 
(Powell et al., 2010), it may be that ‘nearly every man may eventually develop [either 
clinically or non-clinically relevant] PCa’ (Weight et al., 2013: 1022).  Further, as the 
‘natural processes of ageing’ (Armstrong, 2010: 15) are increasingly ‘incorporated into 
a model of pathological disease’ (p. 16) it may be that the massive discrepancy 
between UK/GB incidence and mortality rates of PCa (Figure 1.1) will widen. If so, the 
relative proportion of those with a poor prognosis of PCa will decrease and its public 
face will become healthier (Aronowitz, 2009) potentially resulting in a ‘veneer of 
optimism’ (p. 436) put onto the identity of the expanded group of MWPCa.   
In describing how they disclosed their PCa to audiences of ‘partners’, ‘children 
and wider family’ and ‘friends and others’, some men in 2010 talked about their 
surprise that these audiences did not draw upon the tragic genre of likely suffering and 
death.  Instead audiences drew on a romantic genre of cure and recovery such as “oh 
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well that’s not too bad is it, it’s curable” (Quinn, 2010 in Extract 6.29).  One 
interpretation of such a response could be that these audiences were being supportive 
and encouraging to the man by allowing him to understand his illness through an 
optimistic recovery genre. However, examining the response of the men to this 
disruption of their normative expectation indicates another interpretation.  The 
response to this could be a tentative acceptance of this romantic genre (Neil, 2010 in 
Extract 6.17); an introspective coming to terms with the genre discrepancy (Charlie, 
2010 in Extract 6.20); or a renegotiation back to a tragic genre as in  “well yes, in a lot 
of cases yes, but some, where it’s, where it’s spread, it’s a bit more of a problem, and it 
can be un-, you know, it can be incurable” (Quinn, 2010, in Extract 6.19).  The response 
of these men demonstrated instead the interactional implications of this for an 
increasingly healthy face of PCa. 
Finally, and in conclusion, my findings also have something to say about the links 
which may be drawn between narratives expressed publically in the media and by 
PCaOrgs and those drawn upon in research interview.  Philo (2008: 542) argues that 
‘patterns of belief and understanding can be traced to [elite media producers]’.  This 
optimistically indicates that one might expect less interactional difficulty for MWPCa in 
disclosing their illness when a tragic genre of ‘taboo’ appears less publically available 
to draw upon.  Critically though, this optimistic indication appeared in my study not to 
have the effect that it might predict as my findings imply that with some audiences this 
was often not the case.  My findings thus do not confer with Philo’s contention against 
the trend to seriously neglect media power in favour of the power of a reflective 
resisting audience.   
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 Discussion Chapter 7
7.1 Introduction 
The concern of this thesis was to ask how PCaOrgs and the UK print media have been a 
force for change in the UK regarding how PCa has been addressed and experienced by 
men with this condition.  To answer this question I investigated a variety of narratives: 
narratives about illness to explore how key individuals within PCaOrgs describe how 
they sought to address PCa; illness narratives of MWPCa in the UK national print media 
for changes in the representation of the illness experience of such men since the 
emergence of PCaOrgs in the UK in the mid-1990s; and illness narratives of MWPCa in 
research interviews in 2000 and 2010 to explore how they described their illness 
experience over this time.  I proceed now to summarise my findings from Chapter 4, 
Chapter 5 and Chapter 6 and to discuss how they concur with or differ from those 
available in the existing literature.  I show how my analysis demonstrates the recursive 
nature of social practices common to both individual actors and social structures 
across space and time (Giddens, 1984).  Language practices around PCa are not 
brought into being by those concerned with PCa but rather are ‘continually recreated’ 
(p. 2) from already existing pre-patterned language (Tannen, 2007).  I try and show 
how the concept of ‘interest’, composed of comprehensibility and novelty (Silvia, 
2008)—or resonance and dissonance—can add to an understanding of this recursive 
recreation of language. 
7.2 Summary of findings 
1. Stories of injustice around PCa that come and go: from PCa as a 
‘neglected’ disease in 1990-2000 to one where other ‘pockets of 
injustice’ are found in 2000-2010  
 
1.1. Stories of the neglect of PCa in UK national print media 1990-2000 regarding 
its ‘derisory’ and ‘scandalous’ funding and  ‘Cinderella’ status when compared 
with other diseases (Chapter 4) 
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1.2. Stories of the ‘disgraceful’ and ‘unacceptable’ funding for treatment for PCa 
and the ‘debilitating’ side effects in the UK national print media 2000-2010 
(Chapter 4) 
1.3. Historical stories of the neglect of PCa up to around 2000 narrated by 
advocates around PCaOrgs (Chapter 5) 
1.4. Contemporary stories of neglect of PCa for some audiences narrated by 
advocates around PCaOrgs (Chapter 5) 
1.5. Stories of other ‘pockets of injustice’ around PCa around 2010 narrated by 
advocates around PCaOrgs (Chapter 5)  
 
The analysis of media illness narratives of MWPCa in Chapter 4 demonstrated that 
when journalists wrote about the illness experience of MWPCa in 1990-2000 they used 
certain words more frequently than in 2000-2010 to tell a story of PCa as a neglected 
‘Cinderella’ disease when compared with breast cancer, AIDS and heart disease.  Many 
of these words were in the context of an appeal by the Daily Mail to raise £1million to 
“rectify [the] scandalous situation” of the “derisory” £47,000 of funding that PCa 
received compared to other illnesses.  Other emotive words included ‘appalling’ and 
‘epidemic’.  This neglect was mostly gender-based although there were ageist 
elements.  Blame for this neglect was distributed across: men themselves as those 
stereotypically “suffering in silence”; a society which placed little value on the lives and 
deaths of men; the medical profession; and government.  In contrast, when journalists 
were writing about the illness experience of MWPCa in 2000-2010 they used words 
more frequently which told about the “disgraceful” and “unacceptable” injustices 
around funding for brachytherapy, a treatment for PCa and the “debilitating” side-
effects of hormone treatment and prostatectomy resulting in severe physical and 
financial costs for MWPC.  Unlike in 1990-2000 where concern was only for the risks of 
impotence and incontinence post-prostatectomy, in 2000-2010 there was also a focus 
on the feminising side-effects of hormone drugs.     
The analysis of the narratives about PCa by advocates around PCaOrgs in Chapter 5 
shows how the story of gender-based ‘neglect’, already successfully used in the early 
1990s by breast cancer movement activists in the US, was used in the late 1990s when 
actors around PCa in the UK did not know “what to do in those days” (Extract 5.2).  
Elements of the neglect story still continue to be told to contemporary audiences—
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when opposing “vested” interests and when capturing the interest of the “man in the 
street” or the “family”.  Critically, however, to at least the media audience, the efficacy 
of the neglect story came and went and it no longer worked as a story.  Advocates 
around PCaOrgs then sought to shift the story of PCa from one of a “legacy of neglect” 
to “other pockets of injustice” in their contemporary messaging around PCa.  Such 
‘pockets’ include ‘postcode’ inequalities around mortality rates and support, socio-
economic inequalities in awareness, and age inequalities.   
 
2. Stories of ‘taboo’ around PCa in the UK national print media 1990-2000 
The analysis of media illness narratives in Chapter 4 demonstrated that PCa as a 
“taboo” disease that “no one dares talk about” and about which men kept quiet was 
more explicitly and frequently articulated in the UK national print media in 1990-2000 
than 2000-2010.  Raising awareness was proposed as a solution to this problem with 
particular actants identified both as culpable for this problem and also as those who 
ought to address it including: “every woman who loves a man” and the “we [who] will 
stop making prostate cancer a taboo subject”.  Though journalists did not use the word 
‘taboo’ at all when writing about the illness experience of MWPCa in 2000-2010, PCa 
remained—though to a much lesser extent—an illness which men found difficult to 
talk about.   
 
3. Stories of ‘problematic old waterworks’  
The analysis of the media illness narratives in Chapter 4 demonstrated that words 
around symptoms were used significantly more frequently by journalists in 1990-2000 
than 2000-2010 when writing about the illness experience of MWPCa.  Urinary 
symptoms were those symptoms most frequently articulated and these were 
predominantly frequent/nocturnal/intermittent urination—lower urinary tract 
symptoms (LUTS)—followed by blood in the urine.  Particular phrases included 
“difficulty passing water” and having problems with “the old waterworks”.  MWPCa in 
both 1990-2000 and 2000-2010 were more frequently articulated as having no 
symptoms rather than experiencing symptoms—though men’s narratives showed their 
understanding that LUTS were symptoms of PCa.  The PSA test was often spoken about 
when describing symptoms and described in both periods as helpful in detecting PCa in 
men with no symptoms.   
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4. Stories of young men as at risk from PCa  
The analysis of the media illness narratives in Chapter 4 demonstrated how young men 
were more frequently articulated as being at risk of PCa in 1990-2000 than in 2000-
2010.  This included phrases like:  “Young people like me aren't meant to suffer (...) I 
thought it was something that affected only elderly men. Men in their 40s don't expect 
this to happen to them” (Daily Mail, 03/11/1999, Extract 4.24).  In addition, men in 
1990-2000 were sometimes given a familial identity such as being a brother or a 
father; having a wife; or having older children or grandchildren.  Although significantly 
less frequently articulated as ‘young’ in 2000-2010, there were qualitative similarities 
in each time period with men in 2000-2010 described as much younger: “[PCa] hit me 
at 37 and now I'm living on borrowed time” (Daily Mail, 17/05/2005).  This, as in 1990-
2000, was often in the context of PCa being “just an old man’s disease”.  As in 1990-
2000, men were also placed in a familial setting with having older children and 
grandchildren—though they were more likely to be described as “young family men” 
and as having ‘young children/daughter/kids’ themselves.   
 
5. Stories of socio-economic inequalities in awareness: men as informed, 
misinformed, or uninformed 
The analysis of the narratives about PCa by advocates around PCaOrgs in Chapter 5 
showed how contending stories of men’s level of awareness ostensibly related to their 
socio-economic status; MWPCa may be “a healthy bunch of men (...) [who have] made 
it in their career (...) better able to advocate for themselves (...) [and] in a better 
position to stand up and say, you know, “I’ve got prostate cancer, and here’s what it 
means, and here’s the treatment I want”” (Extract 5.16); they may be uninformed and 
victims of prior neglect in need of someone to fight the “good fight for prostate 
cancer” (Extract 5.17); or they may be misinformed and persuaded that natural 
processes of ageing such as LUTS  are symptoms of PCa. 
 
 
Findings 1 and 2 above directed the analytic enquiry for Chapter 6: Given that PCa as a 
“taboo disease” was more frequently articulated in the media illness narratives of 
MWPCa in 1990-2000 than 2000-2010 (Chapter 4) and that PCa came “out of the 
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shadows of neglect” where men “would not talk about it (…) [but] die quietly”, 
towards the end of the 1990s (Chapter 5), were there differences in how MWPCa 
disclosed their illness over time to various audiences? 
 
6. Stories of overcoming suffering and death with an optimistic cure and 
recovery  
Men in 2000 and 2010 demonstrated a normative expectation that their various 
audiences would draw upon a ‘tragic’ genre of worry or concern about the likely 
suffering and dying of the MWPCa.  Men though either pre-empted or responded to 
this by drawing upon a ‘romantic’ genre of an optimistic outcome for treatment and 
cure that would “sort the problem out”. Though there was some evidence of men 
themselves drawing upon a tragic genre in initial disclosures to ‘partners,’ this was 
countered by a romantic genre by their ‘partner’.   In contrast to ‘partners’ and 
‘children and wider family’, though MWPCa in 2000 and 2010 did not talk about their 
expectation of worry from ‘friends and others’ or ‘colleagues’, they still expected a 
tragic genre of suffering and potential death to be drawn upon.  There was little 
evidence of an imperative to disclose to these audiences.  
 
7. Stories of prompt and delayed disclosures 
Though men almost exclusively, made prompt disclosures to ‘partners’, they very often 
delayed disclosing to ‘children and wider family’, especially if they perceived them as 
vulnerable. There was little explicit talk about delaying to other audiences. 
 
8. Stories of unexpected drawing on a romantic genre 
More men in 2000 than 2010 told how disclosing their PCa to ‘friends and others’ 
discredited them as near death and to be pitied and how they subsequently sought to 
counter this ‘tragic’ genre with a ‘romantic’ genre of recovery.  However, in 2000-2010 
some ‘partners’, ‘children and wider family’ and ‘friends and others’ surprisingly did 
not in fact draw upon the ‘tragic’ genre expected by the men and instead drew upon a 
‘romantic’ genre of an optimistic good recovery.  In some cases this prompted further 
work by the man to renegotiate a tragic genre involving PCa as an incurable condition.   
 
9. Stories of interactional difficulty across time 
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Men across time talked about receiving support from ‘friends and others’ though this 
was often alongside interactional difficulty. This meant “awkwardness” in disclosing 
with men finding it “a very difficult subject to broach” (Calvin, 2000) and their 
audience finding it hard to respond to.  Men, across time indicated that PCa was an 
illness about which they or others kept quiet because of fear of damage to their macho 
image or their own or other’s embarrassment.   
7.3 Resonance and dissonance in the changing 
narratives of prostate cancer 1990-2010 
The trouble with words is that you never know whose mouths they have been 
in. (Dennis Potter n.d.) 
The stories around PCa conveyed in my findings show attention to both the content 
and form of narratives around PCa which were generated through sampling the UK 
national print media from 1990-2010 and interviews with advocates around PCaOrgs in 
2010 and MWPCa in 2000 and 2010.  My findings show that, akin to the words of the 
dramatist Denis Potter in the above epigraph, language around PCa was an 
‘accumulation of prior texts’ (Tannen, 2007: 49, 103) involving taking, or ‘snatching’ 
(Steinberg, 1999: 772), words which existed ‘in other people’s mouths, in other 
people’s contexts, serving other people’s intentions’ (Bakhtin, 1981: 294), to make 
them serve intentions in a PCa context.  The following discussion shows how my 
findings confer with or differ from those available in the existing literature. I propose 
that the PCa stories evident in my findings were not brought into being by those 
concerned with PCa but rather ‘continually recreated’ (Giddens, 1984: 2) from already 
existing pre-patterned language (Tannen, 2007).    
A common feature of the content of narratives from the UK print media and 
advocates around PCa–Orgs was the importance of injustice and how the substantive 
focus of this injustice changed over time. My findings show that when writing about 
the illness experience of MWPCa in 1990-2000, journalists told how PCa was neglected 
in comparison with other diseases and how it was a ‘taboo’ disease which men and 
others found difficult to talk about.  Likewise, my findings from the analysis of the 
narratives of PCa by advocates around PCaOrgs demonstrate how telling the story of 
PCa as a “neglected disease” hidden in the “shadows” and about which “something 
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needed to be done”, was one which effected action in the late 1990s, shortly after the 
emergence of the first PCaOrgs into the UK.  This action was achieved not only through 
the Daily Mail campaign in 1999 to raise money but also by the “general stirring of 
realisation in government and NHS circles and in the media” (Extract 5.1), which led to 
the publication of the NHS Prostate Cancer Programme (NHS, 2000).   
The drawing upon of a narrative of injustice by advocates around PCaOrgs is 
unsurprising given that injustice, as a ‘hot’ emotion (Gamson 1992: 7), has been used 
as ‘leaven’ (Turner, 1969: 399) for social change by all social movements in each main 
historical era (Turner, 1969; Snow, 2004).  But why did the neglect story effect such 
action back in the late 1990s?  One potential answer is that in a ‘world of narrative, 
[where] very little is ever new’ (Frank, 2010: 123), actors around PCaOrgs were able to 
draw upon a pre-patterned (Tannen, 2007) way of talking, or genre (see for example 
Bury, 2001), already familiar to their audiences, at least one of which included the UK 
print media.     
 The ‘neglect’ story in the form of a ‘gender equity frame’ was one of three 
interconnecting culturally relevant stories around ‘family’ and ‘fairness’ successfully 
used in the early 1990s, when breast cancer movement activists in the USA defined 
breast cancer not as a problem of access to screening and treatment but as one of 
gender-based institutional neglect (Kolker, 2004).  This frame was easily mobilised by 
breast cancer activists not only because of its prior use in the women’s movement and 
women’s health movement but also because of the familiarity of the equity story to 
audiences through its use in other movements.  Breast cancer as an ‘epidemic’, with 
unacceptable rates of incidence in the young and old, was the second frame used by 
breast cancer advocates in the US. Kolker (2004) shows that though the epidemic 
frame lacked validity, it was still viable as it ‘resonated strongly with both 
Congressional and public audiences’ (2004: 827) through its prior use by the US media 
in the 1980s.  The analysis of media narratives (Chapter 4) also showed how PCa was 
tentatively framed as an ‘epidemic’ in the UK print media in 1990-2000 and not at all in 
2000-2010.  The analysis of the media narratives also demonstrated that stories of 
‘problematic old waterworks’ were used more frequently in 1990-2000 than in 2000-
2010.  The sheer number of men who experience LUTS as they age means that they are 
present in 50% of men aged over 60 and nearly 100% of men aged 90 (Weight, 2013).   
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This decrease in frequency of LUTS mentions across time may be due to evidence that 
LUTS are not indicative of PCa (Collin et al., 2008), though as Kolker (2004) shows, a 
lack of validity does not necessarily lessen viability.   
 In addition to the public construction of breast cancer as an epidemic and as 
subject to governmental neglect, family-based identities of wives and mothers were 
added to breast cancer sufferers in the USA.  This meant that breast cancer was not 
only a threat to women but also to American families and so ‘the pool of victims 
impacted by the disease expanded significantly to include the entire family’ (Kolker 
2004: 831). Chapter 4 and Chapter 5 showed also how a ‘family’ story was used around 
PCa in the UK print media and by advocates around PCa; potentially then also 
increasing the pool of victims impacted by this illness. 
Thus in the UK, advocates around PCaOrgs and journalists writing about the 
illness experience of MWPCa in print media were able to ‘peer into the actions and 
histor[y]’ (Steinberg 1999: 752) of breast cancer activism and ‘borrow’ its discourse in 
order ‘to articulate identities, grievances, and goals where there [were] gaps and 
silence in the [PCa] discursive field’ (p. 752).  This ‘trafficking and transferring’ (p. 752) 
of the neglect story may be understood by first considering that the possibilities for 
changing ways of understanding are limited and that the messages of new social 
movements must make sense in terms of the existing ways of understanding (Lakoff 
2010: 72).  It demonstrates a useful consequence of social movement ‘spillover’ 
(Meyer and Whittier, 1994)—new movement actors align their messages with what 
they know is already familiar to, or resonant with, their potential audiences through 
the messages of some other social movement.  Resonant language ‘fits’ or ‘rings true’ 
in some way with audiences’ already existing beliefs, values, ideologies or experiences 
(Williams, 2004: 105) and its achievement is considered to be ‘“half the battle”’ 
(Berbrier 1998: 432) in legitimising new ideas.  Viewing the story of ‘neglect’ as 
culturally resonant begins to explain why the ‘neglect’ story from the breast cancer 
movement was used to influence the illness sufferers and other attentive audiences 
around PCa in the UK.   
One of the audiences of PCaOrgs was the UK print media and notable in my 
findings was how the stories journalists told in 1990-2000 and 2000-2010 about the 
illness experience of MWPCa corresponded to those told by advocates around 
PCaOrgs.  Kedrowski and Sarow (2007), in their study of PCa and breast cancer activism 
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in the USA, are concerned with what interests ‘the masses’ (p. 165) and also, by 
extension, with what interests the media as a means of access to these masses.   For 
both the ‘media’ and the ‘masses’ to be interested in an event, they need to evaluate it 
as familiar and comprehensible (Silvia, 2008).  The repetition of the gender-based 
neglect story from its prior use by breast cancer activists in the USA (Kolker, 2004) 
provided familiarity for the media.  This was in the form of a media template where 
meaning could be (re)constructed over time, retrospectively making salient aspects of 
past problems to explain current events (Kitzinger, 2000).  Such reconstruction of 
meaning from repeated texts is suggested as routine by Tannen (2007) and Bakhtin 
(1981)—repetition of prior texts then may then be instrumental for achieving 
resonance. 
Though print media was an audience for the messages of PCaOrgs, print media 
had its own audiences to be concerned with.  Familiarity for media audiences was also 
provided by the repetition of a ‘Derisory £47,000 PCa Spend’ (Extract 4.1) ‘boilerplate’ 
(Cotter, 2010: 171), which was, to varying extents, often included as context for the 
illness narrative of MWPCa by journalists writing in 1990-2000.  This boilerplate 
repeated the figure “47,000” as the “derisory” or “pitiful” amount of money spent by 
the UK government on PCa “last year”, in terms suggesting it was very limited—“just”, 
“but only” and “yet only”. Although a boilerplate is ‘seemingly throwaway material 
(....) repetitious, unattributed (...) and is potentially expendable as text (....) its role in 
framing a news story may also end up influencing public debate’ (p. 171).  Such 
influence was seen in the “lot of fuss in the Houses of Parliament about the amount of 
money spent on prostate cancer research compared to breast cancer research” 
(Extract 5.5) when “the Department of Health made, I think made a big effort to listen 
to the story about men versus women” (Extract 5.5). 
However, although resonance is considered to be ‘“half the battle”’ (Berbrier 
1998: 432) in legitimising new ideas, it is also considered to be ‘only half the story’ 
(Ferree, 2004: 306).  A story, argues Polletta (2006), that is ‘entirely predictable (…) [is] 
no story at all (p. 10).  And so, I suggest, the success of the ‘neglect’ story in effecting 
action cannot be explained solely by its familiar elements.   ‘Interesting’ stories also 
need to be ‘new, unexpected, complex, hard to process, surprising, mysterious or 
obscure’ (Silvia, 2008: 58). ‘Interest’ is thus composed of both comprehensibility (or 
familiarity) and novelty elements (Silvia, 2008)—elements which are also important for 
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other knowledge related emotions such as boredom and confusion.  If an event is 
novel and comprehensible, it is interesting; if novel and incomprehensible, it is 
confusing; but if it is comprehensible and not novel, it is boring. The extent to which 
the ‘neglect’ story was successful in effecting action, I suggest, lay also in the extent to 
which this familiar language was inflected with novel elements (Steinberg, 1999) and 
whether it was considered interesting, confusing or boring.  
There were several ways in which the familiar gender-based neglect story was 
combined with novel elements: it was familiar as it had previously been used by breast 
cancer activists in 1990s; it was novel as men rather than women were neglected—this 
particular novelty also was familiar as it was gender-based as with its use in the breast 
cancer context; it was familiar as it articulated hegemonic discourses about men’s 
passive health behaviour; it was novel as it contrasted the silence of men with the 
noise of women; it was novel as it broadened the constituency of blameworthy agents 
from government to all society. 
The requirement for the familiar to be combined with novelty—or resonance and 
dissonance—in the ‘neglect’ story of PCa indicates how media and social movement 
actors ‘“twitch” the [familiar] plot from time to time in order to retain audiences’ 
interest (...) [and] provide an entertaining disruption of expectations’ (Seale 2002: 36 
emphasis added).  However, and critically, though the gender-based ‘neglect’ story 
with a PCa ‘twitch’ worked because it combined familiarity with unpredictability 
(Polletta, 2006; Silvia, 2008)—the ‘half battle’ (Berbrier, 1998) and the ‘half story’ 
(Ferree, 2003)—over time it too became overly familiar and was no longer seen as a 
“universally true story” (Extract 5.6).  Why was this?  As the ‘twitched’ plot becomes 
the norm, Seale (2002) argues, there is a continuing—indeed chronic—need for 
twitching’ (p. 36).  This helps to explain the shift of stories from injustice around the 
funding and neglect of PCa in the media and advocates around PCa analysis to injustice 
around treatment from 2000.  
Finally, the findings in Chapter 6 demonstrated the ‘dialogic’ nature of talk by 
participants in both time periods—MWPCa in some way repeating, or reconstructing, 
familiar voices from past conversations with others about all sorts of issues related to 
PCa.  These voices were often of those present at the disclosure dialogue, for example, 
the MWPCa, their partners, children or other family member as in the voices of Finlay 
(2000) and his youngest daughter: “‘Oh you'll be alright dad’, (....) I got back my bubbly 
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self and said ‘Well I'm going in for an op, that's it and they're going to fix me”’.  They 
also included the voices of others such as the consultant of the MWPCa: ‘“but listen, 
this, this should be okay, the consultant has told me, ‘removal of the prostrate [sic] will 
sort the problem out’”’ (Keith 2010).  Bakhtin suggests that ‘sooner or later what is 
heard and actively understood will find its response in the subsequent speech or 
behaviour of the listener’ (1986: 69).  While this may be so, the work of Bakhtin, and 
Tannen who argues that ‘one cannot speak another’s words and have them remain 
primarily the other’s words’ (2007: 104) (see also Steinberg, 1999), also suggest that 
these MWPCa may take the words which existed in others’ mouths and make them 
serve their own intention in their own context.    
This reconstruction of voices demonstrated how the ‘private’ voice of MWPCa 
may combine with other voices.  These other voices may be ‘collective’ such as that 
offered by the media or accepted as ‘common sense’.  Or they may be another 
‘private’ voice such as that offered by a medical professional, a partner, child, or 
friend.  When people reconstruct the voices of others they provide evidence not only 
of what they have actively heard from past conversations, and which is resonant, or 
‘rings true’, with their experience, but also how they want those words to be heard in 
the present conversation (Bakhtin 1981; Volosinov 1986; Tannen 2007).    
Volosinov suggests that the reconstruction of voices constitutes an ‘objective 
document’ (1986: 117) of the reception and manipulation of another’s speech by an 
individual speaker.  Learning to decipher such a document provides information not on 
‘subjective psychological processes (...) but about steadfast social tendencies in an 
active reception of other speakers’ speech’ (p. 117).  I did not attempt such a 
deciphering of the dialogic content of men’s talk; I do though recognise its existence 
and propose its relevance in understanding how public narratives may combine with 
private narratives. To borrow the language of Medvedev and Bakhtin; men’s 
experience of disclosing PCa is ‘not within [them], but between [them]’ (1978: 8) and 
society.  Of note also are not only voices heard in men’s dialogic reproduction of their 
experience, but also ‘missing’ voices of concern: “you turn on the television and you 
hear stories about, ‘oh and he heroically fought this’ and all the rest of it, and there 
was great rejoicing all round that you’ve come out of it (...) nobody’s ever said to me, 
‘oh well done, because you’ve fought it, and you’ve won’” (Charlie, 2010).  Though 
‘missing’, these voices were still expected and orientated to. 
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7.4 Conclusion 
In conclusion, how narratives of PCa were constructed depended on what other 
narratives were available to borrow and these included those around breast cancer in 
the early 1990s (Kolker, 2004).  This corresponds to previous studies in the illness 
narrative literature indicating that when people tell stories of illness they 
unconsciously draw on familiar culturally available core narratives (Bury, 2001; Frank, 
2000), or ‘‘genres of expression’ (Bury and Monaghan, 2013a: 81), in the implicit 
expectation that their intended audience does likewise. Notably, and differing from 
what might be expected from this existing literature, my analysis shows that in 
addition to the familiarity aspects that genres provide, narratives need to include novel 
elements in order to work as a story (Polletta, 2006; Silvia, 2008).  My study shows that 
what counted as novel in the different narratives reflected temporal interpretations of 
what counted as interesting.  Rather than a single narrative of neglect, rather more 
complex and interrelated stories of injustice emerged from my study.  Neglect, though 
sufficient as guerrilla warfare (Smith, 2005: p.9) to win the battle to effect action for 
PCa in the late 1990s, was not necessarily the artillery needed to win a war (p.9). What 
mattered was the bigger story of injustice and how this could be ‘twitched’ (Seale, 
2002: 36) to suit the contemporary context and interests. 
There is a strategic necessity by actors around PCaOrgs to construct PCa 
messages in language which ‘fits’, ‘rings true’ or resonates with existing cultural ideas.  
I propose that there has been a combination of resonance and dissonance in the 
language around PCa from 1990-2010 which resulted in an ‘entertaining disruption of 
expectations’ (Seale 2002: 36) to the various PCa audiences.  This combined the 
familiar and the strange in a way which not only ‘sticks in the mind because it 
references the expected but also because it makes some new connection through and 
beyond those categories’ (Bell 2011: 40-41).  This, I suggest, demonstrates the 
recursiveness and self-reproducing discourses inherent in human social practices 
(Giddens, 1984). 
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 Conclusion Chapter 8
8.1 Introduction 
This thesis addresses the distinct lack of UK studies of print media representation of 
PCa, of health social movement (HSM) activity around PCa, the interaction between 
the two, and how any of this may impact on the experience of MWPCa.  In this thesis I 
have asked how PCaOrgs and the UK print media have been a force for change in the 
UK regarding how PCa has been addressed and experienced by MWPCa.  I have 
investigated: 1) how key individuals within PCaOrgs described how they sought to 
address the condition of PCa; 2) changes in how MWPCa described their illness 
experience in research interviews over this time; and 3) changes in how the UK 
national print media has represented the illness experience of MWPCa from the 
emergence of PCaOrgs into the UK in the mid-1990s.   In this final chapter I discuss the 
limitations of the study, propose some potential avenues for future research and 
indicate potential implications for MWPCa and for PCaOrgs and for professional 
sociology.   
8.2 Limitations  
My study has a number of limitations.  Sampling of the public representation of PCa 
was limited as I did not sample NHS or government health policy documents regarding 
PCa or web or hard document representations from PCaOrgs.  This limitation was 
justified by the need to avoid data overload (§3.2).  Sampling of the UK print media 
was also limited.  Only those newspapers fully uploaded to Nexis in 1990-1995 
(§3.4.1.1.1) were sampled as searching hard copy indices of the media was too time-
consuming (Brown et al., 2001).  The impact of the potential loss of data is described in 
§3.4.1.1.2.  Additionally, the media sample was limited in that only those articles which 
were predominantly illness narratives of MWPCa were included (§3.4.1.1.3).  However, 
many of the excluded articles may have been ‘peripheral’ articles of little consequence 
for the research enquiry (see Halpin et al. 2007).  Sampling of the media was also 
limited in that there was no mention of ‘Movember’ despite the first ‘Movember’ 
article occurring in November 2006.  Movember, a global campaign launched in the UK 
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in 2007, asks men to grow moustaches in November to raise money and awareness for 
PCa, testicular cancer and mental health (Movember, 2013).  However, sampling the 
media articles in line with the start of the ‘Movember’ campaign would have been 
detrimental to the research design given the advent of PCaOrgs to UK in the mid-1990s 
and my access to the www.healthtalk.org interviews with MWPCa in 2000.  These 
limitations noted; the sampling was both pragmatically and comparatively efficacious 
for the overall research design.   
Another potential limitation was my explicit research enquiry into how PCaOrgs 
and the UK print media have been a force for change as, consequentially, this ignored 
potentially interesting unchanging things in the data.  For example, the overt focus of 
CKWIC analysis on differences in the frequency of particular words over time neglected 
the way similarly frequent words might also be interesting and relevant in the 
qualitative interpretation (Seale et al., 2006; Seale et al., 2007) of my data.  This 
limitation prompts the question as to whether the media articles could have been 
usefully analysed differently.  Clarke (1999; 2004) and Halpin et al. (2009) (§2.2.2.1) 
conduct a ‘manifest’ and ‘latent’ analysis of PCa in various print media.  They suggest 
that such analysis combine a quantitative counting of themes and a qualitative 
interpretative thematic analysis.  Though their analysis produces interesting findings 
which correspond to some of mine, their research enquiry was not to compare 
differences between datasets (§3.4.2.1).  Seale et al. (2006) use both CKWIC and 
conventional thematic analysis on the same data to evaluate whether the results of 
the former are consistent with the latter.  They conclude that CKWIC is effective in 
revealing similar differences in the data to a conventional analysis while allowing a 
more inductive analysis and economical way of identifying salient aspects of the data 
without a priori conceptual bias.  That my findings show some correspondence with 
those of Clarke (1999; 2004) and Halpin et al. (2009) and also across Chapter 4 and 
Chapter 5 indicates the ability of this method to identify important aspects of changes 
in narratives  around PCa.  That it shows nuanced differences across time shows the 
benefit of this method over a conventional thematic analysis for the particular purpose 
of comparing data across time.   
A final limitation is that the MWPCa participants in my research represent those 
who chose to speak publically about their illness.  Their experiences as described here 
may not therefore represent the experiences of those not willing to speak publically. 
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8.3 Suggestions for future research and articles 
My findings in Chapter 6 suggest the opportunity to produce a paper based on the 
article ‘Thinking differently about thinking positive: a discursive approach to cancer 
patients’ talk’ (Wilkinson and Kitzinger, 2000).  These authors refute the idea that the 
‘thinking positive’ talk of women with breast cancer is concerned with reporting their 
actual cognitions.  Rather, they persuasively demonstrate that when such talk is used, 
it is instead as an ‘idiom (….) that is, it is a common place saying which summarises a 
taken-for-granted piece of cultural knowledge’ (2000: 802).  They argue that: 1) 
thinking positive is ‘interactionally occasioned’, (2000: 809) enabling the disclosure and 
convenient ‘wrapping up’ (2000: 803) of troubles telling and relieving the ‘listeners of a 
potential conversational burden’ (2000: 805); and 2) women with breast cancer are 
morally exhorted to think positive.  The interest of a corresponding paper would be to 
compare the use of the commonplace idiom of ‘thinking positive’ with the negotiation 
between a ‘tragic’ genre of futile suffering and death and a ‘romantic’ genre of 
triumph over adversity. It would also allow examination of the extent to which 
stoicism, as an aspect of hegemonic masculinity, is merely illustrative of a more 
general culture of stoicism.   
Along similar lines is the attention of the organisational and patient safety 
literature to the difficulties people have in speaking out about particular concerns to 
peers.  This literature could be used to further explore how men speak out to other 
men about PCa.  
The global campaign Movember is suggested to mislead men (McCartney, 2012). 
Empirical enquiry into whether this is so might be to compare narratives of Movember 
in the UK print media and its website (launched 15 September 2013) with men’s 
narratives of Movember.  Sampling men of different ages would also allow enquiry 
into the plurality of masculinities at least with regard to age.   Such a research enquiry 
is also intriguing from a dialogical perspective. I was introduced to the idea of dialogic 
talk through the concept of resonance and then onwards into the literary theories of 
Bakhtin (1981), Volosinov (1986) and Tannen (2007).  There is though a growing 
literature on dialogism (see for example Madill and Sullivan, 2010; Märtsin et al., 2011; 
Sullivan, 2011) which I did not explore within this thesis.  It is clear from my findings 
that many participants orientated to the voices of others and often reproduced them 
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in some way.  This may constitute an ‘objective document’ (Volosinov, 1986: 117) of 
the reception and manipulation of another’s speech by an individual speaker—also 
demonstrating how the speaker would like those words heard in the current context.  
Paying attention to this would also allow examination of narrative forms in addition to 
content and why a particular story may be told in a particular way (Riessman, 1993: 2).  
Incidentally, of the three reader responses to McCartney’s (2012) article, two 
mentioned PCa as ‘a gender-equality issue’; a ‘‘Cinderella’ cancer’; and ‘a condition the 
NHS sinfully neglects’.  This is interesting as this way of talking about PCa reflects my 
findings—stories of neglect may be used for some contemporary audiences.  It is also 
interesting McCartney’s original article did not mention such ideas—it may also be a 
valid research enquiry to analyse reader commentary to see what the ‘real’ argument 
is about (O’Halloran, 2010).  
Finally, despite PCa often having ‘a very indolent history’ (Parker, 2004: 102), 
there were 10,837 PCa deaths in the UK in 2012 (Cancer Research UK, 2013a).   Deaths 
in men with non-lethal prostate tumours in the USA have been attributed in error to 
PCa.  Though such error is thought to be less likely the case for the UK (Cancer 
Research UK, 2013a), literature around the social production of statistics—
ethnostatistics—which includes at least the collection and measurement of data and 
how the produced statistics are used in the public domain, may serve to investigate 
this. 
8.4 Implications 
The methods I used to answer my research question involved collecting and analysing 
a variety of illness narratives.  Although the sociological enquiry of illness narratives 
stretches back thirty years (Hyden, 1997; Mishler, 2005), it has been ‘stormy’ (Morse, 
2001) for much of this time. The centre of this debate may reflect the tension between 
public and professional sociologies (Thomas, 2010; Bury and Monaghan 2013a): the 
former concerned with producing extra-academic knowledge for patient groups; the 
latter with producing academic knowledge for peers (Burawoy, 2004). Public and 
professional sociologies are though interfacing ‘ideal types, each of which is internally 
complex’ (Burawoy, 2004: 1609).  Professional knowledge is instrumental for public 
knowledge in that an effective public sociology may depend upon a professional 
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sociology to provide relevant legitimacy, expertise, and analytic techniques (p. 1610).  
Correspondingly, the engagement of public sociologists in political and moral concerns 
makes the pursuit of methodological and theoretical coherence all the more worthy 
(Burawoy, 2004).  This thesis has implications for both professional and public 
sociology. 
The implications of my thesis for public sociology—for MWPCa and PCaOrgs—
are as follows.  When MWPCa talk about their illness they unconsciously draw on 
available and acceptable ways, or genres, of talking and understanding.  These ways of 
talking may be sought, strategically or consciously, by actors around PCaOrgs in order 
to construct messages in language which ‘fits’ or resonates with MWPCa or other 
desired audiences.  Though such resonant language has included ideas of injustice—
the funding neglect of PCa and injustices around funding for treatment and suffering of 
treatment side-effects—types of injustice are subject to dialectic tension and 
contestation.  By the former I mean that though some injustice stories may be 
successful in effecting action, this same success may transform the original belief so 
that similar stories of injustice may no longer be efficacious.  By the latter I mean, 
audiences are not homogenous—the ‘man in the street’ audience is not the same as 
the media audience—and a story of injustice resonant with one audience may be 
contested by another. Critically though, for actors around PcaOrgs, using resonant 
language is not sufficient to sustain the interest of any audience. Those concerned with 
constructing messages around PCa must also use novel, unusual, unpredictable or 
complex language.  The combination of resonant and novel—or dissonant—language 
will work to sustain the interest of audiences.  Notable though is that novel language 
itself is subject to temporal constraints in that it too eventually becomes overly 
familiar and new novel language will then need to be continually sought. 
One potential contested injustice may be around the likelihood of increasing 
numbers of men moving onto the disease spectrum of PCa through the transformation 
of natural processes of ageing such as incontinence and impotence (Armstrong, 2014).  
As more and more men are diagnosed with non-clinically relevant PCa, with no clinical 
symptoms expected during their lifetime  (Schroder et al., 2009), the public face of PCa 
may become healthier as those with a poor prognosis become relatively fewer 
(Aronowitz, 2009).  This expanded group of MWPCa may be “a healthy bunch of men 
(...) able to advocate for themselves” (Extract 5.16), result in an ‘expanded market for 
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interventions and greater clout for disease advocates’ (Aronowitz, 2009: 417-8) and 
also more fully meet the seven characteristics of a successful grassroots survivors’ 
organisation (Kedrowski and Sarow, 2007).   
My findings show that the increasingly healthy face of PCa may lead to some 
interactional difficulties for at least those MWPCa with a poor prognosis but also 
perhaps for those with a good prognosis.  The potential ‘veneer of optimism’ 
(Aronowitz, 2009: 436) onto the identity of the expanded group of MWPCa may lead 
audiences of MWPCa to view PCa as “not too bad” (Extract 6.29). Though this is 
ostensibly good news, it may have a number of unwanted effects.  It may mean that 
those with a poor prognosis will have to work to convince others that their type of PCa 
is not curable and therefore deserving of interactional outcomes such as sympathy and 
so on.  It may also mean that those with a good prognosis may not receive the 
sympathy they expect.  Further, interactional difficulty can be expected when men 
disclose their PCa to some audiences as, despite optimistic signs that PCa is no longer a 
“taboo disease that no one dares talk about” and where men just “die quietly”, men 
and others still find this an embarrassing illness to talk about.  
The implications of this thesis for professional sociology concern elements of the 
‘storm in the academic teacup’ (Morse, 2001: 587) around illness narratives and the 
idea of frame resonance as “half the battle” (Berbrier, 1998: 432) in constructing 
language which ‘fits’ with audiences’ ways of understanding. The principal forces in the 
academic storm are the arguments of Atkinson (1997, reproduced in 2006) and Frank 
(2000, 2010). Atkinson suggests that narrative analysis of illness narratives tends to 
privilege the story-teller over the story-analyser and romanticise illness sufferers as 
heroes in contrast with villainous doctors (Atkinson, 1997, reproduced in 2006). Frank 
(2000) argues that focussing on narrative structures risks excluding what is most 
important to storytellers, for example, their moral accounts of a virtuous self.  Frank 
(2010) though indicates that when illness sufferers offer such accounts they may, 
albeit unconsciously, draw on available and acceptable ways, or structures, of telling—
and so indicating structures which a story analyst might seek.    
This thesis corresponds to previous studies in the illness narrative literature: 
when MWPCa, advocates around PCaOrgs and print media journalists tell stories of 
PCa, they draw on culturally available ways of talking—core narratives (Bury, 2001; 
Frank, 2000), genres (Bury, 2001), pre-patterned talk (Tannen, 2007), or words 
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previously existing in others’ mouths and contexts (Bakhtin, 1981).  They expect their 
intended audience to do likewise and their talk is also likely to be ‘“recipient 
designed”’ (Frank, 2010: 90) or “co-authored” (Williams, 1984) in that it is tailored to 
fit the expected response of their audience (Frank, 2010; see also Riessman, 2008).  
Differing though from what might be expected from this literature and in the “world of 
narrative, [where] very little is ever new” (Frank, 2010: 123), my thesis demonstrates, 
akin to Polletta (2006), that a story which ‘is so familiar as to be entirely predictable 
(…) [is] no story at all (p. 10).  My thesis shows that the familiarity that genres provide 
is not enough to make a narrative work; novel and unpredictable elements are also 
needed.  What counts as novel in narratives may also reflect temporal interpretations 
of what counts as ‘interesting’ (Silvia, 2008).  I propose that those analysing illness 
narratives will need to examine not only familiar genres or ways of talking which 
people draw upon, but also novel and unpredictable language.  Examining the 
combination of resonant and dissonant language will help to understand the 
recursiveness and self-reproducing inherent in human social and discursive practices 
(Giddens, 1984). 
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Appendices          
Appendix 1. Prostate cancer incidence and 
mortality rates, GB 1975-2008 
 
Figure 1. 1 Prostate Cancer, age-standardised (European) incidence and 
mortality rates, GB, 1975-2008  
 
 
The following is a personal email communication from the CRUK Statistical Information 
team 23/05/2012: 
 
“[The chart above] (Figure 1.5: Prostate Cancer (C61), European Age-standardised 
Incidence and Mortality Rates, Great Britain, 1975-2008) has now been superseded by 
charts showing the latest incidence and mortality data separately: Incidence Great 
Britain 1975-2009:   
http://info.cancerresearchuk.org/cancerstats/types/prostate/incidence/uk-prostate-
cancer-incidence-statistics#trends Figure 1.3 [and] Mortality UK 1971-2009:  
http://info.cancerresearchuk.org/cancerstats/types/prostate/mortality/#trends Figure 
2.2 (NB this will be updated to 2010 data within the next month or so).  Unfortunately 
we are unable to make the graph you downloaded available on our website again, as 
those data are now out of date. However, we can confirm the chart you downloaded 
was available on our website in April 2011, and was replaced by the updated chart on 
May 4th 2012.”  
 
I was also later advised that I could recreate the above chart by downloading the Excel 
files of the raw data through the above web pages (personal email CRUK Statistical 
Information team 24/05/2012).   
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Appendix 2. Original research proposal, 
abstract and plan of 
investigation  
 
Original Proposed Title: The public face of prostate cancer in the UK 
Abstract 
This study will apply Health Social Movements (HSM) theory to UK Prostate Cancer 
awareness-raising activity. The purpose is to derive principles from past and current 
experience to guide future strategies for organisations involved in the UK prostate 
cancer HSM. This work comprises a) a comparative study of media, b) focus group 
work, and c) interviews with key people in the HSM.  First there will be a comparative 
study, using linguistically-oriented keyword analysis, of changes over time in mass 
media (newspaper and internet) representations of prostate cancer, and in policy 
documents produced (a) by governmental and NHS sources and (b) prostate cancer 
awareness-raising organisations. Second, a focus group study will involve men with 
prostate cancer and intimate family members.  This will assess the degree to which the 
collective identity ‘offered’ to men through media and policy discourse is incorporated 
into personal biographical experience (known as ‘frame alignment’ within the cultural 
framing approach to HSMs). Third will be a snowball sample of interviews with key 
people in relevant organisations, using resource mobilisation and ‘political 
opportunities’ perspectives within HSM theory to assess strategies pursued in the UK 
over the past 20 years. 
 
Plan of investigation and methodology 
 
(1) Investigation of changing public image 
The aim of this will be to investigate the changing language associated with prostate 
cancer through a systematic study of relevant public documents This will involve a 
random sample of national and local newspaper articles (taken from the Nexis 
database of all UK newspapers) about prostate cancer dating back 20 years, using 
qualitative and quantitative computer-assisted methods to assess changes over time. 
Another sample of relevant health policy documents concerning prostate cancer 
emanating firstly from NHS and governmental sources, and secondly from prostate 
cancer HSMs over this period, will be drawn up and subjected to similar analysis to 
detect changes in the language of prostate cancer over time. Particular attention will 
be paid to the spread and interchange of key terms (e.g.: ‘expert patient’; ‘living with 
prostate cancer’) across mass media and the two categories of policy documents so 
that directions of influence can be assessed. Where found, the analysis will describe 
examples of frame bridging, amplification, extension and transformation (Snow et al., 
1986). 
     The PhD student will be trained in the use of ‘keyword’ analysis, developed by the 
applicant and used on a number of documentary studies. This provides a reliable 
quantitative and qualitative overview of very large amounts of text, and is particularly 
useful for comparative studies (e.g.: comparisons over time or between different types 
of document). 
 
(2) Impact on experience of prostate cancer 
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The experiences of men with prostate cancer and their intimate family members 
(‘carers’) will be investigated with the aim of assessing the extent to which their 
personal approaches to living with the illness, and the language they use to express 
this, is in harmony with the concerns and language of prostate cancer promoted in the 
mass media and in policy documents. This will help in assessing whether the prostate 
cancer social movement is currently successful in achieving one of the core tasks of 
any health social movement: to help individuals with a condition interpret their 
experience as being linked to the ‘collective identity’ provided by the public and policy 
‘discourse’ the HSM promotes(‘frame alignment’).  
     Five focus groups containing men with prostate cancer and/or their ‘carers’ will be 
convened. A proportion of participants will be African or African-Caribbean to enable 
comparisons between these individuals and others, since it seems possible that 
ethnically-based cultural differences may influence the degree to which the collective 
identity ‘offered’ to these individuals is taken up. Participants will be recruited either 
through health services or through connections with prostate cancer charities so NHS 
ethical committee approval for this element of the study will be sought.  
     Focus group participants will be presented with examples of the public and policy 
language of prostate cancer and asked to discuss what these statements mean to 
them. Focus groups will be audio-recorded and transcribed and analysed using 
computer-assisted qualitative data analysis software, of which the lead applicant has 
extensive experience.  
 
(3) Investigation of prostate cancer organisations 
While the above two strands of investigation largely draw on the cultural ‘framing’ of 
prostate cancer and the impact that has on personal experience, the third element of 
the project will focus on understanding resource mobilisation and exploitation of 
political opportunities by the prostate cancer HSM over the past two decades. This will 
be done largely by means of an interview study with up to 20 leading proponents of 
prostate cancer awareness, as well as those associated with such individuals, such as 
influential medical and research scientists and policy makers with responsibility for 
cancer services and research. University ethical committee approval for this aspect of 
the study will be needed. 
     The sample of interviewees will be formed on a ‘snowball’ basis by first contacting 
and interviewing leading figures within prostate cancer organisations such as the 
Prostate Cancer Charity itself. Interviews will focus on the personal biography of the 
individual concerned as this relates to activities associated with prostate cancer, 
reflections on the history and future prospects of the prostate cancer awareness 
movement, and an account of key contacts made by the individual in pursuit of 
awareness raising activities. Where relevant these contacts will themselves be 
approached for similar interviews.  
     Interviews will be audio-recorded and transcribed and analysed using computer-
assisted qualitative data analysis software, of which the lead applicant has extensive 
experience. 
  
222 
 
Appendix 3. Identified keywords in analysis 
of media narratives 
Identified keywords 1990-2010 
There are 8 columns in the tables below.  The first of these (N) simply lists the 
keywords in numerical order and the second (Keyword) lists each keyword.  The third 
(Freq.) gives the frequencies of each keyword as it appeared in the examined corpus 
and the fourth (%) gives this frequency as a percentage of the whole corpus.  As the 
two corpora are different sizes it is useful to consider the % column rather than the 
raw frequency.  Columns 5 and 6 (RC. Freq.) and (RC. %) show the same figures for the 
reference corpus.  Column 7 gives the keyness value of each word and the eighth 
column gives the p value.  The keyness values gradually decrease as the list descends 
and the p value correspondingly increases as the keyness becomes less significant.  The 
first table shows the 138 positive keywords (p<0.01) when the 1990-2000 corpus is 
compared with reference to 2000-2010.  The second shows the 118 positive keywords 
(p<0.01) when the 2000-2010 corpus is compared with reference to 1990-2000.   
 
Keywords 1990-2000 
N Key word Freq. % RC.  
Freq. 
RC. % Keyness P 
1 KORDA 35 0.083157122 0  89.77902222 4.60975E-15 
2 GIULIANI 45 0.106916294 5  86.17584229 5.63225E-15 
3 SENATE 23 0.054646108 0  58.99290085 5.12436E-14 
4 CLINTON 17 0.0403906 0  43.60169601 9.03745E-13 
5 REPUBLICAN 15 0.035638765 0  38.47156906 8.94767E-12 
6 GBP 33 0.078405283 15 0.013682136 34.76482773 7.95644E-10 
7 MAYOR 18 0.042766519 2  34.46268463 1.42032E-09 
8 MILLION 22 0.052270189 6  31.22846222 2.00131E-08 
9 MARGARET 12 0.028511012 0  30.77663803 2.60255E-08 
10 MRS 16 0.038014684 2  29.77790451 4.55235E-08 
11 MICHAEL 24 0.057022024 9  28.73115921 8.02303E-08 
12 GEOFFREY 11 0.026135094 0  28.21172905 1.05819E-07 
13 BRUCE 17 0.0403906 4  25.7498188 3.85739E-07 
14 SENATOR 10 0.023759177 0  25.6468544 4.07039E-07 
15 BENTINE 10 0.023759177 0  25.6468544 4.07039E-07 
16 URINE 47 0.111668132 43 0.039222125 23.90206909 1.0107E-06 
17 STUDYING 9 0.021383259 0  23.08201408 1.54944E-06 
18 HILLARY 9 0.021383259 0  23.08201408 1.54944E-06 
19 HUGHES 9 0.021383259 0  23.08201408 1.54944E-06 
20 PROSTATIC 14 0.033262849 3  22.01153564 2.70724E-06 
21 CHARLES 11 0.026135094 1  21.97735023 2.75595E-06 
22 SHAPED 11 0.026135094 1  21.97735023 2.75595E-06 
23 BPH 12 0.028511012 2  20.59273148 5.67822E-06 
24 DOUG 8 0.019007342 0  20.5172081 5.90683E-06 
25 VEGETABLES 8 0.019007342 0  20.5172081 5.90683E-06 
26 YORK 25 0.059397943 16 0.014594279 19.66991997 9.20096E-06 
27 CLIFF 10 0.023759177 1  19.59455872 9.57122E-06 
28 IT 633 1.50395596 1341 1.223183036 18.13307571 2.05963E-05 
29 MFI 7 0.016631424 0  17.95243835 2.26465E-05 
30 SOUTHON 7 0.016631424 0  17.95243835 2.26465E-05 
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31 ONSLOW 7 0.016631424 0  17.95243835 2.26465E-05 
32 FRUIT 7 0.016631424 0  17.95243835 2.26465E-05 
33 ZINC 7 0.016631424 0  17.95243835 2.26465E-05 
34 TUMOUR 44 0.104540378 47 0.042870693 17.33822823 3.12801E-05 
35 GIULIANI'S 9 0.021383259 1  17.2300663 3.31125E-05 
36 SURROUNDS 9 0.021383259 1  17.2300663 3.31125E-05 
37 EXAMINATION 26 0.061773859 20 0.018242849 16.69498634 4.38939E-05 
38 RACE 17 0.0403906 9  15.9066124 6.65429E-05 
39 MAGDA 6 0.014255506 0  15.38770103 8.75534E-05 
40 MYRA 6 0.014255506 0  15.38770103 8.75534E-05 
41 TRANSRECTAL 6 0.014255506 0  15.38770103 8.75534E-05 
42 ELECTION 6 0.014255506 0  15.38770103 8.75534E-05 
43 LAZIO 6 0.014255506 0  15.38770103 8.75534E-05 
44 CLINTON'S 6 0.014255506 0  15.38770103 8.75534E-05 
45 VOTERS 6 0.014255506 0  15.38770103 8.75534E-05 
46 TABOO 6 0.014255506 0  15.38770103 8.75534E-05 
47 DOLE 6 0.014255506 0  15.38770103 8.75534E-05 
48 ESCALATE 6 0.014255506 0  15.38770103 8.75534E-05 
49 TERENCE 6 0.014255506 0  15.38770103 8.75534E-05 
50 SYMPTOMS 67 0.159186482 93 0.084829248 14.70995808 0.000125379 
51 SPENT 22 0.052270189 17 0.015506421 14.04780388 0.000178219 
52 GENETIC 9 0.021383259 2  13.95037842 0.000187697 
53 MILKEN 9 0.021383259 2  13.95037842 0.000187697 
54 FERGUSON 20 0.047518354 15 0.013682136 13.23761082 0.000274385 
55 ROWE 5 0.011879588 0  12.82299805 0.000342382 
56 CHARMED 5 0.011879588 0  12.82299805 0.000342382 
57 FATS 5 0.011879588 0  12.82299805 0.000342382 
58 EXPOSURE 5 0.011879588 0  12.82299805 0.000342382 
59 DOUGHNUT 5 0.011879588 0  12.82299805 0.000342382 
60 OIL 5 0.011879588 0  12.82299805 0.000342382 
61 GEOFFREY'S 5 0.011879588 0  12.82299805 0.000342382 
62 GOON 5 0.011879588 0  12.82299805 0.000342382 
63 CONLAN 5 0.011879588 0  12.82299805 0.000342382 
64 SEXUALITY 5 0.011879588 0  12.82299805 0.000342382 
65 ANALYSED 5 0.011879588 0  12.82299805 0.000342382 
66 SLOWER 5 0.011879588 0  12.82299805 0.000342382 
67 TOFU 5 0.011879588 0  12.82299805 0.000342382 
68 EVEN 63 0.14968282 90 0.082092822 12.74950981 0.0003561 
69 RUDOLPH 7 0.016631424 1  12.57385349 0.000391178 
70 SHADOWS 7 0.016631424 1  12.57385349 0.000391178 
71 CANDIDATE 7 0.016631424 1  12.57385349 0.000391178 
72 SISTER 7 0.016631424 1  12.57385349 0.000391178 
73 EAT 15 0.035638765 9  12.56341171 0.00039337 
74 MAIL 18 0.042766519 13 0.011857851 12.4467783 0.000418711 
75 WATER 14 0.033262849 8  12.26266956 0.000462107 
76 OCCUR 13 0.030886929 7  11.991436 0.000534453 
77 QUIET 8 0.019007342 2  11.80861568 0.00058957 
78 FAMILY 48 0.114044048 64 0.058377117 11.72367001 0.000617098 
79 I'D 50 0.118795887 68 0.062025685 11.59757996 0.000660374 
80 UPPER 9 0.021383259 3  11.53512192 0.000682933 
81 VITAMIN 9 0.021383259 3  11.53512192 0.000682933 
82 ALMOST 27 0.064149775 28 0.025539989 11.2135849 0.000812004 
83 MEDICAL 50 0.118795887 69 0.062937826 11.15092564 0.000839895 
84 HISTORY 14 0.033262849 9  10.964468 0.000928753 
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85 AGE 46 0.109292217 63 0.057464972 10.47111893 0.00121255 
86 IDENTIFIES 6 0.014255506 1  10.29582405 0.001333313 
87 BIOLOGY 6 0.014255506 1  10.29582405 0.001333313 
88 BIOPSY 46 0.109292217 64 0.058377117 10.03087902 0.001539373 
89 DIET 14 0.033262849 10  9.801968575 0.001743249 
90 HARRY 10 0.023759177 5  9.799973488 0.001745141 
91 ENLARGE 7 0.016631424 2  9.717207909 0.001825503 
92 DUCHESS 9 0.021383259 4  9.632606506 0.001911529 
93 KILLER 16 0.038014684 13 0.011857851 9.59043026 0.001955938 
94 RAISE 16 0.038014684 13 0.011857851 9.59043026 0.001955938 
95 DEVELOPS 8 0.019007342 3  9.57544136 0.001971971 
96 DISEASE 95 0.22571218 165 0.150503501 9.511831284 0.00204151 
97 RECTAL 15 0.035638765 12 0.010945709 9.171572685 0.00245803 
98 AS 271 0.643873692 564 0.514448345 9.01608181 0.002676142 
99 YOUNG 22 0.052270189 23 0.020979276 9.007304192 0.002689025 
100 FREQUENTLY 11 0.026135094 7  8.702689171 0.003177407 
101 ONLY 78 0.185321584 133 0.121314943 8.466990471 0.00361649 
102 FIGURE 10 0.023759177 6  8.375099182 0.003803965 
103 STREAM 10 0.023759177 6  8.375099182 0.003803965 
104 PASSING 13 0.030886929 10  8.346051216 0.003865262 
105 MEAT 9 0.021383259 5  8.081440926 0.004472084 
106 PATHOLOGISTS 5 0.011879588 1  8.066028595 0.004510283 
107 JOKE 5 0.011879588 1  8.066028595 0.004510283 
108 CHARITABLE 5 0.011879588 1  8.066028595 0.004510283 
109 CONTEST 5 0.011879588 1  8.066028595 0.004510283 
110 MAIL'S 5 0.011879588 1  8.066028595 0.004510283 
111 YORK'S 5 0.011879588 1  8.066028595 0.004510283 
112 CAPSULE 5 0.011879588 1  8.066028595 0.004510283 
113 ALL 148 0.351635814 289 0.263609171 7.879816055 0.004998954 
114 SOCIETY 8 0.019007342 4  7.839799404 0.005110825 
115 IDEA 16 0.038014684 15 0.013682136 7.838580132 0.005114273 
116 HAPPEN 16 0.038014684 15 0.013682136 7.838580132 0.005114273 
117 JOHNSON 6 0.014255506 2  7.689846516 0.005553232 
118 POWERFUL 6 0.014255506 2  7.689846516 0.005553232 
119 LINK 6 0.014255506 2  7.689846516 0.005553232 
120 CHEMICALS 6 0.014255506 2  7.689846516 0.005553232 
121 POLICE 7 0.016631424 3  7.684381485 0.005570074 
122 FORTUNATELY 7 0.016631424 3  7.684381485 0.005570074 
123 GENE 7 0.016631424 3  7.684381485 0.005570074 
124 HYPERPLASIA 7 0.016631424 3  7.684381485 0.005570074 
125 REVEAL 7 0.016631424 3  7.684381485 0.005570074 
126 DIGITAL 7 0.016631424 3  7.684381485 0.005570074 
127 MEN 179 0.425289273 362 0.330195576 7.468176842 0.006279909 
128 ULTRASOUND 15 0.035638765 14 0.012769994 7.398842812 0.006526582 
129 CANCER 567 1.347145319 1288 1.174839497 7.331418037 0.006775955 
130 SIGNS 18 0.042766519 19 0.017330706 7.244087219 0.007113484 
131 REMAINS 10 0.023759177 7  7.160042286 0.007454541 
132 ENLARGEMENT 10 0.023759177 7  7.160042286 0.007454541 
133 RISKS 10 0.023759177 7  7.160042286 0.007454541 
134 RUN 16 0.038014684 16 0.014594279 7.069717407 0.007839759 
135 INSTITUTE 16 0.038014684 16 0.014594279 7.069717407 0.007839759 
136 SOON 20 0.047518354 23 0.020979276 6.837277412 0.008927478 
137 BRIAN 9 0.021383259 6  6.790011883 0.009166927 
138 GREATER 9 0.021383259 6  6.790011883 0.009166927 
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Keywords 2000-2010 
N Key word Freq. % RC.  
Freq. 
RC. % Keyness P 
1 BRACHYTHERAPY 60 0.054728545 0  38.99879456 6.40463E-12 
2 MAX 56 0.051079977 0  36.3983078 5.7993E-11 
3 SAID 380 0.346614122 74 0.175817907 33.09715652 5.84198E-09 
4 MEGRAHI 50 0.045607124 0  32.49772644 9.00851E-09 
5 RIPLEY 50 0.045607124 0  32.49772644 9.00851E-09 
6 STEEL 46 0.041958552 0  29.89744377 4.26266E-08 
7 PROCEDURE 52 0.047431406 1  26.44014931 2.68906E-07 
8 DAVID 48 0.043782838 1  23.99838257 9.61242E-07 
9 UK 104 0.094862811 12 0.028511012 21.20781898 4.11788E-06 
10 SHE 198 0.180604205 36 0.085533038 20.09279442 7.37449E-06 
11 ENGLAND 41 0.037397839 1  19.75985527 8.77785E-06 
12 ELLIOTT 28 0.025539989 0  18.19716835 1.99146E-05 
13 ANDY 26 0.023715703 0  16.89723969 3.9456E-05 
14 ROBOT 26 0.023715703 0  16.89723969 3.9456E-05 
15 POWELL 25 0.022803562 0  16.24728203 5.55864E-05 
16 VAL 25 0.022803562 0  16.24728203 5.55864E-05 
17 YES 25 0.022803562 0  16.24728203 5.55864E-05 
18 BOB 53 0.04834355 4  15.73698235 7.27842E-05 
19 DAVE 24 0.021891419 0  15.59733009 7.83622E-05 
20 KID 24 0.021891419 0  15.59733009 7.83622E-05 
21 RUGBY 33 0.030100701 1  14.98816013 0.000108185 
22 GROUNDS 23 0.020979276 0  14.94738293 0.000110548 
23 SPES 23 0.020979276 0  14.94738293 0.000110548 
24 LOVE 61 0.05564069 6 0.014255506 14.63071632 0.000130763 
25 COURT 22 0.020067133 0  14.29744148 0.000156074 
26 RELEASE 31 0.028276416 1  13.81133175 0.000202111 
27 MAUREEN 21 0.019154992 0  13.64750385 0.000220531 
28 JACKIE 20 0.018242849 0  12.9975729 0.000311892 
29 SCOTTISH 36 0.032837126 2  12.85463905 0.000336641 
30 CARMAN 19 0.017330706 0  12.34764576 0.00044154 
31 MARTIN 19 0.017330706 0  12.34764576 0.00044154 
32 PARLIAMENT 19 0.017330706 0  12.34764576 0.00044154 
33 UNIVERSITY 28 0.025539989 1  12.06162453 0.000514701 
34 ANAESTHETIC 18 0.016418563 0  11.69772434 0.000625763 
35 DE 18 0.016418563 0  11.69772434 0.000625763 
36 DICK 18 0.016418563 0  11.69772434 0.000625763 
37 STUFF 18 0.016418563 0  11.69772434 0.000625763 
38 COMPASSIONATE 17 0.015506421 0  11.04780769 0.000887918 
39 GAME 17 0.015506421 0  11.04780769 0.000887918 
40 KEYHOLE 17 0.015506421 0  11.04780769 0.000887918 
41 LOCKERBIE 17 0.015506421 0  11.04780769 0.000887918 
42 TREATMENT 313 0.285500586 81 0.192449331 10.80762482 0.001010826 
43 AGAIN 52 0.047431406 6 0.014255506 10.60055923 0.001130532 
44 GLYNN 16 0.014594279 0  10.39789581 0.001261587 
45 LIBYAN 16 0.014594279 0  10.39789581 0.001261587 
46 MACASKILL 16 0.014594279 0  10.39789581 0.001261587 
47 MEGRAHI'S 16 0.014594279 0  10.39789581 0.001261587 
48 PRESIDING 16 0.014594279 0  10.39789581 0.001261587 
49 RADIO 16 0.014594279 0  10.39789581 0.001261587 
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50 DRUG 51 0.046519265 6 0.014255506 10.17096138 0.001426696 
51 HE 1506 1.373686552 492 1.168951511 10.04950142 0.001523889 
52 GUILDFORD 15 0.013682136 0  9.747989655 0.001795186 
53 JAIL 15 0.013682136 0  9.747989655 0.001795186 
54 LAUNCH 15 0.013682136 0  9.747989655 0.001795186 
55 MONKHOUSE 15 0.013682136 0  9.747989655 0.001795186 
56 PARK 15 0.013682136 0  9.747989655 0.001795186 
57 ZOLADEX 15 0.013682136 0  9.747989655 0.001795186 
58 NOVEMBER 23 0.020979276 1  9.197760582 0.002423111 
59 RETURN 23 0.020979276 1  9.197760582 0.002423111 
60 TV 23 0.020979276 1  9.197760582 0.002423111 
61 ALLOWED 14 0.012769994 0  9.098088264 0.002558765 
62 GRAHAM'S 14 0.012769994 0  9.098088264 0.002558765 
63 REASONS 14 0.012769994 0  9.098088264 0.002558765 
64 SCORE 14 0.012769994 0  9.098088264 0.002558765 
65 TESTICULAR 14 0.012769994 0  9.098088264 0.002558765 
66 NERVES 22 0.020067133 1  8.63481617 0.003297982 
67 NURSE 22 0.020067133 1  8.63481617 0.003297982 
68 YOU'RE 28 0.025539989 2  8.629724503 0.003307213 
69 AROUND 87 0.079356395 16 0.038014684 8.609138489 0.003344802 
70 TRIAL 38 0.034661412 4  8.536099434 0.003481707 
71 SEEDS 33 0.030100701 3  8.487279892 0.003576378 
72 CAROLINE 13 0.011857851 0  8.448191643 0.003654063 
73 CHARITY'S 13 0.011857851 0  8.448191643 0.003654063 
74 DEPRESSION 13 0.011857851 0  8.448191643 0.003654063 
75 FINAL 13 0.011857851 0  8.448191643 0.003654063 
76 MONITOR 13 0.011857851 0  8.448191643 0.003654063 
77 NEEDLES 13 0.011857851 0  8.448191643 0.003654063 
78 OPERATIONS 13 0.011857851 0  8.448191643 0.003654063 
79 RIPLEY'S 13 0.011857851 0  8.448191643 0.003654063 
80 WOOD 13 0.011857851 0  8.448191643 0.003654063 
81 WORK 89 0.081180677 17 0.0403906 8.093930244 0.004441372 
82 LIZ 21 0.019154992 1  8.075832367 0.004485947 
83 MANCHESTER 21 0.019154992 1  8.075832367 0.004485947 
84 LATER 117 0.106720664 25 0.059397943 7.987145901 0.004711059 
85 BONO 12 0.010945709 0  7.798300743 0.005229536 
86 CLUB 12 0.010945709 0  7.798300743 0.005229536 
87 COVER 12 0.010945709 0  7.798300743 0.005229536 
88 INOPERABLE 12 0.010945709 0  7.798300743 0.005229536 
89 KEN 12 0.010945709 0  7.798300743 0.005229536 
90 MCKEOWN 12 0.010945709 0  7.798300743 0.005229536 
91 RELEASED 12 0.010945709 0  7.798300743 0.005229536 
92 PSA 240 0.218914181 63 0.14968282 7.757273197 0.005349664 
93 ON 701 0.639411867 218 0.517950058 7.694582462 0.005538679 
94 EITHER 26 0.023715703 2  7.615805626 0.005785888 
95 PROFESSOR 49 0.044694979 7 0.016631424 7.597306728 0.005845553 
96 AL 31 0.028276416 3  7.545934677 0.006014558 
97 CASODEX 11 0.010033567 0  7.148414135 0.007503028 
98 DIARY 11 0.010033567 0  7.148414135 0.007503028 
99 DOC 11 0.010033567 0  7.148414135 0.007503028 
100 ERIC 11 0.010033567 0  7.148414135 0.007503028 
101 FLIGHT 11 0.010033567 0  7.148414135 0.007503028 
102 HERBAL 11 0.010033567 0  7.148414135 0.007503028 
103 JOIN 11 0.010033567 0  7.148414135 0.007503028 
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104 LRP 11 0.010033567 0  7.148414135 0.007503028 
105 MAXTON 11 0.010033567 0  7.148414135 0.007503028 
106 NIGEL 11 0.010033567 0  7.148414135 0.007503028 
107 PCT 11 0.010033567 0  7.148414135 0.007503028 
108 RECEIVE 11 0.010033567 0  7.148414135 0.007503028 
109 ROAD 11 0.010033567 0  7.148414135 0.007503028 
110 ROBOTIC 11 0.010033567 0  7.148414135 0.007503028 
111 TEA 11 0.010033567 0  7.148414135 0.007503028 
112 TESTICLES 11 0.010033567 0  7.148414135 0.007503028 
113 WEAR 11 0.010033567 0  7.148414135 0.007503028 
114 EMOTIONAL 19 0.017330706 1  6.971316338 0.008282652 
115 POLICY 19 0.017330706 1  6.971316338 0.008282652 
116 ROWING 19 0.017330706 1  6.971316338 0.008282652 
117 OVER 185 0.168746352 47 0.111668132 6.919641018 0.008525406 
118 HIS 984 0.897548139 321 0.762669563 6.64923048 0.009919863 
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Appendix 4. Ethical approvals 
 
1. Queen Mary University of London ethical approval 
              
 
6th April 2010 
c/o Professor Clive Seale     
Room 203 - Centre for Health Sciences 
Queen Mary's School of Medicine and Dentistry 
Abernethy Building 
2 Newark Street 
London E1 2AT     
  
 
To Whom It May Concern: 
 
Re: QMREC2010/27 – The Changing Public Face of Prostate Cancer in the UK 
 
The above study was approved by The Queen Mary Research Ethics Committee Sub-
Board C on the 31st March 2010. 
 
This approval is valid for a period of two years, (if the study is not started before this 
date then the applicant will have to reapply to the Committee). 
 
 
Yours faithfully 
 
 
Ms Elizabeth Hall – QMREC Chair.   
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2. Belfast Health and Social Care Trust ethical 
approval  
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Conditions of Permission 
Research Governance permission is issued provided the researcher(s) involved adhere 
to and abide by the conditions below. 
1. The researcher(s) must adhere strictly to the research protocol. 
2. There must be no changes to the research protocol or approved study 
documentation without the prior consent of the Trust, the Research Ethics 
Committee and, where applicable, the MHRA. 
3. There must be no changes in research staff without prior consent of the Trust. 
4. The Research Office should be informed if the Chief Investigator or Principal 
Investigator (CI/PI) is unable to continue to fulfil his/her duties as CI/PI for any 
reason such as long term absence, change in employment etc. 
5. There must be no increase in the resources required without prior consent of the 
Trust 
6. Researcher(s) must report all untoward incidents and seriuos adverse events to the 
Trust. 
7. Any concerns in relation to the research protocol must be reported to the Trust. 
8. Researcher(s) must report all untoward incidents and serious adverse events to the 
Trust. 
9. Any concerns in relation to the research protocol must be reported to the Trust. 
10. Researcher(s) must adhere to good research practice principles in line with the ICH 
Good Clinical Practice (GCP) guidelines. 
11. Researcher(s) must adhere to the Trust’s Research & Development Standard 
Operating Procedures (available from the Research Office on request). 
12. On request, researcher(s) must make their research project available to Trust 
appointed monitors. 
13. The lead researcher must make an annual report to the Research Office for the 
duration of the project. 
14. The lead researcher should inform the Research office on completion or 
termination of the project.  Completion reports must be sent to the Research 
Office, Research Ethics Committee and, if applicable, MHRA. 
Research Office, 2nd Floor King Edward Building, Royal Hospitals, Grosvenor Road, 
Belfast, BT12 6BA 
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3. Department of Primary Health Care: Health 
Experiences Research Group ethical approval  
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Appendix 5. Information for participants in 
PCaA interviews 
 
 
Information for participants 
Please read the following information carefully before you decide to take part.  This 
will tell you why the research is being done and what you will be asked to do. Please 
ask if there is anything that is not clear or if you would like more information.  It is up 
to you to decide whether or not to take part. If you do decide to take part you will be 
given this information sheet to keep and be asked to sign a consent form.  You are still 
free to withdraw at any time and without giving a reason. 
 
The Changing Public Face of Prostate Cancer in the UK 
My name is Anne Montgomery. I am a PhD student at the Centre for Health Sciences at 
St Barts and The London School of Medicine and Dentistry with Professor Clive Seale 
and Dr Moira Kelly as my supervisors.  The purpose of this research is to provide men 
with prostate cancer and those who care for them and campaign on their behalf, with 
up-to-date information about what the experience of prostate cancer is like. 
 
You have been asked to take part on the basis of your significant activities in raising 
awareness and funding for prostate cancer and in planning policies for its prevention, 
treatment and cure, within the UK. 
 
You should only agree to take part if you would like to, it is entirely up to you. If you 
choose not to take part there will not be any disadvantages for you.  If you choose to 
take part the location and time of the interview will take place at your convenience.  
The length of interviews will be negotiated with you and will depend on what you have 
to say and how much time you feel able to devote.  
 
Interviews will, in the first instance, involve asking you to tell the story of your personal 
involvement with prostate cancer and the organisation(s) associated with it that are 
relevant to your biography. I may ask you further questions on themes relevant to the 
research agenda e.g. how you have used ‘resources’ (e.g. your membership base or 
your contacts with opinion leaders and other key actors in this arena) in response to 
opportunities that have arisen to promote awareness of prostate cancer and/or how 
you have influenced policies for preventing, treating or curing prostate cancer. 
 
The report from this research will be published as a PhD thesis, a report to the funding 
organisation, and in academic publishing outlets such as academic journals.  A 
potential risk from your participation in this research is that you may say something in 
the interview which, if published, would damage either your own or somebody else’s 
reputation.  Additionally, during your interview you may describe some activities that 
are highly publicly visible and thus anonymity will not always be easy to ensure and 
will therefore be negotiated with you on an individual basis.   
 
Your interview will be audio recorded and transcribed so that a written version of the 
interview is produced.  At this point, in order to avert the potential risks detailed 
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above, I will send you a copy of the interview transcript and ask you to highlight any 
passages that cause you any concern and you would prefer not to be published.  In 
addition, you may require me to make changes to particular passages in order that 
they may be written in a way that preserves your anonymity.  Therefore, this gives you 
the opportunity to check, amend and veto anything you say in the interview which you 
would prefer not to be included in reports arising from the study.  The recordings and 
transcripts will be kept in a secure location in my office and only I and my two 
supervisors will listen to your original recording or see your transcript unless you agree 
to the transcripts being deposited in the Qualidata archive so that other researchers 
may analyse them. 
 
I would like to deposit your interview transcript (after you have approved it and after 
the study has finished) with ESRC Qualidata for potential secondary analysis by future 
researchers.  If you would prefer this not to happen, you can either indicate this on the 
consent form or contact me at any point by email or letter after the interview and your 
transcript will be excluded from this deposition.  
 
If you require further information before deciding to take part in this research or after 
you have already done so, or if you wish to withdraw from the study for any reason 
then please contact me using the details below: 
 
Anne Montgomery 
Centre for Health Sciences 
St Barts and The London School of Medicine and Dentistry 
2 Newark Street 
London E1 2AT 
 
Email:   xxxx 
Mobile:   xxxx 
Office:    xxxx 
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Appendix 6. Supplementary questions for 
PCaA interviews 
 
QMREC2010/27: The Changing Public Face of Prostate Cancer 
 
Supplementary Information: Potential Interview Prompts 
 
After the participant has told his/her story, the following prompts are indicative of 
what may be asked if the participant has not already covered them in their narrative: 
 
• Tell me about the different strategies that you/your organisation have/has used to 
raise awareness of prostate cancer over the last 20 years. 
• Have you/how have you sought to influence the media? 
• Have you/how have you sought to influence government policy?  
• Have you/how have you sought to make men aware of the risks of prostate 
cancer? 
• Have you/how have you sought to make the general public aware of the risks of 
prostate cancer? 
• Have you/how have you identified potential ally (or antagonist) organisations in 
your strategy to increase awareness of prostate cancer? 
• Have you/how have you identified any elite decision makers that will aid/hinder 
your aim to increase awareness of prostate cancer?  
• Is there any model of successful influence by another health related organisation, 
either in the UK or internationally, that you particularly like and would like to 
duplicate? 
• In what way has your membership base changed over this time? 
• What do you think of (...)?   
o (e.g. PSA screening/complementary therapies/xyz treatment/nutritional 
guidance or other relevant theme) 
• Does your organisation have a specific policy positions on (...)?   
o (e.g. PSA screening/complimentary therapies/xyz treatment/nutritional 
guidance or other relevant theme) 
• What would you say are the key values of your organisation? 
• How have these values changed over the last twenty years? 
• What are your views about the nature/cause/seriousness of prostate cancer? 
• Is there anything else that you would like to say about how you/your organisation 
has raised awareness of prostate cancer? 
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Appendix 7. Consents 
 
1.Consent for prostate cancer advocate participants  
 
Thank you for considering taking part in this research.  Please complete this form after 
you have read the Information Sheet. If you have any questions arising from the 
Information Sheet, please feel free to contact me before you decide whether to take 
part. You may keep a copy of this Consent Form and Information Sheet to refer to at 
any time.  
 
Title of Study: The Changing Public Face of Prostate Cancer in the UK 
Queen Mary Research Ethics Committee Reference: QMREC2010/27 
 
I understand that if I decide at any time during or after the interview that I no longer 
wish to participate in this research, I can notify the researcher and be withdrawn from 
it immediately.  
 
I consent to the processing of my personal information for the purposes of this research 
study as described in the information sheet. I understand that such information will be 
treated as strictly confidential and handled in accordance with the provisions of the 
Data Protection Act 1998.  
 
I consent to the depositing of my interview transcript (after I have approved it and after 
the study has finished) with ESRC Qualidata for potential secondary analysis by future 
researchers. 
 
Participant’s Statement:  
I ___________________________________________ agree that the research project 
named above has been explained to me to my satisfaction and I agree to take part in 
the study. I have read both the notes written above and the Information Sheet about 
the project, and understand what the research study involves.  
 
Signed:  
 
Date:  
Investigator’s Statement:  
I ___________________________________________ confirm that I have carefully 
explained the nature, demands and any foreseeable risks of the research to the 
participant 
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2.Consent for men with prostate cancer participants 
 
 
Database reference number:  _________________________ 
 
Series title:                           _________________________ 
 
 
CONSENT FORM 
 
Title of Project:  Healthtalkonline – personal experiences of health & illness 
 
Name of Researcher:  _____________________________________________ 
 
  Please initial 
box 
   
I confirm that I have read and understand the information sheet dated 
_____________  (version ______________) for the above study, have had the 
opportunity to ask questions and have had these answered satisfactorily. 
 
  
I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reasons, without my medical care or legal rights 
being affected. 
 
I understand that relevant data collected during the study may be looked at by 
individuals from the University of Oxford, for the purpose of audit and 
monitoring, and where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to the records of my 
participation in this research. 
 
 
I agree to take part in the above study. 
 
 
 
__________________________ 
Name of Participant  (block 
capitals) 
 
_____________________ 
Date 
 
__________________ 
Signature 
   
   
   
__________________________ 
Researcher 
____________________ 
Date 
__________________ 
Signature 
 
 
Version 10 November  2009   
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Appendix 8. Transcription and quote 
notation 
 
Transcription Notation Description 
Word Underlining: speaker’s emphasis or stress 
() Empty parentheses: unclear talk 
(words)  Text in parenthesis: the best possible hearing of talk 
((laughs)) Double parenthesis indicates participants non-verbal 
behaviour 
Quote Notation Description 
(...) 3 full stops in parentheses: small quantity of excluded talk 
(....) 4 full stops in parentheses: quantity of excluding talk 
exceeding one sentence 
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Appendix 9. Letters and information 
 
1. Letter accompanying transcript to prostate cancer 
advocate participants 
 
 
August 2011 
 
Dear  
 
The Changing Public Face of Prostate Cancer in the UK: Research Interview Transcript 
 
I would like to thank you again for agreeing to be interviewed earlier this year for my 
research.   Please find attached the transcription of your interview.  
 
I would like to invite you to view this transcription so that you have the opportunity to 
check, amend or veto anything you said in the interview which you would prefer not to 
be included in reports arising from the research.  Please do then take this opportunity 
to read through the transcription and correct anything you think I have transcribed 
wrongly; make changes to particular passages in order that they may be written in a 
way that preserves your anonymity; or highlight any passages that you would prefer 
not to be published.  Please try not to be alarmed by the verbatim nature of the 
transcription.  It is normal for false starts, repeated words and words like “ehm” and 
“er” to occur in normal conversation but we are not used to seeing these in print.   
 
If you do not make any changes to your transcription then you do not need to take any 
action.  If you do make changes or would like to veto any passage, then please return 
the transcription to me with the relevant changes made and vetoed passages 
highlighted.  I expect that the analysis and writing up of my research and therefore 
potential publications will occur from October 2011 and so I would be grateful if you 
would inform me of any changes or veto to your transcription by this time.   
 
Once again, thank you for your valuable contribution to my research. 
 
Yours truly 
 
 
Anne Montgomery 
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2. Sample access letter to specialist nurse 
gatekeepers to men with prostate cancer 
May 2010 
 
Dear  
 
My name is Anne Montgomery and I am a PhD student in the Centre for Health 
Sciences at Barts and the London School of Medicine and Dentistry. I am writing to 
invite the Urology Centre at Barts Hospital to be a Participant Identification Centre 
(PIC) in a research study called The Changing Public Face of Prostate Cancer.    
 
This research is funded by The Prostate Cancer Charity and is being carried out in 
collaboration with the Health Experiences Research Group at Oxford University.  The 
aim of this study is to provide men with prostate cancer, and those who care for them 
and campaign on their behalf, with up-to-date information about what the experience 
of prostate cancer is like. 
 
The study will include a maximum variation sample of approx 50 participants from 
Belfast and London.  Qualitative semi-structured audio or video taped interviews will 
be conducted with men who have experience of prostate cancer.  Using a narrative 
approach, an oral history of the men’s experience of prostate cancer will be collected 
with supplementary questions prompting reflection on areas of interest identified 
through literature review and ongoing analysis. 
 
Some of the interviews will also contribute to the www.healthtalkonline.org website, 
run by the Health Experiences Research Group, which can be used by people to find 
out what other people in the same situation have experienced. The website is also a 
valuable resource to let doctors and nurses know what patients experience.    
 
The study has been approved by the Berkshire Research Ethics Committee 
(09/H0505/66) under ‘Narratives of health and illness for www.healthtalkonline.org 
(formerly DIPEx) and www.youthtalkonline.org’.   This study requires that your centre 
acts only as a PIC; as such management permission for this study is not required 
although the R&D office should be notified.  You are invited to hand out information 
packs (sample enclosed) about the study and patients who are interested in 
participating in the study return a reply slip directly to me.  All subsequent contact, 
including the interview itself, is conducted away from the clinical setting.  I, as 
researcher, do not have access to any patient data at any point in the study.   
 
I would be grateful if you would let me know the best time to contact you in order for 
you to let me know if you wish to be involved in this study.   
 
If you have any queries about the research please telephone me on xxxx (email: 
a.t.montgomery@qmul.ac.uk) or Sue Ziebland, of the HTO research team, on xxxx.   
 
Yours sincerely 
Anne Montgomery  
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3. Sample introductory letter to men with prostate 
cancer participants 
 
 
May 2010 
 
Dear sir, 
 
My name is Anne Montgomery and I am a PhD student in the Centre for Health 
Sciences at Barts and the London School of Medicine and Dentistry. I am writing to 
invite you to take part in a research study called The Changing Public Face of Prostate 
Cancer.  You are being invited to take part because of your experience of prostate 
cancer.   
 
This research is funded by The Prostate Cancer Charity and is being carried out in 
collaboration with the Health Experiences Research Group at Oxford University.  The 
aim of this study is to provide other men with prostate cancer, and those who care for 
them and campaign on their behalf, with up-to-date information about what the 
experience of prostate cancer is like. 
 
Some of the interviews will also contribute to the www.healthtalkonline.org website, 
run by the Health Experiences Research Group, which can be used by people to find 
out what other people in the same situation have experienced. The website is also a 
valuable resource to let doctors and nurses know what patients experience.  You do 
not have to be video recorded; your interview could appear on the website simply as 
an audio or written version. 
 
I enclose a copy of an information sheet which describes this study. I would be very 
grateful if you would take the time to read this and consider whether you would like to 
take part in the study.  You are, of course, free to decide not to take part in this 
research and your decision would have no effect on your usual medical care. If you do 
decide to take part you would be free to withdraw at any time.   
 
If you have any queries about the research please telephone me on xxxx or Sue 
Ziebland, of the HTO research team, on xxxx.  When you have read the information 
sheet please complete the attached slip and send it to me in the enclosed reply paid 
envelope. Many thanks for your time in reading this.  
 
Yours sincerely 
 
 
 
Anne Montgomery 
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Appendix 10. MWPCa interviews in 2010 
available on 
www.healthtalk.org  
 
The collaboration with HERG at Oxford University responsible for www.healthtalk.org 
led to 12 of my 20 interviews with MWPCa in 2010 being made accessible online at 
www.healthtalk.org. Here, qualitative research into personal stories of health and 
illness enables the general public, patients, families, carers and healthcare 
professionals to benefit from the experiences of others.  Brief and fuller ‘more about 
me’ summaries of the experience of these MWPCa and between 1-6 video/audio clips 
and corresponding transcripts are accessible through the following web-pages: 
 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3061/Cat
egory/133 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3062/Cat
egory/134 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3063/Cat
egory/135 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3064/Cat
egory/132 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3065/Cat
egory/133 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3066/Cat
egory/136 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3067/Cat
egory/133 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3068/Cat
egory/134 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3069/Cat
egory/134 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3070/Cat
egory/132 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3071/Cat
egory/133 
http://www.healthtalkonline.org/Cancer/Prostate_Cancer/People/Interview/3072/Cat
egory/132 
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Appendix 11. Reply slip for men with 
prostate cancer participants 
 
 
Reply Slip for Module: Prostate Cancer 2010-2011 
 
 
Yes, I am happy for a researcher to contact me about this project. 
 
 
Name: …………………………………………………………………….................................................. 
(Block Capitals) 
Address:………………………………………………………………….......................................................... 
 
……………………………………………………………………………............................................................. 
 
………………………………………    Post Code: .……………………...................................................... 
 
Telephone number: Day: ……………………..................... Evening: …………………….............. 
 
Best time to contact me: …………………………………………………............................................... 
 
Age: …………………................................................................................................................. 
 
Date or year of diagnosis: ………………………………................................................................. 
 
Occupation:  ……………………………………………........................................................................ 
(if retired please state and give last occupation) 
 
Ethnic Background………………………………………..................................................................... 
(It is important for us to include perspectives from a range of ethnic groups in our 
research). 
 
Please return to: 
 
Anne Montgomery 
(Address given) 
 
Email: xxxx 
Tel: xxxx 
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Appendix 12. Recruitment through ‘Prostate 
Cancer Voices’ 
 
 
The following recruitment message was included in 3 issues of the ‘Prostate Cancer 
Voices’ bulletin between June-August 2011 (both email and print) and on the website 
http://prostatecanceruk.org/get-involved/volunteer/get-involved-now.   
 
 
External Opportunity: Participate in a research study ‘The Changing Public Face of 
Prostate Cancer’ 
 
 
PhD researcher Anne Montgomery is looking for men with experience of prostate 
cancer, and who live in the London1 area, to take part in a research study which is 
funded by The Prostate Cancer Charity.   The aim of the study is to provide other men 
with prostate cancer, and those who care for them and campaign on their behalf, with 
up-to-date information about what the experience of prostate cancer is like.  
 
Anne is located at the Centre for Primary Care and Public Health at Barts and The 
London School of Medicine and Dentistry at Whitechapel and is collaborating with the 
Health Experiences Research Group at Oxford University. Some of the interviews will 
contribute to the www.healthtalkonline.org website, run by the Health Experiences 
Research Group, which can be used by people to find out what other people in the 
same situation have experienced.  
 
How do I get involved? 
For more information about the research study and to request an information pack, 
please reply to this email or contact Anne directly, on xxxx or by emailing xxxx. 
 
If you have any questions about anything contained within this bulletin, please contact 
us by replying to this email or by calling Philippa on xxxx. 
 
  
                                                     
1 Later amended to also include Belfast 
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Appendix 13. Guiding script for gatekeepers 
 
The following is a short guiding script that I offered to the gatekeeping nurses at Barts 
and The London and Belfast City Hospitals which they could choose to ignore or use if 
helpful to them in distributing the PIPs to MWPCa.   
 
This envelope contains information about research funded by The Prostate 
Cancer Charity.  Its aim is to provide other men with prostate cancer and those 
who care for them and campaign on their behalf with up-to-date information 
about what the experience of prostate cancer is like.  Please take this away and 
read it and consider whether you would like to take part in the study.  You are 
free to decide not to take part and your decision will not affect your usual 
medical care.  If you do decide that you would like to take part in the research 
then use the reply slip inside to contact the researcher directly.  You can 
withdraw from the research at any time. 
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Appendix 14. Selected CKWIC concordance 
displays 
 
‘Raising money for PCa’ keywords 
 ‘GBP’ keyword concordance 1990-2000 
 
Partial ‘raise*’ keyword concordance 1990-2000 
 
N Concordance
1 GBP 350 million empire. He was lived for the company and built it into a 
2 GBP 3.5 million, paid out GBP 1 million year before he died.' His Trust, valued at 
3 GBP 400. It looks as though I've got worried because each scan costs 
4 GBP 47,000 last year, compared to spent on finding a cure is derisory - 
5 GBP 47,000 last year, compared with spent on finding a cure is derisory - 
6 -GBP 47,000 last year. That is why the spent on finding a cure is derisory 
7 GBP to the Daily Mail Prostate Cancer Manchester M60 3JD I am donating 
8 GBP raised by Mail readers the . HERE'S HOW TO DONATE For every 
9 GBP raised by Mail readers the . HERE'S HOW TO DONATE For every 
10 GBP 47,000. I hope the money will help charity received a cheque - for exactly 
11 GBP 1million fundraising campaign - in get there.' The Daily Mail launched its 
12 GBP 47,000 a year on research into out that the Government spent just 
13 GBP 15, and it is appalling that it is not insurance. The blood test costs only 
14 GBP 47,000 last year, compared to spent on finding a cure is derisory - only 
15 GBP 47,000 was spent researching it in 8,000 men in the UK a year but only 
16 GBP 47,000 a year goes on prostate of cancer prevention and cure. Yet only 
17 GBP 1 million a year ago to the , valued at GBP 3.5 million, paid out 
18 GBP 47,000 was spent last year - 10,000 die every year - yet a pitiful 
19 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
20 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
21 GBP 1 million to rectify this scandalous Mail has launched an appeal to raise 
22 GBP 1 million. Sidney Swan was Mail has launched an appeal to raise 
23 GBP 1 million. Here, 58-year-old Mail has launched an appeal to raise 
24 GBP 47,000 for prostate research and I vowed that, when I was better, I'd raise 
25 GBP 47,000. Through my job in UK. I had one mission: to raise 
26 GBP 18 million was spent on Aids, the disease. At the same time, 
27 GBP 18 million spent on Aids. The GBP 47,000 last year, compared to 
28 GBP 18million spent on Aids, which - GBP 47,000 last year, compared to 
29 GBP 500,000 another pound will be by generous Mail readers - up to 
30 GBP 500,000. The money raised will go Charitable Trust will match it up to 
31 GBP 500,000. The money raised will go Charitable Trust will match it up to 
32 GBP 500,000 - another pound will be by generous Mail readers - up to 
33 GBP 18 million spent on Aids, which - GBP 47,000 last year, compared with 
N Concordance
1 raise the profile of a condition many men are cut the number of deaths from the cancer and 
3 raise $6 million to build and equip Britain's first , which Richard Bentine is spearheading, is to 
4 raise even more for research. We all have to themselves checked. Next year I am going to 
11 raise money for the Prostate Research fit. I'd decided to do a half marathon in July to 
12 raise money for the Prostate Cancer Charity,  This message reinforces the Mail's campaign to 
13 raise money for the Prostate Research Campaignand Andrew are running the London Marathon to 
14 RAISE MUCH NEEDED MONEY AND THE MAIL'S CRUSADING CAMPAIGN TO 
15 raise public awareness as well as funds. THE forces with the Prostate Cancer Charity to 
16 raise these matters on behalf of other sufferers the opportunity - which I regard as a duty - to 
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 ‘Pounds/$*/£*’ keyword concordance 1990-2000 
 
 ‘GBP’ keyword concordance 2000-2010 
 
N Concordance
1 (Pounds 335m). The dream then turned to disasterboom of the 1980s. In 1987 he made $ 550m 
2 £12 test can save lives; good health WHEN the cancer.as his son ,I want all men to know a 
3 $1million a year is spent on research, compared funding is needed for research. 'At present about 
4 $400,000 to studying the prostate. Korda is $15 million to breast cancer research as against 
5 $15 million on Aids, but only $1 million on , for example, $40 million on heart disease and 
6 $40m on heart disease. 'We also need to start , compared to $16m on breast cancer and 
7 pounds 18.99 Prostate Research Campaign UK, published on February 6, 1997 by Little, Brown, 
8 $18.99. Prostate cancer: The facts and the future by Michael Korda is published by Little Brown 
9 $ 53m to more than 365 projects worldwide. go to his charity, which has already distributed 
10 $15 million to breast cancer research as against lamentably under-resourced: cancer charities give 
11 $40 million on heart disease and $15 million on $16 million a year on breast cancer, for example, 
12 $ 550m (Pounds 335m). The dream then turned takeover boom of the 1980s. In 1987 he made 
13 pounds 1 million is spent on finding a cure for this a year goes into breast cancer research, a mere 
14 pounds have already been donated after just a and cures of prostate cancer. Thousands of 
15 pounds have been donated by readers to help pay Charity - on November 2. Already thousands of 
16 pounds have already been donated after just a and cures of prostate cancer. Thousands of 
17 $12 and that they can insist on having it. If your , to know that there is a test which costs only 
18 $1 million on prostate cancer. 'I think it's been so heart disease and $15 million on Aids, but only 
19 pounds 5.95 for their book, Prostate Problems: HA6 1HP. Send large sae for free leaflets, or 
20 pounds 250 for his medical. The results showed from cancer." Chris's sons Matthew and Ben paid 
21 $6 million to build and equip Britain's first Richard Bentine is spearheading, is to raise 
22 $ 300,000 over the next three years to investigate Trust is giving the Institute of Cancer Research 
23 $16 million a year on breast cancer, for example, minimal,' Professor Cooper says. 'We spend 
24 $ 1 billion in fines and to settle lawsuits. Just six . He served just under two, and paid more than 
25 pounds 1,000 for prostate cancer research by got the all-clear." Matthew has raised more than 
26 $16m on breast cancer and $40m on heart a year is spent on research, compared to 
27 pounds 16 million a year goes into breast cancer for surgery as breast cancer sufferers. And while 
28 $ 700m - set up CaPCURE, the Association for Forbes magazine recently estimated to be worth 
N Concordance
1 GBP 1a-night room in a Thai guesthouse. Monkhouse's overdose. The 46-year- old was found on a bed in a 
2 GBP 200 - it's not available on the NHS - and came in to have a vacuum pump cylinder, which cost about 
3 GBP 8,000. Bob's royal return; After cancer fight, the a four-night hospital stay, it will cost approximately 
4 GBP 75 million, it helped to ensure the best medical expert on the illness. With the couple worth around 
5 GBP 1million for research. I'm back on line; Sir David raised awareness of the disease and readers donated 
6 GBP 46 million. The straight-talking Londoner, who fell in 1988 and forming SelecTV, which he sold in 1996 for 
7 GBP 7.99 (includes P&P) to Stoll Publishing, 5 Ganton Prostate In The Sun by Ken Robson, send a cheque for 
8 GBP 5,500. Privately, including a four-night hospital down to zero. RADICAL prostatectomy costs the NHS 
9 GBP 170,000 cover. While Permanent Insurance paid bladder cancer. He had two policies, providing a total of 
10 GBP 47,000 was spent on researching it in 1999. And, 10,000 men die of it annually in Britain as a whole, only 
11 GBP 1million in just four months to help fund research . A campaign by Daily Mail readers last year raised 
12 GBP 10,000 benefit, or 20 per cent of the sum assured,cover remains for any future claims. With Skandia, the 
13 GBP 10,000 to policyholders diagnosed with to be launched this week. The insurer will pay out up to 
14 GBP 10,000 benefit to sufferers of a noninvasive breast non-invasive cancer as standard. It is also offering up to 
15 GBP 25,000, or 25 per cent of the policyholder's cover . Its Elixia plan launched in April last year pays up to 
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 ‘Pounds/$*/£*’keyword concordance 2000-2010 
 
 
 
N Concordance
1 £x; 2. A 30-year-old woman with breast cancer. baby with a hole in the heart. Cost to cure, 
2 £x; 3. A 70-year-old man with prostate cancer. woman with breast cancer. Cost to cure, 
3 £x; but you only have £2x to hand out. Whom do man with prostate cancer. Cost to cure, 
4 Pounds 16 DIY test could be an accurate by the Pounds 16 DIY test for prostate cancer A 
5 Pounds 1million da Vinci robot. Despite the Grace Hospital, London, which has just bought a 
6 Pounds 12,000. CANCER TURNED ME INTO A Pounds 5,000. Privately it costs about 
7 pounds 6 and are available by calling 029 2030 Thursday to Saturday. Tickets cost pounds 4 and 
8 Pounds 1,300 more than radical surgery but they , they figure brachytherapy costs approximately 
9 Pounds 5,000. Privately it costs about Pounds 12,prostatectomy costs the NHS approximately 
10 Pounds 3,000 to have done privately. The a permanent cure. * THE operation costs around 
11 pounds 4 and pounds 6 and are available by in Cardiff from Thursday to Saturday. Tickets cost 
12 pounds 12,000 - Mr Powell could have to undergo to pay for brachytherapy privately - it costs 
13 pounds 4.2bn - and that has direct financial medicine industry is now worth an estimated 
14 pounds 1million towards combating the disease. cervical cancer. Last year, the Government gave 
15 pounds 200,000. Even now, as Carman noted, ,000. Last year, it was a barely more impressive 
16 Pounds 115,000, where I played with George signed for Manchester United for a transfer fee of 
17 Pounds 15,000 at the Princess Grace Hospital, but the operation is available privately at a cost of 
18 pounds 1m a year QCs, although his earnings of his generation, he regularly featured in lists of 
19 pounds 300 for a month's supply. It is the stories scientific studies that drive these men to shell out 
20 Pounds 9 million goes in to finding a cure for a year on breast cancer research, yet just over 
21 Pounds 200,000 for the Prostate Cancer Charity, our efforts, we're almost on target to raise 
22 pounds 1m with its "Dying of Embarrassment" ,000. Then last September the Daily Mail raised 
23 Pounds 72million a year on breast cancer female breast cancer. The Government spends 
24 Pounds 14.99 plus p&p from www.homechec. co.I might never have known.' Prostate Disorder Test 
25 pounds 100,000. Then last September the Daily of its Christmas charity and raised more than 
26 Pounds 1million a year. He now plans to use his defender" in addition to earnings of more than 
27 Pounds 1million for research. Last month, ago to highlight the disease and raised more than 
28 Pounds 1,300 difference because it might with 60 to 70 per cent. You cannot pay the 
29 Pounds 16 DIY test for prostate cancer A Pounds or visit www.icr.ac.uk/everyman. Saved by the 
30 pounds 18million spent on Aids which claims 400 . But the contribution is tiny compared to the 
31 pounds 4.2m by 2004. He also promised that by prostate cancer, bringing government funding to 
32 pounds 4.2m by 2004. He said: "Prostate cancer prostate cancer, bringing government funding to 
33 pounds 47,000. Last year, it was a barely more spending on research into the disease totalled 
34 pounds 15 million, learned he had cancer after of his two sons and bitter family rifts.Bob, worth 
35 £800,000, slightly less than the other significant Campaign UK, which last year raised about 
36 £8,000 for surgery to rid him of prostate cancer is paid for life-saving op A man who had to pay 
37 £70,000 worth of shares in the company. He accounts, he decided to prove his point by buying 
38 £7 -- to measure levels of prostate specific is a simple blood test -- it costs the NHS around 
39 £7 TEST THAT COULD HAVE SAVED MY played no part in considerations.' THE 
40 £500,000 in taxes and NHS contributions. I by the NHS," he said. "I must have paid over 
41 £4m, which is still a drop in the ocean. Every , that's enough for a tiny project. Now it's about 
42 '£47,000. That's crap, that's enough for a tiny for prostate cancer research.' He says it again: 
43 £47,000. 'Why that amount? Because that was ago after a radical prostatectomy and raised 
44 £3.2million centre funded by the Institute's cancer research centre in Sutton, Surrey. The 
45 £2x to hand out. Whom do you throw overboard? cancer. Cost to cure, £x; but you only have 
46 £2,000 each. Not that Max shares his skills with Blanc's Le Manoir aux Quat' Saisons, at 
47 £1million to buy an MRI scanner for the New Five Star Scanner Appeal, which aims to raise 
48 $100m (£ 50m) study into the safety and prelude to his biggest success yet. However, the 
49 £100 an hour to consider how long they believed specialist Karol Sikora and two others received 
50 £ 550 a month, dropping to £ 200 for the side effects in about 70% of cases. It costs about 
51 (£ 50m) study into the safety and effectiveness of to his biggest success yet. However, the $100m 
52 £ 3,500. But Elliott still doesn't know what will than the surgical alternative, which costs 
53 £ 200 for the maintenance dose. Unable to afford cases. It costs about £ 550 a month, dropping to 
54 £ 2,000 more than the radical prostatectomy, and treatment. Given that brachytherapy costs just 
55 £ 11,000 and went private he could have the will change our lives.' Bill knows that if he paid 
56 £ 1,500 more expensive than the surgical seeds into the prostate gland to kill the cancer, is 
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‘Treatment’ (procedures, side-effects, policy & 
insurance) keywords 
‘Risks’ 1990-2000 
‘PCT’ concordance 2000-2010 
 
 
 ‘Policy’ concordance 2000-2010 
 
N Concordance
1 PCT for the past seven years, and we've always been huge with it. 'I'm so angry about it,' she said. 'I've worked for a 
2 PCT has a policy for the fair and effective use of NHS test. Kevin Snee, chief executive of the trust, said: "Bolton 
3 PCT would need to approve the funding because for a man in my physical state. There's just one problem; my 
4 PCT became aware that The Observer was looking into Bill's of this decision having been taken. Last week, when the 
5 PCT has refused to explain its decision for the rationing. , to say the least.' What angers Bill so much is that the 
6 PCT. It had agreed my funding. I asked about the other local as I walked through a sultry city my mobile rang. It was the 
7 PCT, the answers that Bill has received are even more come to terms with their diagnosis.' After many calls to the 
8 PCT denied to The Observer that it had a blanket ban on they have other cost pressures. The Guildford and Waverley 
9 PCT had rejected my brachytherapy funding. He reiterated Professor Langley informing me that Guildford & Waverley 
10 PCT says no, then I can appeal and, usually, appeals get . But, reassures the professor, even if Guildford & Waverley 
11 PCT which initially said it would not pay for a course of spent two months battling with the Guildford and Waverley 
N Concordance
1 policy five years ago, and within a year was diagnosed with lives with his girlfriend Maxine Dilloway-Thompson, took out a 
2 policy for the fair and effective use of NHS resources, which Snee, chief executive of the trust, said: "Bolton PCT has a 
3 policy of not funding the treatment. Given that brachytherapy told that they were not clinical, that the trust simply had a 
4 policy and be aware that in some cases complex medical cancer. But buyers are advised to check the terms of any 
5 policy definitions to cut the cover for prostate cancer that is of policies. Over the past year, insurers have changed 
6 policy on brachytherapy, I meet all the clinical criteria for this of string. 'But, according to Health Commission Wales' draft 
7 policy. Sir David will continue his hectic schedule until his Parliament to inflict a defeat on the government on its fishing 
8 policy, it is widely expected that General Powell will not  Seen as an internal critic of much of President Bush's foreign 
9 policy to be launched this week. The insurer will pay out up to cancer that are not lifethreatening under a new critical illness 
10 policy had a clause covering any legal charges attached to a suing the hospital. I discovered that my household insurance 
11 policy. He was diagnosed with potentially fatal prostate cancer.grateful that he decided to take out a critical illness insurance 
12 policy rang to make plans for a routine medical and they found was very lucky,' he said. 'A friend who does my life insurance 
13 'Policy gave me a new life after a death sentence' Cancer The Great, written for the History Channel by his son Peter. 
14 policy for prostate cancer, in the way women are screened for is to fight Government failure to introduce a national screening 
15 policy payout, David has bought an impressive 36ft Dutch-built Sussex, did not even miss a day's work. With the substantial 
16 policy u-turn, Mr Powell was told that his only chance of for 56 prostate cancer patients from Wales. Despite the 
17 policy does not normally allow for the funding of treatments , which aims to ensure equity for all Bolton residents. This 
18 policy has spared many men from unnecessary and eye both on the size of the prostate and the PSA levels. This 
19 policy costs are already escalating. But David's insurer, to prevent further hefty premium rises in a sector where 
N Concordance
1 risks. That required a reporter's notebook. Even then, , but I had no means of measuring the countervailing 
2 risks of incontinence and impotence, when their infection. Others might undergo surgery, with its high 
3 risks. Lowering fat can enhance the immune system meat and dairy produce, seem to enjoy the lowest 
4 risks of incontinence and impotence. And invasive than radical prostatectomy but there are still 
5 risks, even on the Internet. He's asked me to provide . My GP found it extremely difficult to track down the 
6 risks of not having one in my case. For people with risks of having the operation seemed to outweigh the 
7 risks of side-effects are high. The Americans say means that 70 pc of patients will die of it. And the 
8 risks of becoming incontinent or impotent, I returned - did conclude I needed an operation. Daunted by the 
9 risks of having the operation seemed to outweigh the four glasses of wine) to go to the loo. Second, the 
10 risks of not having an operation: the possibility of tests. I learned from my GP and consultant of the 
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Appendix 15. Selected media illness 
narratives 
 
Daily Mail, 10/11/1999 
Context for Extract 4.1, Extract 4.2 and Extract 4.17 
Extract 4.1 
 
I am one victim, but I've raised more cash on my own for prostate cancer than the 
Government did all of last year 
 
PROSTATE cancer has become the disease no one wants to talk about.  Every hour a 
British man dies from it, yet the amount spent on finding a cure is derisory - GBP 
47,000 last year, compared with GBP 18 million spent on Aids, which kills 400 a year. 
That is why the Daily Mail has launched an appeal to raise GBP 1 million. Here, 58-year-
old businessman Ted Clucas, from Jersey, tells VICTORIA FLETCHER of his struggle to 
end the secrecy surrounding prostate cancer after he was told he needed surgery 
within hours of being diagnosed.  
 
[Narrative segment not included in analysis] 
DISBELIEF - that was all I felt when I was told I had cancer.  Total disbelief.  I had been 
visiting my GP for two years saying I was in pain. Each time he sent me away with 
antibiotics and told me it was just an infection.  But it got worse and worse, until I had 
to get a second opinion.  In September last year I went to to see a specialist in London. 
After some preliminary tests, I was told it could be prostate cancer and would need a 
biopsy the next day.  I remember stumbling outside into the pouring rain and just 
walking the streets. I had no idea what to do, who to talk to. I knew nothing about the 
illness.  All I'd heard were horror stories about what the operation does to your body 
and your lifestyle.  What would I do if it was cancer?  I called my wife Jill, and said it 
looked serious. She was shattered.  She didn't cry or ask why it had to happen to me - 
she was the strong shoulder I needed.  She's a tough cookie, and although I felt 
confused and numb, her calm attitude helped me focus on the tests I would face over 
the next few days.  I wandered back to my hotel room and just sat quietly, thinking.  
The biopsy would not be pleasant, and I worried about what it might reveal. Surely 
prostate cancer couldn't happen to me?  The next day, Jill arrived and called my son 
John, 29, who lives in London. I needed him more than ever, to cart me from test to 
test and sit with me while I waited for diagnosis. Eventually the results came and, even 
though I thought I'd prepared myself for the worst, when I was told I had prostate 
cancer, it came as a shock.  I never thought it could be so serious, especially after the 
attitude of my GP. In fact, the specialist said it was so bad, I'd need to say within two 
hours whether I wanted surgery.  Both in shock and exhausted, the only thing my wife 
and I could think to do was visit an old friend, Mike, who lived in London and had 
prostate cancer.  HE'D BEEN diagnosed too late, and seeing him drove it home to me 
that if I didn't act, I could end up like him. Mike told me to jump at the chance that 
he'd never had - to wait would be too risky.  Sadly, he died at Christmas, aged just 55.   
 
[Extract 4.2] 
The next few days were a whirlwind, but in that time I decided to learn all I could 
about the disease. All I kept thinking was: Why had my GP not known all of this? How 
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had he missed the telling signs? And why was there so little information available to 
men, if so many suffer from prostate cancer?  My shock soon turned to anger when I 
found out that the Government spent just GBP 47,000 a year on research into prostate 
cancer. No wonder I'd never heard about it; no wonder my GP wasn't knowledgeable 
about it.  No one was taking it seriously, and at that moment I vowed that, when I was 
better, I'd raise GBP 47,000 for prostate research and education, to prove to the 
Government that just one man was capable of equalling their pitiful donation.  After 
the operation, my recovery was quite quick - I knew I had to beat the disease. I had 
radiotherapy until February and then started to get fit.   I'd decided to do a half 
marathon in July to raise money for the Prostate Research Campaign UK. I had one 
mission: to raise GBP 47,000.  Through my job in international financial services, I know 
some wealthy clients, and with a bit of persuasion I knew I could reach my goal. I 
finished the race, and last week the charity received a cheque - for exactly GBP 47,000.       
I hope the money will help research into the disease.  But more than that, I hope that it 
will be used to educate GPs and encourage the public to get themselves checked.       
Next year I am going to raise even more for research. We all have to beat this disease. 
 
[Extract 4.3] 
HOW TO SPOT THE DANGER SIGNS 
* WHAT is the prostate? A doughnut-shaped gland the size of a walnut that surrounds 
the upper part of the urethra - the tube that carries urine from the bladder to the 
penis. When cells in the gland grow, a tumour develops.  Cancer cells then spread to 
other parts of the body.  * WHEN does it occur? With age, it is normal for the prostate 
to enlarge.  This condition is Benign Prostatic Hyperplasia (BPH) and can occur in men 
as young as 30.  BPH can be easily treated.  * WHAT is prostate cancer? There are two 
types - an aggressive form and a slower one. Pathologists determine the type by 
studying the cells.  * WHAT are the symptoms? You need to urinate frequently.      The 
urine stream is poor. You have lower back pain. There is blood in your urine.  * HOW is 
it diagnosed? There are four types of test. Digital Rectal Examination: A doctor feels 
the prostate and identifies an enlargement.  Prostate Specific Antigen (PSA) test: A 
blood test that measures levels of a protein called PSA. Transrectal ultrasound: A 
probe is placed in the rectum and pictures are taken of the prostate. Biopsy: A sample 
of prostate tissue can be analysed to see how aggressive the cancer is.  * WILL you get 
it? The odds escalate with age: 70 pc of men in their 70s will have it, rising to 80 pc in 
their 80s.  * WHAT are survival rates? Within five years of being diagnosed, the survival 
rate in Britain is less than 50 pc. 
 
The Observer, 09/07/2006 
Context for Extract 4.7 
[Narrative segment not included in analysis] 
Special Report: Both have cancer. But why can't one get the best care?  Observer 
sports writer Bill Elliott was diagnosed with prostate cancer in April. Within an hour, 
his wife Val was told she had breast cancer. Now they have had to come to terms with 
the stark fact that her treatment has 10 times as much funding as his. Health Editor Jo 
Revill examines the human cost of NHS inequalities.  Receiving a diagnosis of cancer is 
difficult for any man to come to terms with; when the news comes on the very day 
that your wife discovers she has breast cancer, it is a doubly hard blow.  Bill and Val 
Elliott received their respective diagnoses within an hour of each other on Thursday, 
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27 April. Both had undergone initial biopsies but didn't know quite what to expect. 
Their grown-up sons, Simon and James, had insisted on accompanying them to the 
clinics in Surrey that day.  'I was seen first in Frimley at around 12.10pm, and then Val 
went over to the breast clinic in Guildford where she was given the news 55 minutes 
later. We met up at an Italian restaurant and consumed several bottles of red wine,' 
recalled Bill. 'It was pretty hard for the boys and for us, well, it was simply mind-
numbing.'  Walking along a deserted beach in Norfolk last week, the couple spoke of 
the remarkable twist their lives had taken. They came for a short holiday to stay at a 
friend's cottage before Val begins her radiotherapy treatment, when in fact they were 
due to be spending this summer taking it easy as Val retired last month after years of 
demanding work as a child protection expert.   But when it comes to adjusting to their 
diagnoses, the hardest part of all has been hitting the biggest brick wall within the 
National Health Service - the stark fact that different cancers are given very different 
funding priorities.  The truth is that some cancers are more equal than others, and 
campaigners know that a more vociferous and passionate group is likely to have more 
success at persuading governments, and the NHS, to fund their treatment than one 
that is less vocal.  Breast cancer currently enjoys 10 times more funding than prostate 
cancer. It has benefited from very glamorous campaigns, such as Ralph Lauren's 
initiative, Fashion Targets Breast Cancer, supported by models such as Kate Moss, 
Naomi Campbell and Giselle. Pictures of men in underpants highlighting prostate 
cancer do not have quite the same appeal as sexy women in white T-shirts.  Val, who 
turned 60 last month, was diagnosed after noticing a small dimple to the side of her 
left breast. She has already undergone a lumpectomy to remove the small tumour 
inside, and she has had to have some lymph glands removed to protect her from the 
risk of it spreading.  Her oncologist has put her on Arimidex, an expensive but highly 
successful drug given after surgery, which will give her the best possible chances of 
survival as it lowers the amount of the oestrogen hormone in the body. This week she 
will begin a course of radiotherapy to kill any surviving malignant cells.   
 
[Extract 4.7] 
For her husband, the story is different. Still working as The Observer's golfing 
correspondent, he has been turned down on cost grounds for the treatment which his 
consultant, Professor Stephen Langley, recommended for him - a relatively modern 
procedure known as brachytherapy. This involves planting around 100 radioactive 
seeds, about the size of rice grains, within the prostate gland in order to kill off the 
cancer through radiation.  The alternative is to have a radical prostatectomy, the 
surgical removal of the prostate which has a higher risk of two major side effects - 
impotence and incontinence.  'I had been having [prostate] tests for the last three 
years, just to make sure there was no risk,' Bill said. 'I'd been having the usual warning 
signs, such as getting up a lot in the night to have a pee. Although my PSA [prostate-
specific antigen] count was relatively low, I had a biopsy which showed that there were 
malignant cells, and Professor Langley said he felt brachytherapy would be right for 
me.  'I had assumed everything would be fine, until the professor received a letter 
from the Primary Care Trust, saying they had turned down the request for the 
procedure. Given that Guildford is the major centre of excellence for cancer, and that 
Langley himself is an expert in brachytherapy it was surprising, to say the least.'      
What angers Bill so much is that the PCT has refused to explain its decision for the 
rationing. 'They didn't even have the courtesy to write to me about why I couldn't have 
brachytherapy. They told me later that they never deal directly with patients. Why 
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not? Is that because they want to remain unaccountable?'  The Prostate Cancer Charity 
is worried that covert rationing of treatment is starting to spread. Although it was 
originally Wales alone which refused to give brachytherapy, it is now hearing of cases 
in Nottingham and Bath. The charity's chief executive, John Neate, said: 'It is a disgrace 
and completely unacceptable that any man with prostate cancer for whom 
brachytherapy treatment is recommended, should be denied access to it.   
 
[Narrative segment not included in analysis] 
'It is not an untested, experimental treatment - it's now recognised by a large body of 
research and can help men whose cancer has not spread. What it means is that 
patients can have a few short visits to the hospital, and post-treatment recovery time 
is minimised to a few days.  'And frankly, no one should have to battle with the 
bureaucracy and financial aspects of their treatment when they need all their energy 
to come to terms with their diagnosis.'  After many calls to the PCT, the answers that 
Bill has received are even more surprising. He asked one official what the clinical 
reasons were for turning him down for treatment and was told that they were not 
clinical, that the trust simply had a policy of not funding the treatment.   Given that 
brachytherapy costs just £2,000 more than the radical prostatectomy, and carries 
fewer side effects, he found this irrational. His home in Rowledge, near Farnham, is 
just 10 miles from the Guildford cancer centre. None of the doctors to whom the 
Elliotts have spoken, including their own GP, was aware of this decision having been 
taken.  Last week, when the PCT became aware that The Observer was looking into 
Bill's experience, the trust told Bill that it would start to look at the treatment on a 
'case-by-case basis'. Bill had a conversation with Nicola Chandler, the PCT's associate 
director of recovery and reform, who told him that part of the problem was that 
doctors kept 'raising patients' expectations' by suggesting treatments that were not 
necessarily available.  Bill's case will come up for consideration before a specially-
convened panel within the next fortnight. There is no cancer specialist among this 
group. Instead, a GP and public health doctor provide the clinical input.   Bill asked 
Chandler if he could attend the meeting so that he could explain the situation from the 
patient's perspective, but was told that this would be impossible as it would be a 
'virtual meeting'. He still doesn't know what that means.  As for Val, she has to stand 
by and watch her husband live with all the uncertainty and fear that his dilemma 
brings with it.  'I'm so angry about it,' she said. 'I've worked for a PCT for the past seven 
years, and we've always been huge supporters of the NHS. I'll defend it to the death, 
because it is a system that works, and I've always felt that it doesn't discriminate 
between the haves and the have-nots, but suddenly you find yourself dealing with a 
lottery. You also find yourself trying to get some sense out of administrators who are 
unaccountable and who will make decisions that will change our lives.'  Bill knows that 
if he paid £ 11,000 and went private he could have the brachytherapy tomorrow. 'It's a 
two-tier service we have now,' he remarked. 'In an area like Guildford, there are 
probably quite a few middle-class guys who would have savings and simply pay up.  
'But what about all the other men I sit next to when I go to the clinic? Are they even 
told that their treatment has been denied to them? It seems to me that men don't kick 
up a fuss about healthcare because they are scared of talking about illness. But it 
shouldn't be up to us to kick up a fuss, should it? This is a treatment which the 
government's own experts have said should be available. Why, then, am I having to 
fight tooth and nail for it?'  Brachytherapy is a treatment first developed 20 years ago, 
but which has been slow to come to the NHS. Radioactive seeds of iodine-125 are 
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inserted within the prostate gland, where they slowly release their radiation over a 
period of three months.  By delivering localised radiation, doctors avoid damaging 
nearby organs such as the rectum or the bladder, and thus reduce the potential side 
effects such as incontinence which can come with surgery.  The treatment is most 
suitable for men whose tumours are not large, and where the cancer is thought 
unlikely to have spread. For those whose disease may have spread, the alternatives 
after surgery may be external beam radiotherapy and a higher dose of brachytherapy.  
The National Institute for Health and Clinical Excellence gave brachytherapy its 
approval in 2005. The funding for it, however, is up to individual PCTs which 
commission care from hospitals. Many of them are facing large deficits, and are under 
pressure to curb hospital spending as they have other cost pressures.  The Guildford 
and Waverley PCT denied to The Observer that it had a blanket ban on funding 
brachytherapy, and said that it had always looked at it on a case-by-case basis.  
'Certainly we will investigate why this gentleman's treatment was turned down,' said a 
spokeswoman. She declined, however, to talk about his case in detail, saying that this 
would constitute a breach of patient confidentiality.  As Bill and Val walk out over the 
sands near Cromer, their closeness is obvious. They retain a strong sense of humour, 
managing to laugh about the unique nature of their situation.  'We will come through 
this together, although the timing of it all is a bit bizarre,' said Bill. 'Our lives have been 
changed forever.' 
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Appendix 16. Conference presentations 
September 2013: Disclosing prostate cancer: juxtaposing the ‘good’, the ‘bad’, and the 
‘unsaid’. MEDSOC, University of York, UK. Oral presentation 
 
October 2012:  Prostate cancer interfaces: the changing media face of prostate cancer 
in the UK 1990-2010. Interdisciplinary Linguistics Conference (ILINC) Queen’s 
University, Belfast.  Poster presentation.  
 
September 2012: Prostate cancer interfaces: resonance and dissonance in the strategic 
and dialogic framing of prostate cancer in the UK. MEDSOC, University of Leicester, UK. 
Oral presentation. 
 
June 2012: The Changing Public Face of Prostate Cancer in the UK. Inter-Varietal 
Applied Corpus Studies (IVACS), University of Leeds, UK. Oral presentation. 
 
April 2012: The Changing Public Face of Prostate Cancer in the UK. British Sociological 
Association (BSA), University of Leeds, UK.  Roundtable discussion. 
 
April 2012: Prostate cancer interfaces: resonance and dissonance in the strategic and 
dialogic framing of prostate cancer in the UK. Blizard Institute Graduate Day, Queen 
Mary University of London, UK.  Oral presentation. 
 
July 2011: The changing public face of prostate cancer.  Health and media symposium.  
Bath Spa University, UK. Oral presentation 
 
June 2010: The changing public face of prostate cancer. Institute of Health Science 
Education.  Queen Mary University of London, UK. Poster presentation 
 
April 2010: The changing public face of prostate cancer. Institute of Health Science 
Education, Queen Mary University of London.  Oral presentation 
 
January 2010: Andrew and Adrian: A Tale of Two Men. Junk the Jargon competition.  
Queen Mary University of London, UK. Oral presentation 
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